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SUMMARY
Ribonucleotide reductase (EC 1.17.4.1.) catalyses the 
direct reduction of all four ribonucleotides to the 
corresponding deoxyribonucleotides, this reaction being the 
first unique step in the de novo pathway of DNA biosynthesis. 
The herpes simplex virus type 1 (HSV-1)-induced enzyme is 
composed of two non-identical subunits, termed large (RRl) 
and small (RR2 ) , which are dimers of the Vmwl36 (RRl) and 
Vmw38 (RR2) polypeptides respectively. These polypeptides 
are specified by two early, unspliced and 3' co-terminal 
mRNAs with sizes of 5.0kb (RRl mRNA) and 1.2kb (RR2 mRNA).
The work presented in this thesis has been primarily directed 
at obtaining the predicted amino acid sequence of the HSV-1 
RRl polypeptide. The HSV-1 RRl and RR2 amino acid sequences 
were analysed for conserved structural and functional 
features by comparisons to equivalent polypeptides of 
herpesviral and cellular origin. Other studies have 
identified the nucleotide changes in a portion of the RRl 
gene of the HSV-1 temperature-sensitive (ts) mutant ts!207 
and have examined the transcriptional regulation of RRl and 
RR2 mRNA expression.
The Nucleotide and Predicted Amino Acid Sequence 
of the HSV-1 RRl Polypeptide.
The nucleotide sequence of the HSV-1 DNA region 
encoding the RRl polypeptide was obtained with the M13 
dideoxy/chain termination method in combination with a 
'shotgun' cloning approach. The sequencing data predicted 
that the RRl DNA coding region is an open reading frame (ORF) 
of 3414 nucleotides which encodes a polypeptide of 1137 amino 
acids in length. In contrast to the remainder of the RRl 
polypeptide, the N-terminal region contains unique amino acid 
composition features and seven sets of tandemly repeated 
amino acid sequences. A hypothetical scheme of evolutionary 
events leading to the formation of this region has been 
postulated. Further, as this region appears not be directly 
involved in enzymatic activity, a possible function has been
suggested on the basis of two potential nuclear localisation 
signals.
Amino Acid Conservation between Herpesvirus 
and Cellular Ribonucleotide Reductases.
Analysis of amino acid conservation between the HSV-1 
RRl and RR2 polypeptides with identified or proposed large 
(RR ) and small (RRC ) subunit polypeptides of herpesviral or
La O
cellular origin was performed using computer programs.
a ) Comparisons of the HSV-1 RRl polypeptide with 
homologue RR^ polypeptides. Comparison of the HSV-1 RRl 
polypeptide with the equivalent herpes simplex virus type 2 
(HSV-2) polypeptide revealed that they are essentially 
colinear with the exception of the N-terminal regions where 
number of insertions or deletions were predicted. Other 
analyses revealed that the RRl N-terminal region was absent 
from other RR^ polypeptides while the colinear parts 
exhibited clustered homology.
b) Comparisons of the HSV-1 RR2 polypeptide with 
homologue herpesviral RR^ polypeptides. Comparisons of the
u
HSV-1 RR2 polypeptide with homologue herpesviral RRg
polypeptides revealed the existence of clustered homology.
The Escherichia coli (E. coli) tyrosine residue, on which the
(essential for function) stable free radical has been
localised, is conserved in all the RRg polypeptides examined
These comparisons strongly indicate that the
herpesviral RR and RRC polypeptides examined are the 
Li D
constituents of the ribonucleotide reductase activities 
specified by these viruses.
Conserved Structural and Potential Functional 
Features of the Herpesviral and Cellular 
Ribonucleotide Reductases.
To identify more precisely regions of clustered 
homology and to determine potential functional features of 
the RR^ and RRg polypeptide sequences, these were aligned 
with the consensus template alignment program and secondary 
structure predictions were obtained.
a) The RR^ alignment. The consensus secondary
structure predictions identified four RR Regions. Region 1
Li
is present only in the HSV-1 and HSV-2 RRl polypeptides and
the majority of sequences within this region are represented
by the RRl N-terminal region. The remaining regions are
present in all the polypeptides and contain sixteen blocks of
clustered homology. A block in Region 4, with a sequence of
GxGxxG (where G=glycine, x=any amino acid) has a predicted
secondary structure of |3-strand/turn/c<-helix. As this
structure approximates to the structure of nucleotide binding
sites, it is likely to represent the RR nucleotide binding
Li
site. One of the blocks in Region 3 and an adjacent leucine
residue are proposed, on the basis of homology to the primary
and secondary structures of the adenylate kinase enzyme, to
nucleotide
participate in the formation of the RR Abinding site. Only
Li
two homologous blocks are retained in a human cytomegalovirus 
(HCMV) ORF which would correspond by genome location to HSV-1 
RRl; the first of these contains a sequence similar to the 
proposed RR binding site.
Li
b) The RRg alignment. This alignment demonstrated that 
the E. coli tyrosine residue is conserved in all the RR0O
polypeptides with the exception of a second HCMV ORF, which 
corresponds by genome location to HSV-1 RR2. Six blocks of 
clustered amino acid homology and a number of conserved 
histidine, aspartic acid and glutamic acid residues where 
identified; the latter could represent ligands of the 
enzyme's non-heme iron atoms which stabilise the free 
radical. None of the homologous blocks within KRg, except 
for three amino acids of a carboxy-terminal block, are 
present in the HCMV ORF which would correspond by genome 
location to HSV-1 RR2.
The Nucleotide Changes within an HSV-1 Mutant ts!207 DNA 
Fragment Encoding Part of the RRl Polypeptide.
The HSV-1 mutant t_sl207 fails to specify any detectable 
ribonucleotide reductase activity at the non-permissive 
temperature because the RRl and RR2 subunits fail to 
associate. Marker rescue experiments demonstrated that the 
ts!207 lesion lies within a DNA fragment encoding part of the
RRl polypeptide. Sequencing studies within this fragment 
identified two nucleotide changes from which the second 
results in a change of a serine residue in the wild-type RRl 
to an asparagine residue in the mutant RRl. The region where 
the second mutation lies appears not to be directly involved 
in subunit association.
The Transcriptional Regulation of the HSV-2 
RRl and RR2 Gene Expression.
The HSV-2 ribonucleotide reductase activity is 
specified by two transcripts, termed RRl and RR2 mRNA, which 
are similarly arranged with their HSV-1 counterparts. To 
study the transcriptional regulation of the RRl and RR2 mRNAs 
a vector was constructed containing the HSV-2 DNA sequences 
specifying these mRNAs. Transient expression assays 
demonstrated that the constitutive RRl mRNA levels were 
readily detectable, whereas, after induction by HSV-1 
infection or trans-activation with HSV-1 immediate early (IE) 
polypeptides moderate increases were observed. Analysis of 
the RRl gene promoter (PI) sequences identified a number of 
potential cis-acting transcription elements one of which is 
identical to the binding site of the 'octamer motif binding 
factor'. It is proposed that, in the absence of HSV 
trans-activating functions, the constitutive RRl mRNA levels 
are due to the interaction of cellular transcription factors 
with the PI sequences. The basal RR2 mRNA levels were barely 
detectable, but in the presence of HSV-1 trans-activating 
functions a significant increase was observed. These results 
in conjunction with other data allow the proposal of a scheme 
for the transcriptional regulation of the HSV ribonucleotide 
reductase gene expression.
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INTRODUCTION
1This thesis reports the study of the enzyme 
ribonucleotide reductase specified by herpes simplex virus 
(HSV), the objective being to elucidate its structure and 
transcriptional regulation. The aim of this Introduction 
is to provide a brief background to the biology of herpes 
simplex virus type 1 (HSV-1), the virus upon which most of 
this study was carried out. Particular reference will be 
made to (i) the HSV-1 transcriptional program, (ii) the 
enzyme functions specified by HSV-1, (iii) the structure and 
function of the ribonucleotide reductases from prokaryotic, 
eukaryotic and viral origin, with the aim of putting into 
context (iv) a detailed account of the HSV-l-specified 
ribonucleotide reductase.
SECTION A .
THE HERPESVIRUSES.
1. Classification of Herpesviruses.
The family of Herpetoviridae comprises at least 80 
different members. Of these, six have been isolated from 
humans and the remainder from a wide variety of eukaryotic 
hosts (Roizman and Batterson, 1985). Membership of this 
family is based on four morphological features of the 
vi rion:
i) The core, which contains the double-stranded viral 
DNA in the form of a ring-like structure. Passing through 
the centre of this structure is a proteinaceous, fibrillar 
spindle, thought to be embedded in the wall of the capsid 
(Furlong et al ., 1972; Nazerian, 1974).
ii) The capsid, which surrounds the core, is 
icosahedral in shape and consists of 162 capsomeres 
(12 pentamers and 150 hexamers; Wildy et a l ., 1960).
2iii) The tegument, which is a rather ill-defined 
layer of proteinaceous material between the capsid and 
the envelope of the virion (Roizman and Furlong, 1974).
The thickness of this layer varies considerably among the 
herpesviruses (McCombs et a l ., 19 71).
iv) The envelope, the outermost structure of the 
virion (Wildy et a l ., 1960), which is derived by budding 
through the inner nuclear membrane (Darlington and Moss, 
1968). The envelope contains numerous protruding spikes, 
estimated to be approximately 8nm in length (Wildy et a l ., 
1960 ) .
Viruses within the family of Herpetoviridae can be 
classified on the basis of their biology and their genome 
structure. On the basis of their biology, they have been 
divided into three subfamilies, the alpha- , beta- , and 
gammaherpesvirinae, using the criteria of host range, 
duration of reproductive cycle, cytopathology and 
characteristics of latent infection (Roizman et a l ., 1978; 
Roizman, 19 78 ) .
C ertain  Alphaherpesvirinae have a variable host range both 
in vivo, in experimental animals, and in vitro. They have 
a short reproductive cycle, spread rapidly during infection 
and frequently establish latent infections in ganglia.
This group includes herpes simplex virus types 1 and 2, 
equid herpesvirus type 1 (EHV-1; Randall et a l ., 1953), 
pseudorabies virus (PRV; Gustafsohn, 1970), bovine 
mammilitis virus (BMV; Martin et a l ., 1966), 
varicella-zoster virus (VZV; Weller, 1953) and 
channel catfish virus (CCV; Wolf and Darlington, 1971; 
Chousterman et a l ., 1979).
Betaherpesvirinae are typified by a narrow host range, 
a long reproductive cycle, spread slowly in culture and may 
become latent in secretory glands and lymphoreticular cells. 
Murine cytomegalovirus (MCMV; Smith, 1954) and human 
cytomegalovirus (HCMV; Smith, 1956) are members of this 
group.
Gammaherpesvirinae, include Epstein-Barr virus (EBV; 
Epstein et a l ., 1965), Marek's disease virus (MDV;
Marek, 1907; Churchill and Biggs, 1967), herpesvirus saimiri 
(HVS; Melendez et a l ., 1968) and herpesvirus ateles (HVA;
3Melendez et a l ., 1972). They vary in duration of 
reproductive cycle and in cytopathology but have a host 
range limited in vitro to lymphoblastoid cells, in which 
they may also give rise to latent infection.
2. Biology and Pathogenicity of Herpesviruses.
Herpesviruses are known to infect numerous eukaryotic 
orders, from fungi (Kazama and Schornstein, 1972) to man, 
who is host to HSV-1, HSV-2, VZV, HCMV and EBV. Recently, 
a novel herpesvirus, HRV-6, originally termed human B-lymphotropic 
virus , has been isolated from immunocompromised patients 
(Josephs et a l ., 1986; Salahuddin et a l ., 1986).
HSV-1 is the agent of 'cold sores', facial lesions 
primarily around the mouth (Fiddian et a l ., 19 83), but the 
virus can infect many organs. Primary infection may be 
asymptomatic or lead to development of a number of clinical 
symptoms such as fever, sore throat, oedema, localised 
lymphadenopathy and malaise (Whitley, 1985). Following 
primary infection, the virus establishes a latent state in 
the trigeminal ganglia and may be periodically reactivated 
to produce recurrent disease. This is evidenced by the 
identical restriction enzyme pattern of viral DNA isolated 
from primary and recurrent lesions (Lonsdale et a l ., 1979).
HSV-2 is the primary cause of genital herpes, 
a vener ally-transmitted disease (Kessler, 1977). HSV-2 
genital infections exhibit periods of exacerbation and 
remission due to reactivation of latent virus in the 
sacral ganglia (Baringer, 1974). This virus has also been 
associated with cervical carcinoma, however, HSV-2 DNA 
sequences are present in only a small percentage of cervical 
carcinomas (Park et a l ., 1983; Macnab et a l ., 1985), 
whilst human papilloma virus DNA can be detected in up to 
80% of cervical carcinomas examined (Macnab et al ., 1986).
VZV is the causative agent of chickenpox (varicella) 
in children. In common with HSV-1 and HSV-2, VZV can 
establish a latent state and reactivate later in life to 
cause shingles (herpes zoster; Weller, 1976).
HCMV usually infects salivary glands but may also be 
found in other tissues, usually resulting in a mild or
subclinical disease although congenital neonatal infection 
can result in mental retardation (Alford and Britt, 1985). 
Blood transfusions or organ transplants in immunosuppressed 
individuals frequently result in outbreaks of HCMV infection 
(Ho, 1982).
EBV is the causative agent of infectious mononucleosis 
(glandular fever) and is involved in the aetiology of 
Burkitt's lymphoma (Epstein et a l ., 19 64) and in 
nasopharyngeal carcinoma (zur Hausen et a l ., 19 70).
5SECTION B .
STRUCTURE AND REPLICATION OF HSV-1 DNA.
3. Structure of the HSV-1 Genome.
a ) Arrangement of DNA sequence elements.
HSV-1 strain 17+ is the third virus with a genome
larger than 10^ base pairs (bp) whose complete nucleotide
sequence has been determined (Davison and Wilkie, 1981;
Preston and McGeoch, 1981; Murchie and McGeoch, 1982;
Dalrymple et a l ., 1985; Quinn and McGeoch, 1985; McGeoch et
ad., 1985; Davison and Scott, 1986a; McGeoch and Davison,
1986a and b; McGeoch et a l ., 1986a and b; Nikas et a l .,
1986; Perry et a l ., 1986; McGeoch et a l ., 1988; Perry and
McGeoch, 1988). Its genome is a linear duplex DNA molecule
of 152,260bp and has a mean G+C content of 68.3% (McGeoch et
ad., 1988). HSV DNA can be fragmented by treatment with
alkali or formamide suggesting that it contains
single-stranded nicks (Kieff et a l ., 1971; Wilkie, 1973;
Ecker and Hyman, 1981).
The HSV genome consists of two distinct segments,
designated Long (L) and Short (S), which are covalently
linked at the junction (Fig. 1; Sheldrick and Berthelot,
19 74). Each segment consists of a unique region (U^ and Ug )
which is flanked by a pair of inverted repeats (R^ and Rg ).
The R and Rc sequences are distinct and, depending on 
Li o
whether they are located at the genomic termini (T) or 
internally (I) at the junction, they are designated TR ,
Li
IR and IRC and TR . The sizes of these regions in bp are:
Li O O
U , 107,943; Ug , 12,978; R , 9,215; Rg , 6,676 (McGeoch et 
al., 1988). The HSV genome possesses a direct
terminal repeat which is also present in one or more 
inverted copies at the junction (see Page 6).
Preparations of HSV DNA contain approximately 
equimolar amounts of four isomers which differ in the 
relative orientation of the L and S segments about the 
junction (Delius and Clements, 1976; Clements, 1976;
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Figure 1 . The genome structure of HSV-1 DNA. Boxed areas 
represent repetitive sequences and single lines represent 
the unique segments. L, the Long segment; S, the Short 
segment; U^, the long unique sequence; Ug , the short unique 
sequence; TR and IR , the terminal and internal repeats of1j Li
the L segment; IRg and TKgr the internal and terminal
repeats of the S segment. The four possible isomers of the
HSV-1 genome are depicted below. P, prototype orientation;
I , inversion of the L segment; I , inversion of the S 
Li O
segment; Ic , inversion of both the L and S segments. 
bJLi
6Wilkie and Cortini, 1976; Cortini and Wilkie, 1978).
One of the four isomers, chosen arbitrarily, is designated
prototype (P) and the remainder are designated as Ig,
I , and Ic (see Fig. 1; reviewed in Roizman, 1979).
Li o ± j
In this thesis, genome representations are given in the 
P orientation.
b) Organisation of HSV-1 genes.
It is estimated that the HSV-1 genome contains
72 genes which encode 70 distinct polypeptides (Fig. 2;
reviewed in McGeoch et a l ., 1988). Two genes, whose
products have been well characterised (see Page 17), map
entirely within the R and Rc repeats and are therefore each
J_i O
represented twice. The UT region contains 56 genes,
Li
designated ULl to UL56 and the Ug region contains 12 genes, 
designated US1 to US12. In general, HSV-1 genes are densely 
arranged and in certain cases, such as US10 and US11
or in the regions between UL5 and UL14 and between UL30 and 
UL33, their coding regions overlap (Rixon and McGeoch, 1984; 
McGeoch et a l ., 1988). Each gene has its own promoter, 
and a feature of their arrangement is that they specify 
families of overlapping and unspliced transcripts with 
common 3' termini.
c ) The a sequence.
The HSV molecule possesses a direct terminal
redundancy, termed the a sequence, which is present in the
inverted orientation at the L/S junction (Fig. 3; Grafstrom
et a l ., 1974 and 1975; Wadsworth et a l ., 1976; Wagner and
Summers, 19 78). The a sequence comprises a direct terminal
repeat of 17bp to 21bp (DRl or reiteration I), adjacent to
which are two unique sequences (Ub and Uc). The latter are
separated by two direct repeat elements of 12bp and 37bp
(DR2 and DR4). Overall, the structure of the a sequence
can be represented by:
DRl - Ub - (DR2) - (DR4) - Uc - DRln m
where n represents 1 to at least 22 copies and m represents 
1 to 3 copies (Davison and Wilkie, 1981; Mocarski and
Roizman, 1981 and 1982a). The a sequences vary in length 
both inter- and intra-strain (Wagner and Summers, 1978;
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Figure 2 . The locations of HSV-1 genes, mapping within the
unique U and U sequences, which encode proteins with known 
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functions or properties. Arrowed lines above or below the 
genome represent genes transcribed rightwards or leftwards 
respectively. The three origins of viral DMA replication 
(see text) are indicated (k\).
UL2, uracil-DNA glycosylase (J. Mullaney personal 
communication); CJL5, (JL8, UL9 , (JL42, and QL52, DNA 
replication (Wu et a l ., 1988; McGeoch et a l ., 1988); UL12, 
alkaline exonuclease (Preston and Cordingley, 1982; McGeoch 
et a l ., 1986b); UL19, major capsid protein Vmwl55 (Costa 
et a l ., 1984; Davison and Scott, 1986a); UL22, glycoprotein 
H (McGeoch and Davison, 1986a); UL23, thymidine kinase 
(McKnight, 1980; Wagner et a l ., 1981); UL27, glycoprotein B 
(Bzik et a l ., 1984; Pellet et a l ., 1985); UL29, major 
DNA-binding protein, DNA replication (Conley et a l ., 1981; 
Quinn and McGeoch, 19 85); UL30, DNA polymerase (Chartrand 
et a l ., 1979; Quinn and McGeoch, 1985); UL39, large subunit 
of ribonucleotide reductase (Preston, V.G. et a l ., 1984; 
Nikas et a l ., 1986; this thesis); UL40, small subunit of 
ribonucleotide reductase (McLauchlan and Clements, 1983a; 
Preston, V.G. et a l ., 1988); UL41, host virion shut-off 
(Kwong and Frenkel, 1987; Kwong et a l ., 1988); UL44, 
glycoprotein C (Frink et a l ., 1983); UL48, major tegument 
protein Vmw65, transcriptional activator (Campbell et a l ., 
1984; Dalrymple et a l . , 1985 ); LJL50, deoxyuridine 
triphosphatase (Preston and Fischer, 1984); (JL54, immediate 
early protein (see Page 17; Everett, 1986).
US1, immediate early protein (see Page 17; McGeoch 
et a l ., 1985); US3, protein kinase (McGeoch and Davison, 
1986b; Frame et a l ., 1987); US4, glycoprotein G (McGeoch 
et a l ., 1985; Frame et a l ., 1986a); US6, glycoprotein D 
(Watson et a l ., 1982); US7, glycoprotein I (McGeoch et a l ., 
1985); US8, glycoprotein E (McGeoch et a l ., 1985); US12, 
immediate early protein (see Page 17;Murchie and McGeoch, 
1982).
7Davison and Wilkie, 1981). In HSV-1 strain 17+ the 
a sequence is approximately 400bp and contains one DR4, 
whereas, in HSV-2 strain HG52 it is approximately 250bp and 
contains one DR2 and one DR4 (Davison and Wilkie, 1981).
The a sequence is present as a single copy at the 
S terminus, but at the L terminus and the L/S junction more 
than one copy may be present (Wagner and Summers, 1978; 
Locker and Frenkel, 1979). The DRl elements at the genomic 
termini are incomplete; the L terminal DRl contains 18bp 
and a single 3' nucleotide extension (total length 18.5bp) 
while the S terminal DRl contains the remaining 1.5bp 
(Mocarski and Roizman, 1982a). Therefore, together these 
partial sequences form a complete DRl element.
The a sequences appear to play a significant role in 
genome circularisation, inversion, cleavage and packaging.
i) Circularisation. After penetration of the infected 
cell nucleus, HSV DNA circularises rapidly (Davison and 
Wilkie, 1983; Poffenberger and Roizman, 1985). This process 
appears to occur by direct ligation of the complementary 
a sequences at the termini (Davison and Wilkie, 1983) rather 
than by annealing of the exposed terminal single-stranded 
ends (reviewed in Roizman, 1979). The former is supported 
by the ability of HSV-l/HSV-2 intertypic recombinants to 
circularise although they contain heterotypic a terminal 
sequences (Davison and Wilkie, 1983). Circularisation takes 
place in the absence of HSV protein synthesis indicating 
that ligation of the termini is mediated either by a host 
function or a virion factor (Poffenberger and Roizman,
1985).
ii) Inversion. Inversion of the L and S segments 
of the HSV genome results in the generation of four HSV 
genome isomers which, at least in tissue culture, appear 
to be functionally equivalent (Jenkins and Roizman, 1986). 
The necessary signal for this process appears to reside 
within the a sequences; insertion of a fragment bearing the 
a sequence into the thymidine kinase (TK) gene of HSV-1 
promoted additional inversions resulting in the formation 
of 12 isomers (Mocarski et a l ., 1980; Mocarski and Roizman,
a b
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Figure 3 . The location of the HSV-1 a sequence on the P 
genomic arrangement. The a sequence is present as a direct 
repeat at the genomic termini, and in inverted orientation 
at the L/S junction. An expansion of the a sequence at the 
L/S junction is shown below. Unique and repeated sequence 
elements within the a sequence are: DRl, a 17-21bp repeat 
present as a direct repeat at the ends of the a sequence;
Ub, a unique sequence located toward the b sequnce; DR2, a 
12bp repeat present as 1 to at least 22 copies; DR4, a 37bp 
repeat present as 1 to 3 copies; Uc, a unique sequence 
located toward the c sequence. The black boxes labelled 
pac-1 and pac-2 indicate unique a DNA sequences conserved in 
a number of herpesviruses.
1982b). Inverting DNA fragments must be flanked by 
homotypic and inverted a sequences relative to those at 
the termini or the junction. Davison and Wilkie (1983) 
demonstrated that an HSV-1 strain 17+ recombinant (RE4), 
possessing an inverted HSV-2 a sequence at the junction, 
failed to invert and was predominantly frozen in the Ig 
arrangement. Likewise, DNA fragments flanked by a sequences 
in the same orientation failed to invert (Mocarski et a l ., 
1980; Mocarski and Roizman, 1981). Deletion analysis within 
the a sequences demonstrated that only the DR2 and DR4 
elements are required for genomic inversion (Chou and 
Roizman, 19 85 ) .
Site-specific recombination need not be postulated for 
the generation of the four genomic isomers. Genomic 
inversion could result partly from the use of alternative 
packaging phases of the precursor concatemer, which could 
account for half of the genome isomerisation events, and 
partly from the summed recombinational activity of sequences 
primarily dispersed throughout R and R c (Varmuza andJ-i O
Smiley, 1985). The HSV genome contains short segments of 
tandemly reiterated sequences which vary in length between 
5bp and 54bp and have a high G+C content (Rixon et a l .,
1984; Whitton and Clements, 1984a and b; Perry et a l .,
1986). These sequences could be highly recombinogenic and 
homologous recombination could occur between any members 
of the same sequence family (Rixon et a l ., 19 84).
Further supportive evidence that recombination leading
to segment inversion is not site-specific is obtained from a
number of reports. An HSV-1 mutant lacking the a sequences
at the junction and predominantly frozen in the Ig
arrangement generated a minor population of Ig molecules
most probably due to recombination between the remaining
b sequences of the junction (see Fig. 3; Longnecker and
Roizman, 1986). Likewise, an HSV-1 mutant containing a
second copy of a U fragment inserted into the TK gene
Li
induced inversion (Pogue-Geile and Spear, 1986) as did a 
fragment from the c sequences albeit at a low frequency 
(Varmuza and Smiley, 1985).
iii) Cleavage and packaging. The a sequence is 
involved in the cleavage of replicated concatemeric DMA into 
unit length linear molecules and their subsequent packaging 
into virus particles; although plasmid constructs containing 
an HSV-1 origin of replication are able to replicate they 
are packaged, as defective particles or 1amplicons1, 
only when they contain an a sequence (Stow et a l . , 1983; 
Deiss and Frenkel, 1986). The necessary signals for these 
processes appear to reside within the Ub and Uc sequences 
(see Fig. 3; Deiss et a l ., 1986). 'Amplicons1 containing 
deletions within the Uc region fail to become packaged while 
those containing deletions within the Ub region are packaged 
only when a wild-type a sequence is acquired from the helper 
virus. The Ub region contains a 28bp sequence which is 
highly conserved in HSV-1, HSV-2 (Davison and Wilkie, 1981), 
VZV and PRV (Davison and Rixon, 1985). Deiss and Frenkel
(1986) termed this sequence pac-1 and identified a less 
homologous sequence, pac-2, within the Uc region (see
Fig. 3). Although the function of these conserved sequences 
is at present unknown, these authors proposed that they 
might play a role in the cleavage and packaging processes.
d ) Proteins interacting with the a sequence.
The processes in which the a sequence is involved 
appear to require the interaction of specific HSV-induced 
and/or host cell proteins. This is evidenced by the 
requirement of at least one trans-acting viral component for 
inversion (Mockarski and Roizman, 1982b) and the occurence 
of genomic circularisation in the absence of de novo protein 
synthesis (Poffenberger and Roizman, 1985). Dalziel and 
Marsden (1984), using competition binding assays with HSV-1 
DNA fragments containing the a sequence, identified two 
polypeptides with sizes of 21,000 and 22,000 mol. wt.
(21K, 22K) which consistently interacted with these 
fragments. It was therefore suggested that these 
polypeptides bind to the a sequence either directly or 
indirectly (Dalziel and Marsden, 1984). MacLean et a l .
(1987) demonstrated, by means of antisera raised against 
oligopeptides corresponding to regions of the predicted 
primary structure of gene US11 (McGeoch et al., 1985), that
10
the latter specified two polypeptides with sizes identical 
to those interacting with the a sequence. Although these 
authors were unable to isolate substantial quantities 
of proteins interacting with a sequences to test with 
anti-USll-peptide sera, they demonstrated that the 
US11 gene products are DNA binding proteins. The a 
sequence-interacting 21K and 22K proteins of Dalziel and 
Marsden (1984) may therefore correspond to the products 
of US11 (McLean et al ., 1987). The relationship between 
the 21K and 22K proteins is not clear.
Immune electron microscopy showed that the US11 gene 
products were localised in the nucleoli of infected cells 
(MacLean et a l ., 19 87). However, viral DNA is located in 
the nucleoplasm and is specifically excluded from the 
nucleoli (Rixon et a l ., 1983; Randall and Dinwoodie, 1986). 
Therefore, it appears that these proteins may not be 
involved in DNA replication and maturation in vivo. This 
suggestion is supported by the viability in tissue culture 
of HSV mutants, which lack the US11 gene (Longnecker and 
Roizman, 1986; (Jmene, 1986; Brown and Harland, 1987 ). 
Recently, Meigner et a l . (19 88) reported that one of these 
mutants was able to establish latency in mice.
4. HSV DNA Replication.
a ) Cis-acting signals for DNA replication.
The mechanism by which HSV DNA replicates is largely 
unknown. Jacob et a l . (19 79) proposed that after infection 
HSV DNA circularises and replication proceeds by a rolling 
circle mechanism. In support of this suggestion is the fact 
that newly replicated viral DNA possessed ewer detectable 
termini indicating that it consists of head-to-tail 
concatemers (Jacob et a l ., 19 79; Jongeneel and Bachenheimer, 
1981). Furthermore, electron microscopic studies using 
cells with replicating viral DNA detected circular unit 
length genome molecules (Shlomai et al ., 1976; Friedmann 
et a l . , 1977; Jacob and Roizman, 1977 ).
Approximate locations for HSV origins of replication 
were initially characterised using defective viral genomes
11
obtained following passage at high multiplicities of 
infection (m.o.i.; Kaerner et al ., 1979; Vlazny and Frenkel, 
1981; Spaete and Frenkel, 1982). These defective genomes 
consisted of tandem repetitions of sequences derived from 
the standard genome and were divided into two classes. Both 
classes contained sequences from the end of the TRg repeat. 
Class I contained in addition sequences from the S segment 
while class II contained sequences from near the centre of 
the L segment. The ability of these defective genomes to 
replicate and package in the presence of wild-type helper 
virus indicated the presence of cis-acting signals for DNA 
synthesis and processing. Thus, it was suggested that the 
HSV genome contains i) two potential origins of replication, 
one in each Rg , termed orig and present in class I defective 
genomes and ii) a potential origin of replication in □ , 
termed ori and present in class II defective genomes1j
(Vlazny and Frenkel, 1981; Spaete and Frenkel, 1982).
i) Qrig . Stow (1982) developed an assay system for 
determining functional origins of replication in which the 
amplification of plasmid DNA sequences containing inserted 
HSV fragments was estimated in the presence of HSV-1 
functions supplied in trans. Using this assay system, 
orig was positioned in a 90bp Rg region (see Fig. 2), 
located between the 5' termini of IE mRNAs 3 and 4/5 
(for a description of these mRNAs see Page 17; Rixon and 
Clements, 1982). This region comprised a 45bp almost 
perfect palindromic sequence, at the centre of which is 
positioned an 18bp A+T-rich tract, and contained all the 
necessary cis-acting sequences for replication (Fig. 4a; 
Murchie and McGeoch, 1982; Stow and McMonagle, 1983).
The A+T-rich segment appears to be important for replication 
since deletion of it completely abolished origin activity 
(Stow, 1985).
Within the HSV-2 strain HG52 Rg, Whitton and Clements 
(1984a) identified two copies of a sequence highly 
homologous to HSV-1 orig ; this sequence is present as 
a 137bp direct repeat and it is the proposed HSV-2 orig.
In VZV a functional orig was identified, cloned copies of 
which could be activated by VZV replication functions
CDO
c
0)
3
O’d)(0
05
14o
I
>
05
X
0)o
c
0)3
D*d)co
I
>
05
X
V < b * V < < V
V E-* O V E-» Eh V
V < E-* V < < V
V Eh O V Eh Eh V
V < T“ < V < < V
V < O V < •
V Eh Eh V E-* Eh V
V <> r o V < < V
V < o V < < V
V Eh < V E-* O V
V o A E-* V o O V
V o A O V o o V
V Eh A O V E-* Eh
V o A O V o O V
V b > A o V E-* O V
V E-* x A o V E-* Eh VV E-* CM A < V E-* Eh V
V o A o V o O V
V c A o V < < V
V o r A o V o o V
V o A o V o o V
V o A o V o o V
V Ehv A < V E-* Eh V
V Eh € 0  A o V Eh Eh
V o A o V o O
V o A o V o o
V oJr A o V o o
V < A o V < <
V < A o V < <
V o A < V o o
V A Eh V o o
V o A < X V o O
V o CO A < V o O
V < A Eh V < <
V < A < ' ' V < <
V o A b > V o o
V < A E-* V < <
V * A E-c V o o
V E-» A E-* V E-* Eh
V o CM A E-* V o OV < A b * > V < <
V < A b * CM V < <
V < A O V < O
V
V
<
<
A
A g f
V
V
<
<
<
<
V < A E-* V < <
V < A O V < <
V E-*j* A E-* V Eh Eh
V < A E-* C5 V <V E-* A O V b > 6
V Eh ** A O V Eh o
V < A t V <c o
V Eh A o V Eh o
V o A E-* V o « o
V o A E-* V o « o
V o A UJi V o « o
V o A O V o « o
V o A O CO V o « oV o A <c V o « o
V G-* A < V b > o
V o A o c V o « o
V o A o o V o « o
V o A o k CO V o « oV O A Eh V o « oV O A o CM u V o « oV E-* A < <0 V EH oV O A < a V o « oV O A < e V o <V o A o o V o <
V o A < o V o * 0V o A o V o
5
oV g AA o< 05•H V * oo
E-* A
A
E-*
>
u
O
b *
<
o
oo A < \ 0 « o
<•E-* A Eh J c-t
O A Eh •H o * o
O A < u o o
O A Eh o o * o
O A < o « o
O A E-» H o * o
A
A
A
A
I>
05
fc*o «o 
<
8
O *
O 
A O *  
A O *
z s
A O 
A O *  
A O *  
A O
£ 5
A O 
A O 
A O 
A O *  
A O 
A  <
E-*
<
<H 
<
E-*
Eh e-»
b *  *  
eh 
Eh
O *
3 *
8 
eh 
b >o o o o
c-»
b:oo « 
<
5:
A O *  
A O *  
Eh *
o * 
< * < «
5.
3 «
A O *  
A <  *
E-* * 
b *  * 
< *
s: < * & *
^ * H *
OOoooooooooooooooooooooooooooooooooooo
E“»o
3oooo
E«ooooooo
8
o
5 a
O A 
O A 
E-» A 
O A
<  A
5 a
O A 
O A 
O A 
O A
<
Eh 
Eh 
<
8
£ 
£ 2
0) 05
Figure 4 . Structure of the HSV-1 origins of replication.
a) The oric sequence. The arms of the palindrome are
u
indicated by (<) or (>) and the binding sites of the UL9 
protein are indicated by (:).
b) The ori sequence. Palindromic sequences are indicated
Li
as above. Numbered arrowed lines indicate regions of 
interrupted and inverted nucleotide repetitions.
c) Comparison of the ori and ori sequences. Asterisks
O  Li
indicate conservation and dots indicate gaps introduced into 
the sequences for optimal alignment. Dashed lines represent 
the sequences essential for orig activity and the 
palindromic sequences and binding sites of the CJL9 protein 
are indicated as above.
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supplied in trans (Stow and Davison, 1986); in addition, 
the cloned VZV otig could be activated by HSV-1 infection 
although at a reduced efficiency (Stow and Davison, 1986). 
The VZV orig contains a tract of alternating A+T residues 
located at the centre of an almost perfect palindrome of 
45bp and displays limited homology to the HSV-1 equivalent.
ii) Ori . The HSV ori is positioned between the
 Li Lj
5' termini of the mRNAs encoding the major DNA-binding 
protein (MDBP) and the DNA polymerase (genes UL29 and UL30 
respectively in Fig. 2), and its sequence has been 
determined for HSV-1 strains 17+ (Quinn and McGeoch, 1985), 
KOS (Weller et a l ., 1985) and the Angelotti class II 
defective of HSV-1 (Gray and Kaerner, 1984). Ori sequences
Li
consist of an A+T-rich region positioned at the centre of a 
perfect palindrome with arms each of 72bp; each arm contains 
three regions of interrupted and inverted repetitions (Fig. 
4b; Weller et a l ., 1985). Comparison between orig and oriL 
sequences revealed that the whole of the orig palindrome is 
quite similar to the central portion of the ori palindromeLi
(Fig. 4c). The latter was shown to be a functional origin 
and deletions within the palindrome abolished activity 
(Weller et a l ., 1985).
HSV-2 contains a perfect palindrome of 136bp which 
is highly homologous to that of HSV-1 ori (Lockshon andLi
Galloway, 1986). On the contrary, VZV does not appear to
have an HSV-1 ori homologue sequence, at least in the
Li
equivalent HSV-1 genomic position (Stow and Davison, 1986).
Recently, it was shown that an HSV-1 deletion mutant
lacking most of the ori sequences, and therefore rendering
Li
ori^ non-functional in the presence of helper virus, was 
able to replicate in vitro (Polvino-Bodnar et a l ., 1987). 
Further, an HSV-1 recombinant that contains ori and a
Li
single copy of orig was viable in tissue culture (Longnecker 
and Roizman, 1986). These observations demonstrate that 
two out of three HSV origins are sufficient for replication, 
and this raises the question of the role of a third origin. 
It is possible that different origins are preferentially 
used during different stages of lytic infection (reviewed 
in McGeoch, 1987).
13
b ) HSV-1 genes required for replication.
A number of HSV-l-induced enzymes have been shown
by genetics to be essential for viral DNA replication
in cultured cells and these are described in Section D.
Recently, Challberg (1986) developed a method for 
identifying viral genes required for DNA replication.
This method was based on the observation that transfected 
HSV DNA could provide in trans the functions to support 
amplification of an ori -containing plasmid introduced 
concurrently. Thus, it was shown that a set of plasmids 
representing most of the HSV genome could substitute 
efficiently for intact virus DNA in supplying replication 
functions and that the DNA polymerase and MDBP genes were 
essential components of this system. Subsequent subcloning 
and inactivation by restriction endonuclease digestion 
identified, in conjuction with DNA sequencing data, five 
additional essential genes (Wu et a l ., 1988; McGeoch et a l ., 
1988); these are UL5, UL8, UL9, UL42 and UL52 (see Fig. 2).
The products of genes UL9 and (JL42 have been 
characterised. Gene (JL9 encodes a protein, identified 
previously by Elias et a l . (1986), which binds to orig .
This protein is present in nuclear extracts of 
HSV-l-infected cells and generates a DNase I footprint 
of 18bp which maps to the left of the palindrome centre 
(Elias et a l ., 1986); however, it has recently been shown 
that this protein has an additional binding site to the 
right of the palindrome centre (see Fig. 4a; Olivo et a l . , 
1988; H. Weir, personal communication). It is notable that 
the DNase I protected region to the left of the palindrome 
centre includes an llbp sequence which is highly conserved 
between HSV-1 or;‘-s anc  ^ VZV or*S s^tow anc  ^ Davison,
1986). Gene UL42 encodes the 65K DNA-binding protein 
(65KDBp; Marsden et a l ., 1987; Parris et a l ., 1988).
This protein is the major species in high-salt eluates from 
double-stranded DNA cellulose columns used to fractionate 
nuclear extracts of HSV-l-infected cells (Marsden et a l .,
1987). Recently, a temperature-sensitive (ts) HSV-1 mutant 
with a mutation lying most probably in gene (JL42 failed
to induce synthesis of viral DNA at the non-permissive 
temperature (NPT) and was unable to replicate an
oriS-containing plasmid (Marchetti et a l ., 1988). Further, 
this mutant at the NPT failed to induce synthesis of the 
true-late class of HSV-1 mRNAs (for a description of these 
mRNAs see Page 17). The functions of the other three 
essential genes are currently being investigated.
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SECTION C .
PROCESSES INVOLVED IN PRODUCTIVE HSV INFECTIONS.
5. Effects of HSV on Host Cell Metabolism.
Productive infection with HSV virus significantly 
impairs several host functions. Following infection, 
host DNA synthesis ceases (Aurelian and Roizman, 19 64; 
Roizman and Roane, 19 64) and host RNA synthesis decreases 
(Hay et a l ., 1966; Flanagan, 1967; Pizer and Beard, 1976). 
However, certain host cell RNAs continue to be synthesised 
at late times post infection (p.i.; Stringer et a l ., 1977) 
and the promoters of cellular genes, integrated into 
the genome of biochemically transformed cell lines, 
are activated after HSV infection (Everett, 1985). The 
steady-state levels of pre-existing host polyadenylated 
mRNAs decrease by 4h p.i., probably due to deadenylation 
(Nishioka and Silverstein, 1977 and 1978; Nakai et a l .,
19 82; Mayman and Nishioka, 19 85).
Infection of cells with HSV results, also, in 
inhibition of host protein synthesis with the exception 
of the heat shock or stress proteins whose production is 
increased (Notarianni and Preston, 1982; LaThangue et a l ., 
1984). Host protein shut-off appears to be more rapid and 
efficient with HSV-2 than HSV-1, although HSV-2 strain HG52 
appears to be an exception to this generalisation (Powell 
and Courtney, 19 75; Pereira et a l ., 19 77). Host protein 
shut-off has been divided into 'early' and 'delayed' stages.
The 'early' stage occurs after HSV infection and is 
mediated by a virion component(s) as it can be achieved 
either by UV-irradiated virus or in the presence of drugs 
which inhibit incoming virus expression (Fenwick and Walker, 
1978; Nishioka and Silverstein, 1978). This stage appears 
to be associated with disaggregation of infected-cell 
polyribosomes which reassemble to form new ones exhibiting 
an altered size distribution (Sydiskis and Roizman, 1967 and 
1968). The majority, but not all, of the mRNA associated 
with new polyribosomes is virally-encoded (Stringer et a l .,
16
1977). Further, the 'early' shut-off appears to be 
associated with host mRNA degradation and with a reduction 
in the half-life of immediate-early and, possibly, early 
and late HSV mRNAs (for a description of these HSV mRNAs 
see below; Schek and Bachenheimer, 19 85; Kwong and Frenkel, 
1987; Strom and Frenkel, 1987; Kwong et a l ., 1988).
A number of HSV-1 mutants defective in virion-associated 
host shut-off (vhs) have been isolated (Read and Frenkel, 
1983). In one mutant, the mutation(s) affecting both 
inhibition of host protein synthesis and stability of 
host and viral mRNAs, most likely maps within gene UL41 
(see Fig. 2; Kwong et a l ., 1988). In certain cell lines, 
host cell mRNA degradation occurs during 'delayed' shut-off 
of host polypeptide synthesis (Nishioka and Silverstein, 
1978 ) .
The 'delayed' stage of the shut-off process completes 
the inhibition of host protein synthesis and requires viral 
gene expression (Nishioka and Silverstein, 1978; Read and 
Frenkel, 1983). The gene(s) involved in 'delayed' shut-off 
can function in the absence of the virion component(s) 
responsible for the 'early' shut-off (Read and Frenkel,
1983 ) .
6. Temporal Regulation of HSV Gene Expression.
The HSV virion is uncoated in the cytoplasm of the 
infected cell and subsequently the viral DNA is transported 
to the nucleus (Hummeler et a l ., 1969). In the nucleus, 
mRNA is transcribed from viral DNA by a process which 
appears to involve cellular RNA polymerase II; this is 
evidenced by the sensitivity to ©c-amanitin (Alwine et a l . , 
1974; Ben-Zeev et al ., 1976), a fungal toxin which 
specifically inhibits RNA polymerase II, and by the absence 
of any novel RNA-polymerasing activity in HSV-l-infected 
cells (Lowe, 1978). The sensitivity against the drug 
persists throughout all stages of infection (Costanzo et 
a l ., 1977). Subsequently, HSV mRNA is transported to the 
cytoplasm where it becomes associated with polyribosomes, 
and is translated (Wagner and Roizman, 1969). HSV gene 
expression is temporally regulated and can be sub-divided
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into three broad stages, immediate early (IE), early (E) 
and late (L) gene expression (Swanstrom and Wagner, 1974; 
Clements et al ., 1977; Jones and Roizman, 1979).
a ) Immediate early gene expression.
i) Immediate early genes. IE or oc genes are the 
subset of genes which are transcribed by an unmodified 
cellular RNA polymerase II (Costanzo et a l ., 1977) in the 
absence of de novo protein synthesis (Kozak and Roizman, 
1974; Roizman et al ., 19 74). IE mRNAs are usually 
detectable by lh p.i. and their accumulation peaks at 
2h to 3h p.i., although, some of them persist in the 
cytoplasm at late times of infection (Harris-Hamilton 
and Bachenheimer, 1985; Godowski and Knipe, 1986).
IE transcription is limited to restricted regions 
of the genome (Fig. 5; Clements et a l ., 19 77 and 19 79; 
Anderson et a l ., 1980; Easton and Clements, 1980). Five IE 
genes have been identified, IE genes 1 to 5, which encode 
polypeptides VmwllO (ICPO), Vmw63 (ICP27), Vmwl75 (ICP4), 
Vhiw68 (ICP22) and Vftiwl2 (ICP47) respectively (the 'Chicago' 
nomenclature is given in brackets). The genome locations 
and sizes of the IE mRNAs encoded by the IE genes have been 
determined. IE mRNAs 1 and 3 map entirely within TR /IR
Li L i
and IRg/TRg respectively, and are therefore encoded by
diploid genes (Rixon et a l ., 1982). IE mRNAs 4 and 5 span
the IRg/Ug and TRg/Ug regions and share identical promoter
and 5' untranslated leader sequences (Watson et a l ., 1981;
Rixon and Clements, 19 82); these are encoded by genes (JSl
and US12 respectively. Finally, IE mRNA 2 maps entirely
within U (Whitton and Clements, 1983) and is encoded by 
Li
gene UL52. Three of the five IE transcripts, IE mRNAs 1, 4, 
and 5, are spliced. IE mRNAs 4 and 5 have a single splice 
located entirely within the R0 repeats (Watson et al.,O
1981a; Rixon and Clements, 1982; Whitton and Clements 1984b) 
and upstream of the polypeptide coding regions (Murchie 
and McGeoch, 1982; Whitton and Clements, 1984b; Rixon and 
McGeoch, 1984). HSV-1 IE mRNA 1 contains two introns with 
sizes of 765 nucleotides (nuc) and 135nuc, both of which are

Figure 5 . A representation of the HSV-1 genome showing 
the location and orientation of the five IE genes. The 
designation of the IE genes mapping in the UL or Ug 
segments is given in brackets (see Fig. 2). The IE 
genes are depicted as arrows and splices are indicated 
as ( A  ) and (V ).
18
located in the translated portion of the gene (Perry et a l ., 
1986 ) .
ii) IE gene regulatory sequences. The 5 '-upstream 
regions of HSV IE genes contain sequence elements that 
clearly differentiate them from the respective regions of 
E and L genes. A chimeric gene comprising the upstream 
control signals and 50bp of leader sequence from IE mRNA 3 
when fused to an early HSV-1 TK gene, behaved as an IE gene 
either when rescued into a TK virus or inserted into 
biochemically transformed cell lines (Post et a l ., 19 81). 
Similar results were obtained when the TK gene was fused 
to the upstream region of IE mRNA 2 (Mackem and Roizman, 
1982a).
Deletion studies within the IE gene 3 upstream region 
identified a promoter region, spanning positions +26 to -108 
(+l=mRNA start site), which is sufficient for transcription 
initiation in the absence of upstream promoter sequences 
(Mackem and Roizman, 1982a; Cordingley et a l ., 1983). This 
region contains elements found in most eukaryotic promoters 
such as the TATA box and two G+C-rich tracts separated by 
an A+T-rich stretch; however, the 5'-CCAAT-3' homology, 
which is usually present at position -80 relative to the 
mRNA start site in many eukaryotic promoters (Benoist and 
Chambon, 1980; Efstratiadis et al ., 1980), is not present. 
Further, they identified a regulatory region spanning 
positions -174 to -331. In all IE genes examined so far 
this region induces IE gene transcription in a process 
mediated by a virion component (see Page 19). Deletion 
studies within the regulatory region (Cordingley et a l ., 
1983; Preston, C.M. et a l ., 1984; Bzik and Preston, 1986) 
and DNA sequence comparisons of the upstream regions of IE 
mRNA 5' termini (Mackem and Roizman, 1982b; Whitton and 
Clements, 1984a) demonstrated that the target sequence for 
the trans-inducing virion component is an A+T-rich sequence 
with a core consensus of 5'-TAATGARAT-3' (R=purine).
Gaffney et a l . (1985) demonstrated that when a 20bp
synthetic oligonucleotide, containing a TAATGARAT element, 
was fused to a promoter driving the chloramphenicol 
acetyltransferase (CAT) gene, it increased CAT activity
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after infection with the HSV-1 tsK mutant; the latter has 
a mutation in IE gene 3 and does not synthesise E or L 
gene products at the NPT (Preston, 1979). The observed 
stimulation of expression was dependent on the number 
of TAATGARAT copies, since increasing the copy number 
had an additive effect (Gaffney et a l ., 1985). However, 
it appears that flanking sequences, although not essential, 
are important for full induction of IE gene transcription. 
Bzik and Preston (1986) demonstrated that an adjacent 
G+A-rich element is required for full activity which, 
although it was unable to confer full activity on its own, 
could activate an otherwise non-functional homologue of 
TAATGARAT (Bzik and Preston, 19 86).
The regulatory region of IE gene 3 has an 
enhancer-like activity comparable to that of the SV40 
enhancer, since it can stimulate expression of target 
promoters in an orientation-independent manner and at 
a distance from the target promoter (Lang et a l ., 1984; 
Preston and Tannahill, 1984). In contrast to a typical 
enhancer, the HSV-1 IE gene 3 enhancer activity is abolished 
when placed downstream from a gene and, also, is further 
stimulated by a virion component (see below; Lang et a l ., 
1984; Preston and Tannahill, 1984). Deletion analysis 
of the upstream regulatory region of HSV-1 IE gene 3 
demonstrated that the enhancer-like activity and the 
responsiveness to the trans-inducing virion component reside 
in distinct sequence elements (Bzik and Preston, 1986). 
Elements important for enhancer-like activity are: i) two 
copies of the hexanucleotide 5'-GGGCGG-3' which can bind the 
mammalian Spl transcription factor (Jones and Tijan, 1985) 
and, ii) a region containing both a 5 1-GCGGAAAC-31 motif, 
which resembles the simian virus 40 (SV40) enhancer core 
(Weiher et a l ., 1983), and a 5'-CGGAAGCGGAA-3' motif, which 
resembles the adenovirus ElA and polyoma virus enhancer 
cores (Hearing and Shenk, 1983; Herbomel et al ., 1984).
iii) Characterisation of the virion factor which 
induces IE gene expression. Experiments designed to
identify the mechanism by which IE gene expression is 
induced demonstrated that a component of the virus particle
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could stimulate IE gene expression (Post e t a l ., 1981;
Mackem and Roizman, 1982b; Cordingley et a l ., 1983; Preston, 
C.M. et a l ., 1984). Campbell et a l . (1984) identified the
virion component as the major tegument protein Vmw65, which 
is distinct from the 65KDBp (see Page 13), and its primary 
structure was determined by Dalrymple et a l . (1985).
DNA-binding studies with Vmw65 indicated that it did 
not directly bind either calf thymus (Marsden et a l ., 1987) 
or HSV DNA (Preston, C.M. et a l ., 1988). However, Vmw65 has 
been shown to be the only viral constituent of a complex, 
termed IEC, which contains cellular factors and binds 
specifically to TAATGARAT motifs via one of the cellular 
factors (Preston, C.M. et a l ., 1988). It has been proposed 
that one of these factors is a protein related to nuclear 
factor III (NF-III; C. Ace, personal communication). NF-III 
facilitates the binding of a complex, involved in initiation 
of adenovirus 2 DNA replication, to core sequences of the 
adenovirus 2 origin (Pruijn et a l ., 1986). The NF-III 
binding site, 5'-TATGATAATGAG-31 (Pruijn et a l ., 19 86), is 
quite similar to the TAATGARAT motif. Interestingly, it has 
been shown that both of these motifs are equally competitive 
for binding of a cellular factor present in mock-infected 
HeLa cell nuclear extracts (O'Hare and Goding, 1988).
iv) Control of HSV IE gene expression. As discussed 
previously, IE gene transcription does not require de novo 
protein synthesis. However, a number of HSV-l-induced 
polypeptides appear to be involved in the control of IE gene 
expression (Fig. 6). First, is the virion component Vmw65 
which, as already mentioned, positively regulates IE gene 
transcription. Second, is Vmwl75 which is involved both 
in positive and negative regulation of IE gene expression. 
Polypeptide profiles of HSV ts-Vmwl75 mutant viruses 
demonstrated that IE gene products were overexpressed, 
and blocking of IE mRNA translation with cycloheximide led 
to production of large amounts of IE mRNAs (Preston, 1979; 
Dixon and Schaffer, 1980; Watson and Clements, 1978 and 
1980). The same results were obtained from transient 
expression assays where increased amounts of Vmwl75 could 
repress both the basal and activated levels of transcription
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Figure 6 . The HSV-1 functions thought to be involved in the 
regulation of immediate early (IE), early (E) and late (L) 
gene expression. The solid lines represent positive 
regulation and dashed lines indicate negative regulation.
The positive regulators include Vmw65, VmwllO, Vmwl75, Vmw63 
and DNA replication (DNA REP). The negative regulators 
include the virion-associated host shutoff (v h s ) factor, 
Vlmwl75, and the major DNA-binding protein (MDBP) . The 
precise roles of Vmwl2 (O' Hare and Hayward, 19 85a) and a 
L function(s) (DeLuca et a l ., 1984) require further 
investigation and this is depicted by (?).
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repress both the basal and activated levels of transcription 
from IE gene promoters (DeLuca and Schaffer, 1985; O'Hare 
and Hayward, 1985a; Gelman and Silverstein, 1986 and 1987). 
It appears that the only exception to this generalisation 
is the HSV-1 IE gene 2 promoter which, in HeLa cells, was 
active in the presence of increased amounts of Vmwl75 
(Gelman and Silverstein, 1987). Reduced levels of Vmwl75, 
however, have been shown to activate IE gene promoters 
(DeLuca and Schaffer, 1985; O ’Hare and Hayward, 1985a;
Gelman and Silverstein, 1986 and 1987). Third, is VmwllO 
which has been shown to activate IE promoters in 
transfection assays (O'Hare and Hayward, 19 85a; Gelman 
and Silverstein, 1986 and 1987). In addition to these 
polypeptides, MDBP (Godowski and Knipe, 19 86) and the 
product of gene UL41 (Strom and Frenkel, 1987; Kwong et a l ., 
1988) appear to have a role in IE gene regulation since 
mutations in these genes increase the half-life of HSV 
IE mRNAs.
b) Early gene expression.
i) Early genes. E or J3 genes are defined as that 
subset of viral genes which are expressed in the presence 
of functional IE gene products and prior to the onset of DNA 
replication (Wagner, 1972; Swanstrom et a l ., 1975; Clements 
et a l ., 19 77). Early transcripts are detectable at 2h p.i. 
and reach their maximum levels at 4h to 6h p.i., after 
which, the levels of individual transcripts either decrease 
or remain unaltered (McLauchlan and Clements, 1982;
Harris-Hamilton and Bachenheimer, 1985). However, some 
variation in their kinetics of appearance is observed.
For example, the polypeptide of the ribonucleotide 
reductase large subunit (Vmwl36), although classified as 
an E polypeptide, can be detected under IE conditions 
(see Results and Discussion, Section E). On the other hand, 
synthesis of glycoprotein D (gD) mRNA requires DNA 
replication to reach maximum expression although moderately 
high levels are detected early in infection (Gibson and
Spear, 1983). E transcripts have been shown to map across 
the entire length of the genome (Clements et a l ., 1977).
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ii) E gene promoter sequences. Two HSV-1 E promoters, 
those of the TK and gD genes, have been studied in detail. 
The TK promoter region, which is positioned immediately 
upstream from the TK mRNA start site, has been divided into 
one proximal and two distal regions (dsl and dsll) by means 
of linker scanning mutations (Fig. 7a; reviewed in McKnight 
and Tjian, 19 86). The proximal region contains the TATA box 
which has been shown to be especially important for TK 
transcription when present on the viral genome (Coen et a l ., 
1986). Each of the distal regions contains an Spl binding 
site (see Page 19) and in addition, dsl contains an inverted 
CCAAT homologue which binds the CBP/CTF transcription factor 
(Jones et a l ., 1985). The gD promoter region has been 
extensively studied by Everett (1983 and 1984a). Deletion 
analysis indicated that the sequence requirements for 
gD-regulated expression reside within an 83bp region located 
upstream from the mRNA start site (Fig. 7b; Everett, 1983). 
Further analysis of this region identified two G-rich 
regions, termed G1 and G 2 , which are quite similar to an
Spl binding site in the human immunodeficiency virus long 
terminal repeat (Jones, K.A., et a l ., 1986), and a 
functional TATA box together with a cap site region 
(Everett, 19 84a). A CCAAT homologue was not identified.
iii) Control of HSV E gene expression. At least two 
IE gene products, Vmwl75 and VftiwllO, appear to be important 
for regulation of E gene expression (see Fig. 6). Transient 
expression assays demonstrated that Vmwl75 and VlmwllO can 
independently stimulate expression of E promoters whereas, 
in combination, their effect is synergistic (Everett, 1984b 
and 1986; O'Hare and Hayward, 1985b; Quinlan and Knipe,
1985; Gelman and Silverstein, 1986; see Results and 
Discussion, Section E).
The requirement for a functional Vmwl75 for E gene 
expression has also been observed during virus infection; 
at the NPT, HSV-1 ts-Vmwl75 mutants fail to induce E gene 
expression and fail to repress IE gene expression (Marsden
et al ., 1976; Preston, 1979; Dixon and Schaffer, 1980;
Watson and Clements, 19 78 and 1980). In an attempt to
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Figure 7 . Cis-acting transcription elements within E gene 
promoters.
a) Elements within the TK promoter (reviewed in McKnight and 
Tjian, 1986). The GC boxes represent the binding sites of 
the Spl transcription factor and arrows above them indicate 
the relative orientation of the sequences. The CCAAT box 
indicates the binding site of the CTF/CBP transcription 
factor. Both the Spl and CTF/CBP transcription factors are 
depicted to interact with the promoter sequences by curved 
arrows and the stronger affinity of the Spl site in dsll is 
depicted by two arrows. A binding factor is thought to 
interact with the TATA box. The TK promoter sequences are 
numbered from -120 to beyond the first TK mRNA cap site
at +1.
b) Elements within the gD promoter (Everett 1984a). The 
open boxes labelled G1 and G2 represent the two G-rich 
regions thought to be binding sites of the Spl transcription 
factor. A binding factor is thought to interact with the 
TATA box. The gD promoter sequences are numbered from -75 
to the gD mRNA start site at +1.
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identify regions important for Vmwl75 function, Paterson and 
Everett (1988) constructed insertion and deletion mutants 
in a plasmid-borne gene encoding Vmwl75. These authors 
identified a region, between amino acids (aa) 275 and 490, 
which is important for both E gene trans-activation and IE 
gene repression, and a carboxy terminal (C-terminal) region 
which is important primarily for E gene trans-activation.
The fact that HSV-1 ts-Vmw!75 mutants fail to activate 
E gene expression is an interesting finding in view of the 
ability of VmwllO to independently trans-activate E 
promoters in transient expression assays. The reason for 
this phenomenon appears to be the transdominance of the 
mutant Vmwl75 protein at the NPT. This is evidenced by the 
fact that certain ts-Vmw!75 mutant polypeptides, which fail 
to accumulate in the nucleus, impair nuclear localisation of 
VmwllO (Knipe and Smith, 1986). Further, a different 
ts-Vmwl75 mutant, which localises in the nucleus and does 
not interfere with nuclear localisation of VmwllO, inhibits 
Vtnwl 10-mediated trans-activation of E promoters at the NPT 
(Gelman and Silverstein, 1986). However, the transdominance 
of mutant ts-Vmw!75 proteins may not be the only reason for 
the inability of VmwllO to induce E gene expression. It is 
quite possible that the trans-activating function of VmwllO 
is not strong enough and is therefore inhibited in the 
presence of negative regulators of IE gene expression 
such as MDBP (see Page 21; Godowski and Knipe, 19 86).
The role of VmwllO in productive infection has been 
studied in two HSV-1 recombinants with deletions in both 
copies of IE gene 1 (Stow and Stow, 1986; Sacks and 
Schaffer, 1987). Although the deleted genes had no 
detectable stimulatory effect on E gene promoters in 
transient expression assays (Perry et a l ., 1986; Sacks and 
Schaffer, 1987), mutant viruses were able to grow in tissue 
culture (Stow and Stow, 1986; Sacks and Schaffer, 1987). 
Growth defects were apparent at low m.o.i., where the 
plaquing efficiency of mutants was reduced, whereas at high 
m.o.i. the amount of gene expression and DNA synthesis was 
indistinguisable from wild-type infection (Stow and Stow, 
1986; Sacks and Schaffer, 1987). Thus, it was suggested 
that although VmwllO is not absolutely essential for virus
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growth in tissue culture, it is required for normal virus 
growth at low multiplicity infections. Everett (1987a and
1988) constructed insertion and deletion mutants in a 
plasmid-borne gene encoding VmwllO, recombined them into the 
viral genome, and studied their effects during recombinant 
virus infection. The results showed that VmwllO is required 
at early stages of low multiplicity infections where its 
absence results in insufficient viral gene expression to 
allow productive infection.
Vmw68 and Vmw63 have no stimulatory function on E gene 
transcription either independently or in combination with 
other IE polypeptides (O'Hare and Hayward, 1985b; Everett, 
1986). By contrast, although Vmwl2 does not stimulate 
E gene expression independently, it appears to augment the 
synergistic effect of Vmwl75 and VmwllO (O'Hare and Hayward, 
1985b) .
iv) The mechanism of E gene trans-activation. The 
mechanism by which Vmwl75 and VmwllO trans-activate E gene 
promoters is unknown. It appears that, at least in the case 
of Vmwl75, this process requires the formation of a complex 
between Vwml75 and cellular protein(s); a partially purified 
Vmwl75 preparation failed to bind to DNA in the absence of 
added cellular proteins, but did so in their presence 
(Freeman and Powell, 1982). This complex subsequently 
interacts with the promoter regions of E genes, via the 
cellular proteins, and positively regulates initiation of 
transcription. A partially purified nuclear Vmwl75 
preparation, where Vmwl75 represented 5% of the total 
protein mass, was able to bind to a region flanking the gD 
mRNA start site and stimulated initiation of transcription 
from this promoter in vitro (Beard et a l ., 1986). When this 
Vmwl75 preparation was incubated with an antibody specific 
for Vmwl75, initiation of transcription was significantly 
impaired (Beard et a l ., 1986). Interestingly the same
preparation stimulated transcritpion from the L gC and VP5
promoters whereas it inhibited transcription from the IE 
gene 4 promoter (Pizer et a l ., 1986).
Faber and Wilcox (1986) have identified two regions
in the pBR322 plasmid vector sequences and one in the
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gD promoter (between positions -111 to -81), which are 
preferentially bound by a partially purified Vmwl75 nuclear 
preparation. Alignment of the protected sequences revealed 
a consensus of 5'-ATCGTCNNNNYCGRC-3' (where N=any 
nucleotide, Y=pyrimidine and R=purine) which was suggested 
to be the Vmwl75/cellular factor(s) binding site (Faber and 
Wilcox, 1986). The relationship between this consensus with 
E gene trans-activation or IE gene repression is unclear. 
First, this consensus is not included in the 83bp promoter 
region which is required for fully regulated transcription 
of the gD gene (see Page 22; Everett, 1983 and 1984a).
Second, this consensus is not protected by the 
Vmwl75/cellular protein(s) putative complex in the upstream 
region of IE gene 2 while, the complete consensus or part 
of it are protected in the promoter regions of IE genes 1 
and 3 (Kristie and Roizman, 1986a and b; Muller, 1987). 
Therefore, it appears that binding sites other than that 
proposed by Faber and Wilcox (19 86) might be involved in the 
interaction between DNA and the putative Vmwl75/cellular 
protein(s) complex.
c ) Late gene expression.
L or ^  gene expression requires the presence of 
functional IE genes and, in addition, viral DNA replication 
for maximal expression. L transcripts are first detectable 
at 2h to 3h p.i. and their accumulation peaks at lOh to 16h 
p.i. (Harris-Hamilton and Bachenheimer, 1985). Two groups 
of late genes have been described, the leaky-late or ^1 and 
the true-late or £2 and these are distinguisable by the fact 
that the former are readily detectable before the onset of 
viral DNA replication whereas the latter are barely 
detectable (Roizman and Batterson, 1985; reviewed in Wagner, 
1985 ) .
Johnson and Everett (19 86a) demonstrated that a fusion 
gene, consisting of the true-late US11 gene promoter linked 
to a rabbit {3-globin gene, was expressed, in the presence 
of a functional orig/ with kinetics similar to its viral 
counterpart after infection with HSV-1. Further, the 
appearance of both the fusion and viral genes coincided with 
the onset of viral replication. Expression of this fusion
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gene from plasmids lacking orig was detectable but severely 
curtailed. These findings indicate that DNA replication, 
although not an absolute requirement for activation of a 
true-late promoter, is essential for abundant expression.
It is possible that L gene promoters are relatively weak 
and therefore high copy numbers are required for abundant 
expression. Alternatively, it is possible that DNA 
replication somehow increases L gene expression by 
alteration of the state of the template; however, such an 
interpretation would not explain why only L gene products 
become more abundant after DNA replication and not E gene 
products.
It appears that a functional TATA box and a cap site 
are sufficient promoter elements for maximal US11 expression 
in the presence of orig (Johnson and Everett, 1986b).
Similar sequence requirements have been described for the 
true-late gC gene promoter (Homa et a l ., 19 86).
Activation of L promoters requires IE gene products 
Vhiwl75 and VmwllO (see Fig. 6). HSV-1 ts-Vmwl75 mutant 
viruses fail to induce late gene expression at the NPT 
(Marsden et a l ., 1976; Preston, 1979; Dixon and Schaffer, 
1980; Watson and Clements, 1978 and 1980). Similarly, two 
different _ts-Vmwl75 mutants, which express IE and E genes 
and induce viral DNA synthesis, do not express L gene 
products at the NPT (DeLuca et a l ., 1984). In transient 
expression assays both Vmwl75 and VmwllO have been shown to 
activate L promoters (Everett, 1986; Mavromara-Nazos et a l .,
1986). However, Everett (1986) observed that, although a 
combination of Vmwl75 and VmwllO gave slight activation of 
the true-late VP5 gene promoter expression, addition of 
Vmw63 further increased activation.
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SECTION D,
HSV POLYPEPTIDE SYNTHESIS.
7. Number and Post-Translational Modifications of 
HSV-Encoded Polypeptides.
Following infection of cells with HSV-1, about 
50 novel polypeptides are induced as identified by 
one-dimensional SDS-PAGE analysis (Honess and Roizman, 19 73; 
Marsden et a l ., 19 76). However, two-dimensional 
polyacrylamide gel analysis revealed the existence of some 
230 virus induced polypeptide species a number of which most 
probably are related forms of the same polypeptide (Haar and 
Marsden, 1981). Virus-specific polypeptide synthesis can 
be divided into IE (or/><_), E (or|2>) and L (or ^ )  temporal 
groups. The E polypeptides have been further subdivided 
into groups £31 and £32 and in contrast to £3l, |3>2 synthesis 
requires fully-functional IE gene products (Pereira et al ., 
19 77). The L polypeptides have been subdivided into groups 
^1 and ^2 which are analogous to the early-late and 
true-late mRNAs respectively (see Page 25; Powell and 
Courtney, 1975). Although HSV infection is predominantly 
regulated at the transcriptional level, there is evidence 
that translational regulation also occurs. This is shown by 
the persistence at early and late times p.i. of a relatively 
large amount of HSV-1 IE mRNA 3 (Harris-Hamilton and 
Bachenheimer, 1985) while at the same time Vmwl75 synthesis 
is greatly reduced (Dixon and Schaffer, 1980). The observed 
lack of correlation between mRNA levels and the rate of 
protein synthesis could be due to translational regulation 
although this possibility needs to be further examined 
(Harris-Hamilton and Bachenheimer, 1985).
The failure of some in vitro synthesised HSV 
polypeptides to comigrate with their in vivo counterparts 
on SDS-polyacrylamide gels indicates that they undergo 
certain modifications (Preston, 1977). Four main types 
of modification occur: phosphorylation, glycosylation, 
sulphation and cleavage (Marsden et al., 1982).
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i) Phosphorylation. This is a reaction by which 
phosphate groups are esterified to a serine or a threonine 
residue in the primary structure of the protein, and is 
catalysed by the enzyme protein kinase (see Page 35). 
Approximately 16 HSV-1 and 18 HSV-2 polypeptides are 
phosphorylated (Pereira et a l ., 19 77; Marsden et a l ., 19 78). 
In several of these phosphoproteins the phosphate can cycle 
on and off (Wilcox et a l ., 1980). Vmwl75 is present as 
three species with different electrophoretic mobilities 
termed a, b, and c; species a and c rapidly cycle between 
the phosphorylated and the non-phosphorylated forms
while species b remains stably phosphorylated. Other 
phosphoproteins in which the phosphate cycles on and off 
include Vmw68, Vmw63 and Vmwl36 (Wilcox et a l ., 19 80). 
Phosphorylation has also been shown to change the 
affinity of certain polypeptides for double-stranded DNA; 
for example, the affinity of Vmwl36 is decreased after 
phosphorylation (Wilcox et a l ., 1980).
ii) Glycosylation. Glycosylation is a process 
by which oligosaccharides are covalently attached to 
the polypeptide chain. At least seven HSV-l-induced 
polypeptides are glycosylated (see Page 30). Studies with 
the antibiotic tunicamycin, which blocks the synthesis of 
glycoproteins, demonstrated that in HSV the mechanism of 
oligosaccharide moiety addition to the polypeptide backbone 
is analogous to that of the glycosylation of the VSV 
glycoprotein G (Pizer et al . , 1980; Hope and Marsden, 1983 ). 
In VSV, oligosaccharide-peptide linkages are predominantly 
N-glycosidic where the oligosaccharide core, which contains 
N-acetylglucosamine and mannose, is linked to an asparagine 
residue. However, O-glycosidic linkages between the core 
and serine or threonine residues have also been reported 
(Olofsson et a l ., 1981). Glycosylation appears to occur in 
discrete steps (Haar and Marsden, 1981; Palfreyman et a l ., 
1983 ) .
iii) Sulphation. At late times of infection, 
inorganic sulphate is added to the major glycoprotein
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species (Hope et a l ., 1982; Hope and Marsden, 1983). In 
most cases this is achieved by attachment of the sulphate to 
N-linked oligosaccharide moieties (Hope and Marsden, 1983).
iv) Proteolytic cleavage. Proteolytic cleavage is 
another form of HSV polypeptide modification although the 
mechanism by which it occurs has been poorly investigated. 
Vmwl36 and the IE polypeptides Vmwl75, VmwllO and Vmw63 
induced by the HSV-1 mutant ^tsK at the NPT are degraded to 
lower mol. wt. products (McDonald, 1980). This degradation 
appears to be specific as it does not occur in the presence 
of protease inhibitors. The Vmwl36 polypeptide has been 
shown, by tryptic peptide mapping, to give rise to products 
of 100,000 mol. wt. and 90,000 mol. wt. which are found 
in the nucleus of infected cells while the polypeptide 
is itself predominantly cytoplasmic (McDonald, 1980). 
Likewise, Ingemarson and Lankinnen (19 87) reported that 
Vmwl36 is proteolytically digested to products with 
mol. wts. of 110,000, 93,000 and 81,000. The maturation 
of HSV glycoproteins also involves proteolytic cleavage. 
Eisenberg et a l . (19 84) demonstrated that 25 amino acids
from the translation product of gD were missing from the 
mature glycoprotein isolated from HSV-infected cells; the 
missing stretch of amino acids, which includes the entire 
amino terminal (N-terminal) hydrophobic domain, is thought 
to constitute the signal sequence which is found at the 
N-terminus of many transmembrane and secreted proteins.
8. Structural Polypeptides.
a ) Virion polypeptides.
Approximately 33 HSV-1 polypeptides have been 
designated as structural components of the virion (Spear 
and Roizman, 1972; Marsden et a l ., 1976). The nucleocapsid 
contains seven polypeptides ranging in mol. wt. from 12,000 
to 155,000. Immune electron microscopy revealed that the 
major capsid protein, Vmwl55, was distributed over the
entire capsid surface whereas polypeptide Vmw50 appeared 
to be located at the capsid vertices (Vernon et a l ., 1981).
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It is quite possible that these two polypeptides bind within 
the capsid structure with disulphide bonds. A third virion 
polypeptide, Vmw40 or p40, also was located over the capsid 
(Vernon et al ., 1981), possibly at positions interior 
to those of Vmwl55, and this protein appears to form 
disulphide-linked complexes, the constituents of which are 
not resolved. Gibson and Roizman (1972) have suggested 
that this protein could be involved in DNA encapsidation 
and this was strengthened by the observation that p40 covers 
the surface of DNA-containing capsids (full nucleocapsids) 
but not of empty ones (Braun et a l ., 1984). However, recent 
immune electron microscopy studies, using two different 
monoclonal antibodies, have localised p40 on the surface 
of partially-cored rather than full nucleocapsids (Rixon et 
al., 1988).
Located in the tegument of the herpesvirion, of note 
are a large polypeptide of 273,000 mol. wt. (Heine et al .,
19 74), the function of which is unclear, and the Vmw65 
protein which is responsible for the trans-induction of IE 
gene transcription (see Page 19). In addition, the presence 
of a protein kinase activity in capsid-tegument structures 
has been described (Lemaster and Roizman, 1980), although, 
similarities between this activity and the host ccvs&in 
kinase II suggest that this enzyme may not be virus-encoded 
(Stevely et a l ., 1985).
b ) Envelope polypeptides.
The virus particle has an external lipid envelope 
(Wildy et a l ., 1960) which, although is normally acquired 
by budding of the intranuclear particles through the host 
cell inner nuclear membrane (Darlington and Moss, 1968), 
is enriched for virus specific glycoproteins (Spear and 
Roizman, 1972; Heine et a l ., 1972; Honess and Roizman,
1975). At least seven HSV-1 glycoproteins have been 
identified, designated B, C, D, E, G, H, and I (reviewed 
in Marsden, 1987; Longnecker et a l ., 1987; McGeoch et al .,
1987) all of which are present
in virions (Spear, 1976; Para et a l ., 1980; Buckmaster et 
al. , 1984; Frame et a l ., 1986a; Richman et al ., 1986 ). 
Immunoprecipitation studies using type common antibodies
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have shown that HSV-2 induces equivalent polypeptides to 
gB, gC, gD, gE and gG (reviewed in Marsden, 1987).
9. HSV-Induced Enzymes.
HSV induces a number of enzyme activities which are 
involved in nucleotide metabolism, and either directly or 
indirectly in DNA replication.
a ) Enzymes involved in DNA metabolism.
i) Ribonucleotide reductase. This enzyme catalyses 
the reduction of ribonucleoside diphosphates to the 
corresponding deoxyribonucleoside diphosphates and its 
properties are described in Section E.
ii) Thymidine kinase. The cellular enzyme catalyses 
the synthesis of deoxypyrimidine nucleotides from preformed 
nucleosides, which are the products of cell death or 
catabolic activity. Kit and Dubbs (1963) first described 
such an HSV-induced activity with properties different from 
those of the host cell enzyme. The HSV enzyme, originally 
thought to phosphorylate only thymidine, was shown in 
addition to phosphorylate deoxycytidine and was thus 
characterised as a deoxypyrimidine kinase (Jamieson et a l ., 
1974; Jamieson and Subak-Sharpe, 1974). By contrast,
PRV and vaccinia virus (VV) specify only a thymidine 
phosphorylating activity while equine abortion virus (EAV) 
does not induce either activity (Jamieson et a l ., 1974).
The two HSV phosphorylating activities appear to be 
catalysed by the same active site although they are quite 
distinct in their biochemical behaviour (Jamieson and 
Subak-Sharpe, 1974). Further, the HSV-induced enzyme 
appears to be associated with a phosphotransferase activity 
which can utilize AMP as phosphate donor to convert 
thymidine to thymidylate (Jamieson et a l ., 1976).
The active enzyme is a dimer consisting of two 
identical subunits of 42,000 mol. wt. (Honess and Watson, 
1974; Jamieson and Subak-Sharpe, 19 78). Jamieson et a l . 
(1974) demonstrated that it was indispensable for virus
growth in serum-starved cells but not in actively growing 
ones indicating that such an activity is required only when 
the de novo metabolism of the host cell is low.
iii) Deoxyuridine triphosphatase (dUTPase). After 
infection, HSV specifies a novel dUTPase activity (Wohlrab 
and Franke, 1980) which is virus-encoded (Preston and 
Fisher, 1984). This enzyme catalyses the reduction of dUTP 
to dUMP and pyrophosphate; in the host cell, the role of 
this enzyme is to reduce the intracellular concentration
of dUTP by reducing it to dUMP. Subsequently, dUMP can be 
methylated to dTMP by the enzyme thymidylate synthetase.
The HSV-l-induced dUTPase has a mol. wt. of 53,000 
(Williams, 1984) and has been shown not to be essential for 
virus growth in cultured cells (Fisher and Preston, 1986). 
Recently, William and Paris (1987) have reported that HSV-2 
induces a dUTPase activity utilising dUTP as a substrate 
and that this activity differs biochemically from the 
HSV-l-induced activity. It appears that HSV, as well as, 
HCMV, PRV and EBV do not encode a thymidylate synthetase, 
although HVS and VZV do (Davison and Scott, 1986b; Honess ot 
al., 19 86; Thompson et a l ., 19 87). This could be due to the 
fact that both HVS and VZV have A+T-rich genomes which 
indicates a possible greater requirement for thymidylate 
synthesis.
iv) Uracil-DNA qlycosylase. During replication
when a cytosine residue in DNA loses its amino group a
uracil:guanosine mispair occurs which can lead to a
guanosine:cytosine to adenine:thymine transition mutation.
The function of the cellular enzyme is the removal of
deaminated cytosine residues from DNA thus reducing
transition mutations. In HSV-infected cells, this activity
appears to be virally encoded and differs biochemically from
the host cell enzyme (Caradonna and Cheng, 1981; Caradonna
et a l ., 1987). Initial mapping data suggested that it is
located at the left portion of U r (Caradonna et al., 1987)
L i
and recent evidence strongly suggests that the gene encoding 
the glycosylase is UL2 (see Fig. 2; J. Mullaney, personal 
communication).
33
b ) Enzymes involved in DNA replication.
i) DNA polymerase. Keir and Gold (19 63) demonstrated 
that HSV-1 induced a DNA polymerase activity which was 
stimulated by high salt concentration (Keir et a l ., 1966). 
The viral enzyme is distinct from the host cell enzyme
not only immunologically (Keir et_al. , 1966), but also 
biochemically by virtue of its 3 1 to 5' exonuclease activity 
and by its sensitivity to low concentrations of 
phosphonoacetic acid (PAA) a pyrophosphate analogue 
(Knopf, 1979; Leinbach et a l ., 1976). The HSV-1 enzyme 
consists of a single polypeptide chain of 150,000 mol. wt. 
(Powell and Purifoy, 1977) and in vitro it is active as a 
monomer (Knopf et a l ., 19 79). Mutations within this gene 
have shown that it is essential for viral DNA replication 
(Purifoy et a l ., 1977).
Purified preparations of the HSV-2 DNA polymerase 
often contained a polypeptide of 54,000 mol. wt. designated 
ICSP 34,35 (Powell and Purifoy, 1977; Knopf, 1979; Vaughan 
et a l ., 19 85). This polypeptide has been shown to be the 
HSV-2 counterpart of the HSV-1 65K described on Page 13
UtSF
(H.S. Marsden, personal communication).
ii) DNA primase. Recently, Holmes et a l . (1988) 
reported a novel HSV-1 primase activity which co-eluted with 
a portion of the HSV-1 DNA polymerase from single-stranded 
DNA agarose columns loaded with high-salt infected cell 
extracts. This activity was biochemically distinct from 
host HeLa cell DNA primase, did not cross-react with 
polyclonal antibodies raised against the calf thymus DNA 
polymerase/primase complex and appeared to be coupled with 
the HSV-1 DNA polymerase. The approximate mol. wt. of this 
novel activity is 40,000 (Holmes et a l ., 1988).
iii) Alkaline exonuclease (AE). A novel alkaline 
exonuclease activity is induced following HSV-1 (Morrison 
and Keir, 1968; Strobel-Fidler and Franke, 1980) and HSV-2
infection (Hay et al ., 1971; Hoffmann and Cheng, 1979) 
with properties different from those of cellular nucleases.
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This enzyme, in addition to its 5 1 and 3 1 exonuclease 
activities, has been shown to possess an endonuclease 
activity (Hoffmann and Cheng, 1979; Hoffmann, 1981).
Marker rescue experiments, using an HSV-2 ts-AE virus 
(Moss et a l ., 19 79), and in vitro translation in Xenopus 
laevis oocytes (Preston and Cordingley, 1982) suggest that 
this enzyme is virally encoded and corresponds to 
polypeptide Vmw85 (Marsden et a l ., 1978). Moss (1986) 
demonstrated that the AE activity is essential for virus 
replication as a ts-AE mutant exhibited considerably reduced 
levels of virus DNA synthesis and growth at the NPT.
iv) Topoisomerase. DNA topoisomerases are enzymes 
that transiently break the phosphodiester backbone of 
DNA and then rejoin the free DNA ends. To date, all 
topoisomerases can be divided into two categories. Type I 
enzymes catalyse the breaking and rejoining of only one 
strand of DNA at a time, whereas, type II enzymes appear 
to introduce transient double-strand breaks (reviewed in 
Gellert, 1981). Both classes relax supercoiled DNA although 
the reaction mechanisms are clearly different (Brown and 
Cozzarelli, 1981) and each enzyme class can be distinguished 
by reaction cofactor requirements. Biswal et a l ., (1983) 
first reported an HSV-induced topoisomerase activity which 
copurified with the DNA polymerase through several 
chromatographic steps. By contrast, Muller et a l . (1985) 
suggested that the HSV-1 topoisomerase activity, which these 
authors classified as type I, was a component of the virion 
envelope or the tegument. Further studies with antibodies 
specific for the cellular and putative viral topoisomerase 
activities will be required to resolve the localisation of 
the enzyme and its role in replication.
c ) Interactions between HSV-1 enzymes involved in
DNA replication.
There is both biochemical and genetic evidence 
that at least four virus-encoded polypeptides form a 
functional complex which is involved in DNA replication.
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The constituents of this putative complex are DNA 
polymerase, AE, 65KDfip, and M D B P . The latter is a virus 
induced protein of 128,000 mol. wt. and its in vitro 
properties include the ability to dissociate double-stranded 
DNA (Powell et a l ., 1981), to stimulate the activity of the 
HSV-encoded DNA polymerase activity and to preferentially 
bind single-stranded DNA (Kuyechan and Weir, 1984). The 
MDBP has been shown to be essential for virus replication 
(Weller et a l ., 1983). Vaughan et a l . (1984) using 
monoclonal antibodies against the MDBP, 65KDfip, and AE 
demonstrated the existence of: i) two very strong binding
complexes, the first between MDBP and AE and the second 
between DNA polymerase and 65KDpp, and ii) an intermediate 
strength association between MDBP and 65KDBp.
The first genetic evidence of the existence of such a 
functional complex in vivo involved studies with ts virus 
mutants (Littler et a l ., 1983). These authors demonstrated 
that two HSV-2 ts-MDBP mutant viruses severely restricted 
DNA polymerase and AE induction in infected cells. 
Furthermore, ts mutations in MDBP induced secondary 
mutations within the DNA polymerase gene which altered its 
sensitivity to PAA (Chiou et a l ., 19 85). These secondary 
mutations could possibly restore the functional interaction 
between the DNA polymerase and the altered MDBP.
10. Other HSV-induced Enzyme Activities.
During lytic infection of cells by HSV, 
virus-induced protein kinase activities have been detected. 
DNA sequencing studies revealed that the predicted primary 
structure of the US3 gene product of both HSV serotypes 
(McGeoch et a l ., 1985 and 1987) and the corresponding gene 
of VZV (Davison, 19 83) were clearly homologous to members 
of the protein kinase family of eukaryotes (McGeoch and 
Davison, 1986b). Frame et a l . (1987) demonstrated, 
by means of rabbit antisera raised against an octapeptide 
corresponding to the eight C-terminal amino acids of the 
predicted US3 gene sequence, that the product of this gene 
is indeed a protein kinase.
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The substrate specificity of the HSV-induced enzyme 
has been shown to be broadly similar to that of the 
PRV-induced enzyme which phosphorylates serine and threonine 
residues (Purves et a l ., 1986). The main conclusions 
regarding the site specificity of the PRV enzyme, as deduced 
by phosphorylation studies with oligopeptide substrates, 
are: i) basic residues, preferably arginines, must be
present at the N-terminal side of the target residue and
ii) at least two basic N-terminal residues are required, 
whereas, additional ones have a further positive effect. 
Additional requirements for maximal phosphorylation include 
the need for the N-terminal arginines to be displaced from 
the target serine or threonine residue for optimal effect, 
hydrophobic residues at the N-terminal side of the target 
residue may cause a decrease in phosphorylation; finally, 
proline residues adjacent to the target residue on the 
N-terminal side increase phosphorylation, whereas, on the 
C-terminal side they decrease it (Purves et a l ., 1986).
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SECTION E .
RIBONUCLEOTIDE REDUCTASES.
11. General Background.
a ) Mechanism of the reaction.
Ribonucleotide reductase (EC 1.17.4.1) catalyses the 
reduction of all four ribonucleotides to the corresponding 
deoxyribonucleotides, the hydroxyl group at the 2' position 
of the ribonucleotide ribose moiety being substituted with 
a hydrogen, and NADPH being the ultimate hydrogen donor 
(Fig. 8; Thelander and Reichard, 1979; Reichard and 
Ehrenberg, 1983). This reaction is the first unique step 
in the de novo pathway of DNA biosynthesis.
b) Hydrogen donor systems.
Efforts to identify the physiological hydrogen donor 
in this reaction resulted in the discovery of two novel 
types of hydrogen carrier systems, the thioredoxin and the 
glutaredoxin systems.
i) The thioredoxin system. This system was originally 
discovered in Escherichia coli (E. coli; Laurent et a l ., 
1964); it consists of two small proteins, thioredoxin and 
thioredoxin reductase, and utilizes NADPH as a hydrogen 
donor. The E. coli thioredoxin is an enzyme of 11,700 mol. 
wt. and contains two redox-active cysteine residues 
(Holmgren, 1968), located on a protrusion of the active 
centre of the enzyme (Holmgren et a l ., 1975). The reduced 
form of thioredoxin serves as an efficient hydrogen donor 
for ribonucleotide reductase while the oxidised form is 
reduced in the cell by the enzyme thioredoxin reductase at 
the expense of NADPH. Thioredoxin reductase consists of 
two, probably identical, subunits each of which has one 
tightly bound FAD molecule and a redox-active disulphide in 
its active centre (Thelander, 1968; Ronchi and Williams, 
1972). Overall, the function of this system involves a
SH
RR\ SH
Base
OHOH
RR. I 
X S
Base
OH
Figure 8 . Reduction of a ribonucleotide to a 
deoxyribonucleotide by ribonucletide reductase (RR).
RR-(S H )2 and RR-S2 represent the reduced and oxidised forms 
of ribonucleotide reductase respectively. P denotes a 
diphosphoryl or triphosphoryl nucleotide.
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shuttle transfer of electrons from NADPH to the substrate 
via a system of redox-active disulphides as shpwn in Fig. 9 
(reviewed in Thelander and Reichard, 1979)
Mammalian cells specify a thioredoxin system, 
comprising a thioredoxin reductase and a thioredoxin, 
similar to that of E. coli. Bacteriophage T4 encodes a 
thioredoxin but not a thioredoxin reductase; oxidised T4 
thioredoxin can be reduced by the host cell thioredoxin 
reductase (Berglund et a l ., 1969; Berglund, 1969).
Further, T4-induced thioredoxin can also be reduced by the 
glutathione system (see below) and thus appears to be a 
functional hybrid between these two hydrogen donor systems 
(Holmgren, 1978). Although the primary structure of the 
T4-induced and E. coli thioredoxins are not homologous 
(Sjoberg and Holmgren, 1972), their three-dimensional 
structures display large similarities (Sodenberg et a l ., 
1978; Hoog et a l ., 1983). Attempts to identify the 
principal hydrogen donor for the HSV-1-induced 
ribonucleotide reductase resulted in the purification of 
a protein, present in both infected and mock-infected 
extracts, with similar physical characteristics to the 
cellular thioredoxin (Darling, 1988); this result, in 
conjunction with the lack of DNA sequence-evidence for the 
existence of a virus-induced thioredoxin, suggests that 
HSV-1 utilises the cellular enzyme as a hydrogen donor.
ii) The glutaredoxin system. This system was 
identified in an E. coli mutant which was unable to 
replicate bacteriophage T7 DNA, failed to express any 
detectable level of thioredoxin and, at the same time, 
displayed no decreased capacity to reduce ribonucleoside 
diphosphates (NDPs) in vitro as compared to the wild-type 
(Holmgren, 1976). The glutaredoxin system consists of 
glutathione, glutaredoxin, and glutathione reductase 
and utilizes NADPH as a hydrogen donor. The E. coli 
glutaredoxin is an enzyme of 11,600 mol. wt. and contains 
two redox-active cysteine residues (Holmgren, 1979a). This 
system functions as shown in Fig. 10 (Holmgren, 1979b).
It is not known which of these two systems is 
functional in vivo; it is possible that both systems
GR G R R
NADPH GSSGy . G- (SHL RR-^ y  , dNDP
NADP+ r \  2GSH ' ^  G-S2 /  \ r -( SH)/ ^  NDP
Figure 10. Reduction of a ribonucleoside diphosphate (NDP) 
to a deoxyribonucleoside diphosphate (dNDP) with the E. coli 
glutaredoxin system. The diagram shows the involvement of 
proteins, with oxidation-reduction active sulhydryl groups, 
in the shuttle electron transfer from NADPH to the NDP. The 
reactions catalysed by glutaredoxin reductase (GR), 
glutaredoxin (G) and ribonucleotide reductase (RR) are 
indicated above the diagram. The reduced forms of GR, G and 
RR are indicated by GR-(SH)2 , G-(SH)2 and RR-(SH)2 while 
the oxidised forms are indicated by GR-S2 , G-S2 and RR-S2 
respectively.
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substitute for each other under different growth conditions.
c ) Classification of ribonucleotide reductases.
Studies on ribonucleotide reductases of prokaryotic, 
eukaryotic and viral origin have suggested that three 
different classes of enzyme exist. Class I, which is 
represented by the enzyme from Lactobacillus leichmannii, 
is monomeric and is found in several prokaryotes and in 
a few eukaryotes. Class II is represented by the E. coli 
enzyme and consists of two non-identical homodimeric 
subunits. This type is found in some prokaryotes, most 
eukaryotes and animal viruses. Finally, class III enzymes 
resemble those of class II in structure but differ from them 
biochemically. This class is found in a number of gram 
positive bacteria. The following part of Section E will 
mainly describe class I and II enzymes which are the best 
characterised.
12. Monomeric Ribonucleotide Reductases.
As already mentioned, the monomeric ribonucleotide 
reductases are represented by the Lactobacillus leichmannii 
enzyme which consists of a single polypeptide chain of
76,000 mol. wt. (Fig. 11; Panagou et al., 1972; Chen et a l ., 
1974). The enzyme has a single regulatory site which binds 
the deoxyribonucleoside triphosphate (dNTP) allosteric 
effectors (Singh et al., 19 77). It is assumed that the 
enzyme has a single catalytic site which binds the 
ribonucleoside triphosphate (NTP) substrates. The existence 
of the latter has not been shown using direct binding 
studies with substrates; however, kinetic experiments showed 
that the best substrate, GTP, binds with a Km as high as
0.24mM (Vitols et al., 1967). Chen et al. (1974) 
demonstrated that the substrates are also able to bind to 
the regulatory site although their affinity is 100 to 1,000 
lower than that of the effectors.
The activity of this class of enzymes is absolutely 
dependent on the presence of adenosylcobalamine (AdoCbl,
B12-coenzyme). AdoCbl binds directly to the polypeptide 
chain and is dependent on effector binding to the regulatory
dATP
dGTP
dTTP
dCTP
SH SH
RS CS
GTP
CTP
TTP
ATP
AdoCbl
Figure 11. A schematic representation of the proposed 
structure of the Lactobacillus leichmannii ribonucleotide 
reductase. The enzyme is depicted as a monomeric protein 
(hatched region) with a single regulatory site (RS) which 
binds the allosteric deoxyridonucleoside triphosphate 
effectors (E) indicated. The enzyme's single catalytic site 
(CS) contains the active sulphydryl groups (SH) and binds 
the ribonucleoside triphosphate substrates (S) shown. The 
CS is also depicted to bind adenosylcobalamine (AdoCbl).
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site (Singh et al., 19 77). It is thought that AdoCbl 
functions in a manner similar to that of the class II enzyme 
subunit which contains the iron centre and the tyrosyl free 
radical (see below; Ashley et al., 19 86).
It is proposed that the enzyme's activity is only 
positively regulated as no strong negative effectors have 
been found (Goulian and Beck, 1966; Vitols et al., 1967; 
Follman and Hogenkamp, 1971). Binding of the positive 
effectors dATP, dCTP, dTTP and dGTP results in reduction 
of the CTP, (JTP, GTP, and ATP substrates respectively 
(Vitols et al., 1967).
13. Oligomeric Ribonucleotide Reductases.
a ) The E. coli enzyme.
The E. coli ribonucleotide reductase is a dimeric
enzyme consisting of two non-identical subunits, B1 and B2
(Fig. 12; Brown and Reichard, 1969a). The respective
polypeptides are encoded by the nrdA and nrdB genes
(Fuchs and Karlstrom, 19 76) which are located at adjacent
regions on the E. coli chromosome (Bachmann et al., 1976;
Yamada et al., 19 82). The active enzyme consists of the B1
and B2 subunits bound in a 1:1 stoichiometry in the presence 
2 +of Mg (Brown et al., 1967; Brown and Reichard, 1969a; 
Thelander, 19 73). This binding is rather weak and the 
two subunits easily dissociate during purification.
i) The B1 subunit. This subunit is a dimer of two 
identical polypeptides (a^) and has a mol. wt. of 160,000 
(Thelander, 1973). Each B1 subunit contains two catalytic 
sites which bind the NDP substrates (von Dobeln and 
Reichard, 1976), and two types of different regulatory 
sites, each type consisting of two sites, which bind the 
allosteric effectors (Brown and Reichard, 1969b).
The catalytic sites. Binding studies with separated 
B1 and B2 subunits showed that only B1 has the capacity 
to bind substrates, indicating that the catalytic sites 
are positioned on B1 (von Dobeln and Reichard, 19 76).
In addition, these authors proposed that all four substrates
ATP
dATP
©
E
ATP
dATP
dTTP
dGTP SH CS
RSh B1 subunit
B2 subunit
Figure 12. A schematic representation of the proposed
structure of the E. coli ribonucleotide reductase. The
enzyme is depicted as a dimer of the B1 and B2 subunits,
each consisting of two identical polypeptides. The Bl
subunit contains two catalytic sites (CS) which contain the
active sulphydryl groups (SH), and bind the ribonucleoside
diphosphate substrates. The regulatory sites (RS) bind the
allosteric effectors (E) shown, and are separated in low (1.)
and high (h) dATP-affinity sites. The B2 subunit contains
the tyrosyl radical (•), which is depicted to conform to
3+ 2 3 +half-site reactivity, and the iron centre (Fe -0 -Fe ).
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bind to the same site since they are equally competitive for 
binding. However, as depicted in Fig. 12, the catalytic 
site, in order to reduce substrates, requires the presence 
of the active sulphydryl groups provided by two cysteine 
residues which are located exclusively on B1 (Thelander,
1974). B2 alone cannot reduce the substrates even after 
incubation with dithiothreitol to increase its sulphydryl 
active content. Furthermore, reduction of substrates 
requires the stable free radical which is provided by B2 
(see below; Thelander, 1974; Ehrenberg and Reichard, 1972). 
In conclusion, although substrate binding takes place in B1, 
the active catalytic site itself is composed by elements 
from both subunits.
The allosteric sites. Brown and Reichard (1969b) 
proposed that the allosteric sites can be separated into 
two types on the basis of their affinity for dATP-effector 
binding; the h sites with high affinity (K^=0.03uM) and the 
1 sites with low affinity for this effector (K^=0.1-0.5uM). 
Competition experiments demonstrated that the h sites also 
bind ATP, dTTP, and dGTP, while, the 1_ sites bind only ATP 
in addition to dATP (Brown and Reichard, 1969b).
ii) The B2 subunit. This subunit is a dimer of two 
identical polypeptides (b^) and has a mol. wt. of 78,000 
(Thelander, 1973). The B2 subunit has two important 
elements namely, the iron binuclear centre and the stable 
free radical.
The iron centre. The E. coli B2 subunit contains two 
non-heme iron atoms which can be removed after prolonged 
dialysis against 8-hydroxyquinoline (Brown et al., 19 69). 
These are in an antiferromagnetically coupled binuclear 
complex and most possibly are liganded with an p-oxo-group 
(Atkin et al., 1973; Petersson et al., 1980; Sjoberg et al.,
1980). Sjoberg et al., (1985) proposed that the E. coli 
iron centre is of the same type as in h emerythrin, where 
the two iron atoms are liganded by one glutamic acid, one 
aspartic acid and five histidine residues (Stenkamp et al .,
1981).
The stable free radical. The E. coli B2 subunit 
contains a stable free radical as part of its structure
1e to B2 2e to
tyrosyl leaving
radical 0H~
1e from 
active site 
tyrosine,
2e from 
B1 thiols
^  v4c ^  rv^ - vri -
OH OH OH OH OH + OH OH H
I r—
Substrate IMI IMII Product
Figure 13. The proposed involvement of the E. coli 
ribonucleotide reductase radical in the reduction of a 
ribonucleotide to the corresponding deoxyribonucleotide 
(see text). The diagram depicts the substitution of the 
2' OH group of the substrate ribose moiety with a hydrogen 
in the product. The balance of electrons (e) is shown and 
the radical is depicted by (•). IMI and IMII indicate the 
intermediate states I and II.
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(Ehrenberg and Reichard, 1972). The radical can be 
destroyed after treatment with hydroxyurea or hydroxylamine 
which are powerful radical scavengers; they most probably 
act by donating an electron to the radical (Ehrenberg and 
Reichard, 19 72 ) .
Isotope substitution experiments located the radical 
to a tyrosine (Sjoberg et al ., 1977) with its spin density 
delocalised over the aromatic ring of the residue (Sjoberg 
et al., 1978). This tyrosine was identified by site 
directed mutagenesis (Larsson and Sjoberg, 1986); 
substitution of it with a phenylalanine produced a mutant 
B2 protein which showed an electron paramagnetic resonance 
(EPR) spectrum identical to that of the host cell, and was 
less than 2% active as compared to the wild-type B2.
Sjoberg et al ., (1987) found a truncated form of B2 dimers
(b^)* lacking the 29 C-terminal amino acids, which resulted 
from limited proteolysis of the normal B2(b^) dimers. 
Although the B2(b'2) subunit had normal tyrosyl radical 
content and a normal iron centre, it had no enzymatic 
activity as it failed to bind the B1 subunit (Sjoberg et 
al., 1987). Further, by mixing B2(b^) and B2(b'2) 
populations, these authors isolated a heterodimeric form of 
B2 with a bb' structure which could weakly bind B1 and the 
resulting B1(a2 )B2(bb') enzyme had low activity. Using this 
mutant enzyme, they proposed that the tyrosyl radical is 
randomly generated in either one or the other of the two 
polypeptides in B2(bb'), thus conforming to half-site 
reactivi ty.
The main involvement of the radical in the reaction is 
the transient transfer of the unpaired electron from the 
enzyme to the substrate. Sjoberg et al. (1983) proposed a 
scheme for this reaction (Fig. 13). First, the radical 
abstracts the hydrogen atom at the 3' position of the 
substrate ribose moiety. The 3' electron is captured by the 
radical and this results in the conversion of the 
radical-containing tyrosine residue to a normal tyrosine 
residue and in the formation of substrate intermediate state
I. Second, the presence of the radical at the 3* position 
destabilises the ribose moiety which rapidly rearranges by 
releasing the hydroxyl group from 2' position thus resulting
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in intermediate state II. Third, donation of two electrons 
from the B1 subunit active sulphydryls and one electron from 
the tyrosine results in formation of a deoxyribose moiety 
and concomitant regeneration of the radical in the B2 
tyrosine residue.
It is unusual to find a stable free radical as an 
integral part of an enzyme. Atkin et al. (1973) proposed 
that the iron centre appears to generate and stabilise 
the radical since when it is chelated out of the protein 
the radical is also lost. Recovery of the iron centre, 
by addition of ferrous iron in the presence of oxygen, 
regenerates the radical as well (Atkin et al., 19 73).
In contrast, destruction of the tyrosyl radical with 
hydroxyurea does not destroy the iron centre, and 
reconstitution of the former requires chelation and 
subsequent reconstitution of the iron centre. In 
conclusion, the enzymatic activity of B2 depends upon the 
presence of the radical which in turn depends upon the 
presence of the iron centre.
iii) Allosteric regulation. Allosteric control of 
the E. coli ribonucleotide reductase has been extensively 
studied. The overall enzyme activity and substrate 
specificity are regulated by the allosteric effectors 
(Brown and Reichard, 1969b). As described above, there are 
two types of binding sites the 1. and h. The _1 sites 
regulate the level of overall activity of the enzyme since 
binding of ATP activates the enzyme, whereas, binding of 
dATP leads to inactivation which can be reversed by the 
addition of ATP. dATP inhibition is accompanied by the 
formation of complexes (dimers) which contain equimolar 
amounts of the Bl and B2 subunits and have a sedimentation 
coefficient of approximately 15.5S while the active enzyme 
has a coefficient of 9.7S (Brown and Reichard, 1969a). The 
h sites regulate the substrate specificity of the enzyme; 
binding of any effector to these sites results in a 
conformational change of the catalytic site which leads 
to preferential binding of the appropriate substrate
(Brown and Reichard, 1969b).
In vitro binding studies, performed by Larsson and
CDP
UDP
GDP
ADP
ATP
-► dCDP -► dCTP
-► dUDP dTTP
ATP
dGDP dGTP
» dADP dATP
-► DNA
Figure 14. Allosteric control of the E. coli ribonucleotide 
reductase. Substrates and reaction products are shown, with 
the direction of reaction pathways indicated by 
thick-arrowed lines. Reactions inhibited by the negative 
effectors are shown by open bars; dashed lines indicate 
reactions stimulated by positive effectors.
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Reichard (1966a,b), demonstrated that in the absence of 
effectors the enzyme activity is low whereas addition of low 
concentrations of dTTP stimulates reduction of all four 
substrates. Addition of ATP or low concentrations of dATP 
selectively stimulates reduction of CDP and UDP, whereas, 
the presence of dGTP stimulates reduction of ADP and, to a 
lesser extent, GDP. These conditions refer to the situation 
where the enzyme has only its h sites occupied; however, in 
vivo, in all probability, the 1 sites are at the same time 
occupied with either ATP or dATP and the ratio of their 
concentrations determines the activity of the enzyme. 
Therefore, it is proposed that in vivo three active and one 
inactive enzyme states exist (reviewed in Thelander, 1969). 
When ATP is bound to the 1 sites, binding of either ATP, or 
dTTP, or dGTP to the h sites will respectively reduce CDP or 
UDP, GDP (and ADP) and finally ADP (and GDP). When dATP is 
bound to the _L site, the enzyme is inactive irrespective of 
effector binding to the h site.
These findings can be summarised into the following 
scheme that links ribonucleotide reduction to DNA synthesis 
(Fig. 14; reviewed in Reichard, 1978). Deoxyribonucleotide 
synthesis begins with the reduction of pyrimidine substrates 
(CDP, UDP) by an ATP-activated enzyme. Subsequently, a 
dTTP-activated enzyme reduces GDP and a dGTP-activated 
enzyme reduces ADP. Accumulation of dTTP shuts off 
pyrimidine substrate reduction whereas accumulation of dGTP 
shuts off both pyrimidine and GDP substrate reduction. 
Finally, dATP shuts off reduction of all four substrates.
b ) Bacteriophage-induced enzymes.
Infection of E. coli with bacteriophages T2, T4, T5, 
and T6 results in the appearance of a new ribonucleotide 
reductase activity (Cohen and Barner, 1962; Biswas et al., 
1965; Berglund et al., 1969; Eriksson and Berglund, 1974).
In contrast T7 and 2\ not synthesise a novel enzyme 
during infection (Eriksson and Berglund, 1974). The 
T4-induced enzyme, which is the most well studied, has a 
mol. wt. of 225,000 and is composed of two subunits called 
T4B1 and T4B2 (Fig. 15; Berglund, 1972a). In contrast to 
the E. coli enzyme, the T4 subunits form a very tight
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complex (Berglund, 1972a).
i) The T4B1 subunit. This subunit is a dimer of two
identical polypeptides ( oC ) each of which has a mol. wt.
2
of 85,000 (Berglund 1972a and 1975). This subunit contains, 
possibly, a single catalytic site which binds the NDP 
substrates and, possibly, two types of allosteric sites, one 
with low and one with high affinity for dATP; the latter 
binds in addition ATP, dTTP, and dGTP (Berglund, 1972b).
Cook and Greenberg (19 83) demonstrated that a T4B1 amber 
mutant (nrdA67) lacking the C-terminal amino acid sequences, 
encoded a truncated polypeptide of 50,000 mol. wt. which 
failed to bind to dATP affinity columns. Therefore, these 
authors suggested that either the C-terminus contains the 
allosteric site or that it is essential for the tertiary 
structure of that site which is located elsewhere along 
the polypeptide backbone.
ii) The T4B2 subunit. This subunit is also a dimer 
and consists of two identical polypeptides ( p>2 ) each of 
which has a mol. wt. of 34,500 (Berglund, 1972a and 1975; 
Cook and Greenberg, 19 83). Sjoberg et al . (19 86) sequenced 
the region between 136.lkb and 137.8kb positions on the T4 
genetic map and identified a putative open reading frame 
(ORF) which exhibited 47% amino acid homology to the E. coli 
nrdB gene product. On the basis of this homology, these 
authors suggested that this ORF encoded the T4B2 subunit and 
called it the T4nrdB gene. Further, they suggested that an 
approximately 625 base intron divided the gene in two parts. 
The proposed exon-intron boundary at the 5' splice donor 
site ends with a TAA stop codon and the intron-exon boundary 
of the 3' splice acceptor site has an ATG codon. These 
intron boundaries were proposed on the basis of homology 
with those of the well characterised intron of the adjacent 
T4 thymidylate synthetase gene (td gene; Chu et al., 1984).
The T4B2 subunit contains two non-heme iron atoms per 
molecule whose optical and EPR spectra are very similar to 
those of the E. coli B2 iron centre (Berglund, 19 72a and
1975). The iron atoms are essential for activity since 
their removal results in loss of activity. This subunit
ATP
dATP
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ATP
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dTTP
;dGTP
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T4B2 subunit
Figure 15 . A schematic representation of the proposed
structure of the bacteriophage T4 ribonucleotide reductase.
The enzyme is depicted as a dimer of the T4B1 and T4B2
subunits. The T4B1 subunit contains two catalytic sites
(CS) which contain the active sulphydryl groups (SH) and
bind the ribonucleoside diphosphate (NDP) substrates. The
regulatory sites (RS) bind the allosteric effectors (E)
shown and are separated in low (1) and high (h)
dATP-affinity sites. The T4B2 subunit contains the tyrosyl
radical (•), which is depicted to conform to half-site
3 + 2 3 +reactivity, and the iron centre (Fe -0 -Fe ).
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also contains a free radical which is located on a tyrosine 
residue with its spin density delocalised over the aromatic 
ring (Berglund, 1972a; Sahlin et a l ., 1982). The EPR 
spectra profiles of the bacterial and bacteriophage radicals 
are overall similar although small differences occur. These 
have been attributed to the different geometry of the 
radicals due to a different angle of the p-methylene group 
relative to the plane of the aromatic ring. Again, in 
analogy to the E. coli radical, the T4 radical is destroyed 
by hydroxyurea although it is ten times more sensitive to 
the drug. Kjoller-Larsen et al. (1982) ascribed the
different suseptibility to the drug, to the different 
topology of the active sites in the bacterial and phage 
enzymes with the latter site being more exposed.
iii) Allosteric regulation. The allosteric properties 
of the T4-induced ribonucleotide reductase are in many ways 
similar to those of the E. coli enzyme (Berglund, 1972b).
ATP affects the reduction of CDP and UDP, dTTP affects the 
reduction of GDP and dGTP affects the reduction of ADP. In 
contrast to the bacterial enzyme where high concentrations
_5
of dATP (>10 M) inhibit enzyme activity, the same dATP 
concentrations positively regulate reduction of the 
pyrimidine substrates by the T4 enzyme (Berglund, 1972b). 
Further, 5'-hydroxymethyl cytosine, which is essentialy 
inert with the bacterial enzyme, stimulates pyrimidine 
reduction by the T4-induced enzyme. The lack of any 
negative effectors of the T4-induced enzymatic activity may 
be related to the fact that T4 DNA synthesis is not turned 
off during infection but continues until the T4-infected 
cell lyses.
c ) The mammalian enzyme.
Ribonucleotide reductase activity has been 
demonstrated in a number of mammalian systems including rat 
hepatoma (Moore, 1977), calf thymus (Engstrom et al., 1979; 
Eriksson et a l ., 1979; Thelander et al ., 1980) rabbit bone 
marrow (Hopper, 1972 and 1978) and human tissue culture cell 
lines (Chang and Cheng, 19 79). Hopper (19 72) demonstrated 
that the mammalian enzyme's properties resemble those of
ATP
dATP
ATP
dATP
dTTP
dGTP
RS
RS
X  SH 
SH CS
HS
CS HS
HO
3 +3 + FeFe
M1 subunit
M2 subunit
Figure 16. A schematic representation of the proposed 
structure of the mammalian ribonucleotide reductase. The 
enzyme is depicted as a dimer of the Ml and M2 subunits, 
each consisting of two identical polypeptides. The Ml 
subunit is shown to contain two regulatory sites (RS) which 
bind the allosteric effectors (E) indicated. The catalytic 
sites (CS) are shown to contain the active sulphydryl groups 
(SH). The M2 subunit contains the tyrosyl radical (•), and 
the iron centre (Fe^+-o^-Fe^+ ).
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E. coli rather than the Lactobacillus enzyme as it contains 
easily separable subunits, it is inhibited by hydroxyurea, 
does not require AdoCbl for activity, and contains Iron.
The mammalian enzyme consists of two non-identical subunits 
called Ml and M2 (Fig. 16; Thelander et a l ., 1980).
i) The Ml subunit. This subunit is composed of two 
identical polypeptides, and its mol. wt. in calf thymus is
170,000 (Thelander et al., 1980). The Ml dimer contains 
two catalytic sites which bind the NDP substrates and
two different types of allosteric effector binding sites.
In analogy to the E. coli enzyme, the first of the 
allosteric effector binding sites binds ATP and dATP while 
the second binds dTTP and dGTP in addition (Thelander e_t 
al., 1980). However, two major differences appear to exist 
between the bacterial and mammalian enzymes. First, 
substrate binding studies indicated that the number of sites 
in Ml is lower than that in B1 (Thelander et a l ., 19 80). 
Second, the Ml sites show equal affinity for dATP-binding 
and therefore they cannot be classified as h or 1 sites as 
the case is with the E. coli B1 (Thelander et a l ., 1980). 
Both of these suggestions require further investigation.
ii) The M2 subunit. This subunit is a dimer composed 
of two polypeptides; in mouse the M2 molecule has a mol. wt. 
of 88,000 (Thelander et al ., 1985). M2 contains a non-heme 
iron centre and a tyrosine free radical. Light adsorption 
spectra for the M2 and B2 subunits gave iron related bands 
at almost similar wavelengths indicating that both proteins 
should have the same type of iron centre (Thelander et al., 
1985). Isotope substitution studies demonstrated that the 
free radical is located on a tyrosine residue and its spin 
density is delocalised over the aromatic ring of this 
tyrosine (Graslund et al., 1982). In analogy to the E. coli 
radical, the M2 radical is inhibited by hydroxyurea 
(Engstrom et al ., 1979). However, the M2 radical can be 
regenerated by the addition of dithiotreitol in the presence 
of oxygen (Graslund et al., 1982) and this is in sharp 
contrast to the bacterial radical where radical regeneration 
requires chelation and subsequent re-introduction of the
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iron centre (see Page 43; Atkin et al., 19 73). Comparison 
of the EPR spectra profiles of the M2 and B2 radicals 
revealed small differences which, as the case is for the T4 
radical, are attributed to the slightly different angles of 
the |3-methylene group relative to the plane of the aromatic 
ring of the tyrosine (Graslund et al., 1982). Another 
property of the mammalian radical is that it is 75 times 
more sensitive to hydroxyurea analogues than the bacterial 
radical. Kjoller-Larsen et al. (1982) and Thelander et al.
(1985) suggested that this is due to different active site 
topologies with the mammalian site being more exposed.
iii) Allosteric regulation. The mammalian enzyme has 
been shown to be allosterically regulated in a similar 
fashion to the E. coli enzyme (Eriksson et al ., 1979). In 
the absence of positive effectors, the enzyme is inactive 
with any substrate. Reduction of pyrimidine substrates is 
stimulated by ATP, reduction of GDP by dTTP and reduction of 
ADP by dGTP. Reduction of purine substrates is further 
stimulated by ATP but only in combination with dTTP and dGTP 
respectively. Each of dTTP and dGTP inhibits reduction of 
the other three substrates. Finally, dATP is a general 
inhibitor but the dATP-mediated inhibition can be reversed 
by high concentrations of ATP. Overall, the E. coli 
allosteric regulation scheme (see Fig. 13) is also 
applicable to the mammalian enzyme, although, allosteric 
control of the latter enzyme is much more strict.
d) Viral-induced enzymes.
Several animal viruses including HSV-1 (Cohen, 1972), 
HSV-2 (Cohen et al., 1974), PRV (Lankinen et al., 1982), EHV 
serotypes 1 and 3 (Cohen et al., 1977; Allen et al., 1978) 
EBV (Henry et al ., 1978), VV (Slabaugh et a l ., 1984) and VZV 
(Spector et al., 1987) have been reported to induce a novel 
ribonucleotide reductase activity in infected cells which 
differs from the host cell enzyme. However, direct evidence 
that this activity is virus-encoded has been obtained only 
for HSV-1. This part of Section E is mainly concerned with 
the properties of the ribonucleotide reductase activity 
induced by HSV-1, HSV-2, PRV, VZV and VV.
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i ) Constituents and structure of the HSV-l-induced 
enzyme. Dutia (19 83) demonstrated that the HSV-1 enzyme 
•is virus-encoded since the multiple HSV-1 mutant tsG 
(Brown et al., 1973) expressed significantly reduced levels 
of ribonucleotide reductase activity at the permissive 
temperature (PT) while at the NPT no activity was observed. 
The enzyme is composed of two non-identical subunits, 
termed RR1 and RR2 (Frame et al., 1985; Cohen et al., 1985; 
Bacchetti et al., 1986; Ingemarson and Lankinen, 1987).
The gene encoding RRl has been shown to be UL39 by marker 
rescue of the mutant HSV-1 virus tsl207 (see Results and 
Discussion, Section D). The product of UL39, Vmwl36 or RRl 
polypeptide, has a mol. wt. of 136,000 (Marsden et al .,
19 78) .
Other studies have accumulated evidence that the RRl 
polypeptide is not the only one involved in ribonucleotide 
reductase activity. First, amino acid comparisons of the 
predicted primary structure of the UL40 gene product,
Vmw38 or RR2 polypeptide, with that of the small subunit 
polypeptide of E. coli exhibited high homology (Standart et 
al., 1985; Sjoberg et al., 1985; McLauchlan 1986; Nikas et 
al., 1986; see Results and Discussion, Section C). Second, 
a monoclonal antibody specific for the RRl polypeptide 
precipitated along with RRl a smaller protein species 
(Preston, V.G. et al., 1984), which was shown to be RR2 
(Frame et al., 1985). Conclusive evidence for the 
involvement of the RR2 polypeptide in enzymatic activity was 
obtained from the HSV-1 mutant _tsl222 which has a lesion in 
□L40 and induces negligible levels of ribonucleotide 
reductase activity at both the PT and NPT (Preston, V.G. et 
al., 1988). The studies with these ts mutants further 
demonstrate that the viral enzyme consists of two 
non-identical subunits. The sedimentation coefficient 
of the active HSV-1 enzyme is 17S which approximately 
corresponds to a mol. wt. of 370,000 (Ingemarson and 
Lankinen, 1987). Given the predicted sizes of the RRl and 
RR2 polypeptides, these authors suggested that the active
enzyme is a homodimeric complex of the <*2^2 structure. The 
complex appears to be a very strong one as the two subunits
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fail to dissociate in columns containing antibodies specific 
for each subunit nor do they sediment separately in glycerol 
gradients (Frame et al., 1985; Ingemarson and Lankinen, 
1987). This type of tight binding between the two subunits 
is similar to that of the T4-induced enzyme subunits 
(Berglund, 1972a).
ii) Physicochemical and binding properties of the
virus-induced enzymes. Unlike the bacterial and mammalian
2 +  . . .  enzymes, Mg or ATP inhibit the viral enzyme (Averett et
al., 1983; Huszar and Bacchetti, 1981; Ponce de Leon et al.,
1977). At least for the HSV-1 and HSV-2 enzymes, the
inhibition appears to be qualitatively similar, although
slight quantitative differences exist (Averett et al., 1984)
However, in the presence of a Mg-ATP complex this inhibition
is reduced most probably because the formation of the
complex lowers the concentration of free ligands in the
reaction mixture. The substrate binding properties of the
HSV-1 and HSV-2 enzymes are quite similar (Averett et al.,
1983 and 1984). Both enzymes have as substrates NDPs which
bind at a common catalytic site; competition binding studies
with CDP and ADP substrates indicated that both are mutual
competitors for binding (Averett et al., 1983). The
products of the reaction, deoxynucleoside diphosphates
(dNDPs), are inhibitors which compete with the substrates
(Averett et al., 1983). Both HSV enzymes are insensitive to
inhibition by dNTPs suggesting that they are not
aliosterically regulated (Averett et al., 1983 and 1984).
The same suggestion can be applied to the PRV- (Lankinen et
al., 1983) and VZV-induced activities (Spector et al.,
1987). Conversely, the VV-induced activity has been shown
to be inhibited by dATP and dTTP and has therefore been
proposed to be allosterically regulated (Slabaugh et al.,
1984).
PRV-infected cells display an EPR spectrum resembling 
that of the tyrosyl radical of the M2 subunit (Lankinen et 
al., 1982). Therefore, it is possible that the viral enzyme 
also contains a free radical. This suggestion is reinforced 
by the strong conservation of the tyrosine residue and the 
flanking amino acid sequences of the polypeptides encoding
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the E. coli B2 and HSV-1 RR2 subunits (see Results and 
Discussion, Section C) ; further it is reinforced by the 
observed inhibition of the HSV and PRV enzymes by 
hydroxyurea (Averett et al., 1983; Lankinen et al., 1982) 
which, as reported above (see Page 43), acts as a radical 
scavenger.
14. Ribonucleotide Reductase is Essential for Virus Growth.
HSV-1 tj5l207 failed to induce any ribonucleotide 
reductase activity at the NPT and its yield at that 
temperature was 100-fold lower than that of wild-type virus 
(Preston, V.G. et al., 1984). These results suggested that 
the enzyme is essential for virus replication. In contrast, 
subsequent reports raised questions as to the validity of 
this proposal. First, Nutter et al., (1985) reported that
concentrations of hydroxyurea, which would otherwise inhibit 
ribonucleotide reductase activity to undetectable levels, 
reduced the HSV-2 virus yield in proliferating cells only by 
six-fold. Second, Wu et al. (1988) demonstrated, by means 
of the plasmid replication assay developed by Challberg
(1986), that a significant amount of DNA replication occured 
in the absence of the ribonucleotide reductase genes. 
Finally, third, Goldstein and Weller (1988a) reported that 
the enzyme is dispensable in dividing cells at 34°C. These 
authors reached this conclusion by studing the growth and 
DNA replication of a mutant HSV-1 virus, hr3, which was 
expressing the N-terminal RRl 434 amino acids fused to the 
p-galactosidase (lacZ) gene.
However, studies with the HSV-1 mutant virus ts!222 
reconciled these apparently conflicting data and showed that 
the enzyme is essential for virus replication. Preston,
V.G. et al. (1988) demonstrated that tsl222 failed to grow
in resting cells at the PT thus indicating that the enzyme 
is essential under these conditions. This is the case with 
TK as well, although, the requirement for actively dividing 
cells appears to be more stringent for ribonucleotide 
reductase negative mutant viruses than in TK viruses. 
Preston and co-workers further showed that, in exponentially 
growing cells and at the PT, ts!222 is dependent on the
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cellular enzyme for replication, while, it was proposed that 
at the NPT the mutant fails to replicate due to inactivation 
of the cellular enzyme at this temperature. Similar 
suggestions were reached by Goldstein and Weller (1988b), 
using the HSV-1 mutant ICP6A which was expressing less than 
10% of the RRl DNA coding region; these authors showed that 
growth and DNA replication of ICP6A were severely -
restricted in non-dividing cells or at 39.5°C.
Conclusive evidence that ribonucleotide reductase is 
an essential HSV function have been obtained from studies on 
the pathogenicity of the ^tsl207 and ts!222 mutants following 
intracranial or intraperitoneal inoculation of albino 
Charles River mice (Cameron et al., 1988). The virulence of 
these mutants was reduced by about a million-fold when 
compared with that of the parental virus (HSV-1 strain 17+ ); 
further, the pathogenicity of a revertant of ts!222 (ts!222 
revl) was restored to about 60- to 200-fold of that of the 
parent virus. Similar evidence was obtained from 
experiments involving HSV infection in epithelium cells of 
hairless mice which were scarified on the flank (H.S. 
Marsden, D.M. Ryan, personal communication). Mice infected 
with HSV-1 strain 17+ gave rise to a zosteriform lesion, as
did ts!222 revl, while infection at doses higher than 4x 10
plaque forming units (p.f.u.) per mouse caused death. In 
contrast, infection with tsl222 did not give rise to 
zosteriform lesions but instead to small blisters which 
healed by 6 days p.i.
15. Ribonucleotide Reductase as a Target for Antiviral 
Compounds.
The herpesvirus-encoded enzyme has been considered 
as an attractive antiviral target for a number of reasons. 
Firstly, as reported above, the enzyme is important for 
pathogenicity in mice. Secondly, the herpesviral enzyme is 
biochemically distinct from the mammalian enzyme. Thirdly, 
the interaction between the RRl and RR2 subunits may itself 
be exploitable as a target for antiviral compounds.
Effort is currently being put in the identification of 
a compound or a class of compounds that would inhibit the
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interaction of the two subunits. This approach resulted 
from reconstitution experiments designed to show that both 
subunits are necessary for activity (Dutia et al., 1986); 
in these experiments an IgG from serum raised against a 
synthetic octapeptide corresponding to the C-terminal seven 
amino acids of RR2 successfully removed this subunit from 
a crude extract of HSV-1 infected cells. Subsequently, 
two different groups reported that the same octapeptide 
inhibited ribonucleotide reductase activity and postulated 
that this was achieved by dissociation of the RR1/RR2 
subunit complex (Dutia et al ., 1986; Cohen et al., 1986a). 
McClements et al. (19 88) demonstrated that indeed the
synthetic oligopeptide acted by dissociating the RRl and RR2 
subunits and that this resulted in inhibition of the 
ribonucleotide reductase activity.
Recently, Huang et al. (1988 ) and Darling et al.
(19 88) demonstrated that the enzymatic activity can be 
restored by reassociation of the two subunits both in vivo 
and in vitro and that no other HSV proteins are required for 
the formation and activity of the reconstituted enzyme. 
Furthermore, Darling and co-workers demonstrated that the 
two subunits exist in a dynamic equilibrium between the 
associated and dissociated states of the enzyme (A.J. 
Darling, personal communication). These observations will 
prove valuable in the further characterisation of the enzyme 
and in studies with antiviral compounds.
16. Regulation of Ribonucleotide Reductase Synthesis.
As already mentioned, the prokaryotic and eukaryotic 
enzymes are allosterically regulated by NTPs and dNTPs. 
However, additional types of regulation exist at the 
transcriptional, translational or post-translational level.
The E. coli genes encoding the bacterial enzyme are 
arranged in one operon and are coordinately regulated (Hanke 
and Fuchs, 19 83a). The enzyme appears to be synthesised 
only once during the cell cycle at a time that coincides 
with the onset of DNA replication. It appears that subunit 
synthesis is primarily controlled at the transcriptional 
level as inhibition of DNA synthesis by thymine starvation
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results in an increased rate of transcription in 
ribonucleotide reductase genes (Hanke and Fuchs, 1983b).
It appears that this increase is mediated by a positive 
regulatory protein(s) which accumulates during inhibition of 
DNA replication and acts to induce ribonucleotide reductase 
transcription (Hanke and Fuchs, 1984). Another type of 
regulation of the E. coli enzyme appears to be at the 
post-transcriptional level; as reported above (see Page 42), 
Sjoberg et al. (1987) encountered a truncated form of B2
which resulted from limited proteolysis of normal B2 by a 
serine protease and which inactivated the enzyme.
Synthesis of the mouse enzyme is regulated in a cell 
cycle-dependent fashion. Activity measurements of the two 
subunits in cells separated in Gl, S and G2 phases of the 
cell-cycle indicated that the Ml catalytic activity was 
constant throughout these phases whereas the M2 activity 
was substantially decreased in Gl as compared to S and G2 
(Eriksson and Martin, 1981; Engstrom et al ., 1985). The 
reduced M2 activity in Gl could be explained either by the 
existence of a latent M2 protein pool, which was activated 
at the start of the S phase, or by the de novo synthesis of 
M2 protein. Eriksson et al ., (1984) demonstrated that the 
latter is correct, since a 3- to 7-fold increase in M2 
radical content is observed when cells are passed from the 
Gl to the S phase. Moreover, these authors proposed that 
this type of M2 regulation primarily occurs at the 
transcriptional level.
In analogy to the mouse enzyme regulation, both 
sea urchin and surf clam oocyte enzymes are regulated at 
the level of M2, although, in the latter the control of 
M2 synthesis appears to be at the translational level. 
Standart et al. (1985) demonstrated that the small subunit 
is expressed after fertilisation of the embryo and that the 
mRNA encoding this subunit is one of the stored maternal 
mRNAs whose translation is induced by fertilisation.
On the other hand, the large subunit is already present 
as a polypeptide in the embryo (Standart et al., 19 86).
MATERIALS AND METHODS
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SECTION A .
MATERIALS.
1. Viruses.
HSV-2 strain HG52 (Timbury, 1971) and HSV-1 Glasgow 
strain 17 (Brown et al., 19 73) were used during the course 
of this work.
2. Cells.
Baby hamster kidney cells (BHK-C13; MacPherson and 
Stoker, 19 62) were used for growth and assay of virus. HeLa 
cells (obtained from Dr J. McLauchlan) were used for 
transient expression assays of plasmid constructions.
3. Bacterial Strains.
E. coli K12 strain DH1 (recAl, F , endAl, gyrA9 6, 
thi-1, supE44, recAl; Hanahan, 19 83) was used as host in all 
recombinant plasmid experiments. E. coli K12 strain JM101 
( (lac; pro) , supE, thi, F'traD36, proAB, lacl^, ZA.M15;
Messing et al., 1981), which harbours an F factor essential 
for the transmittance of the male specific phage, was used 
as host strain of M13 bacteriophage recombinants.
4. Tissue Culture Media.
BHK-C13 cells were grown in Glasgow Modified Eagle's 
medium (Busby et al., 19 64) supplemented with lOOug/ml 
streptomycin, lOOunits/ml penicillin, 0.2ug/ml amphotericin, 
0.002% (w/v) phenol red. The growth medium used (ETC10) 
consisted of 80% Eagle's, 10% tryptose phosphate and 10% 
calf serum.
HeLa cells were grown in Dulbecco's medium 
(Flow Laboratories), a modified version of Eagle's medium, 
supplemented with 20mM glutamine, lOOunits/ml of 
streptomycin, lOOunits/ml penicillin and 0.2ug/ml (w/v)
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amphotericin. In addition to the above ingredients, growth 
medium contained 2.5% calf serum and 2.5% foetal calf serum 
(Gibco Ltd).
For washing and removal of cell monolayers the 
following media were used:
i) PBS, which contained 170mM NaCl, 3.4mM KCl, lOmM 
Na2HP04 , 2mM KH2P04 (pH 7.2)
i i ) Versene, which consisted of PBS containing 
0.6mM EDTA and 0.0015% (w/v) phenol red and,
iii) Trypsin, which comprised 25% (w/v) Difco trypsin 
dissolved in Tris-saline. The constituents of Tris-saline 
were 140mM NaCl, 30mM KCl, 280mM Na2HP04 , lmg/ml dextrose, 
25mM Tris HCl (pH 7.4), 0.005% (w/v) phenol red supplemented 
with lOOunits/ml penicillin and lOOug/ml streptomycin.
5. Bacterial Culture Media.
DH1 bacteria were propagated in L-broth which 
consisted of 177mM NaCl, 10g/l Difco Bactotryptone and 5g/l 
yeast extract (pH 7.5 prior to sterilisation). Solid medium 
for the growth of colonies was agar which contained 1.5% 
(w/v) agar in L-broth. These media were supplemented, where 
appropriate, with ampicillin or chloramphenicol, both at a 
final concentration of lOOug/ml. JM101 were grown in 2YT 
broth which comprised 85mM NaCl, 16g/l Difco Bactotryptone, 
10g/l yeast extract (pH 7.5 prior to sterilisation).
6. Frequently Used Buffers and Solutions.
TE lOmM Tris HCl (pH 7.5), ImM EDTA
TBE 9OmM Tris, 90mM boric acid, ImM EDTA (pH 9.3)
TAE 4OmM Tris HAc (pH 8.0), 2mM EDTA
STET 5OmM Tris HCl (pH 8.0), 50mM EDTA, 8% (w/v) sucrose,
5% (v/v) Triton X100 
5x LB lOOmM Tris HCl (pH 7.5), 20mM MgCl2 , 20mM DTT
SSC 150mM NaCl, 15mM sodium citrate (pH 7.5)
50x DHB 1% (w/v) Ficoll, 1% (w/v) polyvinylpyrrolidone,
1% (w/v) bovine serum albumin (BSA)
(Denhardt, 1966) 
lOx AB lOOmM Tris HCl (pH 8.5), lOOmM MgCl2
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TGM 150 ml 40% polyacrylamide (acrylamide/bisacrylamide
20:1), 50ml lOx TBE, 540g urea, made up to 11 with 
distilled H20
BGM 150 ml 40% polyacrylamide (acrylamide/bisacrylamide
20:1), 62.5ml 40x TBE, 540g urea, 50g sucrose,
10ml 1% bromophenol blue, made up to 11 with 
deionized H20
EB lOOmM NH^Ac, lOmM MgAc, 0.1% (w/v) SDS, ImM EDTA
TE(P ) ImM Tris HCl (pH 7.5), 0.05mM EDTA
HBS 14 OmM NaCl, 50mM HEPES (pH 7.12), 1. 5mM Na2HPC>4
ILB 150mM NaCl, 1.5mM MgCl2 , lOmM Tris HCl (pH 7.8),
0.65% (v/v) nonidet p40.
PEB 7.0M urea, 350mM NaCl, lOmM EDTA, lOmM Tris HCl
(pH 7.9), 1% (w/v) SDS 
5x SP6 200mM Tris HCl (pH 7.5), 30mM MgCl2 , lOmM spermidine 
2x PK lOOmM Tris HCl (pH 8.0), 20mM EDTA, 20mM NaCl,
0.4% (w/v) SDS 
5x M13 3.75M NaCl, 250mM HEPES (pH 6.95), 5mM EDTA
HNE 20OmM NaCl, lOmM HEPES (pH 7.9), ImM EDTA
7. Enzymes.
The majority of restriction enzymes were obtained from 
New England Biolabs or Bethesda Research Laboratories (BRL). 
The Klenow fragment of E. coli polymerase was supplied by 
Boer inger Corporation Ltd or provided by Dr A. Davison, 
ribonuclease T2 was supplied by Calbiochem Ltd, and lysozyme 
and proteinase K, were supplied by Sigma Chemical Company. 
Unless otherwise stated, enzyme digests were performed in lx 
core buffer (50mM Tris HCl, pH 8.0, lOmM MgCl2 , 50mM NaCl), 
supplied by BRL.
8. Radiochemicals.
Radioisotopes were supplied by Amersham International 
PLC at the following specific activities:
5' [ adenosine triphosphate, 5000Ci/mmol
5' [oC-32P] deoxynucleoside triphosphates, 3000Ci/mmol
5' [<2d - ^ P ]  uridine triphosphate, 800Ci/mmol.
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9. Chemicals and Miscellaneous Reagents.
Most chemicals of analytical grade were supplied 
by BDH Chemicals UK or Sigma Chemical Company. Koch-Light 
laboratories supplied acrylamide, bisacrylamide, boric acid 
and caesium chloride; Biorad laboratories supplied 
ammonium • persulphate (APS), and TEMED (N,,N,,N,,JSr 
-tetramethylethylene diamine). The sequencing primer 
(51-GTAAAACGACGGCCAGT-31) was obtained from New England 
Biolabs. Other primers or oligonucleotide probes used 
during the course of this work were constructed by Dr 
J. McLauchlan using a Biosearch 8600 DNA Synthesizer. 
Dideoxynucleoside triphosphates (ddNTPs) and dNTPs, used 
in sequencing reactions, were bought from P-L Biochemicals. 
Ribonucleoside triphosphates, used for the production of RNA 
probes, were obtained from Promega Biotec. Tissue culture 
materials were supplied by Sterilin Ltd. and Nunc.
10. Cloning Vectors.
Most of the constructs made during the course of 
this study used plasmids pUC8 and pUC12 as cloning vectors 
(Vieira and Messing, 1982).
Bacteriophage M13 was used for subcloning of DNA 
fragments for sequencing (Messing and Vieira, 1982). The 
double-stranded DNA replicative form (RF) of this phage can 
be manipulated as a plasmid for subloning of DNA fragments 
into the multiple cloning site (MCS). The infectious phage 
particle contains single-stranded DNA q.v\< v*. secreted,
in high titres, from the host cell inipthe culture medium. 
f W  ^Dwvcan be used as a template for sequencing reactions. 
Throughout this study the M13mp8 RF bacteriophage was used 
(obtained from New England Biolabs).
RNA probes used in transient expression experiments 
were produced with the use of the pGEM-2 Riboprobe Gemini 
transcription plasmid supplied by Promega Biotec (Fig. 17). 
This vector comprises part of the pBR322 vector sequences 
and the bacteriophage SP6 and T7 promoters which are cloned 
in opposite transcriptional directions and are separated 
by a short piece of DNA containing an MCS (Melton et al.,
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Figure 17 . The pGEM-2 Riboprobe Gemini transcription 
plasmid. Black boxes indicate the SP6 and T7 promoters 
and arrowed lines above them indicate their respective 
transcriptional directions. The multiple cloning site (MCS) 
is expanded above the plasmid to show the restriction 
endonuclease cleavage sites. The location and orientation 
of the ampicillin resistance gene (ampr ) and the pBR322 
origin of replication (ori) are also indicated.
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1984). The pGEM-2 plasmid carries the pBR322 origin of 
replication and the gene conferring resistance to 
ampicillin.
11. Recombinant Plasmids.
All recombinant plasmids used during the course of 
this work were constructed by the author with the exception 
of: pHindK, pBamE and pBamT, obtained from Dr J. McLauchlan, 
pBamHIo, obtained from Dr V.G. Preston and pill and pl75 
obtained from Dr R.D. Everett.
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SECTION B .
METHODS.
12. Virus Growth and Assay.
2
BHK-C13 cells, maintained in 850cm roller bottles,
were infected with HSV-2 strain HG52 at a multiplicity of
1 p.f.u. per 350 cells. The infected cells were incubated
in 20ml of ETC10 for 3 to 4 days at 31°C until they could be
readily harvested by gentle shaking; subsequently, they were
pelleted by centrifugation in the cold at l,500rpm for
lOmin. The supernatant was removed and centrifuged at
12,000rpm for 2h. The resultant pellet was resuspended in
5ml of ETC10 and stored in -70°C as cell released virus
(CRV). The pellet from the initial centrifugation was
to 5m I
resuspended in an equal volume/vof ETC10 and sonicated 
briefly. After centrifugation at 3,000rpm for 15min, the 
supernatant was recovered and stored at -70°C as cell 
associated virus (CAV). The CRV and CAV fractions were 
titrated as described in Brown et al. (19 73).
13. Standard Techniques.
a ) Restriction enzyme digests.
Restriction digests were performed at 37°C or, 
in certain cases, at 65°C (for example, BstE II digests). 
Plasmid DNA and restriction enzymes were incubated for lh 
to 4h in lx core buffer, with the exception of Smal digests 
where, instead of NaCl, 20mM KCl was used. For diagnostic 
purposes, digests were carried out in 15ul of lx core buffer 
using 0.5ug of plasmid DNA and lunit of enzyme for 2h at 
37°C, unless the reaction conditions specified by the 
supplier differed radically. For subcloning of DNA 
fragments, the enzyme units and the incubation time varied 
according to the size and amount of the DNA fragment.
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b ) Ligation of DNA fragments.
DNA fragments, produced by cleavage with restriction 
enzymes, were ligated to cleaved plasmid vector which 
contained termini compatible with those of the fragment.
The vector and fragment were mixed in a 1:10 ratio in 5x 
ligation buffer (LB), 0.4mM ATP and 2units of T4 DNA ligase 
and incubated overnight at 15°C.
DNA fragments excised from low melting point agarose 
gels (see below) were not removed from gel slices for 
ligation purposes. The DNA-containing gel slices were 
mixed, an approximately equal volume of distilled H^O was 
added, and the mixture was heated at 65°C until the agarose 
melted. At that point, the sample was incubated at 3 7°C 
and vector DNA, 5x LB and T4 DNA ligase were rapidly added. 
The ligation mixture was then incubated overnight at 15°C.
In order to prevent reannealing of linearised M13mp8 
RF DNA with Sma I, which gives 'blunt-ends', the 
bacteriophage DNA was treated with 25units of bacterial 
alkaline phosphatase in 50mM Tris HC1 (pH 8.5) at 3 7°C 
for 3h.
c ) Gel electrophoresis.
i) Non-denaturing agarose gels. These gels were used 
to analyse DNA digested with restriction enzymes.
Horizontal slab gels (260mm x 160mm) comprising 200ml of 
0.5% to 1.5% (w/v) agarose in lx TBE buffer were run at up 
to 12V/cm submerged in lx TBE; both the gel and the buffer 
contained 0.2ug/ml of ethidium bromide. Samples were 
applied in lx TBE, 10% (w/v) sucrose, 0.02% (w/v) 
bromophenol blue and xylene cyanol.
ii) Low melting point agarose gels. These gels were 
used for the isolation of DNA fragments, of at least 500bp 
in length, for subcloning purposes; they comprised 200ml of 
1% (w/v) agarose in lx TAE buffer and were electrophoresed 
in lx TAE at up to 7.5V/cm.
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iii) Non-denaturing polyacrylamide gels. These 
gels were prepared as described by Maniatis et al. (19 75) 
and were used for analysis of DNA fragments of less
than lkbp. Acrylamide stock of 30% (w/v) acrylamide 
(acrylamide:bisacrylamide 29:1, stored at 4°C) was diluted 
to the required concentration (4% to 10%) in 75ml of lx TBE 
buffer. To this, 0.5ml of 10% (w/v) APS and 50ul TEMED were 
added to intiate polymerisation. The mixture was poured 
quickly into the gel mould and allowed to stand for at least 
45min prior to electrophoresis. Samples were prepared as in 
non-denaturing agarose gels (see Page 61) and gels (260mm 
xl60mm x 1mm) were run in vertical kits up to a maximum 
voltage of 16V/cm. DNA was visualised by ethidium bromide 
staining or by autoradiography.
iv) Denaturing polyacrylamide gels. This type of 
gel was used to analyse the products of ribonuclease T2 
digestion and were prepared as described by Maxam and 
Gilbert (1980). A stock of 20% acrylamide
(acrylamide:bisacrylamide 19:1, stored at 4°C) was diluted 
to 8% in lx TBE buffer containing 7M urea. The solution 
was filtered, degassed, polymerised and gels (450mm x 230mm 
x 0.35mm) were pre-run for 30min at 40W. Lyophilised 
samples were resuspended in 5ul to lOul of 9 0% (v/v) 
formamide, 0.1% (w/v) bromophenol blue and xylene cyanol, 
denatured at 90°C for 3min and chilled rapidly in ice 
prior to electrophoresis. Gels were run at 40W for 2h 
approximately. Radiolabelled RNA was deteced by 
autoradiography. Where appropriate, the amount of 
radioactive product was quantified by densitometry of 
autoradiographs using a Joyce-Loebl scanning densitometer. 
Then areas under the peaks of the densitometer tracing were 
measured by a DEC PDP 11/44 computer linked to a digitising 
tablet.
vi ) Gradient polyacrylamide gels (Sequencing gels). 
This type of gel was used for the analysis of sequencing 
reaction products. The gradient of potential difference is 
constructed by using two different ionic strength buffers, 
the top buffer (TGM), containing a low concentration of TBE,
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and the bottom buffer (BGM), containing a high concentration 
of TBE (Biggin et al. , 1983).
Two gel plates, one plain and one notched (430mm x 
400mm x 0.35mm), were thoroughly cleansed with ethanol.
The inside surface of the plain plate was treated with 1ml 
of Wackersilicone solution (10ml ethanol, 0.3ml 10% acetic 
acid, 50ul Wackersilicone) and the inside surface of the 
notched plate was treated with 1ml of 'Repelcote' (a 2% 
solution of dimethylchlorosilane in 1,1,1-tricloroethane). 
The Wackersilicone solution allows the formation of a 
firm bond between the glass surface and the gel while 
the 'Repelcote' facilitates plate separation after 
electrophoresis. The TGM solution contained 0.5x TBE and 
was polymerised by adding 80ul each of 25% APS and TEMED to 
80ml of TGM. The BGM solution contained 2.5x TBE and was 
polymerised by adding 15ul each of 2 5% APS and TEMED to 15ml 
of BGM. 10ml of TGM and 14ml of BGM were mixed in a 5 0ml 
syringe and then the mixture was carefully injected into the 
gel mould. The remaining TGM solution was subsequently 
injected into the mould, moving the flow from one side 
to the other in order not to skew the BGM to one side; 
the gel was allowed to stand for at least 45min prior to 
electrophoresis and was run for approximately 2h at 40W with 
0.5x TBE in both top and bottom reservoirs. Lyophilised 
DNA samples were taken up in 2ul of formamide dyes (100ml 
formamide, O.lg xylene cyanol, O.lg bromophenol blue and 
2ml of 500mM EDTA), heated at 95°C for lmin and quenched 
in ice prior to electrophoresis.
14. Large Scale Preparation of Plasmid DNA.
A loop of bacteria or a bacterial colony was used 
to inoculate 10ml of L-broth supplemented with lOOug/ml 
ampicillin and incubated overnight at 37°C. 5ml of this 
culture was then diluted in 800ml of L-broth containing 
ampicillin and the culture was shaken vigorously for 6h 
at 37°C; then, plasmid DNA was amplified by the addition 
of chloramphenicol to 50ug/ml and the culture was shaken 
overnight at 37°C.
Isolation of plasmid DNA was essentially performed
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with the method of Holmes and Quigley (1981). Bacteria were 
recovered by centrifugation at 8,000rpm for lOmin and 
resuspended in 60ml of STET followed by the addition of 
8ml of freshly-prepared ice-cold lysozyme (lOmg/ml). The 
suspension was boiled for 40sec, chilled on ice for 2 to 
3min and centrifuged for lh at 15,000rpm. The nucleic acid 
in the supernatant was precipitated by adding an equal 
volume of isopropanol and pelleted by centrifugation at 
3,000rpm for 20min. In order to isolate plasmid DNA., the 
pellet was resuspended in 10.5ml of distilled H^O followed 
by the addition of llg of caesium chloride and 0.5ml of 
ethidium bromide (lOmg/ml). DNA was banded at 4 0,000rpm for 
72h. Supercoiled plasmid DNA was visualised under a long 
wave UV light and recovered by a syringe. The ethidium 
bromide was removed by multiple extractions with 
TE-saturated butan-2-ol followed by overnight dialysis 
against deionised f^O. The dialysed DNA was then treated 
with 50ug/ml RNase A for lh at 65°C and then with 50ug/ml 
proteinase K and 0.1% (w/v) SDS for lh at 37°C. The DNA was 
phenol/chloroform extracted twice and then precipitated with 
ethanol. Lyophilised DNA was finaly resuspended in TE such 
that the final concentration was lug/ml as estimated by 
spectrophotometry (°D2go l*0=50ug of DNA/ml).
15. Small Scale Preparation of Plasmid DNA ('Miniprep1).
20ml bottles containing 3ml of L-broth supplemented 
with ampicillin (lOOug/ml) were inoculated with single 
plasmid-transformed bacterial colonies and shaken at 37°C 
overnight. Half of the bacterial culture was store'd at 4°C 
and the remainder was poured into an 1.5ml reaction vial and 
centrifuged for 15sec in a MSE microfuge. The bacterial 
pellet was resuspended in 200ul of STET and 5ul of lysozyme 
(lOmg/ml), heated in a boiling waterbath for 45sec and 
centrifuged for lOmin. An equal volume of isopropanol was 
added to the supernatant and precipitated nucleic acids were 
centrifuged for 5min, washed in 70% ethanol and lyophilised. 
Finally, the pellet was resuspended in 20ul of distilled H^O 
and stored at 4°C. When DNA from 'minipreps1 was digested 
with restriction enzymes, 0.2ul of lmg/ml ribonuclease A
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(RNase A) was added to remove RNA and this facilitated 
visualisation of bands following gel electrophoresis.
16. Transformation and Transfection of E. coli.
a ) Preparation of competent bacteria.
100ml of L-Broth or 100ml of 2YT were inoculated
with 2ml of an overnight culture of DHl or JM101 bacteria,
respectively, and shaken at 37°C until the OD,-,-,. reached
b o U
0.3. The culture was chilled on ice for lOmin and bacteria 
were pelleted by centrifugation at 8,000rpm for lOmin. The 
pellets were resuspended in a total of 40ml of ice-cold 
lOOmM C a C ^  and incubated on ice for 40min. The cells were 
then harvested again by centrifugation and resuspended in a 
total of 2ml of ice-cold lOOmM CaC^. Competent cells were 
used within 24h.
b) Transformation by plasmid.
lOul of plasmid DNA, usually a ligation mix, were 
mixed with lOOul to 200ul of competent DHl bacteria in an 
1.5ml reaction vial by gentle shaking and the mixture was 
then placed on ice for 45min. After incubation at 42°C 
for 3min, 70ul aliquots were spread on L-broth agar plates 
containing ampicillin and these were incubated overnight 
at 37°C. Prior to spreading the transformation mixture, 
plates were spread with 50ul 5-bromo 4-chloro 3-indonyl p  D 
galactopyranoside (Xgal; 25mg/ml in dimethylformamide), 
in order to select, on the basis of colour, for 
insert-containing plasmid vectors.
In the case of ligations performed in low melting
point agarose, C a C ^  was added to the ligation mixture to a
final concentration of 50mM prior to mixing with competent 
bacteria.
c ) Transformation by Ml3mp8 RF .
lOul of M13mp8 RF/insert ligation mix (see Page 67)
was added to 200ul of competent JM101 and incubated on ice 
for 40min. After this, the transformation mixture was 
incubated at 42°c for 2min and then added to a 5ml glass
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bottle, maintained at 42°C, which contained: 3ml of 
molten top agar, 25ul each of isopropyl-D-thiogalactoside 
(IPTG; 25mg/ml in distilled H20) and Xgal (25mg/ml in 
dimethylformamide) and 200ul of a JM101 overnight culture. 
The final mixture was gently shaken and spread on L-broth 
agar plates which were pre-warmed at room temperature.
The top agar was allowed to set for 5min at room temperature 
and plates were incubated at 37°C overnight.
17. DNA Sequencing.
The dideoxy/chain termination method was used for 
the nucleotide sequence determination of the 
coding region of RRl and the identification of the 
nucleotide changes in an RRl coding region of the HSV-1 
ts!207 mutant (see Results and Discussion, Sections A and D 
respectively). This method was combined in the former study 
with a 'shotgun' cloning strategy while, in the latter 
study, a different approach was followed which is described 
on Page 108.
The principle behind the 'shotgun' cloning strategy
is the generation of a bank of single-stranded M13 clones
containing random fragments of the DNA region to be
sequenced. These can then be sequenced by the dideoxy/chain
termination method. A universal synthetic oligonucleotide
primer is annealed to the M13 recombinant clones and is then
used as a substrate for elongation by the Klenow fragment of
the E. coli DNA polymerase. Four separate reactions are set
up each containing a combination of four ddNTPs together
3 2with dNTPs, one of which is radiolabelled (oc-[ P]dATP). 
Incorporation of a ddNTP in the elongating chain results in 
termination of elongation; thus, the four reactions result 
in a set of radiolabelled chains which extend from the 
primer and randomly terminate at A, T, C and G residues. 
These chains are subsequently electrophoresed side by side 
on gradient polyacrylamide gels (see Page 62) and the 
sequence can then be directly read from the autoradiograph. 
This procedure generates a series of overlapping sequences 
which can then be collated computeri'analysis (see Materials 
and Methods, Section C) thus producing a contiguous sequence
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that spans the DNA region of interest in both the prototype 
and complementary orientations.
a ) DNA cloning into M13mp8 RF by the 'shotgun' method. 
20ug of plasmid containing the DNA fragment to be
sequenced were dissolved in TE and sonicated as described 
in Deininger (19 83) to give rise to random subfragments. 
These were subsequently end-repaired using 8units of T4 DNA 
polymerase, in a reaction 2mM for all four dNTPs in lx T4 
DNA polymerase buffer (lOOmM Tris HCl (pH 7.9), lOOmM MgCl^, 
lOOmM DTT). The reaction was incubated for lh at 3 7°C and 
DNA was phenol/chloroform extracted and ethanol 
precipi tated.
The end-repaired products of sonication were 
size-fractionated prior to cloning. The DNA was run on a 
1.5% agarose gel alongside Hinf I digested pAT153 vector DNA 
as marker (fragment sizes in bp: 1651, 517, 396, 298, 221, 
220, 154, 145 and 75). A trough was cut in the sample track 
just ahead of the 221bp/220bp bands and was filled with 
buffer. Electrophoresis was continued and the buffer in the 
trough was collected and replaced at lmin intervals until 
the majority of 250bp to 500bp fragments were isolated. DNA 
was subsequently phenol extracted and ethanol precipitated. 
Finally, the pellet was taken up in TE buffer to a final 
concentration of 50 to 500ng/ul.
lOng of Smal linearised M13mp8 RF was ligated to 10 to 
500ng of sonicated, end-repaired and size-fractionated DNA 
fragments with 2units of T4 DNA ligase in lx LB buffer for 
15h at 15°C (Sanger et al., 1980). Competent JM101 bacteria 
were transfected with the ligation mixture as described on 
Page 65.
b ) Preparation of single-stranded templates for 
sequencing.
lml of an overnight JM101 culture was added to 100ml 
of 2YT broth and 1.5ml aliquots were placed in 20ml glass 
bottles. A white M13 plaque was transferred into each 
bottle and shaken for about 6h at 37°C. The phage cultures 
were decanted into 1.5ml vials and bacteria were pelleted by 
centrifugation for 2min in a MSE microfuge. The supernatant
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was transfered into a new vial and mixed thoroughly with 
150ul of 2.5M NaCl, 20% (v/v) polyethylene glycol 6000.
The mixture was left to stand for 30min at room temperature, 
the bacteriophage were pelleted for 5min in an MSE microfuge 
and the supernatant was carefully removed. The pellet was 
taken up in lOOul of lOmM Tris HCl (pH 8.0), 0.ImM EDTA, 
phenol extracted and ethanol precipitated. Phage DNA was 
pelleted, lyophilised and dissolved in 30ul TE.
c) Selection of insert-containing recombinant M13 phages.
To select for recombinant phages containing insert
HSV DNA fragments, Southern hybridisations were performed.
lul of single-stranded M13 recombinant DNA was blotted onto
duplicate Schleicher and Schuell nitrocellulose filters and
these were baked in a vacuum oven for 2h. The filters were
then shaken at 70°C with a hybridisation mix, comprising
4ml of 1M Tris HCl (pH 7.5), 60ml of 20x SSC, 40ml of 50x
Denhardt's buffer (DHB), 0.8ml of 250mM EDTA, 5ml of 20%
(w/v) SDS and 1ml of lOmg/ml salmon sperm single-stranded
DNA. After 2h the hybridisation mix was replaced with fresh
mix which in addition contained a specific probe for each
filter. The first filter, which represented the positive
control, was probed with the DNA fragment to be sequenced.
The second filter, which represented the negative control,
was probed with vector plasmid DNA digested at a unique
3 2site. Both probes were end-labelled with [ ol-  P]dNTPs as 
described on Page 67, dissolved in 0.7ml of deionised 
formamide and heated at 9 5°C for 5min prior to adding to the 
hybridisation mix. The filters were then incubated at 70°C 
overnight, washed three times with 300ml of a mixture 
containing 10ml NaH2PO^ (pH 7.5), 100ml of 20x SSC and 10ml 
of 20% (w/v) SDS and autoradiographed. Clones containing 
HSV DNA were retained for sequencing.
d ) DNA sequencing reactions.
Typically 16 to 18 clones were sequenced at the same 
time. lul of template DNA was added to a vial containing 
lul of oligonucleotide primer (2.5ng), lul of lOx AB and 7ul 
of distillied H20 and the reaction was incubated for 30min 
at 37oc> At the end of the incubation lul of Klenow
TABLE I
NUCLEOTIDE CONCENTRATIONS USED IN DNA SEQUENCING REACTIONS
dNTP Mixes
dG mix dA mix dt mix dC mix
0. 5mM dT 200 200 10 200
0.5mM dC 200 200 200 10
0.5mM dG 10 200 200 200
dNTP-mix buffer 50 50 50 50
dNTP-mix buffer = 0.05m Tris-HCl (pH8.0), 1mm EDTA
ddNTP Mixes
0. 2mM 70uM 0. 3mM 70uM
- ddGTP ddATP ddATP ddCTP
5mM ddG 40 - - -
5mM ddA - 14 — —
5mM ddT - - 60 —
5mM ddC - - - 14
h 20 960 986 940 986
dNTP;ddNTP Mix
'Sequencing Mix' dNTP ddNTP
G 400 50 350
A 400 100 300
T 400 200 200
C 400 50 350
69
polymerase (lunit/ul) was added to each annealing reaction 
and mixed thoroughly; 2ul of that mixture was transfered to 
each of four 0.75ml reaction vials, labelled A, T, C and G.
Meanwhile, four vials labelled A, T, C, and G were set
up each containing 36ul of A, T, C or G 'sequencing mix'
respectively (see Table 1). To each of these, 5ul of a mix
32containing 3ul of [oc- P]dATP and 18ul of 12mM dATP was 
added. 2ul of each of these mixtures were added to the 
corresponding 0.75ml vials mentioned above. The elongation 
reactions were allowed to stand for 20min at room 
temperature and then were incubated with 2ul of 'chase mix', 
which contained 0.25mM of each dNTP, for a further 30min 
at room temperature. Finally, samples were electrophoresed 
as described on Page 62.
18. Transient Expression Experiments.
a ) Transfection of DNA into tissue culture.
DNA transfections into HeLa cells were performed with 
the calcium-phosphate transfection procedure as described 
by Wigler et al. (1978) and Corsalo and Pearson (1981).
HeLa cells were seeded at 30% to 40% confluence on 
90mm petri dishes 12h to 24h prior to transfection. lOug 
to 30ug of plasmid DNA was dissolved in TE(P) buffer to a 
final volume of 4 20ul. Then, 60ul of 2M CaCl^ was added 
dropwise to the DNA/TE(P) solution with constant agitation. 
The DNA/CaCl^ solution was added dropwise with constant 
agitation to 480ul of 2x HBS and the precipitate was allowed 
to form at room temperature for 3 0min. This solution was 
then applied dropwise to the cell monolayers and swirled 
into the medium (15ml per 9 0mm petri dish). After 24h 
the medium was replaced with fresh medium and cells were 
incubated at 37°C for a further 24h. When cells were 
infected with virus the medium was removed after the first 
24h incubation and virus added in 5ml of fresh medium. 
Following adsorption at 37°C for lh, a further 10ml of fresh 
medium was added and cells were harvested at 16h p.i.
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b) Preparation of cytoplasmic RNA.
HeLa cell cytoplasmic RNA was prepared from tissue
culture cells grown on 9 0mm petri dishes. All solutions and
vessels used up to the phenol/chloroform extraction steps
were cooled on ice. Following removal of the medium, cells
were washed with PBS and then harvested in 4ml of PBS.
Cells were centrifuged in the cold at 2,000rpm for lmin,
washed in PBS and re-pelleted. Following resuspension in
0.3ml of ILB, cells were left on ice for 3min and the
cytoplasmic fraction was separated from nuclei by
centrifugation at 3,000rpm for 5min. The supernatant
(cytoplasmic fraction) was added to an equal volume of
phenol extraction buffer (PEB) and extracted three times
with phenol/chloroform and once with chloroform. RNA was
precipitated twice with ethanol, washed with 70% ethanol,
lyophilised and resuspended in 20ul of distilled
Concentration of cytoplasmic RNA was determined by
spectrophotometry (OD~,n 1.0=40ug RNA/ml).
z b U
c ) Production of RNA probes.
Detection of cytoplasmic RNAs was achieved using 
probes produced by the pGEM-2 transcription vector (see 
Page 58). The principle behind this system is that in vitro 
transcription of a DNA fragment, spanning the 5' end of the 
RNA-specifying DNA region, will produce a transcript which 
can then be used as a probe for the detection of this RNA. 
The DNA fragment is inserted into the MCS of pGEM-2 in such 
an orientation so that the produced transcript is 
complementary to the RNA of interest. As mentioned on Page 
58, pGEM-2 contains two promoters one of which was used for 
the production of probes (SP6 in this study); in order to 
obtain run-off transcripts of appropriate length, the 
pGEM2/insert plasmid is linearised at a restriction enzyme 
site located doownstream form the insert. The linearised 
construct is then incubated in a cell-free transcription 
system which comprised: an SP6 RNA polymerase, a mixture of 
NTPs and P-UTP and a capped dinucleotide which is added 
to the 5' end of the transcript and is required for its 
stabilisation. After the completion of the reaction, the 
mixture is incubated in the presence of an RNase-free DNase
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which degrades the template, and RNA transcripts are 
electrophoresed on polyacrylamide gels and then isolated.
The main advantage of pGEM-2-produced RNA probes as 
compared to single-stranded DNA probes, usually used for RNA 
mapping, is the high counts per minute (c.p.m.)/ug ratio 
which allows the detection of very low amounts of RNA. 
Further, the RNA probes are specific for the RNA of 
interest, whereas, after separation of double-stranded DNA 
on denaturing polyacrylamide gels, single-stranded DNA 
probes have to be tested for complementarity to the RNA of 
interest.
lul of linearised pGEM2/insert plasmid DNA (lug/ul) 
was added to lul of 2.5mg/ml BSA, 5ul of 5x SP6 buffer, 
1.25ul of 0.2M DTT, 2.5ul of lOx NTPs (ImM each of A, U, C 
and G), 7ul of [oc-^P] DTP, 1.25ul of lOmM G(5 1 )ppp(5 ' )G_U ,
U ri
lul of RNasin, lul of SP6 DNA polymerase (lOunits/ul) and 
4ul of distilled ^ 0 .  The reaction was incubated at 37°C for 
lh and then for a further lOmin in the presence of 2.5ul of 
RNase-free DNase (lunit/ul). The reaction was stopped with 
175ul of 2x PK buffer and the mixture was phenol/chloroform 
and chloroform extracted. RNA transcripts were precipitated 
with 20ul of 6M NH^Ac, 600ul of ethanol and 2ul of tRNA 
(20ug/ul) and pelleted by centrifugation for lOmin in a MSE 
microfuge. The pellet was resuspended in 50ul of TE and the 
suspension was electrophoresed on an 8% denaturing 
polyacrylamide gel (see Page 62) in order to isolate 
full-length transcripts. A gel slice containing the 
transcript was excised from the gel, and RNA was eluted by 
incubating with 1ml of elution buffer (EB) at 37°C 
overnight. Following ethanol precipitation the RNA was 
taken up in 50ul of distilled H^O.
d) Hybridisations and ribonuclease T2 digestions.
Typically, 0.5ug or 4ug of cytoplasmic RNA was added 
to approximately 200ng of pGEM2-produced probe (approximate 
specific activity 2x 108 c.p.m./ug), the mixture was 
lyophilised, and the pellet was resuspended in 15ul of lx 
Ml3 buffer. The solution was heated at 9 5°C for lOmin and 
then incubated at 50°C overnight.
Following hybridisation, samples were treated with
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200ul of HNE buffer and 5units of ribonuclease T2 and 
incubated at 30°C for 30min. The hybrids were then mixed 
with 50ug of proteinase K and 40ug of tRNA, incubated as 
above, phenol/chloroform and chloroform extracted, 
precipitated and lyophilised. The pellets were taken up in 
5ul of formamide dyes, heated for 5min at 9 5°C, quenched on 
ice and then loaded on an 8% denaturing polyacrylamide gel. 
pAT153 plasmid DNA digested with Hpa II was used as DNA size 
markers (fragment sizes in bp: 622, 492, 404, 242, 238, 217, 
201, 190, 160, 160, 147, 122, 110, 90, 76, 67, 34, 26, 26, 
15, 9 , 9 ) .
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SECTION C .
COMPUTER ANALYSIS.
DNA sequencing data were handled and analysed using 
the Institue of Virology Digital Research computer operating 
under the RSX-11M operating system. In this Section 
computer programs utilised throughout this work will be 
briefly described.
19. Accumulation and Processing of Gel Readings.
Gel autoradiographs were read using the DPAD program 
of Dr P. Taylor. This program allows gels to be read on a 
digitising tablet from which the data c e n t e r e d  and stored 
directly into the computer in a form which can be read by 
the Staden programs (see below).
The compilation of the individual gel readings entered 
into the database was achieved using a group of programs 
designated BATCH, based on the DBAOTO system of Staden 
(1982). This program compares a 'file of files', which 
comprises several individual gel readings, with sequences 
held in the existing database. Gel readings showing 
homology to the consensus of the database are entered into 
the database in the appropriate region. Where necessary the 
program will insert padding characters into either the newly 
entered gel or in the consensus sequence thus enabling the 
sequences to be correctly aligned. Gel readings exhibiting 
no homology to any sequence in the database are held as 
separate contigs. Initially the number of contigs 
approximates the number of gel readings, particularly in a 
large project; however, as the gaps between gel readings are 
filled by new overlapping sequences, the number of contigs 
is reduced. Finally, one contig is achieved within which 
all gel readings overlap. Joining of the individual contigs 
can be achieved with the DBUTIL program of Staden (19 80). 
This program can further monitor the state of the database 
by providing lists of all the entered gel readings, details
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on their location, length and orientation.
t
20. Interpretation of Data in the Database.
Analysis of the completed sequence was achieved with 
a number of programs most of which were designed and/or
modified by Dr P. Taylor.
BASES, estimates the frequency of occurence of each 
base in a nucleotide sequence at a specified position 
(for example every third base) or in a whole sequence and 
outputs a table of values.
CINTHOM, compares two nucleotide or amino acid sequences 
and displays the results in a matrix plot (Pustell and 
Kafatos, 1982). This program was designed to score for 
identical amino acids, however, it has been modified by 
Dr P. Taylor to score in addition for conservative amino 
acid changes as evaluated by Dayhoff (19 83). The sequences
are aligned on the X-axis and on the Y-axis. Areas of
conserved sequences are represented by a diagonal on the 
plot while insertions or deletions are represented by 
diagonals which, when extrapolated, cross the X and Y axis 
at different points. Homologous sequences are displayed as 
uppercase or lowercase letters of the alphabet, with A 
representing the the highest homology (100%) and z the 
lowest. The parameters of this program are set by the 
operator.
CHOUFAS predicts the secondary structure of a protein 
(Chou and Fasman, 19 78).
CHOP deletes strings of nucleotide or amino acid 
sequences from a file.
DENS measures the areas under the peaks of densitometer 
tracing.
DSPLAY searches a nucleotide sequence for ORFs which can 
either be displayed or filed to be printed; the minimum
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length of the ORFs is defined by the operator.
FRMSCAN (Staden and McLachlan, 1982) identifies potential 
protein coding regions by evaluating the codon usage of all 
three reading frames in a DNA sequence using as reference 
the codon usage of a 'standard' gene; in the case of HSV-1 
the codon usage of the TK gene was used as reference.
HOMOL (Taylor, 19 84) optimally aligns two nucleotide 
or amino acid sequences by scoring for identical residues. 
The parameters are set by the operator.
MWCALC calculates the molecular weight and amino acid 
composition of an amino acid sequence.
PROFIL produces a graphic display of the hydropathicity 
profile (Kyte and Doolittle, 1982) of an amino acid 
sequence.
PTRANS (Taylor, P., 19 86) predicts the amino acid 
sequence from a nucleotide, sequence. In addition this 
program estimates the mol. wt. of the translated sequence 
and outputs an amino acid content and codon usage table.
The positions where translation starts or ends are set by 
the operator.
SEARCH searches for specified strings of characters in a 
nucleotide or amino acid sequence.
WORDSEARCH (Dereveux et al., 1984) searches the National 
Biomedical Research Foundation (NBRF) protein sequence 
database for homologous sequences. This program was 
implemented on a VAX computer at the Edinburgh Regional 
Computing Centre.
21. Structural Analysis of Amino Acid Sequences.
Amino acid sequences of the polypeptides encoding the 
large and small subunit polypeptides of ribonucleotide 
reductase from eukaryotic, prokaryotic and viral origin were
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aligned with the program of Dr W.R. Taylor (see Results and 
Discussion, Section C). This program can align a number of 
polypeptide sequences on the basis of identical amino acids 
and, in addition, on the basis of amino acids sharing 
similar physico-chemical properties. For the latter reason 
amino acids have been classified in the form of a Venn 
diagram.
a ) The Venn diagram of amino acid classification.
This diagram shows the classification in groups (sets) 
of the twenty naturally occuring amino acids to a selection 
of physico-chemical properties which are important for the 
determination of the secondary structure of a protein 
(Fig. 18; Taylor, W.R., 1986a). The two most prominent sets 
are the 'polar' and 'hydrophobic' ones; the former comprises 
amino acids which have a polar group in their side-chain and 
the latter, which is less rigorously defined, comprises 
amino acids which are hydrophobic. These two sets overlap, 
and the amino acids found in the region between them are 
considered as ambivalent to t^O. A third major set of amino 
acids, 'small', contains amino acids with side-chain volume 
less than 60 A. This set contains a subset of amino acids 
with side-chain volume less than 35 A and this is designated 
as 'tiny'. The location of cysteine in this diagram is not 
well defined as the reduced form (Cu ) of this residue
r i
contains a polarisable sulphur which suggests similarity 
with the serine residue, while the oxidised form (Cgg) lacks 
this property and appears to be more similar to valine.
The remaining sets are defined on the basis of obvious 
properties such as 'aromatic', with ring-containing 
side-chains, 'aliphatic', with a brancfed aliphatic 
side-chain, and 'charged', which are normally fully ionised. 
Proline is generally associated with turns or loops on the 
protein surface due to the structure of its side-chain and 
therefore, despite its very hydrophobic nature, is not 
included in the 'hydrophobic' set of amino acids.
b ) Protein homology by consensus template alignment.
The consensus template alignment (Fig. 19; Taylor,
W.R., 1986b) is a program which can align a number of amino
tiny
smatt
aliphatic
positive
hydrophobic polar
charged
Figure 18. The Venn diagram of amino acid classification 
showing the relationship of the 20 naturally occuring amino 
acids to a selection of physicochemical properties 
(reprinted from Taylor, W.R., 1986a).
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acid sequences. The alignment is obtained with the SETEM 
and FITEM programs and is based on the use of consensus 
templates. The templates are essentially the core amino 
acid sequences from conserved regions of related proteins 
with known three-dimensional structure, which have been 
aligned to related sequences of unknown structure in order 
to become more representative (alignment templates).
The program begins with the tentative alignment of 
sections from a few of the amino acid sequences to be 
aligned with the use of the alignment templates. Then the 
SETEM program will process the aligned sections in order to 
make the alignment templates more representative. Depending 
on the aligned amino acids at a given template position, the 
SETEM will assign a property on the basis of the Venn 
diagram. For example, if at a given template position three 
polypeptides sequences have R, K, and H residues 
respectively, then the program will assign the 'POSITIVE1 
property. Each of the properties is allocated a score 
ranging from 1 to 20. A score of 1 is given when the same 
amino acid occurs at a given template position in all 
sequences, and 20 when the amino acids at that position are 
classified in totally different sets in the Venn diagram.
The SETEM-produced alignment templates are then fitted by 
FITEM to a non-aligned sequence. If the complete set of 
templates fits the new sequence then it joins the alignment. 
The SETEM-FITEM alternating cycles continue until the 
existing alignment cannot be further altered.
Once the alignment is completed, then the program will 
predict the secondary structure for each aligned amino acid 
with the GARNIER algorithm (Garnier et al., 1978), and from 
the combination of the individual predictions it will derive 
a consensus.
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Figure 1 9 . A printout of the consensus template alignment 
program of Taylor, W.R. (1986b). The aligned polypeptide 
amino acid sequences (AA SEQ) are shown to run vertically, 
starting at the initiation codons (IC) and stoping at the 
termination codons (TC). The secondary structure GARNIER 
predictions for each polypeptide (ISSGP) are indicated. The 
consensus secondary GARNIER prediction for each aligned 
amino acid position (CSSGP) is shown. p-strand 
conformation is indicated by (E), oc-helix conformation by 
(H), unstructured or turn conformation by (T) and (-) a^cA C o  
indicate that the consensus prediction for the given 
position is unknown. The hydropathicity values (HP) are 
indicated by asterisks (*). The printout also shows the 
scores (SO assigned by the SETEM program for each aligned 
position, and the property (P) of the aligned amino acids as 
deduced from the Venn diagram of amino acid classification 
(see Fig. 18).
RESULTS AND DISCUSSION
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SECTION A .
1. DNA Sequencing Studies Within the Hind III k Fragment 
of HSV-1.
The HSV-1 strain 17+ ribonucleotide reductase locus 
between 0.54 and 0.60 map units (Fig. 20) specifies a family 
of four nested mRNAs which are comprised of two L and two E 
transcripts (Anderson et a l ., 19 80; McLauchlan and Clements, 
1982 and 1983a; McLauchlan, 1986). The L mRNAs, which are 
presumed to be 5' coterminal, have sizes of 7.0kb and 1.9kb 
and encode the same 54,000 mol. wt. polypeptide (Vmw54; 
McLauchlan, 19 86). The E mRNAs, which are encoded by genes 
UL39 and UL40 are unspliced and have sizes of 5.0kb and 
1.2kb, respectively. The 5.0kb mRNA specifies the RRl 
polypeptide and the 1.2kb mRNA specifies the RR2 
polypeptide. The 5' end of the 5.0kb mRNA is located 194nuc 
upstream from a Xho I site at 0.561 map units and the 5' end 
of the 1.2kb mRNA lies 290nuc upstream from a Hind III site 
at 0.587 map units (McLauchlan and Clements, 19 83a). The E 
mRNAs and the 7.0kb mRNA share a common 3' terminus 
positioned 770nuc to the right of the Hind III site at 0.587 
map units (McLauchlan and Clements, 19 82).
Previous partial sequencing studies predicted that 
the entire coding region of RRl and the N-terminal portion 
of RR2 lie within the Hind III k fragment (McLauchlan and 
Clements, 19 82 and 19 83a; McLauchlan, 19 86). A possible ATG 
start codon for RRl was located 34nuc downstream from the 
Xho I site at 0.561 map units (see Fig. 20). Within the 5 ‘ 
portion of the 1.2kb mRNA two ATG codons were identified, 
but an in-frame TGA stop codon was positioned 12nuc 
downstream from the first ATG (McLauchlan and Clements, 
1983a). It was proposed that the TGA codon was the 
C-terminus of RRl while the second ATG codon represented 
the initiation methionine at the N-terminus of RR2. The 
prediction of the latter was based on two reasons 
(McLauchlan and Clements, 1983a and b; McLauchlan, 1986): 
first, the first ATG codon was absent from the leader of the 
equivalent HSV-2 1.2kb mRNA and, second, the nucleotides
TR. I R t IR , TR,
0 . 5 4 0 . 5 6 0 . 6 0  m ap u n i t s0 . 5 8
H i n d l l l
B a m H I t
X h o I  . f t
B g l l l
_________________  7 .O k b ______________
3 . 8  k b  (V m w 5 4 ) 5 .  O k b _________^ ____l_ .J7kb
1 . 9 k b  , (R R 1# Vm w 13 6 )  ^  ^
( Vmw5 4 ) (R R 2, Vm w38 )
1 .O k b ,i_____1
Figure 20. The HSV-1 strain 17+ ribonucleotide reductase 
locus. This diagram shows the location of restriction 
endonuclease cleavage sites and the arrangement of mRNAs 
between 0.54 and 0.60 map units on the viral genome. The 
transcripts specified by this locus are shown as arrowed 
lines and their sizes in kb are indicated above each line. 
Open boxes denote the polypeptide coding regions of the 
transcripts and their designation is given in parentheses 
below each box.
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flanking the second ATG of the HSV-1 1.2kb mRNA were 
identical to those flanking the ATG of the HSV-2 1.2kb mRNA 
and, furthermore, they resemble those at other functional 
initiation codons (Kozak, 1981). In conclusion, although 
the coding regions of the RR1 and RR2 polypeptides do not 
overlap, the upstream transcription initiation signals and 
part of the untranslated leader of the 1.2kb mRNA map 
entirely within the genome region specifying the C-terminus 
of the RR1 polypeptide.
To determine the nucleotide sequence of the RRl coding 
region, a Xho I/Hind III fragment (0.561 to 0.587 map units) 
was isolated from a cloned Hind III k fragment (obtained 
from Dr J. McLauchlan), and was subcloned into a Sal I/Hind 
III digested ptJC8 vector (Fig. 21). Therefore, the 
resultant plasmid, pYNl, contained the entire proposed 
coding region of RRl and part of the RR2 coding region. 
Sequencing data was obtained using the M13 dideoxy chain 
termination method in combination with a 'shotgun' cloning 
approach and was subsequently collated by computer programs 
as described in Materials and Methods (see Page 73).
Manipulation of the sequencing data resulted in the 
formation of the HINDKK database which consisted of 186 
independent gel readings (Fig. 22). There were 34,286 
characters, which produced a final contiguous length of 
3564bp (Fig. 23). For each contig character an average 
of 9.62 characters were read from gels.
2. Computer Assisted Analysis of the HINDKK Database.
Analysis of the obtained sequence for potential ORFs 
and potential coding regions was performed with the DSPLAY 
and FRMSCAN programs, respectively (see Materials and 
Methods, Pages 74 and 75). The DSPLAY program identified 
in the left-to-right stand a single ORF (frame 1 in Fig. 24) 
starting with the ATG triplet at position 34 and terminating 
with the TGA stop codon at position 3447. The other two 
reading frames on this strand (frames 2 and 3 in Fig. 24) 
are punctuated by stop codons and the longest potential ORF 
is approximately 600 nucleotides long. Analysis of the 
complementary strand sequence identified a frame containing
Sail Hindlll
mndlil
BamHI Xhol
BamHI
(Xhol/^
Sail)
Hindlll
pYN1
Figure 21 . Construction of plasmid pYNl. The pHind k 
plasmid (obtained from Dr J. McLauchlan) was digested with 
Xho I/Hind III. The fragment which contains the DNA region 
encoding the RRl polypeptide and the N-terminus of the RR2 
polypeptide (dark area) was ligated into the multiple 
cloning site (MCS) of a Sal I/Hind III digested p(JC8 vector. 
The location and orientation of the ampicillin resistance 
(ampr ) and ft-galactosidase (lacZ ) genes is indicated.
Figure 22. A sorted list (CONTIG LINES) of the gel readings 
obtained after sequencing the recombinant Ml3mp8 clones 
which contained subfragments of the RRl polypeptide coding 
region. The column termed GEL LINES represents the name of 
the clone given by the author. The columns headed A to E 
are assigned by the DBUTIL program (see Materials and 
Methods, Page 73) and represent:
A Gel reading database number.
B Position of the left-most base of the gel reading in
the contig.
C Length of the gel reading. (-) indicates that the gel 
reading overlaps on the opposite strand.
D Number of the gel reading overlapping to the left.
E Number of the gel reading overlapping to the right.
CONTIG LINES
499 3564 0 138 46
GEL LINES A B C D E
112.G4 1 2869 176 117 71
146.G4 2 361 172 36 86
149.G4 3 2574 -179 77 57
150.G4 4 212 180 6 79
154.G4 5 2908 -159 176 23
155.G4 6 200 -193 21 4
163.G4 7 814 186 84 165
144.G4 8 3388 177 137 46
164.G4 9 3201 -162 27 30
356.G5 10 1609 142 168 60
358.G5 11 3098 -246 112 131
361.G5 12 1836 213 152 65
362.G5 13 1113 246 44 151
365.G5 14 2402 206 178 104
412.G6 15 2986 221 183 53
384.G7 16 29 -150 185 96
322.G8 17 2456 -239 140 45
338.G9 18 2164 -143 130 175
34 3.G9 19 2733 -179 180 117
345.G9 20 2038 160 51 139
303.G10 21 200 -178 90 6
295.Gil 22 1090 19 3 144 25
296.Gil 23 2924 -188 5 61
300.Gil 24 1004 191 167 81
255.G12 25 1094 212 22 103
256.G12 26 394 19 3 28 78
260.G12 27 3197 -141 41 9
264.G12 28 392 -19 7 86 26
266.G12 29 2960 -171 14 7 183
274.G12 30 3350 -156 9 137
276.G12 31 69 7 179 33 56
238.G13 32 2267 205 134 118
254.G13 33 694 -201 91 31
233.G14 34 114 -208 111 67
218.G14 35 1952 -201 47 123
363.G5 36 350 181 108 2
372.G5 37 2372 -165 80 122
423.G6 38 436 -220 78 42
382.G7 39 2888 -170 74 176
323.G8 40 79 3 -200 107 84
329.G8 41 3186 19 7 146 27
330.G8 42 493 183 38 87
336.G9 43 2431 180 104 127
335.G9 44 1105 -205 155 13
34 4.G9 45 2467 178 17 94
352.G9 46 3447 118 8 0
298.Gil 47 19 52 199 95 35
244.G13 48 2878 189 72 74
251.G13 49 3139 -203 131 146
227.G14 50 594 -215 52 115
228.G14 51 2002 -19 7 69 20
231.G14 52 594 211 87 50
235.G14 53 29 89 227 15 97
214.G14 54 1845 214 65 113
393.G6 55 2619 -216 62 85
212.G14 56 716 -163 31 120
223.G14 57 2600 -195 3 83
249.G13 58 3044 178 97 150
243.G13 59 2501 202 161 77
316.G10 60 1611 188 10 116
334.G15 61 2932 203 23 147
108.G15 62 2616 184 83 55
111.G15 63 1771 187 145 133
114.G15 64 971 191 165 153
127.G15 65 1844 -208 12 54
538.G16 66 1386 196 126 163
167.G15 67 171 19 7 34 90
207.G15 68 1889 -198 169 142
539.G16 69 1996 -155 92 51
115.G15 70 274 -191 109 110
118.G15 71 2870 -191 1 72
134.G15 72 2871 -192 71 48
540.G16 73 2651 -143 160 181
552.G16 74 2882 -183 48 39
559.G16 75 1495 161 174 105
563.G18 76 1391 250 163 159
567.G18 77 2531 -224 59 3
561.G18 78 423 -239 26 38
553.G16 79 243 -19 5 4 173
566.G18 80 2332 242 129 37
569.G18 81 1026 -241 24 121
473.G18 82 1137 -252 151 93
465.G18 83 2609 -266 57 62
113.G02 84 809 176 40 7
116.G02 85 2643 201 55 160
480.G18 86 373 -226 2 28
463.G18 87 533 211 42 52
468.G18 88 1517 -226 105 168
184.G15 89 1702 182 116 171
482.G18 90 194 -211 67 21
105.G15 91 618 181 124 33
558.G16 92 1991 209 125 69
550.G16 93 1185 181 82 149
557.G16 94 2474 -180 45 161
237.G13 95 1931 209 106 47
110.G01 96 29 -309 16 132
122.G02 97 3041 -175 53 58
125.G02 98 2308 -204 118 129
129.G02 99 284 -196 110 182
141.G02 100 1348 -182 170 143
HI61 101 1 121 0 0
H163 102 1 25 0 0
HA4 103 1098 -155 25 155
169.G19 104 2410 200 14 43
210.G19 105 1509 -208 75 88
539.G19 106 1925 -226 142 95
140.G19 107 756 236 120 40
173.G19 108 329 212 128 36
222.G19 109 274 -151 173 70
129.G19 110 277 -204 70 99
556.G19 111 113 -214 141 34
560.G19 112 3048 230 150 11
130.G20 113 1874 187 54 172
177.G20 114 1 25 0 0
181.G20 115 601 -165 50 124
117.G20 116 1672 212 60 89
119.G20 117 2836 -198 19 1
125.G20 118 2271 -241 32 98
178.G20 119 1448 19 0 154 174
192.G20 120 752 161 56 107
200.G20 121 1049 207 81 144
195.G20 122 2378 159 37 178
291.G21 123 1953 219 35 125
301.G21 124 617 187 115 91
442.G21 125 19 89 -176 123 92
601.G22 126 1382 126 14 3 66
608.G22 127 2431 -185 43 140
281.G21 128 308 -167 182 108
284.G21 129 2320 -172 98 80
G20.180 130 2155 200 157 18
741.G23 131 3112 -195 11 49
745.G23 132 77 -153 96 184
753.G23 133 1780 183 63 135
621.G24 134 2235 154 175 32
622.G24 135 1784 -113 133 152
623.G24 136 1232 227 149 179
624.G24 137 3383 -178 30 8
629.G24 138 1 -55 0 186
630.G24 139 2092 -188 20 162
631.G24 140 2435 -102 127 17
642.G24 141 99 -195 184 111
658.G25 142 1913 -207 68 106
664.G25 143 1376 182 100 126
666.G25 144 1082 19 4 121 22
667.G25 145 1737 171 171 63
668.G25 146 3180 -190 49 41
671.G25 147 2947 -118 61 29
673.G25 148 1 155 0 0
682.G26 149 1221 130 93 136
686.G26 150 3045 173 58 112
689.G26 151 1135 -176 13 82
695.G26 152 1815 147 135 12
696.G26 153 985 167 64 167
69 8.G26 154 1440 105 159 119
706.G27 155 1102 -183 10 3 4 4
707.G27 156 1 182 0 158
722.G27 157 2119 179 164 130
724.G27 158 22 125 156 0
729.G27 159 1397 112 76 154
730.G27 160 2648 153 85 7 3
733.G27 161 2497 -172 9 4 59
735.G27 162 2103 19 3 139 164:
737.G27 163 1388 -181 66 76
738.G27 164 2107 189 162 157
634.G24 165 841 -186 7 64
638.G24 166 1315 219 179 170
639.G24 167 997 -129 153 24
657.G25 168 1546 228 88 10
683.G26 169 1887 174 172 68
684.G26 170 1348 -159 166 100
692.G26 171 1706 -166 89 145
69 4.G26 172 1886 -19 6 113 169
704.G27 173 273 188 79 109
711.G27 174 1474 -204 119 75
721.G27 175 2201 206 18 134
448.G21 176 2899 -221 39 5
486.G21 177 2714 241 181 180
728.G27 178 2382 191 122 14
434.G21 179 1282 -202 136 166
678.G25 180 2716 19 3 177 19
604.G22 181 2657 143 73 177
610.G22 182 308 -129 99 128
613.G22 183 2985 -118 29 15
751.G23 184 78 -164 132 141
G7.138 185 9 -170 186 16
602.G22 186 1 -88 138 185
Figure 23. The HINDKK database. This printout shows all 
the gel readings in the HINDKK database which are numbered 
(down the side of the sequences) as in column A of
Fig. 22. Computer inserted characters into the gel readings 
entering the contig database are indicated by (*) and those 
inserted by the author are indicated by (X), (/) and (-).
1 0  1 0  30 4 0  5 0  60  70  8 0  9 0  1 0 0  1 1 0  1 2 0
-1J8 t c c a c c c c g c c c a a a c c c c c c c c g t c t c t t c a a a t g c c c a g c c c c c c a c c c c c a t
-186 TCGACCCCCCCCAAACCCCCCCCGTCTCTTCAAATCCCCAGCCGCCCACCCGCATCCTCTCCCCTCCAAGCCCCGGCCCCGCTTGGGC
-115 GCCCAAACCCCCCCCCTCTCTXCAAATGGCCACCCGCCCACCCCCATCCTCTCCCGTCCAACCCCCGCCCCCGGTTCGGCGACACCACGCCGGCGGCCCCACCCCAGCCACC
-16 TG AAATG G CCAGCCGCXCAGCCGCATCCT-TCCCCTCXAAGCGCGGGCCCC* CTTGGGGGACAG* AGGXCXCCGGCCCCAGCGCAGCCACC
-86 XGAAATGGCCAXCCGCCCAGCCGCATCCTCTCCCGTCGAAGCGCCGGCCCC> C TX XXXC C AC AG -AG G XC XG C C G C C XXAXXXC AXC C AXX
-112 CCCCCGTTGCGGGACAGCAGGXCXGCGGCCCCAGCGCACCCACC
-114 CCCXGTTCCGGGACAGCAGGCCCCCGGCCCCa GCGCAGCCACC
-141 XXG CGCCCCCACCGCAGCA* •  C
-111 CAGCXAXX
-34 AG C C A* C
tccaccccgcxmaaacccgccccctctcttcaaatcgccacccgccx> gccccatcctctcccgtcgaagcgcgggccccggttgggccacacgaggccggcggccccagcgcagccacc
1 3 0  1 4 0  IS O  1 6 0  1 7 0  1 8 0  1 9 0  2 0 0  2 1 0  2 2 0  2 3 0  2 4 0
-185 CACCGCGAGGCCCCCGCCCCCCCTCTCCCCCA CCCCCACCA CGTGTA CTCCCAGCCA g 
-16 CAGGGG* AGXCCGCCGGGGCCCCTCTCGCCCa  CGGCCa CCACGTGTACTGCCAGCGA C
-86 XXXG C G *AC TC C G aC XC C G XXC C TC TC C C C XAC G G C XAC XAC XTXTACTCCCAG CCAG TCAATCXCCTCATXG TG CTTTCCCACAACACG CCCG CCTCCXXG TCCTACCG CArCAG CG AT 
-1)2 CAGGGGGACGCCGCCGGGCCCCCTCT- * •  CCACGCCCA CCA CGTGTA CTGCCAGCCAG TCAATCGCGTGA TG G TG CTTTCCG A CA AGA CCCCCCCCTCCCCCTCCTACC
-184 c a c g c g c a g g c c g c c g g g g c c c c t c t c g c c c a c g g c c a c c a c g t g t a c t g c c a g c g a g t c a a t g g c c t g a t g c t g c t t t c c o a c a a g a c g c c c g g g t c c g c g t c c t a c c * • * * CAGCGAT
-141 CAGGGG* AG * CCCC* •  CG G CCCCTCTCC* CCACGGCCa CCa CGTGTACTCCCAGCCAGTCAATGGCGTGATG- TCCTTTCCG ACAAG ACG CCCCG G TCCCCG TCCTACCG CATCACCG AT  
-111 CAGGGGGAGCCCXCXXGGGCCCCTCTCGCX X a  CGGCX a  CCA C C TG Ta CTGCCAGCGAGTCA ATGGCGTGA T X C T G C IT T C C G a Ca  AGA CGCCCGOCTCCOCGTCCTACCGCATCAGCCa T  
-14 CAGGGG* AGGCCGCCCCGGCCCCTCT* • • CCACCGCCA <;CA CGTGTA CTGCCAGCGAGTCA ATGGCGTGA TGG TG CTTTCCG A CA AGA C* *CCCG CTC C C C G TC C TAC C G C ATC AG C G AT  
67 CCAG* GAGTCA ATGGCGTGA TGG TG CTTTCCG A CA AGA CGCCCGGGTCCGCGTCCTACCGCATCAGCGAT
-50 t c c t t t c c g a c a a x a c g c c x c c x t c c / c g t c c t a c c g c a t c a g c x a t
-11 CCGA CA AGA CGCCCGG* TCCGCCTCCT ACCGCA TCAGCGA T
-6 CCGACAA* ACGCCCGGGTCC* CGTCCTACCGCATCAGCGAT
4 CCCGGTCCGCGTCCTACCGCATCAGCGAT
CAGGGGGAGGCCGCCGGGGCCCCTCTCGCCCA CGGCCA CCA CGTGTA CTGCCA GCGAGTCA A TGGCGTGA TGGTGCTTTCCGA CA AGA CGCCCGGGTCCGCGTCCTACCGCATCAGCGa T
 250 2 6 0  2 7 0  2 8 0  2 9 0  3 0 0  3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
-56 AGCAACTTTGTCCAATCTCCTT C C A A C T GCACCA TC A TC ATC G A CCX AGA CCTGGTXCGCGGXCGCCCCXAGGACCCGGGGGCCXXGGCATCCCCCC 
-184 A
-141 AG CAACTTTCTCCAATGTGGTTCCAAC* C C aC C A TG A TC A TC G A C G * AGACGT
-111 AGCAACTTTGTCCAATGTGGTTCCAACTGCACCATGATCATCGACGGAGACGTGGTXXXGGGCGCCCCCXXGGXCCCGGGGGCCGC 
-14 AC«**CTTTGTCCAATGTGGTTCCAACTCCACCATCATCATCGACCGAGACGTGGT* c c c g g g c g *  c c c c a g g a c c *  g gg g
67 A**AACTTTCTCCAATCTGGTTC* AACTGCA CCA TCATCATCGA CGCACACCTCGTCCCCCGGCC* CCCCAGG* *  CCGGGGGCCGCGGCATCCCCXGCT* CCTT* GTTGCGGTGA CA A* C 
-50 ACCAACTTTCTCXAAT/TGGTTCCAACTGCACCATGATCATCGACGXA/ ACXTC/ TGCGCGGGCGCCCCXAGGACCCGGGGGCCGCGGCATCCCCXGCTCCCTTCXTTGCGGTGACAAAC 
-21 ACCAACTTTCTCCAATCTGGTTCCAACTGCACCATGATCATCGACGXAGAOGTCGTGCGCGGGCGCCCCCAGCACCCGGGGGCCGCGGCATCCCCCGCTCCCTTCGTTGCGGTCACAAA* 
-6 AGCAACTTTCTCCAA T * TCGTTCCAACTGCACCATCATCATCGACCX AGACGTCGTGCGCGGTCGCCCCCAGGACCCGGGGGCCG* *  CCATCCCCCGCTCCCTTCGTTGCGGTGACAAAC 
4 ACCAACTTTCTCCAATCTOCTTCCAACTGCACCATCATCATCGACGGACACCTCGTGCGCCG* * GGCCCCA GCACCCGGGGGCCGCGGCATCCCC* GCT* CCTTCCTTGCCGTGA CA a *  C 
-75 CAXCTXXCTCXXATXTCXXTCXAACTCXACXATGATCATCGACCXAXACCTCXTXCCCCGXCGXXCCCAXCACCCGCCGCCCGCGGCATCCCCXGCTCCCTTCCTTGCGGTCACAAAC
CATXATCATCCACGGACACCTGGTGCCCCGGCXCCCCXACGACCCGGGGGCCGCGGCATCCCCCGCTCCCTTCGTTGCGGTGACAAAC 
■“ 5 AXCATGATCGACXXAGACGTGXTCCGCXGGCGCCCCXAGGACCXCGGGXXXGCXGCATCCCCCGCTCCCTTCXTTGCGGTGACAAAC
* '?  ATGATGATCGACaCAXACCTGXTCCGCGGCCGXXCCCAGXACCXXGGGGCCOCXGCATCCCCXGCrCCCrTCXTTGCGGTGAOAAC
ATCATCGACGXACACXTXCTXCXCXGCCCCCeCXAXCACCCCGCCCCCGCGGCATCCCCXCCTCCCTTCXTTGCGCTCACAAAC 
7 .' AXGXAXACXTCXTXCXCCCGCXCCCCCACXACCXXCCGGCCGCGGCATCCCCXCCTCCCTTCGTTXCCGTGACAAAC
CCCAGGACCCGGCGGCCC* « GCAT* CCCCGCTCCCTTCGTTGCGGTGACAAAC•121
108
16
CCCAXCACCCGCGGXCCXXXGCATCCaCXGCTCCCTTCGTTGCGGTGAOAAC
CATCCCCXGCTCCCTTCGTTGCGGTGACAAAC
CGGTGACAAAC
AGCAACTTTCTCCAATGTGGTTCCAACTGCACCATGATCATCGACGGAGAOCTGGTGCGCGGGCGCCCCCAGGACCCGGGGGCCGCGGCATCCCCCGCTCCCTTCGTTGCGGTGACAAAC 
3 70  380  390 400  410 420  430 4 40  450  460  470  480
07 ATCCCAG
-50 ATCGXAGCOGCCACCGACGGCGGGA CCGCCGTCGTGGCATTX GG
-21 * t * * c a g c c g g c a g c x x
-6 ATC* g a g c c g g c a g c g a  CGGCGGGA CCGCCGG
< atc c gag cc gg ca
* 5  ATCCX AGCCCCCACCCA CGGCGGGA CCGCCGTCGTCGCATTCGGGCX A A CCCCA CGTCGCTCGGCCCCCACGTCTA C
-104 *7 CGGAGCCGGCAGCGACGGCGGGACCGCCGTXXTGXCATTXGGGGGAACXXXACCTCCCTCGGCGGXXACGTCTAXCGGTACCXAXAXGGCCGAXXTCX 
-70 CCGA<*C0 CGCACCCACCGCGCCACCGCCGTCCTGGCATTCGGGGX AACCCX ACCTCGCTCCG
-110 ATCOtAGCCCGCAGCGA CGGCGGGA CCGCCGTCGTGGCATTCGGGGXAA CCCCA CGTCGCTCGGCGCGGACGTCTACCGGTACCCACACGGCCGACGTCCXX AC 
-410 ATCGXAGCCGGCX CCGA CGGCGGGA CCGCCCTCGTCGCATTCGGGGXAA CCCCA CGTCGCTCGGCGGGGACGTCTACCGGTACCCACACGGCCGACGTCC CCA CCGAXXXXXTTGGGGXC 
-187 ATCaCAGCCGGCACc GACGGCc GGACCGCCGTCCTGGCATTCGGGGXAA CCCCA CGTCGCTCCGCGGGXACGTCTACCG2XACCCAGACGG CCGA CGTCCCXACCGAGXXXXTTGGGGG 
-128 atc c gag cc c gc a g c c a c g g c g c c a c c g c c c t c c t g g c a t t c g g g c g a a c c c c a c g t *  CCTCCGCGGCGACGTCTA
ATCCGAGCCGGCA GCGACGGCGGGACCCCCGTCGTCXXATTCCGGGX AACCCX ACGTCGCTCCCCCGGXACGTCTACCGXTACCXAGACGG CCGA CGTCCCXACCCAGGCOCTT 
aIS ggaggc g g c a g c g a c g x c g x x  a c c g x x x t c x t x g c a t t c g g c g g a a c c x x  a c g t c g c t x x x c g g g g a c g t c t a c c c g t a c c x  a g a c g g c c c a c g t c c c c a c c g a g g c c c t t g x x x x c
ATCCGAGCCGGCA GCGACGGtXGGACCGCCGTCXTCGCATTCGGGGGAACCXXACGTXXCTCCGCGGXXACGTCTACXCGTACCXAGAXXGGCGACGTCCCXACXCAGGCCXTTGGGXXX 
A TCCCAGCCGGCA CCGA CGGCGGGA CC CCCGG CXXGGXXTTCGGG GGXXCCX XACGTC* • TCCGCGGGGACCTCTACCCGTACCCACACGGCCCACCTCCC* *  CCGACGCCCTTG* * * X *  
AGCCA CGGC CGGA CCGCCGT CX TGX CA T T  CGGGXX AACCCX ACGTCXCTCCXCGGX XACXTCTACOCGTACCXXGACGXCCGACGTCCCCACCGAGGCCCTTGGGGGC 
TCXTXGCATTCGGGXXAACCXXACXTCGCXXXXXXXGGACXTCTACCXGTACCXACACGCXXGAXGTCCCXACCXAGXCCXTTGGXXXC 
X X C CX X TTCGGGX X AA CCX X A CGTCGCTCC* • C GGCA CGTCTA CCGGT A CC* A GA CGGCCCA CGCCCCCA CCGAGCCCCTTCGGGX C 
GXCGGXXACXTCTACXXGTACCXAXACGXCCGACGTCCCX ACCXAGXXCCTTGGGGXC 
AXXCGTACCX AGACGXXXXACXXCCXX ACCX AGXCCXTTGXXXXG 
ATCCGAGCCGGCAGCGACGGCGGGACCGCCGTCGT GGCA TTCGGGGGAACCCCA CGTCGCTCGGCGGGGaCGTCTACCGGTACCCAGACGGCCGA CGTCCCCA CCGA GGCCCTTGGGGGC
108 r r *  4 , 0  5 0 0  5 1 0  5 2 0  5 3 0  5 A 0  5 5 0  S 6°  5 7 0  S S 0  5 , 0  6 0 0
c i^ ^ ^ ^^C TC C C X G d 1XACCXTGGXTXGCGGCI u  1 161 IXCIGICGCGAXAXAXGG 
2 S j 7 CtC1CTCXTCXXCCXTT7CAXXCTGXGTXGCGXXTGXTCTXXCTXTXC 
-86 .•(N-^ TaTCXTCCaCGCTTXa c c x tg g *  TXGC* GCTCTTCTTCXTCTCGAC
-21 i* .,^3 ’ ^'^^33CTCCCXCC 1 4 CACCC1GGGTGGCGGCTG f  16T rOCTCTCCCCA CACACGOCOCOCCTCTCCGGTAT 4 X X OGGCGCA GGGGX A TOC AX TCGCCCCCCCCX A X I I'OCTCT 
v  ^ *3'-TOCTOCTCOCCGCl I'CACCCTGGXTCGCGGCTGTTG r roc rc I CCCCA CA CA CGGCGX CX CTCTGCGGT A I 1 CGGGGGGGAGGGGGATCCAG 1AGGCX X XGOli 
*78 )-.J ? i^ * G* 3'4-47TCOCXCCTTCACCCTCCOTXCCCCCTCTTCTTCXTCTCCCCXXXXXXXOCCCCl3CTCTGOCCTATTXOCOGGGGAGGGXGATXXXXTCGCCCCOi 
. J ,  ^ ” ~^7CCTCCTCCCXGCTTCA CCCTGGX TX CX G GCTGX XGTTCCTCTCCCGa CA CA CGX XGXCGCTCTGCGGTA TTCGGGCGGGA GGGGGA TCCAGTCGGCCCCG CGGA GTTCGTXXCG 
n  CC®TCXTOCTCCCXCCTXXACCXTGGGTXCCGXCTCTXGTXCCTGTCCCCACACACGGCGGCCXTCTCCGXTATTCXGGGGGGAGGGGGATCCAGTCGGCCCCGCCCAGI rCGTCTCX 
17 CCXXCCTTXACCXTGGXTXGCGGCTXTTGTTCXTCTCGCGACACACCGCGCCCCTCTGCGGTATTXGGGCGGGAGGGGGATCXAGTCGGCCCXCCGGAGTTCGTCTCG
52 XXXXXXXXXXCCGCXCXXXXXXATTXGGGGGGGA GGGGGA TOC AGTXGGCCCCGCGGAGTTCGTCTXG
-50 CXTCTTC
CCTCTXX
W-C<XTCCTCCTCCCCGCTTCACCCTGGGTGGCGGCTGrTCTTCCTGTCGCGACACACGGCGCCGCTCTGCGGTATTCGCCGGGGA GGGGGA TCCAGTCGGCCCCG CGGA GTTCGTCTCG 
-7j  x *1 0  6 20  630  640  650  6 60  670 680  6 90  700 710  720
-38 Ca S ^ ^ 2 GTCGTCCGATTCCGACT CCGA TGACT CGGA GGACA CGGA CTCGGAGACCCTGT 
42 to^S^CCTCCCATTCCCACTCCG ATCACTCG G AG G ACACCG ACTCCG ACA
17 caX^^^CCTCXGATTCXCACTCGGATGACTXGGAGGACAXXCAXTXXCACACGCTGTCACa XGCXTXCTXG
SJ -.Tr^OOGGTCCTCXXATTCCGACTXCGATGACTCGGACGACAXCCACTXCCAGACGCTCTCACAXGCXTXCTXGGACGTGTCCGGCGGGGCXACGTACGACGAXCXCCTTGACTOCGAT 
-50 r^^CCGTCCTCCGATTCXGACTCGGATGACTCGGAGGACAOGGACTCGGACACGCTGTCACACGCCTCCTCGGACCTGTCCGGCGGGGCCACGTACGACGACGCCCTTGACTCCGAT 
-Us ^^aXGTCXTTCCGATTCXGACrCGXATXACTCGXAGGACACCGACTCGGACACGCTGTCACACGCCTCCTCGGACXTCTCCGXCGGGGCXACGTACGACGACGCCCTTGACTCCGAT 
124 ^ <7C*CTCGTCCGATTCCCACTC* CATGACTC* CACGACACGGACTCCCAGACGCTGTCACACGCCTCCTCCGACGTGTCC* CCGCGGCCACCTACCACCACGCCCTTGACTCCGAT
51 ATTC* GACTCGGATGA CTCGGAGGACA CGGA CTCGGAGACGCTCT CACA CGCCTCCTCGGACaj 1G1CCGGCGGGG CCA CGTACGACGACGCC*  TTGACT* CCAT
-3) TTCXGACTXGGATGACTOGGAGGACAXGGACTCGGAGACGCTGTCACACGCCTXCTCGGACGrGTCCGGCGGGGCCACCTACGACGACX3 CCTTGACTXCGAT
31 ACGTACGACGACGCCCTTGACTCXXAT
-54 TACGACGACGCXCTTGACTCCGAT
^^CCGGTCGTCCGATTCCGACTCGGATGACTCGGAGGACACGGACTCGGAGACGCTGTCACACGCCTCCTCGGACGTGTCCGGCGGGGCCACGTACGACGACGCCCTTGACTCCGAT
730 7 4 0  7 5 0  760  7 7 0  7 80  7 9 0  800  810  820  8 30  640
J7 WCTCATXGGAGAACTXCCTGCA
52 TOCTCATCGGATCACTCOCTCCAGATAGATGGCCCCGTGTGTCGCCCGTGGAGCAATGACaQCGCGCCCOCGGATGTTIXCCCC 
.50 t c c t c a t c g g a t c a c t c c c t c c a g a t a g a t c g c c c c g t g t c t c g c c c c t g g a g c a a t g a c a c c g c c c c c c t g c a t c t t t g c c x x g g g a  
-115 t c c t c a t c g - a t g a c t c c c t g c a c a t a g a t g g c c c c g t c t g t c g c
124 TCCTCATCGCATCACT* c c t c c a g a t a g a t g g c c c c g t g t c t c g c c g *  *  *  GAGCAATGACAC* g c c c c c *  t *  c a t c t t t g c c c  
31 t c c t c a t c c c a t c a c t x c c t c c a c a t a c a t x g c c c c c t c t c t c x x c c g x c c a g c a a t c a c a x c g c c x x c c t x g a t g t t
-)J  TCXXCATCGXATCACTCCCTCCAXATAXATGCCCCCGTGTXXCGCCCCTCXAGCAATCACACCGCGCCCCTCX ATCTTTGCCCXGGXACCCCCGGCCCGGGCGCCGACGCCGGTGGTCCC 
31 tCCTCATCGCATCACTCOCTGCAGATAGATGGCCCCCTCTGTCGCCCGTGCAGCAATCACAOCGCGCCCCTCCATCTTTGCCCCGGCACCCCCGGCCCGGGCGCCGACGXCCGTGGTCCC 
-56 TXCTCATOGXATCACTCCCTCCAGATACATGCCCCCGTGTCTCGCCCGTGCACCAATGACACCGCCCCCCTQCATGTTTCCCCCCGGACCCCCGGCCCGGGCGCCGACGCCGGTGGTCCC 
120 '
107 
•40 
04 7
CCCCCCTCTGTCCCCCCTGGAGCAATCACACXGCCXCCCTCCATCTTXXCCCXGCCACCCCCGGCCCGGGCGCCCACGXCCGTCGTCCC 
CGTCTGTCGCCCGTGCACCAATGACACCGCCCCCCTCGATCTTTGCCCCGGGACCeCCCGCCCCGCCGCCGACCXCGGTCCTCCC
CATXTTTGXCCCGXCAXCCCCGGCCCGGCCGCCCACGCCCGTGGTCCX
CCCCCGGCCCGXGC3CCCGACGCCGGTGGTCCC
GGCCCGGGCGCCGACGCCGGTGGTCCC
TCCTCATCGCATGACTCCCTGCAGATACATGGCCCCGTCTCTCGCCCGTCGAGCAATCACACCGCGCCCCTGGATCTTTGCCCCCGGACCCCCG<^CCGGGCGCCCACGCCGGTGGTCCC
9 1 0 9 20 9 3 0 9 5 0850 8 6 0  870  860  890  9 00
-13 TCXCCCCT AGA CCCA CACCCCX CCA CGCCACACGCCGGCGCTGGTCTTCCGGCC 
31 TCAGCGGTAGACCXACAXCXCXGCACCOC AGAGGC 
-56 TXXGCCGT AGA CCCA CACXCG CCGA CCXX AX AGGCCCG
120 TCACCCCTACACCXACAXGCGCCCA CCCCA CAGGCCGGCGCTCGTCTTGCGGCCCATCaCGCXGTCXCCCGC
.107 TCAGCGGTACA CCCACACCCCCCGA CCCCA CAGGCCGGCGCTGGTCTTGCCCCCGATXCCGCCGTGGCCCGGGACGACGCGGAGGGGCTTTXGGAXCCCCGGCCACGXXTGGGA ACC GGC 
-40 TCACCCXTACACXCACAXGCCCCXAXGCCAXAGGCCCGCGCTGGTCrT-CCG CCGA TCGCGCCGTGGCCXGGGACGACGCGXAGGGGCTTTCGXACCCCCGGCCACGTCT GGCA ACXGGC 
14 TCAGCGGTACA CCCACACCCCCCGA CCCCA GAGGCCGGCGCTGGTCTTGCGGCCGATCCCGCCGTGGCCCGGGA CGACGCAGGGGGGCTTTCGGACCCCCGGCCACCT'CTCGGA ACGGGC
7 t c a c c g g t a g a c c c a c a c c c g c c g a c g c c a g a g g c c g g c g * t g g t c t t g c g g c c g a t c c c g c c g t g g c c c g g g a c g a c g c g g a g g g g c t t t c g g a c c c c c g g c c a x g t c t g g g a a c c g g c  
-165 t c a x c g x t a c a c c x a c a c c c c c c g a c c c c a c a g g c c g x c g c t x g t c t t g c q c c c c a t c c c g c c g t g g c c c g g g a c g a c g c g x a x g g c c t t t c c x a c c c c c c g c c a c g t c t g g g a a c g g x c  
tcacccg taga  c c c a c a c g c c c c g a  c c c c a  g a g c c c g c c g c t g c t c t t c c g g c c c a t c c c g c c g t g g c c c g g g a c g a c g c c g a g g g c c t t t c c c a c c c c c g g c c a c c t c t g g g a a c c c g c
970  . 980 9 9 0  1 0 0 0  1 0 1 0  1 0 2 0  1
ACGGXCTACCCXCTXXCCCTCGAAXTXACCC 
ACGGCCTACCCCCTCCCCCTXCAACTCACCCC 
ACCCCCTACCC* *  TGCCCCTGGAA
a c c g c x t a c c c c g t c c c c x c g g a a c t c a c c c c *  CACAAC
a c g c c c t a c c c c g t c c c c c t g c a a c t c a c g c c c g a c a a c g c g g a g c c c g t g c c g c g c t t t c t g g g a
c t c a c c c c c g a c a a c c c c c a c c c c c t c g c c c g c t t t c t g c g a g a t c c c c t g a a c c c c c a a c c c c c c c t c a t g c t c c g g t a c t t t t g c c g c t g c g c c
a a c c c c x a c c c c c t c c c g c c c t t t c t g g x a g a t c c c c t x a a c x g c c a a c c c g c g c t c a t g c t g x g g t a c t t t t g c c g g t g c g c c
AGXCCGT* CGCCGCTTTCTGGCAGATGCCGTCAACCGCCAACCCGCCCTCATGCTGGGGTACT T T r GCCGCTGCGCC 
AXATGCCCTXCACCXCCGACCCCCCCTCATCCTCXGXTACTTTTGCCGXTXCGCC
_______  CCCTCATCCTGCCCTACTTTTCCCCGTCCGCC
ACCGCCTA<XCCCTCCC<XTCCAACTCACCCCCCACAACCCGGACCCCCTCCCCCCCTTTCTCGGACATGCCCTGAACCCCCAACCCGCCCTCATCCTCCGCTACrrrrGCCGGTGCGCC
12001090 1 1 0 0  111 0  1 1 2 0  1 13 0  1 1 4 0  1150  1160  117 0  1180 1190
CCCCA GCA AX CCAACCGTCTCCCCCCCAGGA CATT* GGCAGCCCCCTCCTA............. GGAGGA CGACTTTGG* CTTATAGCT
CCCGAGGAAAC* AAGCCTGTCCCCCCA* GGACATTCGGCAGCCCC* *  TCGCCT* ACGGAGGa CCACTTXGG 
CGCGAGXAAACCAAGCCTCTCCCCCCCAXGACATTCGGCAGCCCC 
CCCCACGAAACCAACOCTCTCCCCCCCACCACATTCCGCAGCCCCOCTCCCCTCCCCCACGACCACTTTCCCCTTCTCAA* t a c c c c c t c c t g *  a c a t c c a c c g c *  t g t c t c t g
GGCGACGAAAC*AAGCCTCTCCCCCCCACCACATTCCGCAGCCCCC* TCCCCTCACGGAGGACCA CTTTCGGCTT* TCAACTACCCCCTCCTCCACATCCAGCGC* TCTCTCTGCa CGTT 
CCCAC* AAACCAAGCCTCTCCCCCCCAGGACATTCGGCAGCCCCCCTCGCCTCACCGAGGACCACTTTGCCCTTC* * AACTACGCGCTCCTGCAGATGCAGCCCCTGTGTCTGGACGTT 
*CCAA4JCCT4JTCCCCCCCAGCACATTCCGCACCCCCCCTCCCCTCA CCGA CCA CCa CTTTCCCCTTCTCAACTACCCGCTCCTCGA<^TCCAGCCCCTGTCTCTGGACCTT 
AXCCTCTCCCCCCCC* •  A* A TTTCGCAGCCCCCCTCCCCTCA CCGA GGA CGA CTTTCGGCTT CTCAACTACGCCCTCCTGGAGATCCAGCGCCTGTGTCTGGACGTT 
TCTCCCCCCCACGACATTCCGCACCCCCCCTCCC* TC* CCCA CGA CGACTTTGG* CTTCTCAACTA* CCGCTCCTGGACATCCACCGCCTGTGTCTGGACCTT 
CCCCCCA* GACATTC* CCA G CCCCCCTCGC* TCACG* A * GACGACTTTCGGCTTCTCAACTACCCCCTCCTCGAGATGCAGCCCCTGTGTCTGGACGTT 
CCCAXCACATXCCXCACCXXXXXTCCCXTXACCXAGXACCACTTTCGXCTXCTCAACTACCCGCTCCTCXAGATCCACCCCCTCTGTCTCCACCTT 
ATTCCGCACCCCCCCTCCCCTCA CCCA GGA CCA CTTTCCGCTTCTCAACTACGCGCTCCTGCAGATGCAGCGCCTGTGTCTGCACGTT 
ACC* A* CACCACTT* « GGCTTCTCAACTACGCGCTCGT* GACATGCAGCGCCTGTGTCTG* ACCTT  
OC A GX A CX A CTTTGCX CTX CTCA ACT ACGCCCTCCTCX AGA TCCACCG<XTTGGTCTGX A CCTT
CCTXTXTCTGX AOCTT
^^AAACCAAGCCTCTCCCCCCCAGGACATTCCGCAGCCCCCCTCGCCTCA CCGAGGA CGA CTTTCGGCTTCTCA ACTA CCCGCTCCTGGAGATGCAGCGCCTCTGTCTGGACGTT
r n . . .  1 2 1 0  1 2 2 0  1 2 3 0  1 2 4 0  1 2 5 0  1 2 8 0  1 2 7 0  1 2 8 0  1 2 , 0  1 3 0 0  1 3 1 0  1 3 2 0CCTCCGGTCCCCCCGAACGCATACATGCCCTATTATCTCAGGGAGTATCTGACGCGGCTXGTCAAC
SICCGGTCC* C* OGAACCCATA* *  TC * CCTATTATCTCAGGGAGTATCTGACCC
i V ~ "~ <*7,CCCCCCCAACGCATACATCCCCTATTATCTCAGCGAGTATCTGACCCGGCTGGTCA* X* GGTT* AAG 
^ |CCCCTCC0C4XGA« CCCA TACATGCCCTATT AX CTCA GGCA GTATCTGACGCGGCTGGTCAXXGGGTTCAAGCCGCTGG
l l i ~ ~ GG7CCCCCCCAACCCATACATGCCCTATTATCTXAGGGACTATCTGACGCCGCTGGTCAACGGGTTCAAGCCGCTGGTGAGCXXGTCXXXTXCXCTTX AC
WCCCGTCC43G4XGAACGCATACATGCCCTATTATCTCA* GGAGTATCTGA
ir S ^ ^ C C C C C C A A  CCCA TACATG4XXTATTATCTCA CCGA GTATCTGACGCGGCTGGTCAACCGGTTCAAGCCGCTGGTA
I ^ r r * CTCCCC <XX^C C C >TA C A TC C C C TA TTATCTCAXG G AG TATG TG ACG CG G CTG G TCAACG G G TTCAAG CCG CTG G TG AG CCG G TCCG CTCG CCTTTA CCCCA  
^ r r r * TCCCCCCCAACGCATACATGCCCTATTATCT5CAGCGAGTATGTCACC* CGCTGGTCAXCGGCTTCAAGCCCCrCCTGAGCCCGTCCGCTCGXCTTXACCCCATCCTGGGGXTT 
^ w C GTCCC(XCCAACCCATACATC<XCTATTATCTCAGGGACTATCTCACCCCGCTGGTCAACGCGTTCAAGCCGCTCGTCAGCCCCTCCCCTCCCCTTTACCGCAT 
^rCOOCTCCCGCCCAACCCATACATGCCCTATTATCTCACCXACTATCTCAtXCCGCTCCTCAACCGGTTCAAGCCCCTGGTCAGCCCCTCCCCTCCCCTTTACCGCATCCTGGCCCTT
ATACATCCCCTATTATCTCAGCGACTATCTCACCCCCCTCGTCA* CGGCTTCA* c c c c c t g g t c a g c c g g t c c c c t c g c c t t t a c *  g c a t * c t c c g g g t t  
a t t a t c t c a g g g a c t a t c t g a c c c g g c t g g t c a a c c g g t t c a a g c c g c t g g t g a g c c g g t c c c c t c c c c t t t a c c g c a t c *  t g c g g g t t
CTGAGCCCXTCCCCTCGCCTTTACCGCATCCTCGGGX TT
C^ CGG7CCCCCCGAACCCATACATGCCCTATTATCTCAGGGAGTATGTGACGCCGCTCGTCAACGGGTTCAAGCCGCTGGTGAGCCGGTCCCCTCGCCTTTACCGCATCCTGGGGGTT
1330 1 34 0  13 SO 1360  1 3 7 0  138 0  1 39 0  1 4 0 0  1 4 1 0  1 4 2 0  1 4 3 0  1 4 4 0
13 CTXGTXCACCTXCXGATCCGGACXXXGGA
-82 CTGGTGCACCTCCGCATCCGGACCCGGCAGCCCTCCTTTGACCAGTCCCTCCGATCCAA* CAACTGGC 
83 CTCGTGCACCTGCGGATCXXCACCXXGGACXXCTXCTTTXAXGAG 
149 CT^CTGCACCTCCGGATCCGGACCCXGGAG
1)6 CTCCTCC3CCTGCGGATCOGCACCCGGGAGGCCTC* TTTCAGGAGTGCCTGCGATCCAAGGAAGTGGC43CTCGATTTTGGCCTGA CGGA AAGGCTTCGCGAGCA CGAAGCCX AGCTGGTG 
-179 CTCCTGCACCTGCGGATCCGGACCCXGGAGGCCTCCTTXCAGGAGTGCCTGCGATCCA AGGAAGTCGCCCTGGATTTTGGCX TCA CGGA AACXCTTCGCGAGCA CGA AGCCCAGCTGX TG 
166 CTGGTGC3CCTGCGGATCCGGACCCGGGAGGCCXCXTTTGAGGAGTGGCTGCCATCCAAGGAAGTGGCCCTGGATTTTGGCCTGACGGAAAGGCTTCGCGAGCACGAAGCCX AGCTGGTG 
.170 CAGXXCTCXXTTXACX AXTXGCTCCGATCCAAGXAAGTGGCCCTXGAXTTTGGCXTGACGX AAAGXCXTCGCGAGCACGAAGCCX AGCTGXTG
.100 CAGGCCTCCTTTXAXGAXTXCCTCCCATCCAA* CAAGTGGCCCTXCATnTGGCX TCA CGX A AAGXCTTCGCCAGCA CGA AGCCCAGCTX GTG
14) TCA AGGA ACTGGCCCTCGA TTTTGGCCTCA CGGA AAGGCTTCGCGAGCA CGA AGCC* AGCTGGTG
126 AAGTGGCCCT* CATTTTGGCCTGACGGA AAGGCTTCGCGAGCA* GA AG* CCAGCTGGTG
66 GGCCCTGGATTTTGGCCTGACGGA AAGGCTTCGCGAGCA CGAAGCCX AGCTGGTG
-16) CCCT*GATTTTGGC*TGACG*2AA*GCTTCGCGAGCACGAAGCC* *G C TG **G
76 TGGATTTTGGCCTGA CGGA AAGGCTTCGCGAGCA CGAAGCCX AGCTGGTG
159 TTGGCCTGA CGGA AAGGCTTCGCGAGCA CGA AGCCCAGCTGGTG
154 G
CTCCTGCACCTGCGGATCCGCACCCGGGAGGCCTCCTTTCA GGA GTGGCTGCGATCCAAGGAAGTGGCCCTGGATT TTG CCCTG A CGGA AAGGCTTCGCGAGCA CCAAGCCCAGCTGGTG
1450 1 4 6 0  1470  1480  1 4 9 0  1 5 0 0  151 0  1 52 0  1 5 3 0  1 5 4 0  1 5 5 0  1 5 6 0
136 ATCCTGXCCXAXGCTXT*
-179 ATCCTCGCCCAGGCTCTGCACCATTACCACTXXCTGATCCACA 
166 ATCCTGGCCCAGGCTXXXCACXATTACGACTGTCTGAXXCAXAGCACACXGCACACGCTGGTCGAGCGGGXXCTGCAATXGGCXXTGXAGTAT 
-170 ATCCTGGCCCAGGCTCTGGACCATTACGACTGTCTGATCCACAGCACACXGCACACGCTGGTCGAG
-100 ATCCTGGCCCAGGCTCTGGACCATTACGAXTGTCTGATCCACAGCACACCGCACACGCTGGTCXAGCGGGGGCTGCAATXGGCCXTGAA
143 ATCCTGGCCCACGCTX** CACCATTACCACTGTCTCATCCACACCACACCGCa CACGCTGGTCGACCGGGGGCTGCAATCGC* CCTGAAGTATGAGGAGTTT* A * CT* AAGCGTTTT 
126 ATCCTCGCCCAGGCTXT*GACCATTACGACTGTCTGATC* ACAGCACAC*GCACACGCTGGTCGAGC
66 ATC* * TGCCCAGGCTXT* GA* CATTACGACTGTCTGATC* ACAGCACACCGCACACGCTGGTCGAGCGGGGGCTGCAATCGGCC* TCAAGTAT* AGGAGTTT* A * CT* AAGCXTTT* • GC 
-163 a t c c t c g c c c a g g c t c t g c a c c a t t a c g a c t c t c t c a t c c a c a g c a c a c c g c a c a c g c t g c t c g a g c g g g g g c t g c a a t c g g c c c t g a a g t a t g a g c a g t t t t a c c t a a a g c g t t t t c g c  
76 a tc c t c g c c c a g g c x x tg g a c c a t ta c g a c t g t c t g a t c c a c a g c a c a c c g c a c a c g c t g g t c g a g c g g g g g c tg c a a t c g g c c c t g a a g t a t g a g g a g t t t t a *  c t a a a g c x g t t t c g c  
159 ATCCTCGCCCAGGC*XTGGACCATTACGACTGTCTGATCCACAGCACACCGCACACGCTGGTCGAGCG
154 a tc c tg g c c c a g g c* x t c g a c c a t t a c c a c t g t c t g a t c c a c a g c a c a c c g c a c a c g c t g g t c g a g c g g g g g c t g c a a t c g g c c c t g a a g t a t g a g g a g t t t t a
119 CCCXCGCTCTXGACCATTACGACTGTCTGATCCACAGCACACCGCACACGCTGGTCGAGCGGGGGCTGCAATCGGCCCTGAAGTATGAGGAGTTTTACCTAAAGCGTTTTGGC
-174 CXCATCXACACCACACXGCACACGXTCGTCGAGCGGGGGCTGCAATCGGCCCTGAACTATGAGXAGTTTTACCTAAAXXXTTTTGGC
75 ACGCTGGTCGAGCGGGGGCTGCAATCGGCCCTGAAGTATGAGGAGTTTTACCTAAAGCXTTTTGGC
-105 GCGCCTGCAATCGXCCCTCAAGTATGAGXAGTTTTACCTAAAGCGTTTTGXC
-88 A ATCGX CCCT* *  AATAT* AGXA* -  TTTA  CCT A A* *  C* *  TTTGX C
168 CTAAAGCCTTTTGGC
a t c c t g g c c c a g g c t c t c g a c c a t t a c g a c t c t c t c a t c c a c a g c a c a c c c c a c a c g c t g g t c g a g c g g g g g c t g c a a t c g g c c c t g a a g t a t g a g g a c t t t t a c c t a a a g c g t t t t g g c
1570 1 5 8 0  1S90 160 0  161 0  1 6 2 0  1 63 0  1 64 0  1650  1660 1 67 0  1680
<6 CC* CA* TACATC* a *  t c x g t t  
-163 CGGCACTA
76 CGGGCATACATG* AGTCXCTCTTCCAGATGTACACCXGCATCGC* *  GCTTTT* G* *  CTGCCGGGCX ACGCGCCGCATGCG 
119 CCXCACTACATGXA(CTOCGTCTTCCAGATGTACACCXCCATCCCXGGCTTTTTGGCCTGCXGGGCX ACGCGCGGCAT 
-174 CGGCACTACATGGAGTCtXrrCTTCCAGATGTACACCCGCATCGCCGGC TIITTGGCCTGCCGGGCCACGCGCGGCATGCGCCACATXGCCXTGGGGCGAGAGGGGTCGTGGTGGGAA 
75 CCCCA CTACATGGACTCXGTCTTCCAGATGTACACCXCCATCGCCGGCTnTTCGCCTGCCGGGCXACGCGCGGCATGCGCCACATCGCCXrrGGG 
■105 CGXCACTACATGXAGTCCCTCTTCCAGATGTACACCCGCATCGCCXGCTTTTTGGCCTGCCGGGCCACGCCCGGCATGCGCCACAT* GCCCTGGGGCGAGAGGGGTCGTGGTGGCAAATG *88 CGXCACTACATCXACTCCGTCTTCCCAATGTACACCCGCATCCCCXGCTTTTTGXCCTGCCGGGCCACGCGCGGCATGCGCCACATXXCCCTGGGGCGaGAGGGGTCGTGGTGGGAAATG 
168 CGXCAXTACATGGAGTCCGTCTTCCAGATGTACACCCGCATCGCCGGCTTTTTGGCCTGCCGGGCX a c g c g c g g c a tg c g c c a c a tc g c c c tg g g g c g a g a g g g g tc g tg g tg g g a a a tg  
10 t t t t t g x c c t x c x g g c c c a c g c c c c c x a t c c g c c a x a t c g c c c t c g c x x x a g a g c c o t c c t c c t c g x a a a t c
40 TTTGXCCTGCXGCGCCACGCGCGGCATGCGCCACATCGCCCTGGGGCGAGAGGGGTCGTGGTGGGAAATG
116 TGXXAAATG
CGGCACTACATGGAGTXXCTCTTCCAGATGTACACCCGCATCGCCGGCTTTTTGGCCTGCCGGGCCACGCGCGGCATGCGCCACATCGCCCTGGGGCGACAGGGGTCGTGGTGGGAAATG
1690 1 7 0 0  1 7 1 0  1720  173 0  1 7 4 0  17S 0  1 7 6 0  1770  1780  1790  180 0
•105 TTCAAGTTCTTTTTCCACCGCCTCTACGAC* A * CAC
TTCAAGTTCI r  11 ICCACOGCCTCTACGACCACCAGATCGTACCGTCGACCCX x g c x  a t g c t
TTXAACTrCl 111 1 a c a c x g c c tx x a c g a c x a c x a g a tc g ta c x g tc g a c c x x c g c x A T G C T G A a c x tg g g g a o c x g c a a c ta c ta c a c c tc a  
10 t t x a a c t t c t t t t t c c a c x g c c t c t a c g a c c a c c a g a t c g t a c x g t c g a c c c c x g c c a t g c t g a x x c t g g
40 TTXAAGTrCTTTTTCCACCGCCTCTACGACCACCAGATCGTACCGTCGACCCCCCCCATGCTGAACCTCCCGACCXGCAACTACTACACCTXCACCTGCTACXTGGTAAACCCCX AGG 
114 TTCAACTTCTTTTTCCACCGCCTCTACGACCACCAGATCGTACCGTCGACCCCXGCCATGCTGA ACCTGGGGACCCGCAACTACTACACCTXCACCTGCTACCTGGTAAACCCCX AGGCC 
. CTXTACXACCACCAGATCCTACXGTCGACCCCCGCCATXCTGA ACCTGGGGA CCCGCAACT ACT ACACCTXCA GCTGCTACXTGGT AAA CCCCX AGGCC
*1;1 ACGACXAXCAGATOCTACCGTCGACCCXCGCXATGCTXAACCTGGXGACCCCCAACTACTACACCTXCAGCTGCTACCTGXTAAACCCCCACGCC
143 CATGCTCAACCTCGGGACCCGCAACTACTACACCTCCACCTGCTACCTGGTAAACCCCCAGGCC
63 TCCAGCTGCTACCTGGTAAACCCCCAGGCC
111 TA CCTGGTAAACCCCCAGGCC
*115 TGGTAAACCCCCAGGCC
7TCAACrTCTTTTTCCACCCCCTCTACCACCACCAfcATCGTACCGTCCACCCC,-'GCCATGCTGAACCTCCCGACCCCCAACTACTACACCTCCAGCTCCTACCTGGTAAACCCCCAGGCC
 _____ 1 *1 0  1 8 2 b  1 8 3 0  1 8 4 0  1 85 0  1 8 6 0  1 8 7 0  1 88 0  189 0  1900  1 91 0  192 0
-171 i£ ? A^ AAACAAGGOGACCCTCCCCG<XATCACCA<X>AXCTCXGTGCCATXCTXCCCCCCAAXGGCCGCATXCGGCTATCCCT 
145 ^^CAACGOGACXXTGCCGGCCATCACCACCAACCTCAXTCCCATCCrCGCCXGCAACCGCGCCAT
41 ^ ^ ^ ^ CAAGCCCACCCTGCGCGCCATCACCAGCAACCTCAGTGCCATCCTCGCCCGCAACGGGGGCATCGGGCTATGCGTCCAGGCGTTTAACGACTC« CGCCC
111 i ^ CAAACAACCCGACCCTGCCGCCCATCACCACXAACCTCACTCCCATCCTCCCCCGCAACCGGGCC4TCCGGCTATCCCTCCACCCCTTTAAeG4CTC- CGCCCCCGGACCGCCAGC 
*115 i ^ CAAACAAGGCGACCCTGCCGGCCATCACCACCAACGTCAGTGCCATCCTCGCCCGCAACGGGGGCATCGGGCTATGCGTGCAGGCGTTTAACGACTC* CGCCCCCGGACCGCCAGC 
H j  ^ACAAACAAGGCGA* *  CTGCCGGCCATCACCACCAACGTCAGTGCCATCCTCGCC* g c a a c g g g g g c a t c g g g c t a t g c g t g c a g g c g t t t a a c  
i ,  <^<XCTCCCGCCCATCACCACCAACGTCAGTGCCATCCTCCCCCCCAACGCGCCCATCGGGCTATCCCTGCAGGCGTTTAACCACTC* CGCCCCGGGA* CGCCACC
. »  XAACCTCACTCCCATCCTCCCCCGCAACGGCGGCATCGCGCTATGCGTGCAGGCGTTTAACGACTXCGGCCCCGGGACCGCCAGC
5,  XTGCXATCCTCC* c c g c a a c c c g g g c a t c c g g c t a t *  c *  t g c a g *  c *  t t t a a c *  a c t c c g g c c c c g g c a c c g c c a *  c
n j  TCCCATCCTCGCCCCCAACGGGGGCATCCCCCTATCCGTGCAGCCCTTTAACGACTCCGCCCeCGGGACCGCCACC
CGCTATCCGTCCAGGCGTTTAACCACTCCGGCCCCGGGACCGCCAGC 
1(J AGXCXXTTXACGACTCXGXCCCCGGGACCGCCAGC
*48 GCCGTTTAACGACTCCGCCCCCGGCACCGCCAGC-1<2 CGXTTAACGACTCCC* CCCCGGGA CCGCCA *  C
CCGCCA*C
a(-CACAAACAAGGCGACCCTCCGCGCCATCACCAGCAACGTCAGTGCCATCCTCGCCCGCAACGGGGGCATCGGGCTATGCGTGCAGGCGTTTAACGACTCCGGCCCCGGGACCGCCAGC
1930 1 94 0  1 9 5 0  1 9 6 0  1 9 7 0  I 9 6 0  1 9 9 0  2 0 0 0  2 0 1 0  2 0 2 0  2 0 3 0  2 0 4 0
GTCATGCC* GCC* T *  AAGGTC* TTG A* * * G *  TGGTGG 
CTCATGCCCGCCCTCAAGGTC* TTGACTCGCTGGTGGCGGCG 
GTCATGCC* GCCCT* AAG G T* CTTGACTCGCTGGTGGCGX C
g t c a t g c c c g c c c t c a a g g t c c t t g a c t c g c t g g t g g c g g c g c a c a x c a a x g a g a g c g c c c g t c x g a c x g x c g x g t x c x t g t a c x t
g t c a t g c c c g c c c t c a a g g t c c t  t g a c t c g c t g g t * g c g g c g c a c a a c a a a g a g a g c g c g c g t c c g a c c g g c g c g t g c g t g t a c c t *  g a g c c g t g g c a c a c c g a c g t g c g g g c c g t g c t c  
g t c a t g c c c g c c c t c a a g g t c c t t g a c t c g c t g g t g g c g g c g x a c a a c a a a g a g a g c g c g c g t c c g a c c g g c g x g t g c g t g t a c c t g g a g c c x x x x x a c a c x g a c g t g c g g g c c g t g c t c  
c tca tg c cc g *  c c t c a a g g t c c t t g a c t c g c t g g t g g c g g c g c a c a a c a a a g a g a g c g c g c g t c c g *  c c g g c g * g t g c g t g t a c c t *  g a g c c g t g * c a c a *  c g a c g t g c g g g c c g t g c t c  
g t c a t g c c c g c c c t c a a g x t c c t x g a c t c g c t g g t g x c x g c g c a c a a c a a a g a g a g c g c g c g t c c g a c c g g c g c g t g c g t g t a c c t g g a g c c g t g g c a c a c c g a c g t g c g g g c c g t g c t c  
g t c a t g c c c g c c c t c a a g g t c c t t g a c t c g c t g g t g g c g g c g c a c a a c a a a g a g a g c g c g c g t c x g a c x x g c g x g t x c g t g t a c x t g x a g x c g t g x c a x a c x g a c g t g c g g x c x g t g c t c  
g t c a t g c c c g c c c t c a a g g t c c t t g a c t c g c t g g t * g c g g c g c a c a a c a a a g a g a g c g c g c g t c c g a c c g g c g c g t g c g t g t a c c t g *  a g c c *  t g g c a c a c c g a c * t g c g g g c c * t g c t c  
gtcatgccg*  *  c c t c a a *  g t c c t t g a c t c g c t g g t g * c*  g c g c a c a  a c a  a a g a g a g c g c g c g t c c g a c c g g c g c g t g c g t g t a c c t g g a g c c *  t g g c a c a c c g a c g t * c g g g c c g t g  c t c  
t g x c c g c c c t c a a x g t c c t t g a c t c g c t g g t x g c x g c g c a c a a c a a a g a g a g c x x x c g t c c g a c c g g c g c g t g c g t g t a c c t g g x x c c g t g g x x x x c c g a c x t g c g g g c c g t g c t c  
c c c t c a a g g t c c t t g a c t c g c t g g t g g c g g c g c a c a a c a a a g a g a g c g c g c g t c c g a c c g g c g g c t g c g t g t a c c t g g a g c c g t g g c a c a o c g a c g t g c g g g c c g t g c t x  
t g g t g g c g g c g x a c a a c a a a g a g a g c g c g c g t c c g a c c g g c g c g t g c g t g t a c c t g g a g c c g t g g c a c x c c g a c g t g c g g g c c g t g c t c  
t g g t g x c g x c g c a c a a c a a a g a g a g x c x c c g t c c g a c c g g c g c g t g c g t x x a c c t g g x x c c g t g g c a c a c c g a c g x x x x g g c c g t g c t c
GGTGGCGGCG CACA ACA AAGAGAGCGCGCGTCCGA CCGGCG CGTGCGTGTACCTGGAGCCGT GGCA CA CCGA CGTGCGGGCCGTGCTC
CXGCGCGTGC* TGTACCTG* AGCC* TGGCACACCGACGT* CGGGCCGTGCTC 
GCGCGTGCGTGTACCTGGAGCCGTXGCACACXGA CGTGCGGGCCGTGCTC 
TGC* *  * TACCTG* AGCC* TGGCACACCGACGTGCGGGCCGTGCTC 
TXCCTGX AGCCX TGG CACA CCGA CXXXAGGGCCGTGCTC 
20 CTC
CTCATGCCCGCCCTCAAGGTCCTTCACTCGCTGGTGGCUGCCCACAACA A AGA GAGCGCOCGTCCGACCGGCGCGTGCGTGTACCTGGAGCCGTGGCaCACCGA CGTGCGGGCCGTGCTC
2050  2 0 6 0  2 0 7 0  2 0 8 0  2 0 9 0  2 1 0 0  2 1 1 0  2 1 2 0  2 1 3 0  2 1 4 0  2 1 5 0  2 1 6 0
12
- (5  CGGATGAAGGG 
54 XXGATGAAGGGGGTCXTG
113 * GGATGA AGGGGGTC* TCGC
-172 CGXATGAAGGGGGXCCXCGCCGGCGAAGAGGCCCAGCGCTG 
1(9 XXGATGAXXXGGGTCXTXGC
-(>  c g g a tg a a g g g g g t c c t c g c c g g c g a a g a g g c c c a g c g c t g c g a c a
-142 CGGA TGAAGGGGGTCCTCCCCGGCGA AGA GGCCCAGCGCTGCGACAATATCTTCAGCGCCCTCTG'ATGCCAGACCTGT
-106 CGGA TGAAGGGGGTCCTCCCCGGCGA AGA GGCCCAGCGCTGCGACAATATCTTCAGCGCCCTCTGGATGCCAGACCTGTTTTTCAAGCGCCTGATTCGCCACCT GGA CGG 
95 CGGA TGAAGGGGGTGCTXXXXXGCGX AGA GXCCCAGCGCTG CGA CAATATCTTCAGCGXCCTXTXGATGCXAGAXCTCTTTTXCXAGXGXCTGAXTCGC 
47 CGGA TGAAGGGGGTCCTCGCCGGCGA AGA CGCCCAGCGCTGCGACAXTATCTTXAGCGeCXTCTGXATGOC AGA CXTGTTTTTCAAGCGCXTGATTCGXCACXTGXACGC 
-35 CGGAT<JAA<KJGG<STCCTCCCCGGCGAAGAGGCCCAGCGCTGCGACAATATCTTCAGCGCCCTCTGGATGCCAGACCTGTTTTTCAAGCGCCTGATTCGC43ACCTGGACGGCG 
123 CGGA TGAAGGGGGTCCTCCCCGGCGA AGA GGCC* AGCGCTGCGACAATATCTTCAGCGCC* T * T * GATGCAGA* » CTGTTTTTCAAGCG* CTGATTCGCX AC* T *  GACGGCGAGAAGAAC 
-125 CG* ATGAA* GGGGTCCTCCCCGGCGAAGAGG* CCAGCGCTGCGACA ATATCTTCAGCGCCCTCTG* ATGCCAGACCTGTTTTTCAAGCGCCTGATTC* * CA CCTGGACGGCGAGA AGAAC 
92 CGGATGAAGGGGGTCCTCGXXXXXXXXXAGGCCCAGCGCTGCGACAATATCTTCAGCGCCCTCTGGATGCCAGAXCTGTTTTTCAAGCGXCTGATTCGCXACCTGGACGGCGAGXAGXAC 
-69 CG* ATGAA* GGGGTCCTCCCCG* CGX AGA GGCCCAGCGCTGCGACA ATATCTTCAGCGCCCTCTG* ATGCCAGACCTGTTTTTCAAGCGCCTGATTCGC* ACCTGGACGG 
-51 aCXATGAAGGGGGTCCTCGCCGGCGAAGAGGCCCAGCGCTGCGACAATATCTTCAGCGCCCTCTGGATGCCAGACCTGTTTTTCAAGCGCCTGATTCGCCACCTGGACGGCGAGAAGAAC 
20 CGGA TGAAGGGGGTCCTCGCCGGCGA AGA GG CCCA GCGCTGCGTCAATATCTTCAGCGCCCTCTGGA TGC CAGA/CTGTTTTTCAAGCGCCTGATTCGCCA/CTGGA CGG CGA GA AGA AC
-139 TTCA* CGCCCTCTG* ATG* CAGACCTGTTTTTCAAGCGCCT* ATTCGC* ACCTGG* CGG CGA GA AGA AC
162 * CTGCA TG* CA GA CCTGTTTTTCA AGCGCCTGATTCGCCA CCTGGA CGGCGAGA AGA AC
1(4 ATGCCA GA CCTGTTTTTCA AGCGCCTGATTCGCCA CCTGGA CGG CGA GAAGAAC
157 TTTTTCAAGCGCCTGATTCGCCACCTGGACGGCGAGAAGAAC
130 AAGAAC
CCGA TGAAGGGGGTCCTCGCCGGCGA AGA GGCCCAGCGCfb CGA CAATATCTTCAGCGCCCTCTGGATG CCA GA CCTGTTTTTCA AGCGCCTGATTCGCCA CCTGGA CGGCGA GAAGAAC
217 0  2 1 8 0  2 1 9 0  2 2 0 0  2 2 1 0  2 2 2 0  2 2 3 0  2 2 4 0  2 2 5 0  2 2 6 0  2 2 7 0  2 2 8 0
GTCACATGGAC 
GTCT
CTCACA* •  » •  ACXTGTTCGAXCGGXAX AXCAGCATXTXG 
GTCACATGGACCCTGTTCGACCGGGACACCAGCATGTC 
GTCACATGGACCCTGTTCGACCGGGACACXAGCATGT
GTCACATGGACCCTGTTCGACCGGGACACCAGCATGTCGCTCGCCGACTTTCACGGGGAGGAGTTCGAGAAGCTCTACCAGCACCTCGAGGTCATGGGGTTCGGCGAGCAGATACCCAT 
GTCACATGGACCCTGTTCGACCGGGACACCAGCATGTCGCTCGCCGACTTTCACGGGGAGGAGTTCGAGAAGCTCTXCCAGCACCTCGAGGTCATGGGGTTCGGCGAGCAGATAXCCAT* 
GTCACATGGACCCTGTTCGACCGGGA* * *  CAGCATGTCGCTCCCCGACTT* TCCGGGGAGGAGTTCGAGAAGCTCTACCAGCACCTCGAGGTCATGGGGTTCGGCGAGCAGATACCAATC 
GTCACATGGACCCTGTTCGACCGGGACA* CAGCATGTCGCTCCCCGACTTTCACGGGGAGGAGTTCGAGAAGCTCTAC* * * * ACCTCGAGGTCATGGG* TTCGGCGAGCAGATAXCCAT* 
GTCACATGGACCCTGTTCGACCGGGA CACCAGCATGT///TCGCCGACTTTCACGGGGAGGAGTTCGACAAGCTCTACCAGCACCTCGAGGTCATGGGGTTCGGCGAGCAGATACCCATC 
AXATGGACCCTGTTCGACCCGGACACCAGCATGTCGCTCGCCGACTTTCACGGGX A/GAGXXCGAGAAGCTCTACCAGCACCTCX AGGTCATGGGGTTCGGCGAGCAGATACCCATC
TCG CCGA CTTTCA CGG GGAGGAGTTCGA GAAGCTCTACCAGCACCT CGAGGTCATGGGGTTCGG CGA GCA GAT ACCCATC
CTA* CAGCA* c t c g a g g t c a t g g g g t t c g g c g a g c a g a t a c c c a t c
AGCAGATACCCATC 
GATACCCATC
GTCACATGGACCCTGTTCGACCGGGACACCA GCA TGTCGCTCGCCGA CTTTCA CGGGGA GGA GTTCGA GAAGCTCTACCAGCACCT CGAGGTCATGGGGTTCGG CGAGCAGATACCCATC
2 29 0  2 3 0 0  2 3 1 0  2 3 2 0  2 3 3 0  2 3 4 0  2 3 5 0  2 3 6 0  2 3 7 0  2 3 8 0  2 3 9 0  2 4 0 0
142 CAGGAGCTG* C C T A T  
164 CAGGAGCTG* C C TA T 
157 CAGGAGCTG* CCTATGG
110 CAGGAGCTCGCCTATGGCATTGTGCGCAGTGCGGCCA/GA CCGGGAGCCCCTTCGTCA TGTTX AA AGA CGCGGT 
'18 CAGGAGCTGGCCTATGGX ATTGTGXG
175 CAG4JAGCTGGCCTATGGCATTGTGCGCAGTGCGGCCACXXCXGGGAGCCCCTTCGTCATGTTCAAAGACGCGGTGAA0(G0< AXTACATXTACGACACCCAGGGXXCGXCCATXGCXGGC
114 CAGGAGCTGCCCTATGCCATTGTGCGCAGTGCCGCCA CGA CCGGGAGCCCCTTCGTCATGTTCA A AGA CGCGGTG4ACCGCCA CTA CATCTACGa CACCCAGGGGGCG
12 CAGGAGCTCGCCTATCGCATTGTGCGCAGTGCGGCCA CGA CCGGGAGCCCCTTCGTCATGTTCA AAGA CGCGGT GAACCGCCA CTA CATCTA CGA CA CCCA GGGGGCGGCCATCGOCGGC 
•118 XAGXAGCTGXXCTATGXCATTGTGCGCAXTGCGXCXACGAOCXGGAGCCCCTTCGTCATGTTCAAAXXXXCXGTGAACCGCCACTACATCTACGACACXCXGGGGXCXGXCATCGCCGGC 
*•8 AXTXXGGCXACGACXXGGAGCCCCTTCGTCATGTTCAAAXXXXCXGTGAACCGCCACTACATCTACGACACCOCGGGGXXXXCCATCGCOGGC
■“ * ACXXGGAGCCCCTTCGTCATGTTCAAAGACGCGGTGAACCGCCACTACATCTACGACAXXCXGGGGXCXGCCATCGCCGGC
80 TTCGTCATGTTCAAAGACGCGGTGAACCGOC A CTA CATCTA CGA CA CCCA GGGGGCGGCCATCGCXGGC
*11 ACGACAXXCXGGGXXXXXXCATCGCXXGX
“ 1 CCCAGGXXXCGGCCATCGCXXXX
GGGGGCGGCCATCGCXGGC
CACGAGCTGGCCTATGGCATTGTGCGCAGTGCGGCCACGA CCGGGAGCCCCTTCGTCA TGTTCAAAGACGCGGTGAACCGCCACTACATCTACGACACCCAGGGGGCGGCCATCGCCGGC 
2410  2 42 0  2 4 3 0  2 44 0  2 4 5 0  2 4 6 0  2 47 0  248 0  2 4 9 0  2 50 0  2 5 1 0  2 52 0
US TCXAAC
12 TCXAACCTCTCCACXGACATCGTCCATCXGGCCTCXAAXCGATCXAGTGGGXTCTGCAXXCTGGXAAGCGT
* * •  t c x a x c c t c t< ^ < x x a < ^ t c g t <x a t c c g g c c t c c a a g c g a t c c a g t g g g c t c t g c a a c c t g g x a a g c g t g a a t c t g g c c c g a t g c c t c t c c a g g c a g a c g t t t g a c t t t
TC<* ACCTCTt^Ca^<>TarrCCATCCGGCCTCCAAGCGATCCAGTGCGCTCTGCAACCTGGGAAGCGTCAATCTGCCCCGATGCGTCTCCAGGCACACGTTTGACTTT 
7^A<XTCTGCACCGACATCGTCCATCCGGCCTCCAAGCGATCCAGTGGGXTCTGCAACCTGGXAAGCGTGAATCTGGCCCGATGCGTCT 
■* 7CX AACCTCTGCA CCGA CATCGT CCA TCCGGCCTCCAAGCGATCCAGTGGGGTCTGCAXXCTGGGAAGCGTGAATCTGGCCCGATGCGTCTCXAGGCAGACGTTTGACTTTGGGCGG CTC111 ^ *X -XTXTC <^C C XA X A TC G TX C A TaG X C C rC X A A X C G A TC X A X TG <JG X TC TG X A A C C TG G X A A C C G TG A A TC TG G C C C G A TG C G TC TC C A G C C A -A C G TTTG A C TTTG G G C G C G TC  
Tex AACCTCTGCACCGAGATCGTCCATCCGGCCTCCAAGCGATCCAGTGGGXTCTGCAACCTGGGAAGCGTGAATCTGGCCCGATGCGTCTCXAGGCAGACGTTTGACTTTGGGCGG CTC
J* TC<>A<XTCTGCA<XX^<>TCXn‘CCATCX»iCCTCCAAGCGATCCAGTGGGGTCTGCAACCTCGGAAGCGTGAATCTGCCCCGATGCGTCTCXAGGCAGACGTTTGACTTTGGGCGGCTC 
.44 XXAACCTCTGCACCGAGATCGTCCATCCGGCCTCXAAGCGATCCAGTGGGXTCTGCAACCTGGGA AGCGTGAATCTGGCCCGATGCGTCTCX AGGCAGACGTTTGACTTTGGGCGGCTC 
TGCA CCGACA TCGTCCATCCGGCCT CCAAGCGATCCAGTGGGGTCT GCA ACCTGGGA AGCC TGAATCTGGCCCGATGCGTCTCCAGGCAGACGTTTGACTTTGGG CGGCTC 
GCCTCXAAGCGATCCAGTGGGGTCTGCAACCTGGGAAGCGTGAATCTGGCCCGATGCGTCTCXAGGCAGACGTTTGACTTTGGGCGGCTC 
CCCTXCAAXCGATOC AGTGGGXTCTGCAACCTGGX AAGCGTGAATCTGGCCCGATXCGTCTCX AGXCXX ACGTTTX ACTTTGGXCGGCTC 
CCAA* CGATCCAGTGGGGT CTGCA ACCTGG* A AGCGTGAATCTGCCCCGATGCG* CTCCAGGCAGA CGTTT* ACTTTGGGCGCCTC 
GCAACCTGGGAAXCGTGAATCTGCCCCGATGCXTXXCCAGXCAGACGXTTXACTXXGG-XXXCXC 
AGCGTGAATCTGCCCCGATGCGTCTCCAGGCAGACGTTTGACTTTGGGCGGCTC 
ATCTGXXCCGATXCGTCTOCAGXCAGACGTTTGACTTTGGXCGGCTC 
CAGACGTTTGACTTTGG* C* GCT* 
CGTTTGACTTTGGGCGGCTC
T 'C C A A C C TC TG C A  C C G A  G A T C G T C C A T C C G G C C T C C A A G C G A T C C A G T G G G G T C T G C A  A C C T G G G A  A G C G T G A A T C T G G C C C G A T G C G T C T C C A G G C A G A C G T T T G A  C T T T G G G C G G C T C
178
104
43
*127
*140
-17
45
-94
-161
59
2 5 3 0  2 5 4 0  2 5 5 0  2 5 6 0  2 S 7 0  2 5 8 0  2 5 9 0  2 6 0 0  2 6 1 0  2 6 2 0  2 6 3 0  2 6 4 0
80 XGXGACGCCGTGCAGGC* TG C X TX X X G A TG X TG  
-37 CGCGACGCCGTGCAGG 
122 XGXGACGCCGTGCAGG
178 XGCGACGCCGTGCAGGCXTGCGTGCTCATGCTXAACATCATGATCGACAGCA
14 XGCCAXGCCGTGCAGGCGTGCXXXXTGATGGTACACATXATXATCGACAXCAXGXTAXAACCXAXGCCCXAGTGCACC 
104 • GCGACGCCGTGCACGC**GCGTGCTGATGGTGAACATCATGATCGACAGCACGCTACAACC* ACGCCCCAGTGCACCC
43 XGCGACGCCGTGCAGGCXTGCGTGCTGATGGTGAACATCATGATCGACAGCACGCTACAXCCXACGCCCXAGTGCACCCGCGGCAACGAC 
-127 CGCGAXGCCGTGCAGGCGTGCGTGCTGATGGTGAACATCATGATCGACAGCACGCTACAACCCACGCCCXAGTGCACCCGCGGCAACGACAACCT 
Il40 CGCGACGCCGTGCAGG
-17 CXXXAXGCCXTGCAGXCGTGCXTGCTGATGXTXX AC ATC ATG ATC G AC AG C AC G C TA-AAXCCACG CCCCAG TG CACCCG CG G CAACG ACAACXTG CXG TCCATXG G AATCG G CATG CAG  
45 XGCCACXCCGTGCAGGCXTGCGTGCTGATGGTGAACATCATGATCGACAGCACGCTACAACCCACGCCCCAGTGCACCCGCGGCAACGACAACXTGCGGTCCATGGGAATCGGCATGCAG 
.94 CGCGAXGXCGTGCAGGCGTGCGTGCTGATGGTGAACATCATGATCGACAGCACGCTACAACCCACGCCCXAXTGCACCCGCGGXAACGACAACXTGCGGTCCATGGCAATCGGXATGXAG 
-161 CGCGA*GCCGTGCAGGCGTGCGTGCTGATGGTGAACATCATGATCGACAGCACGCTACAACCCACGCCCCAGTGCACCCGCGGCAACGACAACXTGCGGTCCAT* GGAATCGGCATGCAG
59 x g x x a c g c c g t g c a g x c g t g c x x x x t g a t g c t g a a c a t c a t g a t c g a c a g c a c c c t a c a a c c c a c g c c c c a g t g c a c c c g c g g c a a c g a c a a c c t g c g g t c c a t g g g a a t c g g c a t g c a g
. 7 7  TGCAG G CG TG CG TG CTG AT* GTGAACATCATGATCGACAG CACG CTACAACCCACG CCCCAG TG CACCCG CG G CAACG ACAACXTG CG G TCCAT* GGAATCGGCATGCAG
. 3  G CTACAAXCCACG CCCA**TG CACCCG CG G C AAC G AC AAO C TG C XG TC C ATXG G AATC G G C ATG C AG
. 5 7  *  *  *  *  * AACG ACAAXXXCCG G TC C ATXG G AATC G G C ATG C AG
.83 AC AXC XTXC G X TC X A TG G X A A TC G X C A TG C A G
82 •  CGGTCCATGGGAATCGGCATGCAG
. 5 5  G TXC ATXG G AATCG G CATG CAG
c g c g a c g c c g t g c a g g c g t g c g t g c t g a t g g t g a a c a t c a t g a t c g a c a g c a c c c t a c a a c c c a c g c c c c a g t g c a c c c g c g g c a a c g a c a a c c t g c g g t c c a t g g g a a t c g g c a t g c a g
2 6 S 0  2 6 6 0  2 6 7 0  2 6 8 0  2 6 9 0  2 7 0 0  2 7 1 0  2 7 2 0  2 7 3 0  2 7 4 0  2 7 5 0  2 7 6 0
-17 g * c c t g c a c a c g g c c t g c c t g a a g c t g g g g c t g c a t c t g g a g t c t g c c g a a t t t  
45 GGCC
-94 GGCCTGXAXAXGG
-161 GXCCTGCACACGGCCTGCCTGA AGCTGG 
59 GGCCTGCACACGGCCTGCCTGAAGCTGGGCCTXGATCTXGAGTCTGCCGAATTTCAGGAOCT 
-77 CXCCTGCACACXMCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAAC 
-3 C*CCTGCACACGGCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCA 
-57 C*CCTGCACACGGCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGC04 AATTTXAGGACCTGA ACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCXG 
-83 CXCCTGCACACGCCCTGCCTGAAGCTGGGXCTXGATCTXGAXTCTGCCXAATTTCAGGACCTXAACAAACACATCGCCXAGXTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG 
62 CGCCTGCACACGGCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATCAAGACCAGCAACGCGCTG 
-55 CXCCTGCACAC*GXCTGCCTGAAGCTXGGGCTGGATCTXGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG
15 CCTGCACACGGCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG 
160 ACACGGCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG
-73 CGGCCT4SCCTGAAGCTGGG* CTGGATCTGGAGTCTGCC* AATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG
181 XXXXXXAGCTGGG* CTGCATCTGGAGTCTCCCGAATTT* AGGACCTGA ACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG
177 TCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACG* GCTG
180 GCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG
-19 GTCGGCGATCAAGACCAGCAACGCGCTG
CGCCTGCACACCGCCTGCCTGAAGCTGGGGCTGGATCTGGAGTCTGCCGAATTTCAGGACCTGAACAAACACATCGCCGAGGTGATGCTGCTGTCGGCGATGAAGACCAGCAACGCGCTG
2 7 7 0  2 7 8 0  2 7 9 0  2 8 0 0  2 8 1 0  2 8 2 0  2 8 3 0  2 8 4 0  2 8 5 0  2 8 6 0  2 8 7 0  2 8 8 0
-57 TXCGTTCGCGGGGCCCCTCCCXTCAACCACTTTA
-83 TGCGTTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGCAGCATXTATCXCGCCGGCCGCTTTCACTGGGAGCGCTTTCCGGACGCCCGGCCGCGGTACGAGGGCGAGTXGGAX 
(2 T***TTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGC 
-55 TGCGTTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGCAGCATGTATCGCGCCGGCCGCrrrCACTXGGAGCG 
85 TGC* TTCGCG4WG4XCGTCCCTTCAACCACTTTAAGCGA AGO* TGTATCGCG* CGGCG* * TTTCACTGGC* *
160 TC<XiTTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGCA 
-75 T* CGTTCGCGGGGCCCGTCCCTTCAACCACTTT
181 TGC*TTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGC
177 TGC*TTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGCAGCATGTATCGCGCCGGCCGCTTTCACTGGGAGCGCTTTCCGGACGCCCGGCCGCGGTACGAGGGCGAGTGGGAGATGCTA 
180 TGQCTTCGCGGGGCCCGTCCCTTCAACCACTTTAAGCGCAGCGTGTATCGCGCCGGCCGXTTTCACTGGGAGCGCTTTCXGGACGCCXGGCCGCGGTACGAGGGCGAGTGGGAGATG CTA 
-19 TGCGTTCGCCGGGCCCGTCCCTTCAACCACTTTAAGCGCAGCATGTATCGCGCCGGCCGCTTTCACTGGGAGCGCTTTCCGGACGCCCGGCCGCGGTACGAGGGCGAGTGGGAGATGCTA 
-117 TTTCXGGACGCCCGGCCGCGXTACGAGGGCGAGTGGGAGATXXTA
1 TGGGAGATGCTA
-71 GGGAGATXCTA
-72 GGAGATXXTA
48 CTA
TGCGTTCGCGGGG<Xrv^ rr 'CCTTCAACCACTTTAAGCGCAGCATGTATCGCGCCGGCCGCTTTCACTGGGAGCGCTTTCCGGACGCCCGGCCGCGGTACGAGGGCGAGTGGGAGATGCTA
2 8 9 0  2 9 0 0  2 9 1 0  2 9 2 0  2 9 3 0  2 9 4 0  2 9 5 0  2 9 6 0  2 9 7 0  2 9 8 0  2 9 9 0  3 0 0 0
V.l c g c c a g a g c a tg a t 'g a a a c a *  CGCCTGCGCAACAGCCAGTTTGTCGCGCTGATGCCCAC* GCCGCCT* GGC* *  A 
180 CGXCAGAGCATGATGAAXCAXCGCXTGC 
-19 CCCCAGAGCATGATGAAACACGGCCTGCGCA
-117 CGCCAGAGCATGATGAAACACGGCCTGCGCAACAGCCAGTTTGTCGCGCTGATGCCCACCGCXGCCTCGGCGCAGATCTCGGACGTCAGCGAGXXCTTTGCCCCCCTGTTCACCAACCTG 
1 CGCCAGAGCATGATGAAACACGGCCTGCGCAACAGCCAGTTTCTCGCGCTGATGCCCACCGCCGCCTCGGC* X AGATCTCGGACGTCAGCGAGGGCTTTG* *  CCCCTGTTCACCAACCTG 
*71 CCCCAXA4SCATGATGAAACACGGCCTGCGCAACAGCCAGTTTGTCGCGCTGA TGCCCA CXGCXGCCTCGGCGCAGATCTCGCA CGTCAGCGA GXXCTTTGCCCCCCTGTTCA CCAACCTG 
*72 CGCXACAGCA TCA TGAAACACGGCCTGCGCAACAGCCA XX TTGTCGCGCTGATGCCCACXGCXGCCT CGGCG CAGATCT CGGA CGTCAGCGAGXXCTTTGCCCCCCTGTTCACCAACCTG 
48 OGCCAGAGCA TCA TGAAACACGGCCTGCGCAACAGCCAGTTTGTCGCGCTGATG CCCA CCGCCGCCT CGG OCX AGA TCTCGGACGTCAGCGAGGGCTTTGXCCCCCTGTTCA CCA ACCTG 
-74 XGCAGACCATCATGAAACA CGGCCTGCGCA ACAG* CAGTTTGTCGCGCTGATGCCCA CCGC* CCCTCGGCGCAGATCTCGGACGTCAGCGA* •  GCTTTGCCCCCCTGTTCA CCA ACCTG 
* • '  GCATGATGA AACA CGX *  CT GCG CAA CAGCCA G -T T  GTCGCG CTGA TGCCCA CCGX CGCCTXC-CGX AGATCTCXGACGTCAGCGAGX XCTTTGCCCCCCTGTTCA CCA ACCTG
* CACGCCCTGCGCAACAGCCAGTTTCTCGCGCTGATGCCCACCGC* GCCTCGGCGCAGATCTCGGACGTCACCGA* *GCTTTGCCCCCCTGTT*ACCAACCTG
' -  CGCAACAGCCAGTTTGTCXCGCTGA TGCCCA CGG* * * * CTXGGCGXAGATCT* GGACGTCAGCGAG* *CTTTGCCCCCCTGTTCACCAACCTG
TCGCGCTGATGCCCACCG* CGCCTCXGCGX AGATCTCGGA CGTCAGCGA* « GCTTTGCCCCCCTGTTCACCAACCTG 
,*4 ATGCCCACCGCCGCCTCGGCGX AGATCTCGGA CGTCAGCGAGGGCTTTG* » CCCCTGTTCACCAACCTG
‘  I 7 TCGGCGCAGATCTCGGACGTCAGCGA* GGCTTTGCCCCCCTGTTCACCAACCTG
*”  CGGA CGTCACCGAGG* CTTTCCCCCCCTGTTCACCAACCTG
J* CCTGTTCA CCA ACCTG
”  CTGTTCACCAACCTG
53 . TTCA CCAACCTG
OGCCAGAGCATGATGAAACA CGGCCTGCGCAACAGCCA GTTTGTCGCGCTGATGCCCA CCGCCGCCTCGGCGCAGATCTCGGA CGTCA GCGAGGGCTTTGCCCCCCTGTTCA CCA ACCTG
. . .  3010  3 0 2 0  3 0 3 0  3 0 4 0  3 0 5 0  3 0 6 0  3 0 7 0  3 0 8 0  3 0 9 0  3 1 0 0  3 1 1 0  3 1 2 0
1 3Z C a g C a a g g tg a c c c g g g a c g g x g a g a c g c tg  1 t t c a g c a a g g tg a c c c g g g a c g *  CGAGACGCTGCG* CCCAACAC
TTCACCAA4WTGACCCCGGACCGCGACACXCXXCGCCCCAACACGCTCCTGCTAAAGGAA 
48 " 'CACCa a o G7GACCCCGGACGGCGAGACXCTGCGCCCCAACACGCTCCTGCTAAAGGAACT 
-74 I I CAGCAAGCTGACCCGGGACGXCXAGACGCTGCGCCCCAACACGCTCXTGCTAAAGGAACTGGAA 
-39 ! ! . CAGCAAGGTGA* CCGGGACGGCGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGG 
- i n  ! ! CACCAACGT<!ACCCGGGACGGCCAGACGCTGCGCCCCAACACGCTCCTGCTAAAG
» TTCAGCAAGGTGA<XCGGGACGGCGAGACGCTGCG<XCCAACA*GCTCCTGCTAAAGGAACTGGAACGCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACAGTCTCGACGCCAA 
. j l  3 I GACCAAGGTGACCCGGGACGGCGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGGA a
TTOGCAAG* TCA<^CCGGACGGCCAGACGCTGCCCCCCAACACGCTCCTGCTAAAGGAACTGGAACCCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACA*TCTC 
-147 TTCAGCAAGCTGACCCGGGACG* CGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGGAACGCACGTTTAGCGGGAAGGCC* TCCT* GAGGTGATGGACAGTCTCGACGC* AAG 
-29 IT  CAGCAAGGTGACCCGGGA CGG CGA GACGCTGCGCCCCA ACA CGCTCCTGCTA A AGGAACTGG
-181 II^CCAAGCTCACCCGGGACGGCGA GACGCTGCGCCCCA ACA CGCTCCTGCTAA AG* AACTGGAACGCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACAGTCTCGACGCCAAG 
19 I I S AGCAAG<*rGACCCC<JGACGGCGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGGAACGCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATG
"  7‘TC AG O AG G T4i9C<XG G G ACG * CGA GACGCTGCGCCCCA ACA C G C T*C TG C TAAAG G AAC TG G AACG CACG TTTAG CG G G AAG CG CCTC*TXG AG G TG ATG G ACAG TCTCG ACG C* AAG
* TTCAGCAAGGTGACCCGGGACGXCGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGGAACGCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACAGTCTCGACGCCAAG 
5I  ACACGCTCCTGCTAAAGXAACTGXAACGCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACAGTCTCGACGCCAAG
f - n r - r n f  TGPTAAAGGAACTGGA ACG CACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACAGTCTCGACGCCAAG150
112
-11
•111
c t a a a g x a a c t g x a a c g c a c g t t t a g c g g g a a g c g c c t c c t g g a g g t g a t g g a c a g t c t c g a c g c c a a g  
c g c t c x t g c t a a a g g a a c t g g a a c g c a c g t t t a g c g g g a a g c g c c t c c t g g a g g t g a t g g a c a g t c t c g a c g c c a a g  
r r T *  CTGCTAAAGGAACTGGA ACGCACGTTTAGCGGGA a g c g c c t c c t g g a g g t g a t g g a c a g t c t c g a c g c *  a a g  
c c t g c t a a a g g a a c t g g a a c g c a c g t t t a g c g g c a a g c g c c t c c t g g a g g t g a t g g a c a g t c t c g a c g c c a a g
t g a t g x a x a x t x t o c  a c x x x x a x
g a c g c c a a g
TtCAGCAAGGTGACCCGGGACGGCGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGGAACGCACGTTTAGCGGGAAGCGCCTCCTGGAGGTGATGGACAGTCTCGACGCCAAG
3130 3 1 4 0  3 1 5 0  3 1 6 0  3 1 7 0  3 1 0 0  3 1 9 0  3 2 0 0  3 2 1 0  3 2 2 0  3 2 3 0  3 2 4 0
(1 CAGTCGTCCGTGGC 
-29 CAGTGGTCCG
IS CAGTGCTCCGTGGCGCAGCCGXTCCCGTGCXTGXAGCXXAXCACXCXXXTXCGXX
53 CACTCCTCCGTGGOCCAGGOSCTCCCGTCCCTCCAGCCCACCCACCCCCTXCGGCGATTCAAGAOCGCGTTTCACTACCACCAGAAGTTCCTGAT 
-J7 CAGTGGTCCGTOCCGCAGGCGCTCCCGTGCCTGGAGCCCACCCAXCCCCTCCGGCGATTCAAGACCGCGTTTGACTACGACCAGAAGTTGCTGAT 
ss CAGTGGTCOGTGGOGCAGGOGCTCCCGTGCCTCGAGCCCACCCACCCCCT3 CGGCGATTCAAGACCGCGTTTCACTACGACCAGA AGTTGCTGATCGACCT 
ISO CAGTGGTCCGTGGCGCAGGCGCTCCCGTGCCTGGAGCCCACCCACCCCCTCCGGCGATTCAAGA* c g c g *  TTXSACTACGACCAGAAGTXGCTGATCG
112 CAGTGGTCOGTCGCGCAGGOGCTCCCGTGCCTGGAGCCCACCCACCCCCTCOGGCGATTCAAGACCGCGTTTGACTACGACCAGAAGTTCCTGATCCACCTGTGTGCGCACCGCOCCCCC 
-U  CAXTGXTOCXTOUtXJCAGXXICXTXCCXTGXCTXGAXXCCAXCCAXCCCCraCGGCGATTCAAGAXCGCGTXTGACTACGACCAJtAJCAXTGCTGATOGACCTGTGT* CGGACCGCGCCCCC 
-111 CAGTGGTCCGT*CCGCAGGCGCTCCCGTGCCTGGAGCCCACCCAXCCCCTCCGGCGATTCAACACCGCGTTTGACTACGACCAGAAGTTCCTGATCGACCTGTCTGCGGACCGCGCCCCC 
-49 2CXGCTCCOGTGCCTXGAGCCttCCCAXCCCCTCCGGCGATTCAAGACCGCCTTTGACTACGACCAGAAGTTGCTGATCGACCTGTGTGCGGACCGCGCCCCC
-146 c a a g a c c g c g ^ t t g a c t a c g a c c a g a a g t t g c t g a t c g a c c t g t g t g c g g a c c g c g c c c c x :
41 CGCGTTTGACTACGACCAGAAGTTGCTGATCGACCTGTGTGCGGACCGCGCCCCC
-27 ACGACCAGAAGTTGCTGATCGACCTGTGTGCGGACCGCGCCCCC
-9 XXXXAAGTTGCTGATCGACCTGTGTTC* GACCGCGCCCCC
CAGTGGTCCGTGGCGCAGGCGCTCCCGTGCCTGGAGCCCACCCACCCCCTCOGGOGATTCAAGACCGCGTTTGACTACGACCAGAAGTTGCTGATCGACCTGTGTGCGGACCGCGCCCCC
3250 3 2 6 0  3 27 0  3 2 8 0  3 29 0  3 30 0  331 0  332 0  3 3 3 0  3 34 0  33S 0 3 3 6 0
112 TACGTCGACXATAGCCAATXCATGAXCCTGTATGTCA
-11 TACGTCGACCATAGCCAATCCATGACCCTGTATGTCA CGGA GAAGG CGGA CGGGACCCTCCCAGCCTCCACCCTGGTCCGCCTTCTGGTCCACGCATATAAGC 
-131 TACGTCGACCATAGCCAATCCATGACCCTGTATGTCACGGAGAAGGCGGACGGGACCCTCCCAGCC
-49 TACGTCGACCATAGCCAATCCATGACCCTGTATGTCACGGAGAAGGCGGACGGGACCCTCCCAGCCTCCACCCTGGTCCGCCTTCTGGTCCACGCATATAA
-146 TACCTCGACCATAGCCAATCCATGACCCTGTATGTCA CGGA GAAGGCGGACGGGACCCTCCCAGCCTCCACCCTGGTCCGCCTTCTGGTCCA CCCA TATAAGCGCGGACTAAAAACAGGG 
41 TAC42TCGACCATAGCCAATXCATGACCCTGTATGTCACGGAGAAGGCGGACGGGACCCTCCCAGCCTXCACCCTGGTCCGXCTT-TGGTCCAXGCATATAAGCGCGGACTAAAAACAGGG 
-27 TACGTCGACCATAGCCAATCCATGACCCTGTATGTCACGGAGAAGGCGGACGGCACCCTCCCAGCCTCCACCCTGGTCCGCCTTCTGGTCCACGCAT
-9 TACGTCGACCATAGCCAATCCATGACCCTGTATGTCACG*AGAAGGCGGACGCGACCCTCCCAGCCTCCACCCTGGTCCGCCTTCTGGTCCACGCATATAAGCGCGGACTAAAAACAGGG
TAAAAACAGGG
TACGTCGACCATAGCCAATCCATGACCCTGTATGTCACGGAGAAGGCGGACGGGACCCTCCCAGCCTCCACCCTGGTCCGCCTTCTGGTCCACGCATATAAGCGCGGACTAAAAACAGGG
3370 3 38 0  3 3 9 0  3 4 0 0  3 4 1 0  3 42 0  343 0  3440  3 45 0  3 46 0  3 4 7 0  3 48 0
-146 ATCTACTAC 
41 ATGTACTACTGCAAGGTTCGCA 
-9 ' AT
•30 ATGTACTACTGCAAG4JTTCGCAAGGCGACCAACACCGGGGTCTTTG4JCGGCGACGACAACATTGTCTGCATGAGCTGCGCGCTGTGACCGACAAACCCCCTCOGCGC43AGGCCCGCCGCC
-137
46
AGGCGACCAACAGCGGG* TCTTTG* C* GCGACGACAACAT* CT CTGCA TGAGCTGCGCGCTGTGA CCGA CAACC47CC* TCCGCG CCAGGCCCGCCGCC\ ACCA ACA GCGGGGTCTTTGCCGGCGACGACAACATTGTCTGCATGAGCTGCGCGCTCTGACCGACAAACCCCCTCCGCG*CAGGCCCGCCGCC
ACCCACAAACCCCCTCCGC/CCAGGCCCGCCGCC
ATCTACTACTGCAAGCTTCGCAAGGCGACCAACAGCGGGGTCTTTGGCGGCGACGACAACATTGTCTGCATGAGCTGCGCGCTGTGACCGACAAACCCCCTCCGCGCCAGGCCCGCCGCC
. .  3490  3 5 0 0  3 5 1 0  3 5 2 0  3 5 3 0  3 5 4 0  3 55 0  3 56 0  3 5 7 0  3 58 0  3 5 9 0  3 6 0 0
-JO a c t g t c g t c g c c g t c c c a c g c t c t c
,  ^CTGTCGTCGCCGTCCCA CGCTCTCCCCTGCTGCCA TGGA TTCCGC* GCCCCAGCCCTCTCCCCCGCTCTGACG 
» A /TG TC // CG* CGTCCCA*/GTCTCCCXTGCTGCCATGGATTC* GCGGCCCCAGCC* TXTCCCCXGXTXTX AXGGCCXTTAXGG 
”  ACTCTCGTCGCCGTCCCAC«CTCTCCCCTGCTGCCATGGATTCCGCGGCCCCAGCCCTXTCCCCCGCTCTGACGGCCCrTACGG 
ACTCTCCTCCCCGTCCCACGCTCTCCCCTGCTGCCATGGATTCCGCCGCCCCAGCCCTCTCCCCCGCTCTGACGGCCCTTACGG
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Figure 24. Analysis of the HINDKK database for open reading 
frames (ORFs) with the DSPLAY program. ORFs are indicated 
by lines, and in-frame stop codons by arrowheads. The 
reading frames are numbered on the left; 1, 2 and 3 for the 
left-to-right DNA strand, and,. 4, 5 and 6 for the 
complementary strand.
1~V" •Jt—\
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Figure 25. Codon usage evaluation of the HINDKK database 
with the FRMSCAN program. The top panel (reading frames 1, 
2 and 3) represents the codon usage evaluation for the 
left-to-right strand while the lower panel (reading frames 
4, 5 and 6) represents the codon usage evaluation of the 
complementary strand. The y axis represents the log 
probability function using an arbitrary scale (Staden and 
McLachlan, 19 82). The x axis shows nucleotide positions
in the HINDKK database; on the line parallel to the x axis 
the in-frame stop codons (i) are displayed.
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no putative ORFs (frame 4 in Fig. 24), while the remaining 
frames are blocked by stop codons (frames 5 and 6 in Fig.
24); the longest potential ORF is approximately 430 
nucleotides.
A representation of the FRMSCAN output is shown in 
Fig. 25 for both the left-to-right and complementary 
strands. This program identified in the former strand a 
single potential coding region spanning the entire sequence 
(frame 3 in Fig. 25).
These data predict that the coding region of the RRl 
polypeptide is an ORF of 3414 nucleotides located between 
positions 34 and 3447 of the HINDKK contig. Translation of 
the obtained sequence with the PTRANS program (see Materials 
and Methods, Page 75) predicted that the encoded polypeptide 
is 1137 amino acids in length (Fig. 26).
DISCUSSION.
3. The HSV-1 RRl Polypeptide.
The 1137 amino acid polypeptide predicted from the 
DNA sequence has a mol. wt. of 124,017 (Table II); this 
is lower than the estimate of 136,000 obtained from gel 
electrophoretic mobility of the protein (Marsden et a l ., 
1978). However, RRl is phosphorylated (Pereira et al ., 
1977; Marsden et al ., 1978, Wilcox et al., 1980), and this 
may partly account for the observed size discrepancy.
a ) Analysis of the RRl amino acid content.
The overall G+C content across the coding region is 
66% (Table II), although, at the third base position of 
amino acid codons it is markedly higher (83.2%). This is 
consistent with the codon usage of other HSV proteins which 
show that, in most cases, the third base position of amino 
acid codons has a higher G+C content as compared with first 
and second positions (McGeoch, 1984). The most pronounced 
triplet periodicity is observed in the alanine residues 
where the G+C content at the third base position is 91.2%.
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Figure 26. The DNA sequence and the predicted amino acid 
sequence of the RRl polypeptide coding region and the 
N-terminal portion of the RR2 polypeptide. The methionine 
initiation codon at the N-terminus of RRl is underlined as 
is the stop codon at the C-terminus of RRl. The methionine 
at the RR2 N-terminus is indicated by a double line. 
Underlined amino acids indicate the run of prolines (P) 
and the two discrete aspartic acid (D) and serine (S) rich 
stretches.
TABLE II
AMINO ACID COMPOSITION OF THE HSV-1 RRl POLYPEPTIDE
Ala 114 10.0% Val 75 6.6% Leu 107 9.4% H e 30 2.6%
Gly 94 8.3% Pro 71 6.2% Cys 29 2.6% Met 32 2.8%
His 29 2.6% Phe 46 4.0% Tyr 33 2.9% Trp 10 0.9%
Asn 35 3.1% Gin 33 2.9% Ser 84 7.4% Thr 69 6.1%
Lys 32 2.8% Arg 84 7.4% Asp 71 6.2% Glu 59 5.2%
Approximate Molecular Weight = 124016.63
CODON USAGE OF THE HSV-1 RRl POLYPEPTIDE DNA CODING REGION
TTT Phe 24 2.1%
TTC Phe 22 1.9%
TTA Leu 0 0.0%
TTG Leu 2 0.2%
CTT Leu 10 0.9%
CTC Leu 24 2.1%
CTA Leu 6 0.5%
CTG Leu 65 5.7%
ATT lie 3 0.3%
ATC lie 25 ,2.2%
ATA lie 2 0.2%
ATG Met 32 2.8%
GTT Val 7 0.6%
GTC Val 31 2.7%
GTA Val 4 0.4%
GTG Val 33 2.9%
TCT Ser 4 0.4%
TCC Ser 27 2.4%
TCA Ser 3 0.3%
TCG Ser 18 1.6%
CCT Pro 6 0.5%
CCC Pro 40 3.5%
CCA Pro 8 0.7%
CCG Pro 17 1.5%
ACT Thr 0 0.0%
ACC Thr 38 3.3%
ACA Thr 7 0.6%
ACG Thr 24 2.1%
GCT Ala 4 0.4%
GCC Ala 67 5.9%
GCA Ala 6 0.5%
GCG Ala 37 3.3%
TAT Tyr 8 0.7%
TAC Tyr 25 2.2%
TAA -- 0 0.0%
TAG -- 0 0.0%
CAT His 3 0.3%
CAC His 26 2.3%
CAA Gin 4 0.4%
CAG Gin 29 2.5%
AAT Asn 4 0.4%
AAC Asn 31 2.7%
AAA Lys 5 0.4%
AAG Lys 27 2.4%
GAT Asp 12 1.1%
GAC Asp 59 5.2%
GAA Glu 12 1.1%
GAG Glu 47 4.1%
TGT Cys 8 0,.7%
TGC Cys 21 1,. 8%
TGA -- 1 0,.1%
TGG Trp 10 0,.9%
CGT Arg 6 0,.5%
CGC Arg 45 4,.0%
CGA Arg 6 0,,5%
CGG Arg 23 2,.0%
AGT Ser 4 0.,4%
AGC Ser 28 2.,5%
AGA Arg 0 0,.0%
AGG Arg 4 0.,4%
GGT Gly 6 0.,5%
GGC Gly 39 3.,4%
GGA Gly 9 0.,8%
GGG Gly 40 3.,5%
BASE COMPOSITION OF THE HSV-1 RRl POLYPEPTIDE DNA CODING REGION
Y T C A G R ALL
NUMBER 1841 595 1246 617 1106 1723 3564
PERCENT 51.7 16.7 35.0 17.3 31.0 48.3 100.0
81
The most common amino acids in RRl are alanine, 
glycine and leucine, comprising 27.7% of all residues. 
Examination of the amino acid distribution throughout the 
length of RRl revealed a region at the N-terminus (aa 150 to 
280, see Fig. 26) which is extremely rich in aspartic acid, 
serine, proline and glycine residues. At the start of this 
region there is a run of five prolines and further on there 
are two discrete stretches rich in aspartic acid and serine 
residues (underlined regions in Fig. 26). Aspartic acid and 
serine residues together comprise 32% of all amino acids in 
this region, whereas, their overall percentage of occurence 
in RRl is 13.6%.
Analysis of other HSV-1 polypeptide N-termini revealed 
that stretches of prolines occur in the AE polypeptide 
(Draper et al ., 1986), in the IE trans-inducing factor Vmw65 
(Dalrymple et al ., 19 85) and in Vmwl75. The latter contains 
two stretches of prolines the first of which is located at 
the N-terminus while the second is located approximately 
in the middle of the polypeptide (McGeogh et a l ., 19 86a). 
However, it should be stated that in at least 10 other HSV-1 
polypeptides proline-rich stretches were identified in the 
C-terminus. Examination of HSV-1 sequences for stretches of 
aspartic acid and serine residues revealed, 
notably, that these were present in the N-terminal region of 
all the IE polypeptides with the exception of Vmwl2 (Perry 
et al., 1986; McGeoch et al ., 1985, 1986a and 1988) and in 
the protein kinase (McGeoch et al., 1985). Further, a 
stretch rich in aspartic acid and glutamic acid was 
identified approximately in the middle of the DNA polymerase 
(Quinn and McGeoch, 19 85).
b) The RRl hydrophathicity profile.
The RRl hydropathicity plot (Fig. 27) was obtained 
with the PROFILE program (see Materials and Methods,
Page 75). The program predicted two major hydrophilic 
regions; the first one corresponding to the first stretch 
of aspartic acid and serine residues and is the most 
hydrophilic region, while the second, from aa 914 to 961, 
is the longest/vpredicted region. The most hydrophobic 
regions are located between aa 833 to 847 and at the
Figure 27. Hydropathicity of the RRl polypeptide. 
Hydrophobic regions lie between 0 and 40, and hydrophilic 
regions between 0 and -40. The RRl amino acid sequence is 
shown below the plot and is numbered as in Fig. 26. Hatched 
regions represent the most hydrophilic regions while dotted 
regions represent the most hydrophobic regions. Program 
settings were: group length = 9, shift = 1, spacing of 
plotted points = 10. The underlined sequence represents a 
block of highly conserved amino acids between HSV-1 RRl and 
other homologue herpesviral polypeptides for which a 
putative function has been postulated (see General 
Discussion, Page 130).
-46______________________________________________ _______________________________
MASRPAASSPVEARAPVGG&EAGGPSAATGGEAACAPLAHCHHyYCG'RVNGVMVLSDKTPGSASYRISDSNFVGC 7 5
46
-46 ____________________________________________________________________
CSNCTMIIDCDVVRCRPGDPCAAASPAPFVAVTNIGAGSDGCTAVVAFGCTPRRSACTSTGTQTADVPTEALGGP
-46_____________________________________________________________________________________
PPPPRFTLGCCCCSCRDTRRRSAVFGCECDPVCPAEFVSDDRSSDSDSDDSEDTDSETLSHASSDVSCGATYDDA
46
-46_____________________________________________________________________________ _______
SDPRPRLCTCTAYPVPLELTPENAEAVARFLCDAVNREPALKLEYFCRCAREETKRVPPRTFCSPPRLTEDDFCL
46
• ~4&______________________________ ___ ____________________
LNYALVEMQRLCLDVPPVPPNAYMPYYLREYVTRLVNCFKPLVSRSARLYRILCVLVHLRIRTREASFEEWLRSK
46'
  __________________________
EVALDFCLTERLREHEAQLVILAQALBHYDCLIHSTPHTLVERCLQSALKYEEFYLKRFCCHYMESVFQMYTRI
46 --------------------------------
1 5 0
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2 9 9
3 7 4
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5 2 3
-46____________________________ ._________________________ ________________________
AGFLACRATRGMRHIALGREGSWUEMFKFFFHRLYDHQIVPSTPAMLNLGTRNYYTSSCYLVNPQATTNKATLRA 5 9 8
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IT SNVSAIL ARNCGICLCVC AFNDSCPGT ASVMP ALKVL DSL VA AHNKESARPTG AC V YLEPUHTDVR AV'LRMKG
40
-40_______________________________________________________________________________ __
VLACEEAQRCDNIFSALUHPDLFFKRLIRHLDCEKNVTUTLFDRDTSHSLADFHCEEFEKLYQHLEVHCFGEQIP
40 '
-40________________________________________
IGELAYCIVRSAATTCSPFVMFKDAVNRHYIYDTGCAAIACSNLCTEiyHPASKRSSCVCNLCSVNLARCVSRG
-40____________________________________________________________________________________
TFDFCRLRDAVQACVLHVNIMIDSTLQPTPGCTRCNDNLRSHCICMQCLHTACLKLCLDLESAEFQDLNKHIAEV
40
m l l s a m k t s n a l c v r c a r p f n h f k r s m y r a c r f h w e r f p d a r p r y e g e w e h l r q s m m k h g l r n s q f v a l m p t a a s
40
-40___________________________________________________________________________________
AQISDVSECFAPLFTNLFSKVTRDCETLRPNTLLLKELERTFSCKRLLEVMDSLDAKQWSVAQALPCLEPTHPL
40
RRFKTAFDYDGKLLIDLCADRAPYVDHSQSMTLWEKADCTLPASTLVRLLVHAYKRGLKTCMYYCKVRKATNS
40
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8 2 2
8 9 7
9 2 7
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-40________________
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C-terminal five residues of the polypeptide.
c ) Repetitions within the RRl N-terminus.
Examination of the RRl amino acid sequence for 
possible repetitions was performed with the CINTHOM program 
(see Materials and Methods, Page 74; Fig. 28). As can 
be seen, a number of small letter homology diagonals were 
identified indicating that amino acid sequences positioned 
in different parts of the RRl N-terminus share homology. 
These sequences were then aligned with the HOMOL program 
(see Materials and Methods, Page 75), and the results are 
shown in a graphical form in Fig. 29. Seven tandemly 
repeated stretches of amino acids were identified which 
mostly contained identical and/or conserved residues as 
determined by the Venn diagram of amino acid classification 
(Taylor, W.R., 1986a). Interestingly, the stretch 
designated 7 comprises two blocks of residues from which the 
first one is inverted in 7' and this is indicated by arrows 
in Fig. 29.
Examination of other HSV-1 polypeptide N-termini with 
the analysis described above demonstrated the existence of 
five tandemly repeated stretches of amino acids in the 
Vhiwl75 polypeptide and these are shown in Fig. 30.
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Figure 28. Analysis of the HSV-1 RRl polypeptide amino acid 
sequence for repetitions with the CINTHOM program. The 
small letter homology diagonals correspond to RRl regions 
containing amino acid repetitions. Program settings were: 
range = 15; scale factor = 0.95; minimum value plotted =
30%; compressed xl5.
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Figure 29. Repeated amino acid sequences within the HSV-1 
RRl N-terminus. The diagram depicts the region in a linear 
form starting at the N-terminal methionine (M) and 
terminating at a tyrosine residue (Y) at amino acid position 
312. Black boxes indicate the position of each repetition; 
the first set of boxes are numbered 1 to 7 and their 
corresponding boxes are numbered l 1 to 7'. The amino acid 
sequence of each repetition is given above each box and the 
first amino acid is numbered as in Fig. 26. Asterisks 
within the sequences indicate any amino acid and the arrows 
indicate the stretch of residues in block 7 which is 
inverted in block 7'.
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Figure 30. Repeated amino acid sequences within the HSV-1 
Vmwl75 N-terminal region. The diagram depicts the region in 
a linear form starting at the N-terminal methionine (M) at 
amino acid position 1 and terminating at a glutamic acid (E) 
residue at amino acid position 314. Black boxes indicate 
the position of each repetition; the first set of boxes are 
numbered 1 to 5 and their corresponding boxes are numbered 
1' to 5'. The amino acid sequence of each repetition is 
given above each box and the first amino acid is numbered as 
in McGeoch et al. (19 86a).
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SECTION B.
4. Amino Acid Sequence Conservation of HSV-1 RRl with 
Other Viral, Eukaryotic and Prokaryotic Equivalent 
Polypeptides.
Comparisons of the N- and C-terminal portions of 
HSV-1 RRl with herpesviral polypeptides and the polypeptides 
encoding the mouse Ml and E. coli B1 subunits demonstrated 
the existence of homology (McLauchlan, 19 86; Swain and 
Galloway, 19 86). In this part of Section B the complete 
sequence of RRl is compared, using the CINTHOM and HOMOL 
programs, with these polypeptides and, in addition, with a 
W  polypeptide and a recently obtained putative ORF of HCMV. 
The purpose of this analysis was to determine whether RRl 
shares any homology with the equivalent viral, eukaryotic 
and prokaryotic polypeptides and if so, to identify 
conserved features between these polypeptides.
a) Amino acid sequence conservation of HSV-1 RRl with 
other viral polypeptides.
i ) HSV-1 RRl shares homology with HSV-2 RRl.
Sequencing studies in HSV-2 strain 333 identified a 
polypeptide, Vmwl3 8 or RRl, which was homologous to the N- 
and C-terminal portions of HSV-1 RRl (McLauchlan, 1986;
Swain and Galloway, 1986). A CINTHOM comparison between 
these polypeptides revealed that they are essentially 
colinear (Fig. 31). The lettering in the diagonal indicates 
that the N-terminal 315 amino acids of both polypeptides are 
relatively poorly conserved whereas the remainder show 
extremely high homology. Optimal alignment of the 
polypeptides with the HOMOL program predicted that the 
highly conserved regions extend from the tyrosine residues 
at HSV-1 RRl aa 312 and HSV-2 RRl aa 319 to the respective 
C-termini (Fig. 32). The percentage similarity for these 
regions is 9 3% with 57 changes out of 827 aligned residues. 
However, most of these changes are conservative ones 
according to the Venn diagram of amino acid conservation 
(Taylor, W.R., 1986a) and are predominantly between amino
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Figure 31. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RRl with that of HSV-2 RRl. The position of the 
homology diagonal after which the two amino acid sequences 
share higher homology is indicated by an arrow. Program 
settings were: range = 15; scale factor = 0.95; minimum 
value plotted = 30%; compressed xl5.
First sequence: HSV-1 RR1 
Second sequence: HSV-2 RR1
1 MASRPAASSPVEARAPVGGQEAGGPSAATQGEAAGAPLAHGHHVYCQRVNGV MVLSDKTPGSASYRISDSNFVQ 
** ***** ** * ** * * * * ** * ****** ** * ****** ***
1 MANRPAASALAGARSPSERQEPREPEVAPPG GDHVFCRKVSGVMVLSSDPPGPAAYRISDSSFVQ
75 CGSNCTMIIDGDWRGRPQDPGAAASPAPFVAVTNIGAGSDGGTAVVAFGGTPRRSAGTSTGTQTADVPTEALG 
***** ******* ** * * * *** * ** ** ***** *** * *  * *  * * * *  * *
66 CGSNCSMIIDGDVARGHLRDLEGATSTGAFVAISNVAAGGDGRTAWALGGTSGPSATTSVGTQT SGEFLH
149 G PPPPPRFTLGGGCCSCRDTRRRSAVFGGEGDPVGPAEFVSDDRSSDS DSDDS EDT
* * * * * *  * * * * * * *  * *  * *  * *  * *  * * * *  * * *  *  * * *
137 GNPRTPEPQGPQAVPPPPPPPFPWGHECCARRDAR GGAEKDVC-AAESWSDGPSSDSETEDSDSSDEDT
205 DSETLSHASSDVSGGATYDDALDSDSSSDDSLQIDGPVC RPWSNDTAP LDVCPGTPGPGADAGG
* * * * *  * *  * * *  * *  * * * *  * * * *  * * * * * *  * *  * *  * *  * *  *
205 GSGSETLSRSSSIWAAGATDDDDSDSDSRSDDSVQPDVWRRRWSDGPA.PVAFPKPRRPGDSPGNPGLGAGTGP
T
269 PSAVDPHAPTPEAGAGLAADPAVARDDAEGLSDPRP RLGTGTAYPVPL ELTP ENAEAVARFLGDAVNREPALML 
* *  * *  *  *  * *  *  * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * *
279 GSATDPRASADSDSAAHAA APQADVAPVL DSQPTVGTDPGYPVPLELTPENAEAVARFLGDAVDREPALML
k
343 EYFCRCAREETKRVPPRTFGSPPRLTEDDFGLLNYALVEMQRLCLDVPPVPPNAYMPYYLREYVTRLVNGFKPL
350 EYFCRCAREESKRVPPRTFGSAPRLTEDDFGLLNYALAEMRRLCLDLPPVPPNAYTPYHLREYATRLVNGFKPL
417 VSRSARLYRILGVLVHLRIRTREASFEEWLRSKEVALDFGLTERLREHEAQLVILAQALDHYDCLIHSTPHTLV 
★ * ★ ★ * ★ * ★ * * ★  ♦ * * * ♦ * * ★ * * * ★ ★ * ★ *  * * * * *  * * * * * * * * * * * * * * * *  * * * * * *  * * * * * * * * *  ★ ★ ★
424 VRRSARLYRILGILVHLRIRTREASFEEWMRSKEVDLDFGLTERLREHEAQLMILAQALNPYDCLIHSTPNTLV 
491 ERGLQSALKYEEFYLKRFGGHYMESVFQMYTRIAGFLACRATRGMRHIALGREGSWWEMFKFFFHRLYDHQIVP 
498 ERGLQSALKYEEFYLKRFGGHYMESVFQMYTRIAGFLAC RATRGMRHIALGRQGSWWEMFKFFFHRLYDHQIVP 
565 STPAMLNLGTRNYYTSSCYLVNPQATTNKATLRAITSNVSAILARNGGIGLCVQAFNDSGPGTASVMPALKVLD 
572 STPAMLNLGTRNYYTSSCYLVNPQATTNQATLRAITGNVSAILARNGGIGLCMQAFNDASPGTASIMPALKVLD 
639 SLVAAHNKESARPTGACVYXiEPWHTDVRAVLRMKGVLAGEEAQRCDNI FSALWMPDLFFKRLIRHLDGEKNVTW 
646 SLVAAHNKQSTRPTGACVYXiEPWHSDVRAVLRMKGVLAGEEAQRCDN I FS ALWMPDLFFKRLI RHLDGEKNVTW 
713 TLFDRDTSMSLADFHGEEFEKLYQHLEVMGFGEQIPIQELAYGIVRSAATTGSPFVMFKDAVNRHYIYDTQGAA
720 SLFDRDTSMSLADFHGEEFEKLYEHLEAMGFGETIPIQDLAYAIVRSAATTGSPFIMFKDAVNRHYIYDTQGAA
787 IAGSNLCTEIVHPASKRSSGVCNLGSVNLARCVSRQTFDFGRLRDAVQACVLM'^'N I MI DSTLQPTPQCTRGNDN 
* * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * *  * *  * *
794 IAGSNL2 TEIVHPSSKRSSGVCNLGSVNLARCVSRRTFDFGMLRDAVQACVLMVNIMIDSTLQPTPQCARGHDN 
861 LRSMGIGMQGLHTACLKLGLDLESAEFQDLNKHIAEVMLLSAMKTSNALCVRGARPFNHFKRSMYRAGRFHWER 
868 LRSMGIGMQGLHTACLKMGLDLESAEFRDLNTHIAEVMLLAAMKTSNALCVRGARPFSHFKRSMYRAGRFHWER 
935 FPDARPRYEGEWEMLRQSMMKHGLRNSQFVALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTLLLK 
942 FSNASPRYEGEWEMLRQSMMKHGLRNSQFIALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTLLLK 
1009 ELERTFSGKRLLEVMDSLDAKQWSVAQALPCLEPTHPLRRFKTAFDYDQKLLIDLCADRAPYVDHSQSMTLYVT 
1016 ELERTFGGKRLLDAMDGLEAKQWSVAQALPCLDPAHPLRRFKTAFDYDQELLIDLCADRAPYVDHSQSMTLYVT 
1083 EKADGTLPASTLVRLLVHAYKRGLKTGMYYCKVRKATNSGVFGGDDNI VC MSCAL 
1090 EKADGTLPASTLVRLLVHAYKRGLKTGMYYCKVRKATNSGVFAGDDNIVCTSCAL
Figure 32. A HOMOL plot comparing the amino acid sequence 
of HSV-1 RRl with that of HSV-2 RRl. Arrowheads denote the 
amino acid positions where the sequences become highly 
homologous and asterisks denote conserved residues. The 
program parameters were: mutation weight = 5, 
gap weight = 3k+7, k up to 2000.
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TCC GGC GCG GCCCAC TCG GAG ACG CTG TCA CACGAC GAC ACC
GCC GCA GGG GCGGAC GAO GAT ACG GGC TCG GGT TCC GAG ACG CTG TCTGAG
TGT CGC CCG TCG AGC AAT GAC ACCCTG CAGGAC GAC GCC CTT
CCT CGC AGA TGG ACC GAC GGC CCTCAC CAT GAC AGC
GTACTG GAT CTT TGC CCC GGG ACC CCC GGC
ACGGTG GCC TTT CCC AAG CCC CGG CGC CCC GGC GAC TCC CCC GGA AAC CCC CGC
CTT GCG GCC CAT CCC GCC GTG CCC CGG GAC CAC GCG CAG GGG CTT TCG GAC CCCCAC CCG CCC ACG CCA
GAC ACCGCA CCC CAG GCG GAC GTG CCG CCG GTT CTGCAC GCC CCCCGC CCG TCC GCC GAC
CGT CTG
ACT GTG
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TCG TCC GAC TCC
ATA GAT GGC CCC CTG
CCC CAC GTT CTC GTT
GAC TCG GAT GAC TCG
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TCC TCT TCG ATC TGG
GAG CCC CGC GCT CGT
TCC GAT TCC GCG CCC
GCA ACG CGC ACG GCC
GGA ACG CAG CCC GGC
GAC TCC GAC TCG CGG TCG GAC CAC TCC
GAC TCC GAT TCG TCA TCG GAT GAC TCC
CCG GGC CCC CAC GCC
CTG GGC GCC GGC ACC
GGT GGT CCC TCA GCG
GGG CCG GGC TCC GCG
Figure 33. Alignment of the DNA sequences end predicted 
amino acid residues at the N-termini of HSV-1 RRl and HSV-2 
RRl. Conserved bases are indicated by asterisks. The 
predicted amino acid sequence of the HSV-1 RRl polypeptide 
is shown above the HSV-1 DNA sequence and amino acid 
residues which are not conserved in HSV-2 RRl are indicated 
below the HSV-2 DNA sequence. The HSV-1 RRl repeated amino 
acid sequences, shown in Fig. 29, are boxed as are the 
corresponding HSV-2 RRl amino acid sequences.
84
acids with small or tiny side-chains, such as glycine, 
alanine, serine and threonine (15 changes) or between 
hydrophobic residues such as methionine, isoleucine, leucine 
and valine (10 changes).
In contrast, the N-terminal HSV-1 312 and HSV-2 319 
amino acids of both polypeptides, designated as the 
N-terminal regions, show considerably lower homology (38%), 
and contain a number of predicted insertions and deletions, 
the longest being 14 amino acids (Fig. 33, HSV-1 RRl aa 
149). Interestingly, the prolines and the stretches rich in 
aspartic acid and serine residues are well conserved. 
Further, the only HSV-1 RRl repetitions which are well 
conserved in the HSV-2 sequence are , 4, 6, 7, 1' and 7'; 
the remainder share either limited homology or are not 
conserved at all (Fig. 33). The low conservation of the 
N-terminal regions can also be observed at the DNA level. 
Nucleotide comparison of shared amino acid sequences 
indicates that the strongest homology is 73% (Fig. 33, HSV-1 
RRl aa 41 to 139 ) . This percentage homology is lower than 
that obtained from nucleotide sequence comparisons of the 
colinear parts of both polypeptides (9 0%, data not shown).
ii) HSV-1 RRl shares homology with VZV Vmw87. The entire 
sequence of the VZV genome has been determined by Davison 
and Scott (1986b). Analysis of the sequence predicted that 
the genome contained 71 potential ORFs distributed almost 
equally between the two strands. One of these encodes a 
polypeptide with a predicted size of 87,000 mol. wt. (Vmw87) 
which is homologous to HSV-1 RRl (Davison and Scott, 1986b; 
Nikas et al ., 1986). Comparison of RRl and Vmw87 with the 
CINTHOM program (Fig. 34) revealed that the N-terminal 400 
amino acids of RRl are not present in the VZV polypeptide, 
whereas, the remainder of both sequences are quite 
homologous and no major insertions or deletions occur. The 
colinear parts of the sequences display 43% similarity and 
are separated into three highly conserved regions (marked A, 
B and C in Fig. 34) by stretches of low homology. Optimal 
alignment of the colinear sequences with the HOMOL program 
(Fig. 35) indicated that the homology percentage for the A,
B, and C regions is 54%, 61%, and 56% respectively.
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Figure 34. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RRl with that of VZV Vmw87. Underlined parts of 
the homology diagonal denote the A, B and C polypeptide 
regions of higher homology. Program settings were: range = 
15? scale factor = 0.95; minimum value plotted = 30%; 
compressed xl5.
First sequence: VZV Vmw87
Second sequence: HSV-1 RRl
VZV MEFKRIFNTVHD IINRLCQHGYKEYIIPPESTTPVELMEYISTIVSKLKAVTRQDERVYRCCGEL 65* * *** ** * * ** * * * * * * *
HSV-1 TFGSPPRLTEDDFGLLNYALV EMQRLC LDVPPVPPNAYMPYYLREYVTRLVNGFKPLVSRSARLYRILGVL 430
VZV IHCRINLRSVSMETWLTSPILCLTPRVRQAIEGRRDEIRRAILEPFLKDQYPAL ATL GLQSALKYE 131
* * •  * * *  * *  * * * * * •  * * * * • *  * * * * * * * * *
HSV-1 VHLRIRTREASFEEWLRSKEVAL DFGLTERLREHEAQLVILAQAL DHYDCLIHSTPHTLVERGLQSALKYE 501
VZV DFYLTKLEEGKLESLCQFFLRLAATVTTEIVNLPKIAT LIPGINDG YTWTDVCRVFFTALACQKIVPATPV 202 
*•* ** * * * * ** * * * ** * *** * *
HSV-1 EFYLKRFGGHYMESVFQMYTRIA GFLACRATRGMRHIALGREGSWWEMFKFFFHRLYDHQIVPSTPA 568
VZV MMFLGRETGATASCYLMDPESITVGRAVRAITGDVGTVLQSRGGVGISLQSL.NLIPTENQTKGLLAVLKLLDCM 276
* * *  * * * * •  * * * • * *  * * * *  * * * * * *  * *
HSV-1 MLNLGTRNYYTSSCYLVNPQATTNKATLRAITSNVSAILARNGGIGLCVQAFN DSGPGTASVMPALKVLDSL 640
VZV VMAINSDCERPTGVCVYIEPWHVDLQTVLATRGMLVRDEIFRCDNIFCCLWTPDLFFERYLSYLKGASNVQWTL 350
*  * *  * * * *  * * *  * * * *  * * •  * * *  * * * * * *  * *  * * * * *  * *  if * *  * * *
HSV-1 VAAHNKESARPTGACVYLEPWHTDVRAVLRMKGVLAGEEAQRCDNIFSALWMPDLFFKRLIRHLDGEKNVTWTL 714
VZV FD NRADILRTLHGEAFTSTYLRLEREGLGVSSVPIQDIAFTIIRSAAVTGSPFLMFKDACNRNYHMNTQGNAI 423 
* *  * * * *  *  * * *  * * * * *  * * * * * *  * * * * *  * * * * *  * *  *  * * *  * *
HSV-1 FDRDTSMSLADFHGEEFEKLYQHLEVMGFG EQIPIQELAYGIVRSAATTGSPFVMFKDAVNRHYIYDTQGAAI 787
VZV TGSNLCTEIVQKADAHQHGVCNLASINLTTCLSKGPVSFNLNDLQLTARTTVIFLNGVLAAGNFPCKKSCKGVK 497 
********* * ***** * ** * * * *  * *  * *
HSV-1 AGSNLCTEIVHPASKRSSGVCNLGSVNLARCVS RQTFDFGRLRDAVQACVLMVNIMIDSTLQPTPQCTRGND 859
VZV NNRSLGIGIQGLHTTCLRLGFDLTSQPARRLNVQIAELMLYETMKTSMEMCKIGGLAPFKGFTESKYAKGWLHQ 571 
* ** **« ***** ** ** ** * ** *** ** **** * * ** * * * * *
HSV-1 NLRSMGIGMQGLHTACLKLGLDLESAEFQDLNKHIAEVMLLSAMKTSNALC VRGARPFNHFKRSMYRAGRFHW 932
VZV DGF STISYLDLPWCTLRDDICAYGLYNSQFLALMPTVSSAQVTECSEGFSPIYNNMFSKVTTSGELLRPNLDL 644
*  *  * *  * *  * * * •  * * * * *  * * *  * * * *  * * * * * * *  * *  * * * *  *
HSV-1 ERFPDARPRYEGEWEMLRQSMMKHGLRNSQFVALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTLL 1006
VZV MDELRDMYSCEEKR LEVINILEKNQWSVIRSFGCLSNSHPLLKYKTAFEYEQEDLVDMCAERAPFIDQSQSMT 717
* *  * * *  * * *  * * * * *  * *  * * *  * * * *  * * *  * * *  * * *  * * * * * *
HSV-1 LKELERTFS GKRLLEVMDSLDAKQWSVAQALPCLEPTHPLRRFKTAFDYDQKLLIDLCADRAPYVDHSQSMT 1078
VZV LFIEERPDGTIPASKIMNLLIRAYKAGLKTGMYYCKIRKATNSGLFAG GELTCTSCAL
*  *  * « *  * * *  * *  **+ * * * * * * * * * *  * * * * * * *  *  *  *  * * * *
HSV-1 LYVTEKADGTLPASTLVRLLVHAYKRGLKTGMYYCKVRKATNSGVFGGDDNIVCMSCAL
Figure 35. Optimal alignment of the amino acid sequences 
of HSV-1 RRl with those of VZV Vmw87. Regions of clustered 
homology are underlined. Asterisks denote conserved 
residues. The program parameters were: mutation weight = 5, 
gap weight = 3k+7, k up to 2000.
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Interestingly, most of the identical residues in the 
colinear parts are clustered rather than distributed evenly 
throughout the sequences. The longest of these clusters is 
located close to the C-termini (Fig. 35, HSV-1 RRl aa 1101 
to 1123) and displays 90% homology.
iii) HSV-1 RRl shares homology with EBV Vmw9 3 . The 
sequence of the entire EBV strain B 95-8 genome has been 
obtained (Baer et al., 1984), and mapping data exist for a 
number of genes. One of these encodes a polypeptide with a 
predicted size of 93,000 mol. wt. (Vmw93) which is 
homologous to HSV-1 RRl (Gibson et al., 19 84; Nikas et a l ., 
1986). Comparison of RRl and Vmw93 with the CINTHOM program 
indicated that the RRl N-terminal 400 residues are not 
present in the EBV polypeptide (Fig. 36). Beyond this 
region, homology extends to the C-terminus of the HSV-1 
polypeptide and the remaining 80 C-terminal residues of
Vmw93 are absent in RRl. The major interruption in the 
homology diagonal is due to an insertion of 35 amino acids 
in the EBV sequence (Fig. 37, EBV aa 420 to 454). It is of 
interest to note that the insertion corresponds by position 
to the non-homologous stretch of amino acids separating the 
highly conserved A and B regions in the HSV-1 RRl/VZV Vmw87 
comparison (see Fig. 34). As indicated in Fig. 37, 
identical residues are clustered and the overall homology of 
the colinear parts is 33%. This percentage homology, which 
is lower than that obtained in the HSV-1 RRl/VZV Vmw87 
comparison,, is an interesting result considering that the 
G+C DNA content of HSV (66%) is closer to that of EBV (54%) 
than to that of VZV (40%) in these coding regions.
iv) HSV-1 RRl shares homology with VV Vmw86.
Recently, Tengelsen et al., (19 88) identified and sequenced
a VV strain WR gene (1-3) encoding a polypeptide of 86,000 
mol. wt. (Vmw86). As the 1-3 deduced amino acid sequence 
was found to be highly homologous to the mouse Ml 
polypeptide, these authors suggested that 1-3 encodes the 
VV-induced large ribonucleotide reductase subunit 
polypeptide. CINTHOM comparison of HSV-1 RRl and VV Vmw86 
displayed significant homology extending approximately
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Figure 36. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RRl with that of EBV Vmw9 3. A major insertion in 
the EBV sequence is indicated by an arrow. Program settings 
were: range = 15; scale factor = 0.95; minimum value plotted 
= 30%; compressed xl5.
First sequence: EBV Vtnw9 3
Second sequence: HSV-1 RRl
9 0 VSSGYLSALRYYDTYLYVGRSGKQES VQHFYMRLAGFCASTTCLYAGLRAALQRARPEIESDME
* * * * *  * * *  * * *  * * * * *  * * * * *
480 CLIHSTPHTLVERGLQSALKYEEFYLKRFGGHYMESVFQMYTRIAGFLA CRATRGMRHIALGREGSWWE
154 VFDYYFEHLTSQTVCCSTPFMRFAGVENSTLASCILTTPDLSSEWDVTQALYRHLGRYLFQRAGVGVGVTGAGQ 
*  *  * * * *  * * * * *  * * * * * * *
549 MFKFFFHRLYDHQIVPSTPAMLNLGTRNYYTSSCYLVNPQATTNKATLRAITSNVSAILARNGGIGLCVQAFND
228 DGKHISLLM RMINSHVEYHNYGCKRPVSVAAYMEPWHSQ1FKFLETK LPENHERCPGIFTGLFVPELF 
*  * * * * *  * *  * * * * *  * * * * *  * *  * * **
623 SGPGTASVMPALKVLDSLVAAHNKESARPTGACVYLEPWHTDVRAVLRMKGVLAGEEAQRCDNIFSALWMPDLF
296 FK LFR DTPWSDWYLFDPKDAGDLERLYGEEFEREYYRLVTAGKFCGRVSIKSLMFS1VNCAVKAGSPFIL 
** * * * *** * * * * * *  * * * * * * * *  * * * * *
69 7 FKRLIRHLDGEKNVTWTLFDRDTSMSLADFHGEEFEKLYQHLEVMG FGEQIPIQELAYGIVRSAATTGSPFVM
366 LKEACNAHFWRDLQGEAMNAANLCAE VLQPSRKSVATCNLANICLPRCLVNAPLAVRAQRADTQGDELLLALP
770 FKDAVNRHYIYDTQGAAIAGSNLCTEIVHPASKRSSGVCNLGSVNLARCVRSQ «-----------------  35aa
439 RLSVTLPGEGAVGDGFSLARLRDATQCATFVV ACSILQGSP TYDSRDMASMGLGVQGLADVFADLGWQY
* ****** * * * * * * ******* * *
823 > TFDFGRLRDAVQACVLMVNIMIDSTLQPTPQCTKGNDNLRSMGIGMQGLHTACLKLGLDL
508 TDPPSRSLNKEIFEHMYFTALCTSSLIGLHTRKIFPGFKQS KYAGGWFHWHDWAGTDLSIPREIWSRLSERIVR 
* * *  * * * ★ * *  * * *  * * * * * *  * * *
883 ESAEFQDLNKHIAEVMLLSAMKTSNALCVRGARPFNHFKRSMYRAGRFHWERFPDARPRYEGE WEMLRQSMMK 
582 DGLFNSQFIALMPTSGCAQVTGCSDAFYPFYANASTKVTNKEEALRPN RSFWRHVRLDDREALNLV
* * * * * * * * * * *  *  *  k k  k  k  k  k  k k k k k  k k k k k
956 HGLRNSQFVALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTLLLKELERTFSGKRLLEVMDSLDAK
648 GGRV SCLPEALRQRYL RFQTAFHYNQEDLIQMSRDRAPFVDQSQSHSLFLRE EDAARASTLANLLVRSYE 
* *  * * * * * * * * *  * *  * * * * * * * * *  * * * * * * * * * *
1030 QWSVAQALPCLEPTHPLRRFKTAFDYDQKLL1DLCADRAPYVDHSQSMTLYVTEKADGTLPASTLVRLLVHAYK 
718 LGLKTIMYYCRIEKAADLGV MEC
k k k  k  k  k  k k k k k  k
1104 RGLKTGMYYCKVRKATNSGVFGGDDNI
Figure 37. Optimal alignment of the amino acid sequences 
of HSV-1 RRl with those of EBV Vftiw93. Regions of clustered 
homology are underlined, and the major EBV insertion 
identified in Fig. 36 is indicated. Asterisks denote 
conserved residues. The program parameters were: mutation 
weight = 5, gap weight = 3k+7, k up to 2000.
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Figure 38. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RRl with that of VV Vtnw86. Program settings were: 
range = 15; scale factor = 0.95; minimum value plotted =
30%; compressed xl5.
First sequence: VV Vmw86
Second sequence: HSV-1 RRl
150  
54 0  
223  
588  
29 6
653 
363 
72 7  
43 6  
800  
510  
874  
582  
9 4 8
654 
1022
771
1 096
TLEKSYLLKINNKIVERPQHMLMRVAVG1HQW DIDSAIETYNLLSEKW FTHASPTLFNAGTSRHQMSSCFLLN 
■* *  *  * * * * * * * * * *
LGREGSWWEMFKFFFHR LYDHQIVPSTPAMLNLGTRNYYTSSCYLVN
M ID D S IE G IY D TLK R C ALIS KM A G G IG LS IS N IR A S G SY IS G TN G ISN G IIP M LR V Y N N TA R Y ID Q G G N K R P 
* * *  * * * * *  * *  * *  * * * **
Q A TTN KATLR AITSN V SA IL A R N G G IG LCVQAFNDSG PGT ASVMPALKV LDSLVAAHNKESARF
VM AIYLEPW HSD IM AFLD LK KNTGNEEHRTRDLFIALW IPDLFMKR VKDDGE WSLMCPDECPGLDN 
* * * * * *  * * * *  * * *  * * * *  * * * *  * *  * * *  * * * *
GACVYLEPWHTDVRAVLRMKGVLAGEEAQRCDNIFSALWMPDLFFKRLIRHLDGEKNVTWTLFDRDTSMSLAD
W GDEFERLYTLYERERRYKSIIKARVVW KAIIESQ IETG TPFILYKDACNKKSNQ Q NLG  T IK C S N LC TE IIQ  
*  * * *  * *  *  *  *  *  * *  * *  * * *  *  *  *  * * * * * * *
HGEEFEKLYQHLE VM GFGEQIPIQELAYGIVRSAATTGSPFVMFKDAVNRHYIYDTQGAAIAGSNLCTEIVH
A D A N EV A VC N LASVALN M FVID G R FD FLKLKVVVKVIVR N LN K IID IN YYPIPEAEISN KR H R PIG IG VQ G LA 
*  * * * *  * *  *  *  * * *  * * * * * *  * *  * *  * * *  * * *
ASKRSSGVCNLGSVNLARCVSRQTFDFGRLRDAVQACVLMVNIMIDSTLQPTPQCTRGNDNLRSMGIGMQGLK
A F 1L LN Y P F D S LE A Q D IN K K IFE T IY Y G A LE A S C E L AEKEGPYDTYVGS YASNGILQYDLWNVVPSDLWNk 
* * * * * * * * * *  * * * ★ * *
ACLKLGLDLESAEFQDLNKHIAEVMLLSAMKTSNALCVRGARPFNHFKRSMYRAGRFHWERFPDARPRYEGEW
PLKDKIRTYGLRNSLLVAPLPLHQHAQILG NNESVEPYTSNIYTRRVLSGEFQ VVNPHLLRVL TERKLWND 
* * * * * *  * *  * * * *  * * * * *  * * *  * *
MLRQSMMKHGLRNSQFVALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTLLLKELERTFSGKRLL
IKNRIM ADGGS IQ N TN LPED IKR VY K TIW E IP Q K TIIK M AA D R G A FID Q SQ S M  N IH IA D  PSYSKL
* * * * * *  * *  * * * *  * * * * *  * *  * *
VMDSLDAKQWS VAQALPCLEPTHPLRRFKTAFDYDQKLLIDLCADRAPYVDHSQSMTLYVTEKADGTLPASTI/
SMHFYGW SLGLKTGMYYLRTKPASAPIQFTLDKDKIKPPVVCDSEICTSCSG
RLLVHAYKRGLKTGMYYCKVRKATNSGVFGGD DNIVCMSCAL
Figure 39. Optimal alignment of the amino acid sequences 
of HSV-1 RRl with those of VV Vmw86. Regions of clustered 
homology are underlined. Asterisks denote conserved 
residues. The program parameters were: mutation weight = 5, 
gap weight = 3k+7, k up to 2000.
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between RRl aa 645 and Vmw86 aa 300 to the respective 
C-termini (Fig. 38). Comparison of the colinear parts of 
these polypeptides with the HOMOL program demonstrated that 
they share 29% homology which, as the case is with the other 
viral polypeptide comparisons, is primarily retained in 
stretches of identical amino acids (Fig. 39). The overal 
percentage homology between these polypeptides is 21% (data 
not shown).
v ) HSV-1 RRl shares limited homology with a putative 
HCMV QRF. Sequencing studies by Barrell and co-workers in 
HCMV strain AD169 revealed the existence of a putative ORF, 
termed M4.PRO, which exhibits homology to RRl (B.G. Barrell, 
personal communication). Amino acid comparison of RRl and 
M4.PRO with the CINTHOM program displayed limited but 
detectable homology extending approximately between RRl aa 
855 to 9 75 and M4.PRO aa 650 to 750 (Fig. 40). Comparison 
of the colinear parts of RRl and M4.PRO with the HOMOL 
program demonstrated that they share 22% homology and that 
two regions of more than 60% clustered homology exist 
(underlined regions in Fig. 41). The overall percentage 
homology is 18% (data not shown).
b) Amino acid sequence comparison of HSV-1 RRl and
mouse Ml polypeptides.
Comparison of HSV-1 RRl with the mouse Ml polypeptide 
(Caras et al., 1985) is represented as a CINTHOM plot in 
Fig. 42. As is the case with the viral polypeptide 
comparisons, the RRl N-terminal region is not present in the 
Ml polypeptide whereas the remainder of the sequences are 
colinear; the homology diagonal extends approximately 
between RRl aa 720 and Ml aa 330 to the respective C-termini 
and contains a major shift at aa 335 of the mouse sequence 
(indicated by arrow in Fig. 42). Comparison of the 
polypeptides with the HOMOL program demonstrated that the 
shift is due to a deletion of 13 amino acids in the mouse 
sequence (Fig. 43). The plot also demonstrated a major 
insertion of 18 amino acids at the C-terminus of the mouse 
polypeptide. It is of interest to note, that 15 out of 18 
residues comprising this insertion are charged ones (lysine,
HCMV M 4 .PRO 
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Figure 4 0 . A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RR1 with that of a putative HCMV ORF termed M4.PRO 
(B. Barrell, personal communication). Program settings 
were: range = 15; scale factor = 0.95; minimum value plotted 
= 30%; compressed xl5.
First sequence: HCMV M4.PR0
Second sequence: HSV-1 RR1
600 CDMPVQRLTVNVARCVFARSDEQKLHLPDWLGNTRRYFDLSVLRELVTEAVVWGNARLDALMSASEWWVESAL 
** * ** * * * *
825 DFGRLRDAVQACVLMVNIMIDSTL QPTPQCTRGN
674 EKLRPLHIGVAGLHTALMRLG FTYFASWDLIERIFEHMYFAAVRASVDLCKSGLPRCEWFERTIYQEGKFIF 
** ** ***** ** ** * * * * * ** * * * * * *
859 DNLRSMGIGMQGLHTACLKLGLDLESAEFQDLNKHIAEVMLLSAMKTSNALC VRGARPFNHFKRSMYRAGRFHW
746 ELYRLPRLSIASARWEALRADMLEFGLRNCQFLAVGPDDEVAHLWGVTPSVWASRGTVF EEETVWSIC P
*  *  * *  * *  *  * * * *  * * * * * *  * * *
933 ERFPDAR PRYEGEWEMLRQSMMKHGLRN5QFVALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTL
815 PNRECYFPTWRRPLRVPWNYA WLEQHQEEGKATQCLFQAAPAIQND VEMAAVNLSVFVDQCVAL
* * * *  * * * * * * * * * *
1006 LLKELERTFSGKRLLEVMDSLDAKQWSVAQALPCLEPTHPLRRFKTAFDYDQKLLIDLCADRAPYVDHSQSMTL
881 VFYYDSGMTPDVLLARMLKWPYHWRFKVG VYKYCAS
*  * * * * * * * *  * * *
1080 YVTEKADGTLPASTLVRLLVHAYKRGLKTGMYYCKVRKATNSGVFGGDDNIVC MSCAL
Figure 41. Optimal alignment of the amino acid sequences of 
HSV-1 RRl with those of a putative HCMV ORF termed M4.PR0 
(B. Barrell, personal communication). Polypeptide regions 
of higher homology are underlined. Asterisks denote 
conserved residues. The program parameters were: mutation 
weight = 5, gap weight = 3k+7, k up to 2000.
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Figure 4 2 . A C1NTH0M plot comparing the amino acid 
sequences of HSV-1 RRl and mouse Ml. The location of a 
major deletion in the mouse sequence is indicated by an 
arrow. Program settings were: range = 15; scale factor 
0.9 5; minimum value plotted = 30%; compressed xl5.
First sequence: Mouse Ml
Second sequence: HSV-1 RRl
289 
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1084 
774
GGNK RPGAFAIYLEPWHLDIFEFLDLK-- KNTGQGRTASTRSLLCTLD «--  1 3aa -vPNQDWSLMC
* *  * *  * * * * * *  * * *  * * * *  * * *
AHNKESARPTGACVYLEPWHTDVRAVLRMKGVLAGEEAQRCDNIFSALWMPDLFFKRLIRHLDGEKNVTWTLFD
PNECPGLDEVWGEEFEKLYESYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLG TIKC 
* * * * * * * * *  * * * * * * *  * *  * * *  * *  * *
RDTSMSLADFHGEEFEKLYQHLEVMG FGEQIPIQELAYGIVRSAATTGSPFVMFKDAVNRHYIYDTQGAAIAG
SNLCTEIVEYTSKDEVAVCNLASLALNMYVTPEHTYDFEKLAEVTKVIVRNLNKIIDINYYPIPEAHLSNKRHR 
* * * * * * * *  * *  * * * *  * * *  * * * *  * * * *  * *  * *
SNLCTEIVHPASKRSSGVCNLGSVNLARCV SRQTFDFGRLRDAVQACVLMVNIMIDSTLQPTPQCTRGNDNLR
PIGIGVQGLADAFILMRYPFESPEAQLLNKQIFETIYYGALEASCEL AKEYGPYETYEGSPVSKGILQYDMWN 
* * * * * * *  * * * * * * * * *  * * * * * *
SMGIGMQGLHTACLKLGLDLESAEFQDLNKHIAEVMLLSAMKTSNALCVRGARPFNHFKRSMYRAGRFHWERFP
VA PTDLWDWKPLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDL 
* * * * * * * * *  ***** *** * * * ** * * * * *
DARPRYEGEWEMLRQSMMKHGLRNSQFVALMPTAASAQISDVSEGFAPLFTNLFSKVTRDGETLRPNTLLLKEL
TERGLWNEEMKNQIIACNGS IQSIP EIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEP 
* * * * * * * *  * *  * *  * * * * * *  *
ERTFSGKRLLEVMDSLDAKQWSVAQALPCLEPTHPLRRFKTAFDYDQKLLIDLCADRAPYVDHSQSMTLYVTEK
NYGKL t s m h f y g w k q g l k t g m y y l r t r p a a n p i q f t l ^k e k l k d k e k a l k e e e e k e )r n t a a m v c s l e
*  *  * * * * * * * * * * *  * * * *  * * * *
ADGTLPASTLVRLLVHAY KRGLKTGMYYCKVRKATNSGVFGGD^-----  1 8aa  >DNIVCMSCAL
NREECLMCGS
Figure 43 . Optimal alignment of the amino acid sequences 
of HSV-1 RRl with those of mouse Ml. Regions of clustered 
homology are underlined. The major insertion in the Ml 
sequence identified in Fig. 42 is indicated and the region 
of high percentage of occurence of charged residues in Ml is 
boxed. Asterisks denote conserved residues. The program 
parameters were: mutation weight = 5, gap weight = 3k+7, k 
up to 2000.
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aspartic acid, glutamic acid), although, the immediate 
flanking sequences do not contain such an extreme amino acid 
composition. The HOMOL plot also indicated the existence of 
clustered homology; the overall percentage homology of the 
colinear sequences is 31%.
c ) Amino acid sequence comparison of HSV-1 RRl and
E. coli B1 polypeptides.
Carlson et al., (19 84) reported the amino acid
sequence of the E. coli B1 polypeptide, which subsequently 
was amended (J. Fuchs, personal communication; Nilsson 
et al ., 19 88a). Comparisons of RRl with the amended B1 
sequence are represented as CINTHOM and HOMOL plots in Figs. 
44 and 45, respectively. The CINTHOM plot displayed no 
homology at the N-terminus of RRl for 720 amino acids and 
for 360 amino acids at the N-terminus of B1 (Fig. 44).
After these non-homologous regions, both sequences exhibit 
low but detectable amino acid conservation. The HOMOL 
alignment predicted a deletion of 20 residues close to the 
C-terminus of the E. coli polypeptide (Fig. 45, at E. coli 
B1 aa 700), and demonstrated that the colinear parts share 
21% homology.
5. Amino Acid Sequence Conservation of HSV-1 RR2 with 
Other Viral Polypeptides.
The amino acid sequences of the polypeptides encoding 
the small ribonucleotide reductase subunit have been 
determined for HSV-2 strain HG52 (RR2; McLauchlan and 
Clements, 1983), E. coli (B2; Carlson et al., 1984), surf
clam Spisula solidisima (M2; Standart et al., 1985) and
mouse (M2; Thelander and Berg, 19 86), and comparisons of 
these polypeptides have been performed by these authors.
The sequence of the HSV-1 RR2 polypeptide has also been
reported for HSV-1 strain KOS (Draper et al., 19 82) and was
subsequently amended (K. Draper, personal communication), 
and for HSV-1 strain 17+ (McLauchlan, 1983a; McGeoch et a l ., 
1988). Further, the potential small ribonucleotide 
reductase subunit sequences have been reported for EBV 
(Vmw34; Baer et al., 19 84), VZV (Vmw35; Davison and Scott,
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Figure 4 4 . A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RRl with the amended E. coli B1 polypeptide 
sequence (Nilsson et al., 1988a). A major deletion in the 
B1 sequence is indicated by an arrow. Program settings 
were: range = 15; scale factor = 0.95; minimum value plotted 
= 30%; compressed xl5.
First sequence: E. coli Bl
Second sequence: HSV-1 RRl
345 TRLLKGEDITLFSPSDVPGLYDAFFADQEEFERLYTKYEKDDSIRKQRVKAVELFSLMMQERASTGRIYIQNVD 
* * * * * * *  * *  * * *  * * *  *
720 SMSL ADF HGEEFEKLYQHLE VMGFGEQIPIQELAYGIVRSAATTGSPFVMFKD
419 HCNTHSPFDPAIAPVRQSNLCLEIALPTKPLNDVNDENGEIALCTLSAFNLGAINNLDELEELAILAVRALDAL 
* * * * * * * *  * *  * * * * * *
773 AVNRHYIYDTQGAAIAGSNLCTEIVHPASKRSSGVCNLGSVNLARCVSRQTFDFGRLRDAVQACVLMV NIM
49 3 LDYQDYPIPAAKRGAMGRRTLGIGVINFAYYLANDGKRYSDGSANNLTHKTFEAIQYYLLKASNELAKEQGACP 
* * * ** * *** * * * * * * * * * *  
844 IDSTLQPTPQCTRGNDNLRSMGIGMQGLHTACLKLGLDLESAEFQDLNKHIAEVMLLSAMKTSNAL CVRGARP
567 WFNETTYAKGILPIDTYKKDLDTIANEPLHYDWEALRESIKTHGLRNSTLSALMPSETSSQISNATNGIEPPRG
it ^  * * * *  * *  * * * * * * *  * * * *  * * * *  * *
917 FNHFKRSMYRAGRFHWERFPD ARPRYEGEWEMLRQSMMKHGLRNSQFVALMPTAASAQISDVSEGFAPLFT
641 YVSIKASKDG ILR QVVPDYEHLHDAYELLWEMPGNDGYLQLV*  20aa  >GIMQK FI
* * * * *  * * * * *  * * * * 
9 88 NLFSKVTRDGETLRPNTLLLKELERTFSGKRLLEVMDSLDAKQWSVAQALPCLEPTHPLRRFKTAFDYDQKLLI
69 0 DQSISANTNYDPS RFPSGKVPMQQLLKDLLTAYKFGVKT LYYQNTRDGAEDAQDDLVPSIQDDGC
* * * * * * * * * *  * * *  * *  * * * *
1062 DLCADRAPYVDHSQSMTLYVTEKADGTLPASTLVRLLVHAYKRGLKTGMYYCKVR KATNSGVFGGDDNIV
755 ESGACKI 
1132 CMSCAL
Figure 45. Optimal alignment of HSV-1 RRl with the amended 
amino acid sequence of E. coli Bl (Nilsson et al ., 1988a). 
The major deletion in the Bl sequence predicted in Fig. 44 
is indicated. Regions of clustered homology are underlined 
and asterisks denote conserved residues. The program 
parameters were: mutation weight = 5, gap weight = 3k+7, k 
up to 2 000.
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1986b; Nikas et al ., 1986), VV (Vmw37; Slabauch et a l ., 
1988), bacteriophage T4 (T4B2; Sjoberg et a l ., 1986) and 
Saccharomyces cerevisiae (Elledge and Davis, 1987; Hurd 
et a l ., 19 87); likewise, each of these sequences has been 
compared with other proposed or identified small subunit 
polypeptide sequences by the respective authors. In this 
part of Section B the polypeptide sequences of HSV-2 RR2,
VZV Vmw35, VV Vmw3 7 and the putative HCMV ORF M3.PRO are 
compared with HSV-1 RR2.
i ) HSV-1 RR2 is highly homologous to HSV-2 RR2. 
Comparisons of the RR2 polypeptides of HSV-1 strain 17+ 
and HSV-2 strain HG52 are shown as CINTHOM and HOMOL plots 
in Figs. 46 and 47. The lettering of the CINTHOM diagonal 
indicates that the N-terminal 40 amino acids of both 
polypeptides exhibit relatively low homology while the 
remainder are essentialy colinear (Fig. 46). Analysis of 
homology with the HOMOL program indicated that the colinear 
parts extend from HSV-1 aa 34 and HSV-2 aa 31 to the 
respective C-termini (Fig. 47). The percentage homology 
for these regions is 9 3% and from 308 aligned residues 19 
changes were observed; five of these are conservative ones 
according to the Venn diagram of amino acid conservation 
(Taylor, W.R., 1986a). The percentage homology for the 
N-terminal 40 amino acids is 44% and no major insertions 
or deletions are observed which is in contrast to the case 
with the equivalent regions of HSV-1 RRl and HSV-2 RRl 
(see Page 84).
Larsson and Sjoberg (1986) reported the localisation 
of the ribonucleotide reductase radical at a tyrosine 
residue at E. coli B2 aa 122. Comparison of the E. coli B2 
amino acid sequence with that of HSV-2 RR2 demonstrated that 
the tyrosine and adjacent amino acids are well conserved in 
the RR2 polypeptide; it was therefore proposed that the 
HSV-2 radical is localised on this tyrosine (McLauchlan,
1986). As can be seen in Fig. 47 the tyrosine residue 
(indicated by •) is conserved in the HSV-1 RR2 polypeptide 
as well, and therefore, by analogy with HSV-2 RR2, it is 
proposed that the HSV-1 RR2 radical is localised on this 
particular tyrosine.
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Figure 46. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RR2 with that of HSV-2 RR2. Program settings were: 
range = 15; scale factor = 0.95; minimum value plotted =
30%; compressed xlO.
First sequence: HSV-1 RR2
Second sequence: HSV-2 RR2
▼
1 MDSAAPALSPALTALTDQSATADLAIQIPKCPDPERYFYTSQCPDINHLRSLSILNRWLETELVFVGDEEDVSK 
* *  * *  * * *  * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
1 MD PAVSPASTDPLDTHASGAGAAPIPVCPTPERYFYTSQCPDINHLRSLSILNRWLETELVFVGDEEDVSK
A •
75 LSEGELSFYRFLFAFLSAADDLVTENLGGLSGLFEQKDILHYYVEQECIEVVHSRVYNIIQLVLFHNNDQARRE 
****** ******************************************************************
72 LSEGELGFYRFLFAFLSAADDLVTENLGGLSGLFEQKDILHYYVEQECIEVVHSRVYNIIQLVLFHNNDQARRA
149 YVAGTINHPAIRAKVDWLEARVRECASVPEKFILMILIEGIFFAASFAAIAYLRTNNLLRVTCQSNDLISRDEA 
*** ******** ************ ************** *********************************
14 6 YVARTINHPAIRVKVDWLEARVRECDSVPEKFILMILIEGVFFAASFAAIAYLRTNNLLRVTCQSNDLISRDEA
223 VHTTASCYIYNNYLGGHAKPPPDRVYGLFRQAVEIEIGFIRSQAPTDSHILSPAALAAIENYVRFSADRLLGLI 
*************** **** *** *** ** ************** **** ********************
220 VHTTASCYIYNNYLGDHAKPEAARVYRLFREAVDIEIGFIRSQAPTDSSILSPGALAAIENYVRFSADRLLGLI
29 7 HMKPLFSAPPPDASFPLSLMSTDKHTNFFECRSTSYAGAVVNDL 
** ** *** * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
29 4 HMQPLYSAPAPDASFPLSLMSTDKHTNFFECRSTSYAGAVVNDL
Figure 47. Optimal alignment of the amino acid sequences of 
HSV-1 RR2 with those of HSV-2 RR2. Arrowheads indicate the 
amino acid positions where the two sequences become highly 
homologous. The proposed location of the tyrosine radical 
(•) is indicated and asterisks denote conserved residues.
The program parameters were; mutation weight = 5 f 9^ S-P weight 
= 3k+7, k up to 2000.
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ii) HSV-1 RR2 shares homology with VZV Vmw35. A VZV 
potential ORF encoding a polypeptide of 35,000 mol. wt., 
Vmw35, was shown to share homology with HSV-1 RR2 (Davison 
and Scott, 1986b; Nikas et al., 1986). A CINTHOM comparison 
of VZV Vmw35 and HSV-1 RR2 revealed that both sequences were 
colinear, although the position of the homology diagonal 
indicates the existence of additional amino acids at the 
N-terminus of RR2 (Fig. 48). Alignment of the two sequences 
with the HOMOL program indicated that this region consisted 
of 28 amino acids (Fig. 49); the remainder of both sequences 
share 54% homology. In common with the HSV-1 RRl/VZV Vmw87 
comparison (see Fig. 35), clusters of conserved amino acids 
exist and these are underlined in Fig. 49. The longest 
cluster, positioned between HSV-1 aa 111 to 139 and VZV aa 
83 to 112, contains a tyrosine residue (indicated by •) 
which corresponds by position to the RR2 tyrosine on which 
the radical could be localised. In addition, this cluster 
contains an RR2 sequence of KDILHYYVE from which six 
residues are identical in VZV and one residue is replaced by 
a conserved one (isoleucine to valine, see Fig. 49). 
Interestingly, McLauchlan (19 86) reported that the HSV-2 
equivalent block is retained at the C-terminal portion of 
the homologous E. coli B2 polypeptide.
iii) HSV-1 RR2 shares homology with VV Vtnw37.
Recently, Slabaugh et al. (1988) identified and sequenced a
gene which encodes a polypeptide of 37,000 mol. wt. (Vmw37) 
as deduced by translation of the nucleotide sequence. This 
polypeptide was found to be highly homologous to the mouse 
M2 polypeptide and was therefore suggested to encode the 
small subunit of the VV-induced ribonucleotide reductase. 
Amino acid comparison of HSV-1 RR2 with VV Vmw37 with the 
CINTHOM program revealed the existence of homology (Fig.
50). Alignment of the two polypeptides with the HOMOL 
program identified three clusters of identical amino acids 
and the sequences displayed 27% overall homology (Fig. 51). 
Further, one of these clusters contain a tyrosine residue 
corresponding by position to the RR2 tyrosine on which the 
radical could be localised. Analysis of the amino acid
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Figure 48. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RR2 with that of VZV Vmw35. Program settings were: 
range = 15; scale factor = 0.9 5; minimum value plotted =
30%; compressed xlO.
First sequence: VZV Vtnw35
Second sequence: HSV-1 RR2
1
1
47
75
MD<-
* *
•28aa- ->QKDCSHFFYRPECPDINNLRALSISNRWLESDFIIEDDYQYLDC 
* * *  * * * * *  * *  * * *  * * * * *  *
MDSAAPALSPALTALTDQSATADLAIQIPKCPDPER YFYTSQCPDINHLRSLSILNRWLETELVFVGDEEDVSK
LTEDELIFYRFIFTFLSAADDLVNVNLGSLTQLFSQ 
* ★ ** ***★ * ********* *** * **
LSEGELSFYRFLFAFLSAADDLVTENLGGLSGLFEQ
KDIHHYYIE2ECIEVVHARVYSQIQLMLFRGDESLRVQ
* * * * * * * * * * * * * *  * * *
KDILHYYVE3ECIEVVHSRVYNIIQLVLFHNNDQARRE
121 YVNVTINNPSIQQKVQWLEEKVKDNPSVAEKYILMILIEGIFFVSS FAAIAYLRNNGLFVVTCQFNDLISRDEA 
* *  * * *  * * * *  * * *  * *  * *  * *  * * * * * * * * * * *  * * * * * * * * *  * * * * * *  * * * * * * * * *
149 YVAGTINHPA1RAKVDWLEARVRECASVPEKFILMILIEGIFFAASFAAIAYLRTNNLLRVTCQSNDLISRDEA
19 5 IHTSASCCIYNNY VPEKPAITRIHQLFSEAVEIECAFLKSHAP KTRLVNVDAITQYVKFSADRLLSAI
* *  * * *  * * * * *  * *  * * *  * * * * *  * * **  * *  ** * * * * * * *  *
223 VHTTASCYIYNNYLGGHAKPPPDRVYGLFRQAVEIEIGFIRSQAPTDSHILSPAALAA1ENYVRFSADRLLGLI
263 NVPKLFNTPPPDSDFPLAFMIADKNTNFFERHSTSYAGTVINDL 
** **** *** * ** ***** ****** * ***
29 7 HMKPLFSAPPPDASFPLSLMSTDKHTNFFECRSTSYAGAVVNDL
Figure 49 . Optimal alignment of the amino acid sequences 
of HSV-1 RR2 with those of VZV Vmw35. The proposed location 
of the tyrosine radical (•) is indicated and regions of 
clustered homology are underlined. Boxed amino acids 
indicate N-terminal sequences which are conserved at the 
C-terminus of the E. coli B2 polypeptide (McLauchlan, 19 86). 
Asterisks denote conserved residues. The program parameters 
were: mutation weight = 5, gap weight = 3k+7, k up to 2000.
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Figure 50. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RR2 with that of VV \rtnw37. Program settings were: 
range = 1 5 ;  scale factor = 0.9 5; minimum value plotted =
30%; compressed xlO.
First sequence: W  Vmw37
Second sequence: HSV-1 RR2
M EPILAP NPNRFVIF PIQYYDIWNMYKKAEASFWTVEEVDISKDINDWNK
* 1c ★
MDSAAPALSPALTALTDQSATADLAIQIPKCPDPER YFYTSQCPDINHLRSLSILNRWLETELVF VGDEEDVSK
51 LTPDEKYFIKHVL£ 
* * * *
FFAASDGIVNENLAERFCTEVQITEARCFYGFQMAIENIHSEMY SLLIDTYVKDSNEK 
5 * >  * * * *  * * * * * * * *  * *
75 LSEGELSFYRFLFAFLSAADDLVTENLGGLSGLFEQ KDILHYYVEQECIEVVHSRVYNIIQLVLFHNNDQARR
123 NYLFNAIETMPCVKKKADWAQKWIHDSAGYGERLIAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRD 
* * *  * * *  * * *  ***** *** * * * ** ***** 
14 8 EYVAGTI NHPAIRAKVDWLEARVRECASVPEKFILMILIEGI ^FFFAAStFAAIAYLRTNNLLR VTCQSN DLISRD
19 7 EGLHCDFACLMFKHLL HPPSEETVRSIITDAVSIEQEFLTAALP VKLIGMNCEMMKTYIEFVADRLIS 
* * *  * * *  * * * * *  * * * * **** 
221 EAVHTTASCYIYNNYLGGHAKPPPDRVYGLFRQAVEIEIGF1RSQAPTDSHILSPAALAAIENYVR FSADRL L
265 ELGFKKIYNVTNPFDFMENISL EGKTNFFEKRVGEYQKMGVMSNEDNHFSLDVDF 
* * * * * *  * * * * *  * * * *
29 4 GLIHMKPLFSAPPPDASFPLSLMSTDKHTNFFECRSTSYAGAVV NDL
HSV-1 RR2
1 100 _200 300 340
I----------------------i----------------------  «-----   1
FFAAS
VV Vmw37
1 _  100 200 300 319«--------------■ ------ 1______________________i---------------------- i----1
FFAAS
20aai____i
Figure 51. Optimal alignment of the amino acid sequences 
of HSV-1 RR2 with those of VV Vmw37. Regions of clustered 
homology are underlined and the proposed location of the 
tyrosine radical (•) is indicated. Boxed residues indicate 
a N-terminal RR2 amino acid sequence which is conserved at 
the C-terminus of the VV polypeptide. Asterisks denote 
conserved residues. The program parameters were: mutation 
weight = 5, gap weight = 3k+7f k up to 2000. Below the 
alignment, the two polypeptides are depicted in a linear 
form showing the respective locations of the conserved amino 
acid sequence.
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sequences demonstrated the existence of one stretch of 
residues (boxed residues in Fig. 51) which is present 
in different positions along each polypeptide backbone.
iv) HSV-1 RR2 is not homologous to HCMV M3.PRO.
The sequencing studies of Barrell and co-workers in HCMV 
strain AD169 identified a putative ORF, termed M3.PRO, 
which corresponds by position to HSV-1 RR2 (B.G. Barrell, 
personal communication). This ORF has an extreme C-terminal 
composition of three interrupted stretches of 7, 21 and 12 
glycine residues. CINTHOM comparison of HSV-1 RR2 with 
M3.PRO revealed low conservation (Fig. 52). This was 
clearly demonstrated with the HOMOL alignment of the two 
sequences; the homology percentage was 17%, and only one 
small stretch of identical amino acids exists (underlined in 
Fig. 53). Further, the RR2 tyrosine residue (indicated by 
•) on which the radical could be localised is not conserved 
in the HCMV sequence. Interestingly, the amino acid 
sequence LGGLSG which is located close to the N-terminus of 
RR2 (Fig. 53, HSV-1 aa 101 to 106), is retained close to the 
C-terminus of M3.PRO (Fig. 53, M3.PRO aa 326 to 331) with 
only one conservative change from a serine to a glycine.
DISCUSSION.
In the first part of Section B the HSV-1 RRl 
polypeptide was compared with homologous herpesvirus 
sequences and with the equivalent polypeptides of the 
eukaryotic and prokaryotic enzymes. In the second part, the 
HSV-1 RR2 polypeptide was compared with recently obtained 
viral polypeptide sequences. The main feature that emerges 
from this analysis is thatsimilaritybetween colinear 
polypeptide regions is primarily retained in stretches of 
identical or conserved amino acids. Other features are; 
i) the RRl N-terminal region is conserved only in HSV-2 RRl, 
whereas it is absent from other viral, eukaryotic and 
prokaryotic polypeptides, ii) EBV Vmw93 contains an
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Figure 52. A CINTHOM plot comparing the amino acid sequence 
of HSV-1 RR2 with that of putative HCMV ORF termed M3.PRO 
(B. Barrell, personal communication). Program settings 
were: range = 15; scale factor = 0.9 5; minimum value plotted 
= 30%; compressed xlO.
First sequence: HCMV M3.PRO
Second sequence: HSV-1 RR2
1 MDRKTRLSEPPTLALRLKPYKTAIQQLRS VIRALKENTTVTFLPTPSLILQTVRSHCVS KITFNSSCLYITDKS 
* * * * * * * * * * * * *
1 MD SAAPALSPALTA LTDQSATADLAIQIPKCPDPERYFYTSQCPDI
75 FQPKTINNSTPLLGNFMYLTSSKDLTKFYVQDIS DLSAKISMCAPDFNMEFSSACVHGQDIVR ES ENSAVH VDL 
★ * * * * * * *  * * *
47 NHLRSLSILNRWLETELVFVGDEEDVS KLS EGELSFYRFLF
149 DFGVVADLLKWIGPHTRVKRNVKKAPCPTGTVQILVHAGPPAIKFILTNGS ELEFTANNRVSFHGVKNMRINVQ 
* * * *  * * * * * * *  * * * *
88 AFLSAADDL VTEt^LGGLS^LFEQKDILHYYVEQE CIEVVHSR VYNI IQLVL
223 LKNFYQTLLNCAVTKLPCTLRIVTEHDTL LYVASRNGLFAVENFLTEEPFQRGDPFDKNYVGNSGKSRGG 
* *  * * * *  * * *  * * *  * *
139 FHNNDQ ARREYVAGTINHPAIRAKVDWLEARVRECASVPEKF ILMILIEGIFFAASFAAIAYLRTNNLLR V
29 3 GGGGGSLSSLANAGGLHDDGPGLDNDLMN EPMCjLGGLGGbGGGGGKKH DRGGGGGSGTR KMSSGGGGGDHDHGL 
* * * * * * * * * * *
210 TCQSNDLISROEAVHTTASCYIYNNYL GGHAKPPPDRVYGLFRQAVEIEIGFIRSQAPTDS
367 SSKEKYEQHKITSYLTSKGGSGGGGGGGGGGLDRNSGNYFNDAKEES DSEDSVTNFEFVPNT KKQKCG 
* * ★ ★ * * * * * * * *
271 HILSPAALAAIENY VRFSADRLLGLIHMKPLFSAPPPDASFPLSLMSTDKHTNFFECRSTSYAGAVVNDL
HSV-1 RR2
1________________ ^ _____________ 200_____________ 3Q0 3if0
LQGLSG
HCMV M3.PRO
1________________ 100_____________ 200_____________ 3Q0 ^ _________ 4Q0 434
LGGLGG
t^Oaa,
Figure 53. Optimal alignment of the amino acid sequences of 
HSV-1 RR2 with those of a putative HCMV ORF termed M3.PRO 
(B. Barrell, personal communication). The single region of 
clustered homology is underlined and the proposed location 
of the tyrosine radical in RR2 (•) is indicated. Boxed 
residues indicate a N-terminal RR2 amino acid sequence which 
is conserved at the C-terminus of the M3.PRO. Asterisks 
denote conserved residues. The program parameters were: 
mutation weight = 5, gap weight = 3k+7, k up to 2000.
Below the alignment, the two polypeptide sequences are 
depicted in a linear form showing the respective positions 
of the conserved amino acid sequence.
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insertion which separates highly conserved regions in 
the HSV-1, HSV-2 and VZV homologue polypeptides, and
iii) the first of two putative HCMV ORFs, which corresponds 
by position to RRl exhibits low but detectable homology; 
the second ORF, which corresponds by position to RR2 
exhibits extremely low conservation.
6. Relationship Between HSV-1 and Other Herpesviral
and Non-herpesviral Polypeptides.
a ) Polypeptide conservation between HSV-1 and HSV-2.
The comparisons presented in this section clearly 
demonstrate that the highest percentage homology is observed 
between the HSV-1 and HSV-2 polypeptides. The DNA sequences 
for a number of genes such as TK (McKnight, 1980; Wagner 
et al., 1981), gC (Swain et al., 1985), AE (Draper et al.,
19 86) and for most of the polypeptides encoded by the Ug 
segment (McGeoch et al., 19 85 and 19 87), have been obtained 
for both HSV serotypes. Comparisons between equivalent 
polypeptides indicate relatively low homology for the 
N-termini, as compared with the remainder of the coding 
regions which are quite well conserved (McGeoch et al.,
1987); the only exception reported so far is the HSV-1 IE 
\Anw63 which differs in one out of twenty N-terminal amino 
acids from its HSV-2 counterpart (Whitton et al., 1983).
In some instances, most of the N-terminal amino acid changes 
are conservative and, therefore, their predicted secondary 
structures are quite similar as is the case for the AE 
(Draper et al., 1986) and RRl (Nikas et al., 1986; see 
Results and Discussion, Section C). Only two cases of major 
differences within the N-termini of homologous HSV-1 and 
HSV-2 polypeptides have been reported so far; the first 
one is for HSV-2 gG, which contains an insertion of 
approximately 480 residues (McGeoch et al., 1987), and 
the second for HSV-1 gC, which contains an additional 
28 amino acids (Swain et al., 1985).
92
b ) Polypeptide conservation between HSV-1 and VZV.
The genomes of HSV-1 and VZV are quite similar in that 
they both have U^, Rg and Ug segments. VZV does have an 
segment but this is only 88bp (Davison, 1984). Comparisons 
of equivalent HSV-1 and VZV polypeptide coding regions 
demonstrated a wide variation of homology, ranging from 
similar polypeptides, such as the HSV-1 Vmwl75 and VZV 
Vmwl40 (McGeoch et al., 19 86) and the DNA polymerase 
(McGeoch et al., 1988), to the very limited relationship of 
the polypeptides encoded by the HSV-1 (JS10 and VZV RS3 genes 
(Davison and McGeoch, 1986). In most comparisons reported 
so far, there is a significant dissimilarity in length and 
amino acid composition at the C- and, particularly, the 
N-termini, the latter being the least conserved regions 
(Davison and McGeoch, 1986). In that respect, these authors 
reported that HSV-1 Vmw68, US3, US10 and VZV Vmwl40, US1,
LJS4, have more residues in their N-terminal portions than 
their counterparts; in contrast, HSV-1 Vmw65, the IE 
trans-inducing factor, has 80 C-terminal amino acids which 
are not present in the VZV Vmw5 4 homologue (Dalrymple 
et al., 1985). However, an N-terminal difference of 
approximately 360 residues, as the one observed in the HSV-1 
RRl/VZV Vmw87 comparison (see Page 84), has not been 
reported as yet (D.J. McGeoch, personal communication).
c) Polypeptide conservation between HSV-1 and EBV.
Although the genome sequences of both HSV-1 and EBV
have been obtained, comparisons have been performed for only 
a limited number of polypeptides such as the DNA polymerase 
(Quinn and McGeoch, 1985) and gB (Pellet et al., 1985) where 
homology is approximately 40%; a systematic analysis such as 
the one performed for HSV-1 and VZV has not been carried out 
as yet. However, Davison and Taylor (19 87) have compared 
all the VZV and EBV ORFs and found three major regions of 
approximate colinearity in the UL segments (Fig. 54, regions 
A, B and C) while no relationship was observed for the 
repeats or the UQ segments. Within the A, B and C regions, 
certain genes are strongly conserved while the majority 
have barely detectable homology; their identification
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Figure 54. This diagram shows the relationship between the 
VZV and EBV genomes. The VZV genome comprises two unique 
components (U^ and (Jg ) each flanked by inverted repeats 
(TR^, IR^f IRg and TRg ). The EBV genome also consists of 
two unique components (U. and Uc) joined by a variable
Li O
number of copies of a direct repeat (IR). The VZV (JT
Li
component is represented as three major regions (A, B and C) 
which correspond on the basis of homology to regions C, A' 
and B in the EBV (JL component. A' denotes the A region in 
reverse orientation.
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as homologues was based on characteristics such as 
hydropathicity profiles or glycoprotein-like sequences. 
Further, the VZV genes 9 through to 17 which map between 
the A and B regions have no obvious homologue in the EBV 
genome. The HSV-1 counterparts of these VZV genes are UL41 
through to UL49 and these include the genes for the IE
trans-inducinq factor Vttiw65, qC and the protein.DBF
d ) Polypeptide conservation between HSV-1 and HCMV.
As reported above, the lowest percentage homology was 
observed in the RRl and RR2 comparisons with the respective 
putative HCMV ORFs. To date, the only HCMV available 
sequencing data are for the Uc, Rc, a portion of the TR 
segment (Weston and Barrell, 1986), and a 20kbp fragment 
in UT (Kouzarides et al., 1987). Comparisons of the HCMV
±J ---------------------------
(Jg ORFs with HSV-1, VZV and EBV (Jg sequences revealed no 
homology at all (Weston and Barrell, 1986). However, from 
the eight ORFs in the (J fragment one exhibits 31% homology
1j
to the HSV-1 DNA polymerase and another to HSV-1 gB 
(Kouzarides et al., 1987). These homologous pairs of 
sequences exhibit extremely low conservation at the 
N-termini while close to the C-termini a substantial degree 
of conservation can be observed (Kouzarides et al., 1987).
e ) Polypeptide conservation between HSV-1 and 
non-herpesviral polypeptides.
Apart from the ribonucleotide reductase genes, which, 
as already mentioned, share homology with non-herpesviral 
polypeptides only two other HSV-1 genes have been shown 
to share homology. Earl et al. (19 86) reported that the 
herpesvirus DNA polymerase shares homology with the 
corresponding adenovirus gene, and McGeoch and Davison 
(1986b) demonstrated that a non-characterised HSV-1 ORF 
exhibited homology, spanning an 80 amino acid region at 
the middle of the ORF, with a eukaryotic protein kinase. 
This ORF was subsequently shown to encode a protein kinase 
(see Introduction, Page 35) and is the first HSV-1 gene 
for which a function has been assigned by this approach.
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7. Constituents of the Viral Ribonucleotide Reductases.
As already mentioned (see Introduction, Page 49), 
the HSV-l-specified enzyme consists of the RR1 and RR2 
polypeptides. On the basis of the strong homology observed 
in the HSV-1 RR1/VZV Vmw87 and HSV-1 RR2/VZV Vmw35 
comparisons it appears that these VZV ORFs code for the 
large and small subunits of the VZV-induced enzyme, 
respectively. This is further supported by the similarity 
of the properties of the HSV- and VZV-induced enzymes 
(Spector et al., 1987). Dutia et al. (19 86) attempted 
to immunoprecipitate the VZV activity by means of an 
oligopeptide antiserum directed against the 7 C-terminal 
amino acids of HSV-2 RR2. This approach, based on the 
observation that the C-terminal portions of the HSV-2 and 
VZV small subunit polypeptides are highly conserved 
(McLauchlan, 1986; Nikas et al., 1986), resulted in the 
precipitation of the Vmw35 protein species. However, the 
antiserum did not precipitate the Vmw87 polypeptide, most 
probably because different immunoprecipitation conditions 
are required to achieve this.
On the basis of the strong homology observed in 
the HSV-1 RR1/EBV Vimw9 3 (see Page 85) and in conjunction 
with the observed similarity of HSV-1 RR2 with EBV Vmw34 
(McLauchlan, 1986) it appears likely that these polypeptides 
encode the large and small subunits of the EBV-specified 
activity in infected cells. Equally, the observed 
percentage homologies of the VV Vmw86 and Vmw37 polypeptides 
with HSV-1 RR1 and RR2 would indicate that they code for the 
large and small subunits of the VV-induced enzyme.
The same suggestions cannot be applied with certainty 
to the HCMV putative ORFs. The larger of these, M4.PR0, 
exhibited some homology to HSV-1 RRl and as can be seen 
in Fig. 41 two regions were conserved. The first region 
contains a sequence that resembles the proposed nucleotide 
binding site identified in the ribonucleotide reductase 
large subunit polypeptides (see Page 103). The second 
region corresponds to a region in the large subunit 
polypeptides which appears to be important for structure of 
the enzyme (see Page 112). These similarities would suggest 
that M4.PRO resembles a remnant of a protein which contains
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a nucleotide binding site; this could possibly be the large 
subunit of ribonucleotide reductase although for the time 
being there are no reports describing such an HCMV-specified 
activity.
On the other hand, M3.PRO exhibits the lowest 
similarity to HSV-1 RR2 observed so far. Further, the RR2 
tyrosine residue on which the radical is thought to be 
localised and a block of residues which are highly conserved 
in all the small subunit polypeptides (see Page 100) are not 
conserved in M3.PRO. The observed lack of similarity would 
suggest that this ORF does not code for the ribonucleotide 
reductase small subunit, although, it should be stated that 
lack of homology of the primary structure of two proteins is 
not adequate evidence for assigning different functions to 
these proteins. The latter has been clearly shown in the 
EBV/VZV comparisons (see Page 92) and in the case of the 
HSV-1 protein kinase which shares limited degree of 
conservation with the eukaryotic equivalent polypeptide 
(McGeoch and Davison, 1986b). In conclusion, although the 
available data are insufficient to propose whether the HCMV 
ORFs code for a ribonucleotide reductase, it is suggested 
that at least in the corresponding HSV-1 genomic position 
this virus does not code for such an activity.
8. Putative Common Epitopes in the HSV-1 RRl and RR2 
Subunits.
A number of immunoprecipitation studies using 
monoclonal antibodies or anti-oligopeptide sera specific 
for either the RRl or RR2 polypeptides resulted in the 
co-precipitation of both subunits (Frame et al., 1985; 
Bacchetti et al., 1986; Cohen et al., 1986b; Dutia et al., 
1986; Langelier et al., 1986). It was therefore suggested 
that this is due either to the tight binding of the RRl and 
RR2 subunits or that these subunits share common epitopes. 
Cohen et al. (1986b) investigated the latter suggestion by 
raising a polyclonal antiserum(P9) against a nonapeptide 
representing the C—terminus of RR2 and demonstrated that P9 
could precipitate RR2 and in addition, albeit less 
efficiently, RRl. The P9 antiserumwas reacted with RR2
TABLE III
CONSERVED AMINO ACID STRETCHES IN THE HSV-1 
RRl AND RR2 POLYPEPTIDES
Sequence
*
RRl AA Position
*
RR2 AA Position
TAD 139 21
LGG 147 236
TDS 204 268
AVA 119 335
AGA 281 333
PAL 338 10
REYV 403 147
HLR 432 48
NLG 571 100
. AAIA 785 19 6
LGL 878 29 3
PDA 936 307
DVS 977 71
RLL 1018 287
(*) The numbers indicate the position of the first amino 
acid (AA) in the RRl and RR2 sequences shown.
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which was bound to nitrocellulose paper and RR2-specific 
antibodies were eluted; these were then reacted with a 
partially purified HSV-l-infected cell extract which was 
separated by SDS-polyacrylamide gel electrophoresis and 
electroblotted to nitrocellulose paper. The RR2-specific 
antibodies reacted with both the RR2 and RRl polypeptides 
thus indicating that the two subunits share common antigenic 
determinants.
Comparison of the nonapeptide amino acid sequence 
with the RRl amino acid sequence showed that the peptides 
AVA and AVV were present in RRl (Cohen et al., 1986b).
These authors suggested that, although the homologous 
sequences were not particularly stri king, they could be 
considered as common epitopes. It is generally believed 
that protein epitopes comprise five to seven amino acids 
which can either be consecutive or reside in different parts 
of the primary structure of the protein (conformational 
epitopes). However, shorter epitopes of three consecutive 
amino acids have been reported (Wehland et al., 1984), and 
on that basis the suggestion of Cohen et al. (1986b) is
plausible. Further to these RRl and RR2 homologous 
stretches, a number of others were identified which could 
represent common epitopes (Table III). However, it is 
equally possible that these may simply reflect similarities 
of the codon usage in the RRl and RR2 polypeptide DNA coding 
regions. Further studies are required in order to 
distinguish between these possibilities.
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SECTION C .
9. Alignment and Secondary Structure Predictions of 
the Identified or Potential Large and Small Subunit 
Ribonucleotide Reductase Polypeptides.
The results presented in Section B and other reports
(see Page 87) indicate that there is a high degree of
clustered conservation between the identified or potential
large (RR ) and small (RRC ) ribonucleotide reductase 
-Li O
subunits of viral, prokaryotic and eukaryotic origin.
Thus, it became of interest to identify conserved structural 
or functional elements and to determine, if possible, the 
secondary structure of the enzyme's subunits. The program 
used for this alignment was the consensus template alignment 
program (Taylor, W.R., 1986b; see Materials and Methods,
Page 77). In contrast to the HOMOL program, which can align 
only two sequences and scores only for identical amino 
acids, the consensus template alignment program can align 
more than two sequences and scores for both identical 
residues and residues with similar physico-chemical 
properties. Due to the difference in scoring between these 
programs the sequence alignments are slightly different 
and some of the insertions or deletions predicted with the 
HOMOL program map within aligned polypeptide regions of the 
consensus template alignment output. The latter program can 
further predict the secondary structure for each amino acid 
sequence with the GARNIER algorithm (Garnier et al., 1978), 
and from the combination of the individual predictions a 
consensus one can be derived. Below the aligned sequences 
there are two consensus lines; the first line indicates 
conserved amino acids and the second line contains the 
consensus secondary structure prediction. As individual 
predictions did not give identical answers, the most 
frequent prediction was taken for each position. Gaps 
introduced into the sequences for alignment were designated 
as unstructured areas and boxed regions represent blocks 
within which the majority of amino acids are conserved.
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a ) Alignment of the RR^ polypeptides.
The RR^ polypeptide alignment contained the HSV-1 RRl,
HSV-2 RRl, VZV Vmw87, EBV Vmw93, the amended E. coli B1 and
the mouse Ml polypeptide sequences. On the basis of the
secondary structure predictions, the RR sequences can beLi
divided into four regions.
Region 1 contains the HSV-1 RRl and HSV-2 RRl 
N-terminal regions, spanning HSV-1 positions 1 to 312 
(see Page 84) and, in addition, sequences up to HSV-1 
position 400 (Fig. 55); the latter were included because 
they are not present in other RR polypeptides (see
J_i
Page 91). The predicted secondary structures for each 
Region 1 were homologous and 80% of aligned residues had 
similar structural predictions (data not shown). The 
consensus secondary structure emphasised four distinct 
parts. The first part starts at HSV-1 RRl position 1 and 
terminates at the short run of prolines at aa 150 to 155 
where there are two deletions comprising a total of 12 amino 
acids in the HSV-1 sequence. Within this portion of the 
sequence, 30% of aligned amino acids were predicted to adopt 
p-strand conformation and 1% to adopt ac-helical 
conformation. Most of the amino acids adopting ^-strand 
conformation were clustered so that the first part of the 
sequence is punctuated by short |$-strand stretches. The 
intervening sequences were predicted as unstructured regions 
and contain all the predicted insertions and deletions. 
Interestingly, 90% of amino acids in the |3-strands are 
either identical or replaced by similar residues and 36% of 
them are hydrophobic ones, predominantly isoleucine, valine 
and alanine. The second and third parts extend beyond the 
stretch of prolines up to HSV-1 RRl position 255 where there 
is a deletion of eight amino acids in the HSV-1 sequence; 
these parts are separated between them by a deletion of six 
amino acids at HSV-1 RRl position 205. Parts 2 and 3 are 
predicted as unstructured, and within them the sequence 
becomes more hydrophilic with few conserved clusters of 
hydrophobic residues. The fourth part spans HSV-1 RRl 
amino acid positions 256 through to 400. Within this part 
the sequence becomes increasingly od.~helical with a small 
number of predicted fi-strands.
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Figure 55. Alignment of the HSV-1 and HSV-2 RRl polypeptide 
Region 1. The consensus line below the alignment (C) shows 
the consensus GARNIER secondary structure prediction for 
each aligned position; (E) represents |3-strand conformation 
and (H) represents (X-helical conformation. The blocks of 
prolines are boxed and amino acid sequences in numbered 
boxes indicate the short |5-strand stretches thought to 
punctuate the RRl region between positions 1 to 150. The 
Regions are shown separated in four parts (P) on the basis 
of the consensus GARNIER prediction and the predicted HSV-1 
RRl deletions. Underlined amino acids indicate the 
potential nuclear localisation signals (see General 
Discussion, Page 127). The amino acid positions of the 
alignment are numbered as in HSV-1 RRl (see Fig. 26) and 
asterisks, introduced by the operator, denote conserved 
amino acids. Dots within the aligned sequences have been 
introduced by the program to optimise the alignment.
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Region 2 extends approximately from HSV-1 aa 400 
to 530 where there are two major insertions of 16 and 12 
residues in the eukaryotic and prokaryotic polypeptides, 
respectively (Fig. 56). Within this region, 50% of the 
amino acids were predicted to adopt ck-helical conformations 
and no [3-strands were observed. Region 2 contains 4 
conserved residues and one block of identical amino acids,
labelled 1 in Fig. 56, which is conserved in the viral RR .
Li
The remainder of the polypeptides have been separated
into Regions 3 and A by two EBV insertions at HSV-1 RRl aa
842 and aa 856 (Fig. 56). These insertions, which comprise
a total of 30 residues, approximately correspond to the
major insertion of 34 amino acids in the HSV RRl/EBV Vmw9 3
comparison (see Fig. 37); however, as described on Page 97,
the length and positions of these insertions differ slightly
between different programs. The secondary structure
prediction for Regions 3 and 4 identified areas of both
jj-strand and oC-helix, which occur one after the other so
that most of the ck-helices are separated by ^-strands
along the sequences and vice versa. Region 3 is the most
conserved RR region; it contains 21 conserved amino acids 
Li
and the majority of the blocks are retained in all the 
polypeptides (Fig. 56, blocks 2, 3, 4, 6 and 7). In Region 
4 only blocks 9, 11 and 15 are conserved in all the RR^ and 
the program identified 20 conserved amino acids.
b) Alignment of the RR^ polypeptides.
The small subunit comparison contained the HSV-1 RR2,
HSV-2 RR2, VZV Vmw34, EBV Vmw34 and E. coli B2 polypeptides
(Fig. 57). The program identified 33 conserved amino acids
and two major insertions of 19 and 23 amino acids in the E.
coli B2 polypeptide (Fig. 57, HSV-2 RR2 aa 156 and 315).
In common with RR. Region 2 (see above), 50% of the amino
Li
acids were predicted to adopt DC-helical conformation 
although there were a few ^-strand structures observed close 
to the C-termini of the polypeptides. The BRg alignment 
further identified six blocks of conserved residues (Fig.
57, blocks 16 through to 21); these were subsequently 
compared with other RHg sequences reported on Page 87, which 
were not previously available. In these additional
Figure 56. Alignment of Regions 2, 3 and 4 of the
identified or proposed ribonucleotide reductase large
subunit polypeptides of viral eukaryotic and prokaryotic
origin (RR ). Below the alignment, the first consensus line 
Li
(Cl) displays the amino acids conserved in all RR and the
Li
second line (C2) shows the consensus GARNIER secondary 
structure prediction for each aligned position. (E) 
represents |3-strand conformation and (H) represents 
od-helical conformation. The amino acid positions of the 
alignment are numbered as in HSV-1 RRl (see Fig. 26), and 
amino acids sequences of higher homology are boxed. Dots 
within the aligned sequences denote gaps introduced by the 
program for optimal alignment.
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Figure 57. Alignment of the identified or proposed 
ribonucleotide reductase small subunit polypeptides of viral 
eukaryotic and prokaryotic origin (RRg ). The first 
consensus line (Cl) displays the amino acids conserved in 
all RRg and the second line (C2) shows the consensus GARNIER 
secondary structure prediction for each aligned position.
(E) represents p-strand conformation and (H) represents 
oc.-helical conformation. The proposed location of the 
tyrosyl radical is indicated (•) and amino acids sequences 
of higher homology are boxed. The amino acid positions of 
the alignment are numbered as in HSV-1 RR2 (McGeoch et al.,
1988), and dots within the aligned sequences denote gaps 
introduced for optimal alignment.
1 0 0
comparisons only block 19 was retained in all the RR 
polypeptides.
DISCUSSION.
In the discussion of this Section the available 
biochemical data are combined with structural features
identified from the RR and RRC alignments.
Li O
10. Structural and Functional Features of the RRr■ — - -    Jj
Polypeptides.
a ) Region 1.
The function of the HSV Region 1 is at present 
unknown. The absence of this region from other viral RRIj
and the amino acid length of the mammalian and E. coli 
polypeptides would probably suggest that it is not required 
for enzyme activity. As reported in the Introduction (see 
Page 29), proteolytic degradation of HSV-1 RRl gives rise to 
products of 110,000, 93,000 and 81,000 mol. wt. (Ingemarson 
and Lankinen, 1987). In vitro enzyme activity assays with 
these products demonstrated that at least the 9 3,000 mol. 
wt. was able to associate with RR2 to form an active 
complex. The 81,000 mol. wt. may be active as well, 
however, at that stage of proteolysis the RR2 subunit had 
dissappeared and therefore a functional complex was not 
formed. So far there is no indication about the exact 
polypeptide positions where proteolysis takes place; perhaps 
it occurs after HSV-1 RRl aa 146 since an oligopeptide 
antiserum directed against amino acids 137 through to 146 
failed to label the proteolysis products in immunoblots (H. 
Lankinen, personal communication). Thus, it can be proposed 
that, at least in vitro, the first part of the N-terminal 
region is not required for enzymatic activity.
On the other hand, the observed conservation of these 
regions in both HSV serotypes and the similarity of their 
predicted secondary structures suggest that there is
1 0 1
evolutionary pressure at the level of protein structure. A 
possible structure that would incorporate the GARNIER 
predictions for these regions and a putative function are 
discussed in the General Discussion.
b) Region 2.
On the basis that conserved regions of enzymes which 
catalyse the same reaction are important for activity it is 
possible that Region 2, which is the least conserved RR,
Lt
region, is not directly involved in enzymatic activity. 
However, this region is present in all RRT polypeptides and1j
is well conserved between the viral RR, (percentage homology
Li
ranging from 24% to 32%) and between the prokaryotic and 
eukaryotic RR, (percentage homology 26%); thus it is
Li
possible that Region 2 has a structural role in the adopted 
tertiary structure of the enzyme.
The DNA regions of the HSV-2 genome contained in the 
Bgl II c and n fragments (HSV-2 map units 0.54 to 0.58 and 
0.58 to 0.62 respectively) appear to be involved in 
morphological transformation of cultured cells (reviewed in 
Macnab, 1987). Jones, C., et al. (1986) reported that the 
minimal region of the right-hand 30% of Bgl II c fragment, 
responsible for transformation of immortalised cell lines, 
comprises the DNA region coding for the last 60 amino acids 
of RRl Region 1 and the first 100 amino acids of Region 2. 
These authors proposed that transformation may be initiated 
by insertion sequences and alternating purine- and 
pyrimidine-rich stretches contained within these DNA coding 
regions; further, the inability of the respective HSV-1 RRl 
DNA coding regions to induce transformation was attributed 
to the absence of similar structures from the latter 
regions. However, such sequence elements are frequently 
present in the HSV-2 DNA and hence their correlation with 
any function remains to be established (reviewed in Macnab, 
1987).
c) Region 3.
This region, which is the most well conserved region, 
appears to be directly involved in enzymatic activity.
1 0 2
Seventeen amino acids upstream from block 4, Eriksson et al. 
(1986) identified, using photoaffinity labelling reactions, 
an E. coli cysteine residue on which the dTTP allosteric 
effector was localised; this cysteine was part of a tryptic 
octapeptide with sequence of KSCSQGGV (see Fig. 56, HSV-1 
RRl aa 642 to 649). Similar photoaffinity experiments with 
the mouse Ml subunit gave several-fold lower dTTP 
incorporation (Eriksson et al., 1986). This result could be 
explained by the fact that, although the equivalent Ml 
sequence aligns well with the Bl sequence, the former does 
not contain a cysteine residue (see Fig. 56; octapeptide 
RYVDQGGN). It was therefore proposed that the cysteine is 
part of the h allosteric site of the E. coli enzyme.
However, photoaffinity labelling experiments with a mutant 
Bl polypeptide where the cysteine was substituted to an 
alanine showed that, although the mutant Bl was not labelled 
in the presence of dTTP, it still had 60% activity in the 
presence of the general effector ATP and 40% in the presence 
of dTTP (Nilsson et al., 1988b); these results indicate that 
the mutation did not confer a substantial conformational 
change of the allosteric site. Clearly, further studies are 
required to assess whether this cysteine binds the effector 
or that it provides an active side-chain in the vicinity of 
the allosteric site.
As already mentioned (see Introduction, Page 50) the 
VV-specified activity appears to be allosterically 
regulated. Interestingly, the VV Vmw86 polypeptide which is 
thought to be the large subunit polypeptide of the 
VV-specified enzyme, aligns extremely well with the Bl 
octapeptide. In contrast, the HSV enzyme which is 
insensitive to allosteric regulation by dNTPs (see 
Introduction, Page 50) does not contain an equivalent region 
(see Fig. 56).
Further downstream from the proposed allosteric site, 
there is a highly conserved sequence of GEEFE (see Fig. 56, 
block 6). Comparison of this sequence with protein 
sequences contained in the NBRF data base with the 
WORDSEARCH program (see Materials and Methods, Page 75) 
revealed that it was present in adenylate kinase (AK). AK 
is an enzyme involved in the dephosphorylation of MgATP to
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MgADP and binds the substrate in a site similar to the 
proposed RR binding site (see below). The tertiary 
structure of AK revealed that GEEFE is part of an £X.-helix 
located close to the ATP-binding site (von Zabern et a l ., 
1976); further, the side-chain of a leusine which is located 
11 residues upstream from GEEFE was proposed to participate 
in the formation of the hydrophobic pocket that binds the 
adenine moiety of ATP (Fry et al., 1985). In common with 
the crystallographic data of AK, the RR GEEFE block isLi
shown to adopt an DC-helical conformation and, moreover, 
upstream from this block there are two conserved leucines 
(see Fig. 56). Although in the RR polypeptides the block
i - i
and the adjacent leucines are positioned 130 amino acids
upstream from the RR binding site (see below), whereas, inLj
AK they are 9 0 amino acids downstream from the binding site, 
it is possible that they participate in the formation of the 
hydrophobic pocket of the RR, binding site.
Lj
Thirty six amino acids downstream from block 6 there 
is a conserved glycine (see Fig. 56, at HSV-1 aa 764).
Platz et al. (1985) reported that substitution of this 
residue with serine in the E. coli Bl polypeptide 
drastically reduced the subunit activity (90 to 95%) for all 
four substrates in vitro. Thus, it was argued that this 
glycine participates in the formation of the proposed 
binding site. Alternatively, the serine may have disrupted 
the three-dimensional structure of the enzyme in such a way, 
that the enzymatic activity is abolished although it is 
notable that the glycine and serine residues are considered 
as conserved ones according to the Venn Diagram of amino 
acid classification (Taylor, W.R., 1986a).
Finally, Region 3 contains all the conserved 
cysteines; two in blocks 2 and 7 and a third one in block 8 
although the latter is not present in the E. coli 
polypeptide. These conserved cysteines are of special 
interest because two of them could contribute redox-active 
sulphydryls to the composite catalytic site of the enzyme.
d ) Region 4.
The first block within this region (block 9), has 
a consensus sequence of GxGxxG, although the last glycine
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is replaced by a glutamine in the E. coli polypeptide 
(see Fig. 56). This consensus is identical with 
nucleotide binding site sequences which are shown to adopt 
a jB*j& secondary structure (p<x^8-fold) . Wierenga et al.
(1985) reported that the most important ('fingerprint') 
amino acids of these sites are (Fig. 58a):
i) three glycines; the first one forms the C-terminus 
of the first |B-strand and the second is the N-terminus of 
the adjacent <?c-helix. The first and third glycines form a 
sharp turn between the |3-strand and the<X,-helix, whereas, 
the second interacts with the nucleotide phosphate moiety.
ii) six hydrophobic residues, which are indicated
by squares in Fig. 58a. Two of these are located upstream 
and four downstream from the GxGxxG pattern and form the 
hydrophobic core of the fold.
iii) a negatively charged residue (either aspartic 
acid or glutamic acid) at the end of the second ^-strand 
which hydrogen bonds with the 2'-hydroxyl group of the 
nucleotide ribose moiety and, finally,
iv) a hydrophilic residue which is indicated by a 
triangle in Fig. 58a. This is positioned 5 amino acids 
upstream of the first glycine and its function is not known.
In most of the binding sites identified so far, the 
glycines and the negatively charged residue at the end of 
the fold are strongly retained, whereas, variation has been 
observed in the hydrophobic residues (Sternberg and Taylor, 
1984; Wierenga et al., 1986). The length of the binding 
folds varies from 29 to 31 residues due to the variable 
length of the loop connecting the ot-helix with the second 
(S-strand.
The alignment of the RR^ polypeptides in this region 
shown in Fig. 58b is different from the one shown in Fig. 56 
as spaces (indicated by *) were introduced to optimise the 
binding fold requirements as reported by Wierenga et al.
(1986). All the spaces were introduced between positions 21
VAL
1 2 4 6 8 11 15 18 27 29 31
A  ■ ■ G G G ■ ■ ■ ■ 9
HSV RR1 N L £ G G G A K * A F D
VZV Vmw87 N £ £ G G G T £ * * Q_ A £
EBV Vmw93 D M £ G G G V £_ * * * _T JP £
Mouse M1 R H_ JP G G G A L * P_ A £
E. coli B1 G R T G G N Y £ * G A N
“ “
HCMV M 4.PR O K L P H G G A R W L E
W  Vmw86 R H P G G G A L ■k L A D
Figure 58.
a) A representation of the secondary structure of the 
spiny dogfish M-lactate dehydrogenase ADP-binding 
fold (reprinted from Wierenga et al., 19 86). The 
'fingerprint' amino acids of the fold are shown in 
the three letter amino acid code and are numbered.
The triangle represents the hydrophilic residue and 
the hatched circle the negatively charged residue.
Boxes represent the hydrophobic residues and semi-filled 
circles the glycines. The negatively charged residue 
(aspartic acid) is depicted to form a hydrogen bond with 
the 2 '-hydroxyl group of the nucleotide ribose moiety.
b) Alignment of RR sequences proposed to be nucleotide
L j
binding folds. The 'fingerprint' amino acids are 
designated and numbered as above. Underlined amino acids 
represent residues not conforming with the 'fingerprint' 
positions of the fold as reported by Wierenga et al.
(1986). Asterisks denote gaps introduced between 
positions 21 to 24 of the fold for optimal alignment.
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through to 24 of the fold which correspond to the variable
loop region. Further, homologous sequences of the HCMV
M4.PRO ORF and the VV Vmw86 polypeptide, which were not
available at the time of the alignment, have been included.
As can be seen, the hydrophilic residues at the start of the
sequences are well conserved, with the exception of Bl and
M4.PRO, while a greater degree of variation is observed in
the positions corresponding to hydrophobic residues; this is
clearly apparent at position 4 where none of the aligned
residues is hydrophobic. The glycines are well conserved in
all the polypeptides, except the last one in the E. coli
polypeptide and the first one in M4.PR0. Finally, the
C-terminal negatively charged residue is present only in the
HSV and VV polypeptides and in the M4.PRO. The secondary
structure predictions identified the first j3-strand and the
adjacent tx-helix but not the second ^-strand (see Fig.
56). It is therefore apparent that the proposed RR binding
J-l
fold differs in structure and in amino acid composition from 
the folds observed so far. However, as reported in the 
Introduction (see Section E), studies with the E. coli, HSV 
and VZV enzymes indicate one substrate binding site for all 
four substrates, and this could possibly influence the 
structure of the binding site (Nikas et al. , 1986).
Wierenga et al. , (1986 ) reported that the |3<x|3 binding
folds always occur near the N-terminus of the nucleotide 
binding domains studied. In the RR^ alignment this sequence 
is located just 3 amino acids downstream from the second EBV 
insertion, and given that insertions are indicative of 
domain junctions, it can be proposed that Region 4 or part 
of it participates in the formation of the RR^ binding 
domain. Another feature of these folds is that, as they are 
located at the N-terminus of the binding domain and are 
formed by local interactions, it is possible that during 
the translation process they form spontaneously and then 
function as a nucleation centre for the folding of the 
domain (Wierenga et al., 1986).
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11. Structural and Functional Features of the RR
u^
Polypeptides.
The RRg comparison highlighted a number of important 
features, namely: the conservation of the tyrosine residue 
on which the radical is thought to be localised, conserved 
potential iron ligands and the primary structure of the RR
u
C-termini.
a ) The tyrosyl radical and the iron ligands.
As described in the Introduction (see Page 43) the 
E. coli tyrosine radical is stabilised by the iron centre 
which is liganded by one aspartic acid, one glutamic acid 
and five histidine residues. Further, individual alignments 
performed in the second part of Section B indicated that the 
E. coli tyrosine at position 122 was conserved in all of the 
herpesviral polypeptides with the exception of the HCMV 
M3.PRO ORF. It therefore became of interest to investigate 
whether the consensus template alignment program would 
predict that this tyrosine residue is conserved in all the 
RRg polypeptides and, further, to identify conserved 
potential iron ligands.
As can be seen in Fig. 57 the tyrosine residue was 
predicted to be conserved in all the aligned RRg 
polypeptides (at HSV-1 RR2 position 132); moreover, it is 
retained at the same position in other RRg sequences which 
were not available at the time of the alignment with the 
exception of the HCMV M3.PRO. The program also identified 
two conserved aspartic acid residues at HSV-1 RR2 positions 
68 and 220 which are conserved at identical positions in the 
non-aligned RRg sequences. Finally, seven conserved 
glutamic acid residues were identified from which those at 
HSV-1 RR2 positions 119, 124 and 221 are conserved in 
non-aligned RRQ. Of particular interest are the conserved
u
histidine and glutamic acid residues which are located 
upstream from the tyrosine residue. These residues are part 
of a predicted <*,-helix and the distance between them is 
approximately one helix turn. Thus it is possible that in 
the tertiary structure of the enzyme they are brought close 
to each other and ligate the iron atoms which subsequently 
stabilise the adjacent tyrosyl radical. Conserved aspartic
107
acid and glutamic acid residues can be found upstream from 
the second hystidine and these could equally be the iron 
ligands.
b) The RRg C-terminal regions.
Another important RRg region is at the C-termini. As 
mentioned in the Introduction (see Page 42) Sjoberg et al.
(1987) encountered a truncated form of the E. coli B2 
protein which lacked thirty C-terminal amino acids and which 
failed to associate with Bl although it had an almost 
identical conformation to the normal B2. Therefore, it is 
likely that the two subunits interact via the C-terminus of 
RRg. The same suggestion can be proposed for the viral 
enzyme although the viral termini exhibit no homology with 
the respective E. coli region; in fact, only eleven E. coli 
C-terminal amino acids align with the viral terminal 
sequences and from these nine are not conserved. The 
suggestion is indirectly supported by studies with the 
oligopeptide antiserum directed against the seven C-terminal 
amino acids of HSV-2 RR2 (Frame et al., 1985). These 
authors demonstated that the antiserum precipitated only the 
free form of RR2 while it failed to precipitate its 
complexed form under non-denaturing conditions, thus 
indicating that the C-terminus of RR2 is masked by RRl.
Further, the sequncing data of Preston, V.G. et al.
(19 88) localised the nucleotide change in HSV-1 mutant 
ts!222 within the HSV-1 RR2 C-terminus. The change was 
shown to be a deletion of a thymine which resulted in the 
alteration of all but one amino acids at the RR2 C-terminus 
and the removal of the termination codon; the latter was 
positioned 42 residues downstream from the wild-type RR2 
C-terminus. In the RRg alignment, the mutation is localised 
within block 21 (see Fig. 57), and alters the second 
phenylalanine residue to a serine.
A summary of the RR^ and RRg structural and functional 
features discussed in this Section is shown in Fig. 59.
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Figure 59. This diagram shows in a schematic form the 
combination of structural and biochemical features of the 
RRl and RRg polypeptides. Amino acid blocks of higher 
homology are indicated by numbers and blocks conserved in 
all the RR^ and RRg polypeptides are underlined.
The RR^ polypeptides are divided in four Regions 
on the basis of the secondary structure predictions shown. 
(<x) represents oc-helix conformation, (j8) represents |3-strand 
conforamtion and unstructured or loop conformation is 
depicted by (NS). The locations of the run of prolines (P), 
the stretches of roughly alternating aspartic acid and 
serine residues (DS) and conserved cysteine residues (C) are 
indicated. A leucine residue which could participate in the 
formation of the RRr nucleotide binding site (GxGxxG) is
Li
depicted by (L). Other RR features include the proposed
1j
allosteric site in E. coli, the major EBV insertion of 30 
amino acids and the location of the amino acid substitution 
in the RR1 polypeptide encoded by the HSV-1 mutant ts!207 
(see Page 111).
The RRC polypeptides are shown as a single Region on 
the basis of the secondary structure predictions. The 
location of the conserved tyrosine residue on which the 
E. coli radical is localised is depicted by (Y) and the 
amino acid substitution in the RR2 polypeptide encoded by 
the HSV-1 mutant tsl222 is indicated.
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SECTION D.
12. Sequence Determination of the Mutation(s) in the RR1 
Xho I/Bgl II DNA Fragment of the HSV-1 mutant ts!207.
Dutia (19 83) reported that the multiple HSV-1 mutant 
tsG failed to induce detectable ribonucleotide reductase 
levels at the NPT. As this isolate had multiple mutations, 
Preston, V.G. et al. (1984) isolated the Bam HI o fragment
from tsG DNA, which spans the region between map units 0.574 
to 0.600, and recombined it into HSV-1 strain 17+ DNA giving 
rise to the HSV-1 ts!207 mutant virus. The mutation(s) was 
located, with marker rescue experiments, within the Xho 
I/Bgl II fragment contained in the coding sequences of RRl 
(Fig. 60). Thus, it was of interest to identify any 
nucleotide changes within this fragment and from the deduced 
amino acid sequence to determine any effect of the 
mutation(s) on the predicted secondary structure of the 
enzyme.
For these reasons, the ts!207 Xho I/Bgl II fragment 
was isolated from a cloned Bam HI o fragment (obtained from 
Dr V.G. Preston) and sequenced with the M13 dideoxy/chain 
termination method. However, given the relatively small 
size of the fragment, it would be inappropriate to follow 
the 'shotgun' cloning approach followed for the nucleotide 
sequence determination of the RRl coding region. Instead, 
the intact Xho I/Bgl II fragment was cloned into a Sma I 
digested Ml3mp8 RF vector. Then, with the use of the New 
England Biolabs primer (see Materials and Methods, Page 58), 
approximately 200 bases were read in either orientation.
From the sequences at the ends of the obtained gel readings 
two new pentadecamers were synthesised, shown in Fig. 62, 
and these were used as primers in sequencing reactions thus 
advancing the data by approximately 200 bases in either 
direction. This procedure was repeated and finally the 
entire sequence was obtained in both orientations.
The sequencing data were collated with computer 
programs and gave rise to the M1207 data base. This data 
base contained 26 gel readings (Fig. 61). There were 4865 
characters, which produced a final contiguous length of
TR,
0.57 0.58 0.59
BamHI o
X h o I  B g l l l
irl irs t r s
TT
0.60
5.Okb mRNA
RR1
1.2kb mRNA 
I . I * 
RR2
Figure 60. This diagram shows the location of the 
Xho 1/ Bgl II fragment (black box) of the HSV-1 mutant 
ts!207 with respect to the Bam HI o fragment between 0.57 
to 0.60 map units. The mRNAs specifying the RRl and RR2 
polypeptides are indicated as arrowed lines and their 
lengths are given above each line. The polypeptide coding 
regions are indicated as open boxes.
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G2.007;1 4
G3.029 ; 1 5
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G6.1P1 15
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G6.2P4 17
G6.3P4 18
G8.38 19
G8.D 20
G9.40 21
G9.41 22
G9.44 23
G9.45 24
G10.62 25
G10.63 26
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C D E
238 0 2
268 1 26
-223 4 9
-238 7 3
-47 0 0
219 0 0
228 18 4
-38 19 11
-188 3 24
212 25 12
-38 8 16
241 10 15
229 15 21
228 26 25
201 12 13
218 11 17
217 16 18
208 17 7
-180 22 8
-19 3 0 0
-209 13 22
-174 21 19
94 24 0
99 9 23
-216 14 10
-221 2 14
715
B
1
1
467
452
1
1
391
328
528
156
328
156
158
2
158
377
380
381
264
1
234
264
622
617
11
2
Figure 61. A sorted list (CONTIG LINES) of the gel readings 
within the M1207 data base. The column termed GEL LINES 
represents the name of the clone given by the author. The 
columns headed A to E are assigned by the DBtJTIL program 
(see Materials and Methods, Page 73) and represent:
A Gel reading database number.
B Position of the left-most base of the gel reading
in the contig.
C Length of the gel reading. (-) indicates that the 
gel reading overlaps on the opposite strand.
D Number of the gel reading overlapping to the left.
E Number of the gel reading overlapping to the right.
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TCCa GCTCATCCCCTT* GGCGa GCAGATACCCATCCAGGAGCTGGCCTATGGCATTGTGCGCAGTCCGGCCACGA CCGGGAGCCCCrTCGTCATGTTCAAAGACGCGCTCAACCCCCACT 
TCGAGCTCATCGGGTT* CGCGa GCACa TACCCATCCAGGAGCTGGCCTATGGCATTCTGCCCACTCCGGCCACGa CCGCCACCCCCTTCCT* ATCTTCAAAG a CGCOGTCA ACCGCCACT
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XGGGTTCGCCGa GCACATACCCATCCACGACCTGGCCTATCCCATTGTGCGCA- TCCGGCCACCa CCGCGACCCCCTTCCTCATCTTCAAACa CC* *CTGAACCGCCACT 
TCGAGGT CATGGGGTTCGGCGAGCa Ga TACCCATCCAGGAGCTGGCCTATGGCATTGTGCGCAGTGCGGCCACGa CCGGGa GCCCCTTCGTCATGTTCA A AGa CGCGGTGA ACCGCCACT
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Figure 62. The M1207 database. All the gel readings in the 
database are shown numbered down the side of the
sequences as in column A of Figure 61. Computer inserted 
characters into the gel readings entering the contig 
database are indicated by (*) while those inserted by the 
author are indicated by (X) or (/). Underlined sequences 
represent synthetic oligonucleotide primers used in 
sequencing reactions; primers built in the left-to-right 
orientation are indicated by solid lines and those built in 
the complementary orientation are indicated by dashed lines.
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715bp (Fig. 62). For each contig character, an average of 
6.8 characters were read from gels.
The obtained nucleotide sequence of the mutant Xho 
I/Bgl II fragment was compared with that of the equivalent 
wild-type fragment with the HOMOL program (Fig. 63). As can 
be seen, the program identified two nucleotide changes both 
from a guanine to an adenine at positions 2439 and 2915 of 
the HINDKK database consensus sequence (see Fig. 26); the 
nucleotide changes can also be observed in the sequence 
autoradiograph comparisons in Fig. 64. Translation of the 
wild-type and mutant fragments with the PTRANS program 
indicated that the first nucleotide change did not alter the 
encoded amino acid whereas the second changed a serine 
residue to an asparagine (see Fig. 63).
DISCUSSION.
13. The Mode of Action of BUdR as a Mutagen.
Both nucleotide changes in the ts!207 fragment 
were transitions from a guanine:cytosine pair to an 
adenine:thymine pair. These changes are compatible with the 
procedure followed in order to isolate the initial mutant 
tsG by Brown et al., (19 73); these authors treated HSV-1 
strain 17 syn infected cells with 5'-bromodeoxyuridine 
(BUdR). The base of BUdR, 5'-bromouraci1 (BU), is similar 
to thymine with the exception that BU has a bromine atom in 
place of the 5'-methyl group of the thymine ring (reviewed 
in Freese, 19 63). This mutagen can be in the keto and enol 
states.
In the keto state, the deoxyribonucleoside 
triphosphate of BU (dBUTP) can base pair to adenine with two 
hydrogen bonds thus incorporating the deoxyribonucleoside 
monophosphate of BU (dBUMP) in DNA. This increases the 
probability of this base pair to mutate because BU undergoes 
pairing mistakes more frequently than thymine; in the next 
DNA duplication event, dGTP may pair with dBUMP thus leading 
to the appearance of a guanine:cytosine pair in the progeny
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Figure 63. Alignment of the nucleotide sequences of the 
Xho I/Bgl II fragment of the HSV-1 wild-type and HSV-1 
ts!207 RRl DNA coding regions. The predicted amino acid 
sequence of the HSV-1 RRl polypeptide is shown above the 
HSV-1 DNA sequence, and the amino acid residue which is 
altered in HSV-1 ts!207 RRl is indicated below the ts!207 
DNA sequence. Conserved bases are indicated by asterisks 
and the nucleotide and amino acid positions are numbered as 
in Fig. 26.
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Figure 64. Autoradiographs of sequencing gels showing the 
nucleotide changes (NC) in HSV-1 jtsl207 (TS) compared to the 
HSV-1 wild-type (WT) sequence. The wild-type and substituted 
nucleotides are indicated by arrows. The panel designated 
NCI shows the first nucleotide change at position 2439 and 
the panel designated NC2 shows the second nucleotide change 
at position 2915 (see Fig. 63).
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DNA in place of the original adenine:thymine pair.
In the enol state, dBUTP can base pair with a guanine 
present in DNA with three hydrogen bonds thus incorporating 
dBUMP in DNA. In the next DNA duplication event, dBUMP can 
base pair with dATP, adenine being the 'normal' 
complementary base of BU, and dAMP is incorporated into the 
new strand. Thus, an adenine:thymine pair appears in some 
of the progeny DNA in place of the original guanine:cytosine 
pa i r.
14. How does the Mutation in HSV-1 ts!207 Inhibit the 
Association of the RRl and RR2 Subunits?
As reported in the Introduction (see Page 49),
Preston, V.G. et al. (19 84) demonstrated that the mutation
in the RRl polypeptide resulted in the inability of ts!207 
to express any detectable activity at the NPT. The 
mechanism by which the mutation inhibits ribonucleotide 
reductase activity was investigated by means of 
immunoprecipitation studies using a monoclonal antibody 
directed against RRl and an anti-oligopeptide serum directed 
against the RR2 (Frame et al., 19 85). It was shown that, at 
the PT and in the presence of 0.5% SDS, the antibody and the 
antiserum precipitated both polypeptides. At the NPT and in 
the presense of equal SDS concentrations, however, the 
antibody precipitated only RRl while the antiserum 
precipitated only RR2.
These results indicated that, although at the NPT 
both RRl and RR2 polypeptides are expressed, the mutation in 
RRl prevents the respective subunits from forming a 
functional complex. On that basis and in the absence of any 
biochemical data it was proposed that the region where the 
ts!207 mutation lies could either be a subunit contact 
region or an important structural RRl region. These 
suggestions resulted from a comparison of the predicted 
secondary structures of the wild-type and mutant RRl 
polypeptides with the CHOUFAS program (see Materials and 
Methods, Page 74). This program predicted that the 
wild-type RRl serine residue is located in an unstructured 
region between an od-helix and a p»—strand (Table IV); this
TABLE IV
SECONDARY STRUCTURE PREDICTIONS FOR THE HSV-1 RRl 
AND HSV-1 tsl207 MUTANT RRl POLYPEPTIDES
AA
Number AA
HSV-1 RRl 
Hy SS
HSV-
AA
1 tsl207 
Hy
RRl
SS
950 R 0.300 H R 0.300 H
951 Q -0.314 H Q -0.314 H
952 S 0.300 H S 0.300 H
953 M 0.486 H M 0.486 H
954 M 0.057 H M 0.057 H
955 K -0.229 H K -0.229 H
956 H 0.157 H H 0.157 H
957 G 0.371 H G 0.371 H
958 L 0.600 H L 0.568 H
959 R 0.200 t R 0.186 t
960 N -0.086 t N -0.100 t
961 S -0.300 N -0.314 t
962 Q -0.114 B Q -0.129 H
963 F -0.800 B F -0.814 H
964 V -1.014 B V -1.029 H
965 A -1.057 B A -1.057 H
966 L -1.143 B L -1.143 H
967 M -0.857 h M -0.857 H
968 P -0.714 h P -0.714 h
969 T -0.600 h T -0.600 h
970 A -0.414 h A -0.414 h
AA = amino acid
Hy = hydropathicity value
SS = secondary structure prediction
H = strong oc-helical conformation
h = tL -helical conformation
B = £ -strand conformation
t = turn
Ill
prediction is in good agreement with the individual GARNIER 
prediction for the HSV-1 RRl polypeptide obtained with the 
consensus template alignment program (data not shown). In 
contrast, the asparagine of the mutant RRl polypeptide, 
which substituted the wild-type serine, was predicted to 
adopt a turn conformation; further, the ^ 3-strand following 
the wild-type serine was altered to an cxl-helix in ts!207 
(tel207 positions 961 to 968; Table IV). These were the 
only changes in the secondary structure of the mutant RRl as 
compared to that of the wild-type RRl (data not shown). 
Hence, if the region where the tsl207 mutation is located is 
a subunit contact region, alteration of its secondary 
structure would inhibit subunit association. Equally, if 
this region is an essential structural RRl region not 
directly involved in subunit association, alteration of its 
secondary structure may alter the structure of a 'true1 
subunit contact region(s) positioned elsewhere along the 
polypeptide backbone; as a result, the two subunits unable 
to associate.
Another reason for proposing that the mutation in 
ts!207 may lie within a contact region or within a region 
important for RRl structure is the primary structure of this 
region. As can be seen in Fig. 65, the wild-type serine is 
located within block 10 of the RRr alignment. This residueLi
is a polar one according to the Venn diagram of amino acid 
classification (see Fig. 18). Polar amino acids are usually 
positioned in a hydrophilic region (exposed region) of the 
protein and are the least conserved amino acids between 
related proteins (Creighton, 1983). As can be seen in Fig. 
65, the serine and the adjacent polar asparagine residue are 
located close to the end of a hydrophilic HSV-1 RRl region 
which, notably, was predicted to be the longest hydrophilic 
region of the polypeptide (see Page 81). However, both 
amino acids are highly conserved in the herpesviral, 
mammalian and E. coli RRL polypeptides and this would 
suggest that these residues may have a specific function in 
RRl. On the basis that substitution of the serine in tsl207 
inhibits subunit association, this function would most 
probably be related to subunit interaction or to the 
structure of RRl although in the latter case it would not be
+ 2 0
•20
RRl Sequence AA Position
i----------- 1 i---------------------------------- 1--i-------- 1
HSV-1 RRl M K H G L R N S Q F V A L M P T A (954-970 )
HSV-2 RRl M K H G L R N S Q F I A L M P T A (961-967 )
VZV vmw87 C A Y G L Y N S Q F L A L M P T V (592-608)
EBV Vmw9 3 V R D G L F N S Q F I A L M P T S (580-596)
Mouse Ml A K Y G I R N S L L I A P M P T A (580-596)
E. coli B1 K T H G L R N S T L S A L M P S A (607-623)
Block 10 Block 11
Figure 65. Alignment of the proposed or identified large
subunit ribonucleotide reductase polypeptides (RR ) in the
Li
region where the HSV-1 tsl207 amino acid change is located. 
The amino acid position of each polypeptide region is 
given in parentheses. RR sequences contained withinlj
blocks 10 and 11 of Fig. 56 are shown. The diagram above 
the alignment shows the hydropathicity plot corresponding 
to the aligned HSV-1 RRl region. Hydrophobic regions lie 
between 0 and 20 and hydrophilic regions between 0 and -20. 
Program settings were: group length = 9, shift = 1, spacing 
of plotted points = 10.
1 1 2
directly involved in contact with RR2. In either case, the 
tsl207 mutation would result in the two subunits being 
unable to associate.
Experiments designed to distinguish between these 
possibilities suggest that the region where the mutation 
lies is not involved in subunit association (A.J. Darling, 
personal communication). First, high concentrations of a 
synthetic oligopeptide representing the amino acid sequences 
flanking the wild-type serine residue (oligopeptide 
RNSQFVALMPTA, spanning HSV-1 RRl positions 959 to 969; see 
Fig. 63), failed to inhibit wild-type enzymatic activity. 
Second, this oligopeptide failed to inhibit the in vitro 
reconstituted activity from the non-defective ribonucleotide 
reductase large and small subunits encoded by the HSV-1 
ts!222 and ts!207 mutants respectively, as did an antibody 
raised against this oligopeptide. Third, a second synthetic 
oligopeptide with the serine residue positioned 
approximately in the middle (oligopeptide MKHGLRNSQFVALMPT 
at HSV-1 RRl positions 954 to 968; see Fig. 63) failed to 
inhibit the ts!207/tsl222 in vitro reconstituted activity. 
Therefore, it appears more likely that the region where the 
tsl207 mutation is located is an important structural RRl 
region.
Finally, another possibility, which was not previously 
considered, was that the region where the mutation lies is a 
contact region between the RRl polypeptides forming the RRl 
subunit as opposed to an RR1/RR2 contact region. If the 
former was the case, the ts!207 mutation may prevent the 
formation a functional RRl subunit in ts!20 7-infected cells 
and this may be the reason for the two subunits being unable 
to associate. However, this possibility was also excluded 
since the size of the HSV-1 ts!207-encoded RRl subunit was 
found to be identical to the size of the wild-type RRl 
subunit by means of gel filtration (A.J. Darling, personal 
communication).
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Figure 66. The HSV-2 strain HG52 ribonucleotide reductase 
locus. This diagram shows the genomic location of the Bam 
HI e and t fragments and the arrangement of mRNAs between 
0.55 and 0.60 map units on the viral genome. The 
transcripts specified by this locus are shown as arrowed 
lines. The lengths of the late transcripts are indicated 
above each line and the mRNAs specifying the ribonucleotide 
reductase are labelled RRl and RR2.
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SECTION E.
Having identified a number of structural and 
functional features arising from the enzyme's primary 
structure, experiments were designed to express the 
HSV-encoded ribonucleotide reductase in eukaryotic cell 
lines. These experiments are reported in this Section and, 
in addition, studies on the transcriptional regulation of 
the ribonucleotide reductase genes in the presence of HSV 
trans-activating functions are described.
15. The HSV-2 Ribonucleotide Reductase Locus.
The HSV-2 strain HG52 ribonucleotide reductase locus 
(Fig. 66) specifies two L and two E transcripts which are 
similarly sized and arranged as in the equivalent HSV-1 
locus (McLauchlan and Clements, 1983b; McLauchlan, 1986; 
Swain and Galloway, 1986). The L mRNAs are 5' co-terminal, 
have sizes of 6.4kb and 1.7kb and are presumed to encode the 
same 54,000 mol. wt. polypeptide. The E mRNAs share a 
common 3' terminus with the L 6.4kb mRNA and have sizes of 
4.5kb (RRl mRNA) and 1.2kb (RR2 mRNA; Fig. 66). These mRNAs 
encode the RRl and RR2 polypeptides which constitute the 
HSV-2-encoded ribonucleotide reductase (McLauchlan, 19 86).
DNA sequencing and RNA mapping studies within this 
locus positioned the 3' end of the 1.7kb mRNA 404nuc 
downstream from the Sst I site at 0.558 map units and the 5' 
end of the RRl mRNA 582nuc downstream from the same site 
(McLauchlan, 1986; Fig. 67). The start site of the RR2 mRNA 
was positioned 139nuc upstream from the Bam HI site which 
separates the Bam HI e and t fragments (Fig. 67). Finally, 
the 3' co-terminus of the ribonucleotide reductase mRNAs and 
the 6.4kb mRNA was located approximately lOOOnuc downstream 
from this Bam HI site (McLauchlan and Clements, 1983b). In 
common with the HSV-1 equivalent locus, although the HSV-2 
ribonucleotide reductase mRNAs overlap, the coding regions 
of the RRl and RR2 polypeptides do not (McLauchlan, 1986).
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Figure 67. The nucleotide sequences flanking the HSV-2 RRl 
and RR2 mRNA start sites. The positions of the 5' ends of 
these mRNAs and the 3' end of the late 1.7kb mRNA are shown. 
Underlined sequences denote the length of the protected RRl 
and RR2 mRNAs after hybridisation to the specific 
pGEM-2-produced RNA probes and digestion of hybrids with 
ribonuclease T2 (see Pages 116 and 117). Restriction 
endonuclease cleavage sites are indicated by a double line. 
The sequences are numbered with respect to the Sst I site 
(+1) at HSV-2 0.558 map units.
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16. Construction of Plasmids Used in Transient Expression 
Assays.
In order to express the RRl and RR2 mRNAs in 
eukaryotic cell lines, plasmid pRR was constructed which 
contains the DNA sequences specifying these mRNAs as they 
are arranged on the HSV-2 genome (Fig. 68). An Sst I/Bam HI 
fragment from a cloned Bam HI e fragment (obtained from 
Dr J. McLauchlan) was subcloned into an Sst I/Bam HI 
digested p(JC12 vector to give plasmid pYNE. Then, a Bam 
Hl/Xho I fragment from a cloned HSV-2 Bam HI t fragment 
(obtained from Dr J. McLauchlan) was subcloned into a Bam 
Hi/Sal I digested pUC12 vector resulting in plasmid pYNT. 
Lastly, the Bam HI/Hind III fragment from pYNT was ligated 
into Bam HI/Hind III digested pYNE to give pRR. Therefore, 
pRR contains the entire DNA region specifying the RRl and 
RR2 mRNAs and, in addition, the region specifying the 3' end 
of the L 1.7kb mRNA.
RNA probes specific for the detection of the RRl and
RR2 mRNAs were constructed with the use of pGEM-2 Riboprobe
Gemini transcription vectors (see Materials and Methods,
Page 58). For RRl mRNA, a 636nuc Sal I fragment spanning
the DNA sequences specifying the 5' end of the RRl mRNA (see
Fig. 67), was ligated into Sal I digested pGEM-2. For RR2
mRNA, a 547nuc HSV-2 Bgl II/Bam HI fragment spanning the DNA
sequences specifying the 5 1 end of the RR2 mRNA (see Fig.
67) was ligated to Bam HI linearised pGEM-2 vector.
Recombinants were analysed by restriction endonuclease
digestion for appropriate insert orientation relative to the
SP6 promoter, such that transcripts synthesised from the SP6
promoter would be complementary to RRl and RR2 mRNAs. This
screening procedure resulted in the selection of plasmids
pR45 and pR12 (Fig. 69). Subsequently, both plasmids were
digested to completion with Hind III and SP6 transcripts
3 ?labelled with [ oc - P]UTP were prepared as described in 
Materials and Methods (see Page 71).
17. Transient Expression Assays with Plasmid pRR.
Expression of RRl and RR2 mRNAs in eukaryotic cells 
was investigated by short-term transfection assays.
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Figure 68. Construction of plasmid pRR. At the top left 
of the diagram, the HSV-2 Bam HI e and t DNA fragments are 
depicted in a linear form showing the region (dark area) 
specifying the RRl and RR2 mRNAs and the 3' end of the 1.7kb 
mRNA. The mRNAs are shown as arrowed lines and the part of 
the 1.7kb mRNA specified outwith this area is indicated by a 
dashed line. To construct pRR, the Sst I/Bam HI subfragment 
of Bam HI e was ligated to a Sst 1/ Bam HI digested pUC12 
vector to give pYNE. The Bam Hl/Xho I subragment of Bam HI 
t was ligated to a Bam Hi/Sal I digested p(JC12 vector to 
give pYNT. Finally, the pYNT Bam HI/Hind III fragment was 
ligated to a Bam HI/Hind III linearised pYNE to give pRR.
The ampicillin resistance (ampr ) and j3-galactosidase genes 
(lacZ) of pUC12 are indicated.
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Figure 69. The structure of the pR45 and pR12 plasmids 
used for the production of RNA probes specific for the RRl 
and RR2 mRNAs respectively. pR45 plasmid was constructed 
by inserting a Sal I fragment, spanning positions 58 to 695 
relative to the Sst I site at HSV-2 0.558 map units (see 
Fig. 67), into a Sal I digested pGEM-2 vector. pRl2 plasmid 
was constructed by inserting a Bam HI/Bgl II fragment, 
spanning positions 3771 to 4318 relative to the above 
mentioned Sst I site (see Fig. 67), into a Bam HI digested 
pGEM-2 vector. The lost Bgl II site is shown in brackets. 
Recombinant plasmids were screened for appropriate insert 
orientation with the use of the restriction endonuclease 
site indicated within each insert. The SP6 and T7 promoters 
are shown as hatched boxes and the transcriptional direction 
of SP6 is depicted by an arrow. The location of the Hind 
III site used to linearise the pR45 and pRl2 plasmids is 
depicted by (•).
115
Sub-confluent monolayers of HeLa cells in 90mm petri dishes
were transfected each with 20ug of pRR using the
calcium-phosphate transfection procedure (see Materials and
Methods, Page 69). However, the RRl and RR2 genes have been
considered as essentially E genes and as such they should
require the presence of HSV trans-activating functions for
maximal expression (see Introduction, Page 21). Therefore,
some dishes of pRR-transfected HeLa cells were infected with
HSV-1 strain 17+ at a multiplicity of 10 p.f.u./cell. This
virus was selected, in preference to HSV-2 strain HG52, to
allow descrimination between virus-encoded (HSV-1) and
plasmid-encoded (HSV-2) ribonucleotide reductase mRNAs.
Further, this virus was selected because, although pRR
specifies the HSV-2 ribonucleotide reductase mRNAs under the
control of their own promoters, HSV-1 IE functions can
trans-activate HSV-2 E promoters (O' Hare and Hayward,
1985b). The controls consisted of HeLa cells infected with:
HSV-2 strain HG52 at a multiplicity of 10 p.f.u./cell, HSV-1
strain 17+ at a multiplicity of 10 p.f.u./cell or
mock-infected. Cells from all five treatments were
harvested at 16h p.i. and cytoplasmic RNA was isolated as
described in Materials and Methods (see Page 70). Then, 4ug
of cytoplasmic RNA from the pRR transfected dishes and 0.5ug
from the control dishes were hybridised to approximately
200ng of RNA probes specific for RRl and RR2 mRNA. RNA
hybrids were digested with ribonuclease T2 and the products
were analysed on 8% denaturing polyacrylamide gels. Size
standards were Hpa II digested pAT153 DNA fragments which
32were end-labelled with [oc- P]dCTP. After suitable exposure 
of the gel, the relative levels of hybridisation were 
measured by densitometry of autoradiographs as described in 
Materials and Methods (see Page 62).
a ) pRR-borne constitutive and induced levels of RRl mRNA.
Fig. 70 shows the results obtained after hybridisation 
of cytoplasmic RNA with the RNA probe produced from plasmid 
pR45. The RNA samples analysed were isolated from HeLa 
cells: transfected with pRR (track 1), transfected with pRR 
and infected with HSV-1 (track 2), infected with HSV-2 
(track 3), mock-infected (track 4) and infected with HSV-1
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(track 5). Comparison of the protected RNA bands appearing 
on tracks 1 and 2 with the negative and positive control 
tracks (tracks 3, 4 and 5), indicates that the bands arising 
from hybridisation of the probe to RRl mRNA migrate at 
approximately 115nuc (indicated by solid arrowheads in Fig. 
70). This is in good agreement with the size of the 
protected RNA (113nuc) as deduced from DNA sequence and RNA 
mapping data (McLauchlan, 1986; see Fig 67). The size 
difference observed probably reflects the higher mol. wt. of 
RNA as compared to the DNA size standards.
Ribonuclease T2 analysis generated a number of 
additional bands on tracks 2 and 3 of Fig. 70. As shown in 
Fig. 67, the HSV-2 DNA fragment which was subcloned in 
pGEM-2 in order to obtain the probe specific for RRl mRNA, 
spans the 5' end of the RRl mRNA and in addition the 3' end 
of the L 1.7kb mRNA. Comparison of the HSV-2 nucleotide 
sequence of the probe with the corresponding HSV-1 region 
revealed the existence of a 209nuc highly conserved region 
within the 3 1 end of the 1.7kb mRNA (HSV-2 probe positions 
58 to 267 in Fig. 71). Therefore, in HSV-1 infected samples 
the HSV-2 probe is likely to hybridise to the
HSV-l-specified 1.7kb mRNA and this would generate the bands
at around 217nuc on track 2 (indicated by 4 in Fig. 70). 
These bands are also present in the HSV-l-infected control
sample (track 5 in Fig. 70).
Three other obvious bands can be observed on track 2 
(indicated by open arrowheads) from which the longest one 
migrates above the RRl mRNA main bands and the others have 
sizes of approximately 95nuc and 80nuc. As already 
mentioned (see Results and Discussion, Page 78), the HSV-1 
ribonucleotide reductase locus specifies a L 7.0kbmRNA 
which overlaps entirely with the RRl and RR2 mRNAs. 
Therefore, these bands of track 2 probably result from 
hybridisation of the probe to portions of the 7.0kb mRNA 
spanning the intergenic region between the 1.7kb and RRl 
mRNAs of the infecting HSV-1 virus (see Fig. 71). As 
expected, these bands also appear on the HSV-l-infected 
control track (track 5 in Fig. 70), although, their 
intensity is low due to the small amount of RNA analysed on 
this track (0.5ug) as compared to that analysed on track 2
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Figure 70. Ribonuclease T2 analysis of pRR-borne 
constitutive and HSV-l-induced RRl mRNA levels with the 
pR45-produced RNA probe. Cytoplasmic RNA samples were from 
HeLa cells transfected with plasmid pRRl which were either 
mock-infected (track 1) or HSV-l-infected (track 2). The 
negative and positive control cytoplasmic RNA samples were: 
HSV-2-infected HeLa RNA (track 3), mock-infected HeLa RNA 
(track 4) and HSV-l-infected HeLa RNA (track 5). Following 
hybridisation at 50°C, samples were digested with 
ribonuclease T2 and the T2-resistant products were analysed 
on 8% denaturing polyacrylamide gels. The position of the 
RRl mRNA main hybrids is indicated by arrowheads; other 
obvious bands are indicated by symbols and have been 
accounted for in the text (see Pages 117 and 118). The 
DNA size standards (M) were pAT153 DNA digested with Hpa II.
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Igigure 71. Nucleotide sequence comparison of the HSV-2 DNA 
region which was subcloned into pGEM-2, in order to produce 
the RNA probe specific for the HSV-2 RRl mRNA, with the 
corresponding HSV-1 DNA region. The 3' end of the HSV-2 
.Ukb mRNA and the 5 ’ end of the RRl mRNA are indicated.
The nucleotide sequences sharing extremely high homology 
are boxed and the HSV-2 sequence is numbered as m  Fig. 67.
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(4ug). Track 2 also contains a minor band (indicated by o) 
with an approximate size of 400nuc. This band is likely to 
represent pRR-specified transcripts which are not proccessed 
at the 3' co-terminal polyadenylation signal for the RRl and 
RR2 mRNAs; possibly, these transcripts run throught this 
signal and terminate at the polyadenylation signal of the 
1.7kb mRNA which is present in pRR. This is based on the 
fact that the size of the band approximates the size of the 
probe region that corresponds to the HSV-1 DNA region 
specifying the 3' end of the 1.7kb mRNA. A similar 400nuc 
band appears in the HSV-2-infected control sample (track 3 
in Fig. 70) and this probably results from the probe 
hybridising to the 3' end of the L 1.7kb mRNA specified in 
HSV-2-infected cells. Further, this band appears as a major 
species because cytoplasmic RNA was isolated at L times p.i. 
(16h; see Materials and Methods, Page 69). Finally, the 
band appearing in the HSV-2 control sample (indicated by p; 
track 3) most probably represents the full-length 
pR45-produced probe hybridising to the L 6.4kb mRNA which, 
as shown in Fig. 66, overlaps entirely with the RRl and RR2 
mRNAs.
As can be seen in Fig. 70 the pRR-specified 
constitutive levels of RRl mRNA are readily detectable while 
after induction by HSV-1 infection a moderate increase is 
observed; this increase is approximately 5-fold (S. Simpson, 
personal communication).
b ) pRR-borne constitutive and induced RR2 mRNA levels.
For the detection of the RR2 mRNA, equal amounts of 
cytoplasmic mRNA to those used for the detection of the RRl 
mRNA were hybridised to the RNA probe produced from plasmid 
pR12. The results obtained after hybridisation are shown in 
Fig. 72 where the order of RNA samples analysed is similar 
to that of Fig. 70. The expected ribonuclease T2-resistant 
hybrid should be 144nuc (see Fig. 67); however, due to the 
higher mol. wt. of RNA, the bands resulting from 
hybridisation of the pR12-produced probe to RR2 mRNA migrate 
between the 147nuc and 160nuc bands of the DNA size 
standards (Fig. 72).
As mentioned on Page 113, the HSV-2 ribonucleotide
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reductase locus specifies a family of three 3' co-terminal 
mRNAs, comprising the RRl, RR2 and 6.4kb mRNAs. As a result 
of the overlapping nature of the transcripts specified by 
this locus, a probe specific for RR2 mRNA will also 
hybridise to RRl and 6.4kb mRNAs. This can clearly be seen 
in tracks 1, 2 and 3 of Fig. 72 where bands of size greater 
than 622nuc were detected (indicated by p). In track 1, the 
band represents the probe hybridising to pRR-borne RRl mRNA. 
In track 2 the probe hybridises to pRR-borne RRl mRNA and, 
in addition, to mRNA specified by the infecting virus; this 
is proposed on the basis of the high homology between the 
HSV-1 and HSV-2 regions upstream from the RR2 mRNA cap site 
(Fig. 73). Finally, in the HSV-2-infected control sample 
(track 3 in Fig. 72) the probe hybridises, as expected to 
the HSV-2 specified RRl and 6.4kb mRNAs. Other bands of 
different sizes appearing on track 2 probably arise from the 
probe hybridising to HSV-1 infecting virus mRNA; these bands 
appear also in track 5 although, as already noted, their 
intensity is low due to the small amount of RNA analysed on 
this track (0.5ug) as compared to that analysed on track 2 
(4 u g ).
As can be seen in Fig. 72, the pRR-borne constitutive 
RR2 mRNA levels were barely detectable (track 1) whereas, 
after induction by HSV-1, elevated RR2 mRNA levels were 
observed (track 2).
18. Trans-activation of Ribonucleotide Reductase Gene 
Transcription by HSV-1 IE Polypeptides.
The rationale behind these experiments was to study 
effects of the HSV-1 IE polypeptides Vmwl75 and VmwllO on 
mRNA basal levels specified from pRR. For this purpose 
pRR-transfected HeLa cells were co-transfected with 
plasmids: i) pl75, which contains the coding sequences of 
Vmwl75 under the control of the SV4 0 E promoter and enhancer 
(Perry et al., 1986) and ii) pill, which encodes VmwllO 
(Perry et a l ., 1986).
Sets of four sub-confluent 9 0mm dishes of HeLa cells 
were transfected each with lOug of pRR. From each set, in 
addition, the second was transfected with lOug of pill, the
m
mm
2x160
Figure 72. Ribonuclease T2 analysis of pRR-borne 
constitutive and HSV-l-induced RR2 mRNA levels with the 
pR12-produced RNA probe. Cytoplasmic RNA samples were from 
HeLa cells transfected with plasmid pRRl which were either 
mock-infected (track 1) or HSV-l-infected (track 2). The 
negative and positive control cytoplasmic RNA samples were: 
HSV-2-infected HeLa RNA (track 3), mock-infected HeLa RNA 
(track 4) and HSV-l-infected HeLa RNA (track 5). Following 
hybridisation at 50°C, samples were digested with 
ribonuclease T2 and the T2-resistant products were analysed 
on 8% denaturing polyacrylamide gels. The position of the 
RR2 mRNA main hybrids is indicated by arrowheads and the 
full-length protected pRl2-produced probe is indicated by 
(p). The DNA size standards (M) were pAT153 DNA digested 
with Hpa II.
First sequence: HSV-1
Second sequence: HSV-2
1 CTCGGACGTCAGCGAGGGCTTTGCCCCCCTGTTCACCAACCTGTTCAGCAAGGTGACCCGGGACG
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * *
3770 CTCGGACGTCAGCGAGGGCTTTGCCCCCCTGTTCACCAACCTGTTCAGCAAGGTGACCAGGGACG
65 GCGAGACGCTGCGCCCCAACACGCTCCTGCTAAAGGAACTGGAACGCACGTTTAGCGGGAAGCGCCTCCTGGAG 
3835 GCGAGACGCTGCGCCCCAACACGCTCTTGCTGAAGGAACTCGAGCGCACGTTCGGCGGGAAGCGGCTCCTGGAC
139 G T G A T G G A C A G T C T C G A C G C C A A G C A G T G G T C C G T G G C G C A G G C G C T C C C G T G C C T G G A G C C C A C C C A C C C C C T  
* * * * * * * *  * * * * * *  * * * * * * * * * * * * * *  * * * * *  * * * * *  * *  * *  * * * * * * * *  * * *  * * * * * * * * * *
39 09 G C G A T G G A C G G G C T C G A G G C C A A G C A G T G G T C T G T G G C C C A G G C C C T G C C T T G C C T G G A C C C C G C C C A C C C C C T
213 C C G G C G A T T C A A G A C C G C G T T T G A C T A C G A C C A G A A G T T G C T G A T C G A C C T G T G T G C G G A C C G C G C C C C C T A C G  
* * * * * *  * * * * * * * *  * *  * *  * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * *  * * * * * * * * * * * * * *  *
39 83 C C G G C G G T T C A A G A C G G C C T T C G A C T A C G A C C A G G A A C T G C T G A T C G A C C T G T G T G C A G A C C G C G C C C C C T A T G
287 T C G A C C A T A G C C A A T C C A T G A C C C T G T A T G T C A C G G A G A A G G C G G A C G G G A C C C T C C C A G C C T C C A C C C T G G T C  
* * *  * *  * * * * * * * * * * * * * *  * * * * * * * * * * *  * * * * * * * * * * * * * * * * *  * * * * *  * * * * * * * * * * * * * * *
4056 t t g a t c a c a g c c a a t c c a t g a c t c t g t a t g t c a c a g a g a a g g c g g a c g g g a c g c t c c c c g c c t c c a c c c t g g t c
361 c g c c t t c t g g t c c a c g c a t a t a a g c g c g g a c t a a a a a c a g g g a t g t a c t a c t g c a a g g t t c g c a a g g c g a c c a a  
* * * * * * * *  * * * * * * * * * * * * * * * * * * * *  * *  * *  * *  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
4141 C G C C T T C T C G T C C A C G C A T A T A A G C G C G G C C T G A A G A C G G G G A T G T A C T A C T G C A A G G T T C G C A A G G C G A C C A A
♦ ■ ' -> 5' end RR2 mRNA
435 CAGCGGGGTCTTTGGCGGCGACGACAACATTGTCTGCATGAGCTGCGCGCTGTGACCGACAAACCCCCTCCGCG 
* * * * * * * * *  * *  * * * * * * * * * * * * * * * *  * * * * * * *  * * * * * * * * * * * * *  * * * * *  * * * * * *
4205 CAGCGGGGTGTTCGCCGGCGACGACAACATCGTCTGCACAAGCTGCGCGCTGTAAGCAACA GCGCTCCGAT
509 C C A G G C d C G C C G C C A C T G T C G  T C G C C G T C C C A C G
* * *  * * * *  * * *  * * *  * * * * *  * *
4275 C G G G G T C A G G C G T C G C T C T C G G T C C C T C A T A T C G C C A T G G A T C C
Figure 73. Nucleotide sequence comparison of the HSV-2 DNA 
region which was subcloned into pGEM-2, in order to produce 
the RNA probe specific for the HSV-2 RR2 mRNA, with the 
corresponding HSV-1 DNA region. The 5* end of the RR2 
mRNA is indicated and the HSV-2 sequence is numbered as in 
Fig. 67.
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third with lOug of pl75 and the fourth with lOug each of 
pill and pl75. The total amount of transfected plasmid DNA 
in all four dishes was 30ug, and this was made up by the
addition of an appropriate amount of pUC8 plasmid DNA. As a
positive control, subconfluent monolayers of HeLa cells were
infected with HSV-2 strain HG52 at a multiplicity of 10
p.f.u./cell. After a 24h incubation, the medium was 
replaced with fresh medium, and the dishes were incubated 
for a further 16h at 37°C (see Materials and Methods, Page 
69). At the end of the second incubation, cells were 
harvested and cytoplasmic RNA was prepared. Then, 4ug of 
RNA from co-transfected cells and 0.5ug of RNA from 
HSV-2-infected cells were hybridised to probes produced from 
plasmids pR45 and pR12; the hybrids were treated with 
ribonuclease T2 and analysed on 8% denaturing polyacrylamide 
gels.
The autoradiographs of Figs. 74 and 75 show the 
results obtained after hybridisation of cytoplasmic RNA to 
the pR45- and pR12-produced probes respectively. The RNA 
samples analysed on these gels were isolated from HeLa cells 
co-transfected with: pRR and p(JC8 (track 1), pRR, pill and 
pUC8 (track 2), pRR, pl75 and p(JC8 (track 3), pRR, pill and 
pl75 (track 4). The RNA sample analysed on track 5 was from 
HeLa cells infected with HSV-2. As can be seen, the bands 
due to the probes hybridising to the RRl (Fig. 74) and RR2 
(Fig. 75) mRNAs migrate at positions corresponding to those 
observed in Figs. 70 and 72 respectively. These bands were 
quantitated as described in Materials and Methods (see Page 
62), although, cells were not transfected with a control 
plasmid, to allow standardisation of the transfection 
procedure; this was due to the limited amount of DNA that 
can be taken up by transfected cells (30ug per 9 0mm Petri 
dish; R.D. Everett, personal communication). The results of 
this analysis, shown on Table V, demonstrated that VmwllO 
had no detectable effect on RRl mRNA basal levels, whereas, 
Vmwl75 or a combination of VmwllO and Vmwl75 resulted in a 
2- to 3-fold increase. In contrast, Vmwl75
substantially increased the RR2 mRNA levels by 
12-fold ln the presence of both of these IE
polypeptides, the highest increase was observed resulting in
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Figure 74, Transcriptional activation of pRR-borne RRl 
mRNA levels by plasmid-borne HSV-1 IE Vtnwl75 and VmwllO 
polypeptides. Cytoplasmic RNA samples were from HeLa 
cells co-transfected with plasmids:
pRR and pUC8 (track 1)
pRR, pill and pUC8 (track 2)
pRR, pl75 and pUC8 (track 3)
pRR, pill and pl75 (track 4)
As a positive control, HeLa cells were infected with HSV-2 
virus (track 5). Samples were hybridised to pR45-produced
probe at 50°C, digested with ribonuclease T2 and the
T2-resistant products were analysed on 8% denaturing 
polyacrylamide gels. The position of the RRl mRNA hybrids 
is indicated by an arrow. The DNA size standards (M) were 
pAT153 DNA digested with Hpa II.
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Figure 75. Transcriptional activation of pRR-borne RR2 
mRNA levels by plasmid-borne HSV-1 IE Vmwl75 and VmwllO 
polypeptides. Cytoplasmic RNA samples were from HeLa 
cells co-transfected with plasmids:
pRR and pUC8 (track 1)
pRR, pill and p(JC8 (track 2)
pRR, pl75 and pLJC8 (track 3)
pRR, pill and pl75 (track 4) k
As a positive control, HeLa cells were infected with HSV-2 
virus (track 5). Samples were hybridised to pRl2-produced 
probe at 50°C, digested with ribonuclease T2 and the 
T2-resistant products were analysed on 8% denaturing 
polyacrylamide gels. The position of the RR2 mRNA main 
hybrids is indicated by an arrow. The DNA size standards 
(M) were pAT153 DNA digested with Hpa II.
TABLE V
RELATIVE INCREASES OF THE RRl AND RR2 mRNA CONSTITUTIVE 
LEVELS AFTER TRANS-ACTIVATION WITH THE HSV-1 
IE POLYPEPTIDES VmwllO AND Vtowl75
vmwlio Vmwl7 5 vmwlio/ 
vmwl75
RRl mRNA 1 2 2-3
RR2 mRNA 1 12 17
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17-fold elevated RR2 mRNA levels.
DISCUSSION.
In this Section, in vitro expression of the RRl and 
RR2 genes was studied using transient expression assays. 
Further, studies were performed on regulation of expression 
of these genes using HSV-1 infection or trans-activation 
with plasmid-borne IE polypeptides. In the Discussion, the 
results obtained from these experiments will be combined 
with other available data on the regulation of 
ribonucleotide reductase gene expression.
19. Regulation of HSV-2 RRl Gene Transcription.
The main observations on HSV-2 RRl gene expression 
were: i) RRl mRNA basal levels are readily detectable in the 
absence of HSV-1 trans-activating functions, ii) HSV-1 
infection or trans-activation with the HSV-1 IE polypeptide 
Vmwl75 results in a 5- and 3-fold increase of RRl mRNA basal 
levels respectively and iii) the HSV-1 IE polypeptide VmwllO 
has no detectable effect on RRl mRNA basal levels.
a ) Constitutive transcription from the HSV-2 RRl gene
promoter.
A striking observation on RRl gene expression was that 
RRl mRNA basal levels were readily detectable in the absence 
of viral trans-activating functions. The RRl gene has been 
classified as an E gene because studies on the kinetics of 
appearance of the RRl mRNA in the cytoplasm of HSV-infected 
cells demonstrated its detection by 2h p.i. and levels 
continued to accumulate by 6h to 8h p.i. after which there 
was no increase in abundance (McLauchlan and Clements, 19 82; 
McLauchlan, 1986). As an E gene, activation of RRl 
expression should require the presence of functional IE 
polypeptides (see Introduction, Page 22). However, further 
to the data presented in this Section, a number of reports
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have identified either the RRl mRNA or the RRl polypeptide 
present under IE conditions: in fact, certain of these 
reports have classified the RRl gene as an IE gene. First, 
Clements et al . (1977) detected, by blot hybridisation to 
viral DNA fragments, low levels of the RRl mRNA under IE 
conditions; following reversal of the cycloheximide block, 
RRl mRNA was rapidly and abundantly synthesised and its 
synthesis preceded that of other E mRNAs such as the DNA 
polymerase or the TK. Second, Watson et a l . (1980) detected 
the RRl polypeptide after in vitro translation of pooled IE 
mRNA. Third, the RRl polypeptide is expressed by HSV 
ts-Vmwl75 or ts-VmwllO mutants grown at the NPT (Marsden et 
al., 1976; Preston, 1979; DeLuca et al ., 1985; Stow and 
Stow, 1986; Sacks and Schaffer, 1987). Fourth, infection 
with HSV-1 or HSV-2 result in the expression of the RRl 
polypeptide at very early times (Pereira et al ., 1977;
Easton et al., 1980; Frame et a l ., 1986b; A. Cross, personal 
communication). Finally, by nuclease SI analysis, RRl mRNA 
was detected after infection with HSV-1 mutant tsK at the 
NPT or HSV-1 wild-type virus infection under IE conditions, 
although, its levels were lower than those of other IE mRNAs 
(J. McLauchlan, personal communication).
Since E gene promoter activity is generally low in the 
absence of HSV trans-activating functions (reviewed in 
Everett, 1987b) the readily detectable pRR-specified RRl 
mRNA levels would suggest that the RRl gene promoter (Pi) is 
activated by cellular transcription factors. For this 
reason, the upstream HSV-2 PI DNA sequences were analysed 
for the presence of sequence elements known to bind cellular 
transcription factors.
i ) Potential binding sites of the Spl cellular 
transcription factor within the Pi sequences. Initially, Pi 
sequences were examined for potential binding sites of the 
Spl transcription factor known to enhance transcription from 
RNA polymerase II promoters (see Introduction, Page 19; 
reviewed in Kadonaga et al., 19 86). This analysis revealed 
the presence of a C-rich sequence located between -50 to 
-4Onuc relative to the RRl mRNA start site ( + 1) whose 
complement exhibits reasonable homology to the Spl consensus
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(Fig. 76). Further upstream from the putative Spl binding 
site, there is a G-rich tract on the complementary strand at 
position -110 relative to the RRl mRNA start site. G-rich 
motifs like the latter were observed in the E gD promoter 
and share similarities with the Spl binding site in the 
human immunodeficiency virus long terminal repeat (see 
Introduction, Page 22). Further, the complement of this 
motif has been found located at a similar distance from the 
cap sites of several HSV mRNAs and, although not all E 
promoters contain these sequences, they appear to be absent 
from most L promoters (reviewed in Wagner, 1985). The 
highly conserved nature of this motif would indicate that it 
may represent a functional component of PI. Interestingly, 
both of these elements are well conserved in the promoter of 
the HSV-1 RRl mRNA although their distances from the HSV-1 
mRNA start site differ from those observed in HSV-2.
ii) A potential binding site of the cellular 'octamer 
motif binding factor1 in the PI sequences. Further analysis 
of the PI sequences revealed the existence of a 
5'-ATGCAAAT-3' sequence (octamer) at position -136. This 
sequence element is well conserved in the SV40 enhancer, in 
the enhancer and the promoter of both heavy- and K 
light-chain immunoglobulin genes (Falkner and Zachau, 1984), 
in different H2B histone promoters (Harvey et a l ., 1982) and 
in the enhancers or promoters of several other genes 
(Falkner et al., 1986). Studies with different octamer 
motifs demonstrated that each gave rise to complexes with 
fractionated HeLa cell nuclear extracts which had identical 
mobilities in gel retardation assays and that different 
motifs were almost equally competitive for binding to the 
same factor of the complex (Bohmann et al ., 1987). Purified 
'octamer motif binding factor' has a stimulatory effect on 
transcritpion in vitro (Bohmann et al ., 1987; Flether et 
al., 1987). The protein factors that bind the octamer 
motifs have been designated either OTF-I, or OBPlOO, or 
IgNF-A (reviewed in Jones et al., 1988), and they appear 
closely related to each other and to NF-III (see 
Introduction, Page 20; reviewed in Hames and Glover, 1988).
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Figure 76. Cis-acting transcriptional elements within 
the promoter sequences of the HSV-2 RRl and RR2 genes.
The nucleotide sequences of both DNA strands are shown 
and the locations of the mRNA 5 1 ends are indicated. The 
consensus sequence of the Spl cellular transcription factor 
binding site is given in the 3' to 5 1 direction and is 
aligned with homologous RRl and RR2 promoter sequences. 
Residues on the mRNA coding strands which have homology to 
the Spl consensus are indicated by asterisks. The two 
G-rich motifs (G) are boxed as is the putative 'octamer 
motif binding factor' consensus.
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Analyses of the PI sequences for potential binding 
sites of other cellular transcription factors, such as the 
CTF/CBP (see Introduction, Page 19), were negative. It is 
therefore suggested that the readily detectable 
pRR-specified RRl mRNA constitutive levels of expression are 
mainly due to the interaction of a complex of cellular 
transcription factors, one of which is the 'octamer motif 
binding factor1, with the PI sequences. This is based on 
the fact that, in analogy to PI, the RR2 gene promoter (P2) 
sequences contain both a potential Spl binding site and a 
G-rich motif (see Fig. 76). However, P2 lacks the octamer 
sequence and this may possibly account for the extremely low 
pRR-borne RR2 mRNA levels observed (see Page 118). This 
suggestion is currently being investigated by means of 
deletion mutagenesis (J. McLauchlan, personal 
communication).
b) Effects of HSV-1 trans-activating functions on RRl
mRNA transcription.
Activation of pRR-specified RRl mRNA levels with 
VmwllO had no detectable effect. As has been noted 
previously, an internal control plasmid was not included in 
the co-transfection experiments due to the limited amount of 
DNA that can be taken up by transfected cells. Nevertheless, 
VJnwllO is most probably present in cells transfected with 
pRR and pill, since the pRR-borne RR2 mRNA levels are 
increased (see Table V). Thus, the failure of VmwllO to 
increase RRl mRNA levels may reflect a real inability, 
rather than a failure of transfection. On the contrary, 
Vtnwl75, either independently or in combination with VmwllO, 
induced RRl mRNA constitutive levels by 3-fold. This is in 
good agreement with the increase in CAT activity observed 
after co-transfection of a Pl-CAT construct with Vmwl75 
(S. Simpson, personal communication). Equally, induction by 
HSV-1 infection resulted in an increase of RRl mRNA levels 
which, however, was higher than that observed with Vmwl75 
(5-fold; S. Simpson, personal communication). This result 
suggests that perhaps one or more of the remaining HSV-1 IE 
functions may account for this. The most likely candidate
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appears to be Vmwl2, which is thought to augment the effect 
of Vmwl75 and VmwllO in activation of E gene expression (O' 
Hare and Hayward, 1985b).
20. Constitutive and Induced Transcription Levels from the 
HSV-2 RR2 Promoter.
The main observations on HSV-2 RR2 gene expression 
were: i) RR2 mRNA basal levels are extremely low in the 
absence of HSV-1 trans-activating functions, ii) HSV-1 
infection or trans-activation with HSV-1
results in a substantial increase of RR2 mRNA basal levels
The observation that the RR2 mRNA basal levels are 
barely detectable in the absence of viral trans-activating 
functions is consistent with the regulation pattern of HSV E 
genes whereby, in the absence of these functions, E gene 
promoter activity is generally low (reviewed in Everett, 
1987b). In the presence of HSV-1 IE functions, however, a 
substantial increase of RR2 mRNA levels was observed (see 
Table V). From the two IE products used in this study, 
Vmwl75 activates P2 more efficiently than VmwllO and this is 
in good agreement with other reports on E gene regulation of 
expression (O'Hare and Hayward, 1985b; reviewed in Everett, 
1987b; S. Simpson, personal communication). However, the 
effect of these polypeptides in combination was additive, 
whereas, in a study by O'Hare and Hayward (1985b), it 
resulted in a synergistic increase of P2-CAT-specified CAT 
levels. Analysis of the trans-activation efficiency of the 
gD promoter under a variety of experimental conditions 
demonstrated that quantitative differences, like the one 
described above, may be due to different cell types and/or 
transfection methods used (Everett, 1987c). For example, it 
was shown that co-transfection of a gD promoter-CAT plasmid 
with Vmwl75 and VmwllO in WSHeLa cells had a very strong 
synergistic effect whereas in Flow HeLa or BHK cells the 
effect of these IE products was additive rather than 
synergistic.
GENERAL DISCUSSION
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The work presented in the Results and Discussion 
Sections has identified a number of points concerning the 
HSV-l-encoded ribonucleotide reductase, namely:
i) structural and potential functional features 
resulting from the predicted primary and secondary 
structures of the large and small subunit polypeptides
ii) the conservation of these features in homologue 
herpesviral polypeptides and in the equivalent subunit 
polypeptides of the eukaryotic and prokaryotic enzymes and,
iii) the transcriptional regulation of the HSV-induced 
ribonucleotide reductase mRNAs.
This Section is concerned with the evolution and the 
function of the RR1 N-terminal region and with unique 
features of the RRl and RR2 subunits which could represent 
targets for antiviral compounds. Further, the enzyme's 
transcriptional regulation during the IE and E stages of the 
HSV lytic cycle is also discussed.
1. The HSV-1 RRl N-terminal Region.
a ) On the evolution of the HSV-1 N-terminal region.
The most interesting feature resulting from the 
analysis of the HSV-1 RRl predicted amino acid sequence is 
the N-terminal region, whose amino acid composition differs 
from the remainder of RRl, and which is absent from other 
r r  polypeptides; as already mentioned (see Results and
Ij
Discussion, Page 81), this region contains a run of 
prolines, two stretches of roughly alternating aspartic acid 
and serine residues and seven sets of tandemly repeated 
amino acid sequences.
On the basis of these amino acid composition features 
a hypothetical scheme of evolutionary events leading to the 
formation of this region can be proposed.
i) It appears likely that an ancestral RRl gene, which 
would be similarly sized to the other herpesviral RRT ,
126
acquired part of the DNA sequences coding for the N-terminal 
region by a recombination event; this step is suggested by 
the absence of the RRl N-terminal region from other RRT1j
polypeptides. The acquired sequences may have originated 
from a second virus in the cell or from the host cell.
ii) Second, the DNA regions coding for certain amino 
acid sequences were duplicated by a gene duplication event 
whereby the DNA regions corresponding to certain amino acid 
sequences were duplicated. This step is proposed on the 
basis of the repeated amino acid sequences observed
within this region (see Fig. 29). A number of proteins 
appear to have evolved by gene duplication (reviewed in 
Doolittle, 1981), a process resulting in increased stability 
of the protein or in the enhancement of its functions 
(reviewed in Li, 19 83). One example of this evolutionary 
mechanism is the ovomucoid protein of bird egg white which 
is involved in the inhibition of trypsin. It appears that 
this protein evolved by triplication of the DNA sequences 
coding for a primordial domain because it consists of three 
domains exhibiting between them 33% amino acid homology 
(Kato et al ., 19 78). As a result of this event, each of the 
three domains is capable of binding one molecule of trypsin 
or other serine protease thus enhancing the catalytic 
activity of the protein.
iii) Finally, it appears that mutations accumulated 
within the duplicated DNA sequences, and this is reflected 
by the observed insertions and deletions within the 
N-terminal regions of the HSV-1 and HSV-2 RRl polypeptides 
(see Figs. 33 and 55). It has been proposed that 
accumulation of mutations within duplicated regions of 
proteins is due to a relaxation of evolutionary restraints 
imposed by natural selection (reviewed in Doolittle, 1981).
This evolutionary scheme, however, does not exclude 
other possible events which lead to the formation of the RRl 
N-terminal region (D.J. McGeoch, personal communication).
For example it is possible that, instead of this region 
being acquired by a recombination event, it evolved by 
mutation of sequences which were originally located upstream 
from the coding sequences of the ancestral RRl gene.
Further, the evolutionary events might not have occured in
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the order described above such that the DNA sequences 
acquired by the ancestral RRl gene might have already been 
duplicated; therefore, the duplication event might have 
preceded the recombination event.
b) A possible function for the RRl N-terminal region.
Although the RRl N-terminal region appears not to be 
directly involved in ribonucleotide reductase activity 
(see Results and Discussion, Page 100), it is thought that 
it has an additional function. This is primarily based on 
the retention of this region in RRl and on its distinct 
amino acid composition as compared to the remainder of RRl.
A similar case exists between the HSV-1 Vmw65 IE 
trans-inducing virion polypeptide which contains a 
C-terminal region of 80 amino acids not present in its VZV 
homologue Vmw54 (Dalrymple et al., 1985). Studies 
concerning the function of this Vmw65 region demonstrated 
that it is required for the trans-induction of IE gene 
expression as an HSV-1 Vmw65 insertion mutant in this region 
displayed strongly reduced ability to trans-induce IE 
polypeptides (Ace et al., manuscript in preparation). On 
the other hand, Vmw54, which does not contain a 
corresponding region, appears to be unable to trans-induce 
the VZV IE polypeptides (T. McKee, personal communication).
It is interesting to propose that certain portions of 
RRl Region 1, which comprises the N-terminal region (see 
Results and Discussion, Page 98), are involved in nuclear 
localisation of the polypeptide. This suggestion arises 
from analysis of the amino acid sequences of RRl Region 1 
for motifs indicative of a certain function, whereby, a 
sequence of KRVPPR was identified (at HSV-1 position 356; 
see Fig. 55). This sequence is also present in HSV-2 RRl 
and closely resembles the proposed nuclear localisation 
signal for the yeast MATO.2 which comprises three hydrophobic 
amino acids, one of which is a proline, flanked by basic 
amino acids (Hall et al., 1984). However, it has been 
proposed that multiple signals may be present in polypeptide 
domains involved in nuclear localisation (Dingwall et al ., 
1987). In that respect, another highly conserved HSV-1 and
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HSV-2 sequence of RPAAS was also identified (at HSV-1 RRl 
position 4; see Fig. 55). Interestingly, this sequence is 
quite similar to one of the proposed signals for nuclear 
localisation of nucleoplasmin (RPAAT; Dingwall et al.,
1987). Analysis of other HSV-1 polypeptides known to 
translocate to the nucleus of infected cells identified at 
the C-terminus of the DNA polymerase two sequences of KRPR 
and KPRK which resemble the proposed signal for nuclear 
localisation of the adenovirus E1A gene products (KRPR; 
Krippl et al ., 1985). As can be observed, these signals are 
homologous to the first of the potential RRl signals.
Large protein molecules appear to accumulate in the 
nucleus by an ATP-dependant selective entry mechanism which 
is mediated by the part of the protein containing the 
nuclear localisation signals (Feldherr et al ., 1984; 
reviewed in Dingwall and Laskey, 1986). This is evidenced 
by the fact that the rate of nuclear uptake is faster than 
can be accounted for by diffusion. Feldherr et al. (1984) 
studied the selective entry mechanism of nucleoplamin, a 
165,000 mol. wt. nuclear protein of the Xenopus laevis 
oocyte. These authors proposed that nucleoplasmin binds to 
proteins, termed the annular material, at the cytoplasmic 
surface of the nuclear pores and that this binding occurs 
only when the domain comprising the nuclear localisation 
signals is present. Then, nucleoplasmin is transported in 
the nucleus through the centre of the nuclear pore where it 
is dissociated from the annular material.
If RRl is transported to the nucleus, one could 
speculate that binding of RRl to the annular material and 
subsequent transport in the nucleus is mediated by part 1 of 
the N-terminal region (RRl positions 1 to 150, see Fig. 55). 
The GARNIER program demonstrated that this part of the 
N-terminal region is punctuated by seven stretches of 
hydrophobic amino acids, predicted to adoptJ3-strand 
conformation, while the intervening sequences were predicted 
as unstructured. Hence, part 1 may adopt an ordered 
three-dimensional structure consisting of a hydrophobic core 
of seven j3-strands which are joined by unstructured or loop 
regions and which are arranged in one or more jS-sheets 
(Nikas e t a l . , 1986). This structure resembles the
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three-dimensional structure of the immunoglobulin V
Li
domains; these consist of seven ^-strands which are arranged
in two ^-sheets and which are joined between them by
hypervariable loops (Poljak et a l ., 1974). On the basis of
the similarity of the three-dimensional structures of part 1
with the immunoglobulin VT domains and in conjunction with
Li
the fact that the latter are involved in antigen binding, it 
is possible that part 1 of the RRl N-terminal region is 
involved in protein-to-protein interactions (W.R. Taylor, 
personal communication). These could possibly be 
interactions with the annular material of the nuclear pore 
in order to transport RRl into the nucleus. In that 
respect, it is interesting to note that the mammalian Ml 
subunit, which lacks the N-terminal region, is exclusively 
localised in the cytoplasm of cells as deduced from studies 
using monoclonal antibodies directed against Ml (Engstrom et 
al., 1984). Clearly, the involvement of the N-terminal 
region in RRl nuclear localisation requires rigorous 
investigation.
It is unclear as yet why the RRl polypeptide should 
localise to the nucleus of infected cells. A strong 
possibility is that nuclear localisation of RRl is not 
related to ribonucleotide reduction as dNTPs are formed in 
the cytoplasm of cells (reviewed in Reichard, 1988). As 
reported on Page 81, the N-terminal region contains two 
aspartic acid and serine rich stretches which are similar in 
amino acid composition to stretches present at the 
N-terminal regions of all the IE polypeptides with the 
exception of Vmwl2. One could therefore speculate that the 
RRl and the equivalent IE polypeptide stretches may be 
involved in similar processes. In an attempt to elucidate 
the function of the aspartic acid and serine rich stretch of 
Vttiwl75, Paterson and Everett (19 88) have shown that deletion 
of these sequences reduces, althought not drastically, the 
ability of Vmwl75 to trans-activate E gene expression in 
short-term transfection assays.
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2. Ribonucleotide Reductase as a Target for Antiviral 
Compounds.
As reported in the Introduction (see Page 53), studies 
with the synthetic oligopeptide YAGAVVNDL demonstrated that, 
in vitro, it selectively inhibited the HSV-specified 
activity by subunit dissociation. Thus, it became apparent 
that inhibition of subunit interaction may have important 
therapeutic implications. However, exposure of infected 
cell monolayers to various concentrations of the nonapeptide 
did not reduce the yield of infectious virus most probably 
because it was too large to enter the cell (Dutia et a l .,
19 86) . As a result, effort is currently being put into the 
development of antiviral compounds designed to mimic the 
mode of function of the nonapeptide; these compounds should 
have a three-dimensional structure similar to the 
nonapeptide and be able to enter the infected cell.
The RR^ alignment identified a number of amino acid 
sequences which are not conserved in the prokaryotic or 
eukaryotic polypeptides and which may be contact regions of 
the RRl and RR2 subunits or may represent regions related to 
the activity of the HSV-l-induced enzyme. These sequences 
are retained in blocks 1, 5, 12 and 13 of the RRr alignment 
(see Fig. 56). From these, of particular interest is block 
5 which is missing from the mammalian polypeptide and is 
predicted to map within a hydrophobic region of the HSV-1 
RRl polypeptide (see Fig. 27); therefore, it is quite 
possible that it may be located at the interface of the RRl 
and RR2 subunits and be involved in their association. 
Further, as block 5 is highly conserved between the 
herpesviral RR^/ compounds that prevent its function could 
prove general inhibitors of the herpesviral enzymes.
Another region of interest i^ the N-terminal region which is 
unique to the HSV RRl and may be required for translocation 
to the nucleus. As postulated above, any nuclear 
localisation of RRl may be unrelated to ribonucleotide
s r e l  cj<te
reduction but insteadxto some as yet unknown function. If 
this was an essential HSV function, compounds preventing 
nuclear localisation of RRl may prove potential antivirals.
In contrast to the RRL polypeptides, the majority of
the RRS blocks are present in
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the mammalian enzyme (McLauchlan, 19 86 ). The only exception 
appears to be block 16 which, along with its flanking amino 
acid sequences, is conserved only in the HSV and VZV 
polypeptides (see Fig. 57). However, this region may not be 
involved in subunit association as it was predicted to map 
within a hydrophilic region of HSV-1 RR2 (data not shown).
3. Regulation of the HSV Ribonucleotide Reductase Activity.
The results reported in Results and Discussion Section 
E, in conjunction with the unpublished data of J. McLauchlan 
and S. Simpson, allow the proposal of a general scheme for 
the transcriptional regulation of the ribonucleotide 
reductase genes under IE and E conditions.
a ) Transcriptional regulation of the RRl and RR2 genes
under IE conditions.
On the basis that RRl mRNA constitutive levels are 
readily detectable in the absence of functional IE 
polypeptides (see Results and Discussion, Page 117), it is 
proposed that during viral infection, RRl gene expression is 
activated under IE conditions. This is most probably 
achieved by the interaction of cellular and/or viral 
transcription factors with target sequences positioned in 
the PI promoter. One of the cellular factors may possibly 
be Spl, potential binding sites of which have already been 
identified in the PI sequences (see Results and Discussion, 
Page 121). Second, RRl expression could be activated by a 
complex containing Vmw65 and cellular transcription 
factors. Vmw65 is considered as a PI activator because 
co-transfection of a Vmw65-expressing plasmid with a Pl-CAT 
construct resulted in a significant increase of CAT levels 
(S. Simpson, personal communication). However, as Vmw65 
does not bind HSV DNA directly (see Introduction, page 20), 
it is expected to act as a constituent of a complex with 
cellular transcription factors. One of these may be related 
to the 'octamer motif binding factor', this suggestion being 
based on the presence of the octamer in the Pi sequences 
(see Results and Discussion, Page 122). Recent data 
indicate that HSV-2 DNA fragments containing the Pi octamer
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are retarded in gels by Vmw65/cellular transcription factors 
complexes (J. McLauchlan, personal communication). 
Interestingly, these complexes have similar mobility in gels 
with the 1EC complex formed between DNA fragments containing 
the TAATGARAT motif of the regulatory region of the IE gene 
promoters (see Introduction, Page 20).
In contrast to RRl, under IE conditions, the RR2 gene 
is not expressed. This suggestion is clearly evidenced by 
the extremely low contitutive RR2 mRNA levels observed: 
i) in the absence of functional IE products (see Results and 
Discussion, Page 119) and ii) after infection with the HSV 
mutant tsK in the presence of cycloheximide (J. McLauchlan, 
personal communication).
b) Transcriptional regulation of the RRl and RR2 genes 
under E conditions.
In the presence of functional IE gene products the RRl 
mRNA levels increase further as compared to the levels 
observed under IE conditions; upon reversal of the 
cycloheximide block and in the presense of actinomycin D, 
tsK specified elevated levels of RRl mRNA as compared to 
those specified under IE conditions (J. McLauchlan, personal 
communication). Likewise, under E conditions, RR2 gene 
expression is also activated and this is evidenced by the 
substantial increase of RR2 mRNA levels in the presence of 
Vhiwl75 and/or VmwllO (see Results and Discussion, Page 119).
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